1 00:00:05,480 --> 00:00:35,680 >>WELCOME TO NIDCR COUNCIL 2 00:00:35,680 --> 00:00:37,360 EMAIL WE WILL DISPLAY AT THE END 3 00:00:37,360 --> 00:00:38,760 OF THE SESSION. 4 00:00:38,760 --> 00:00:40,320 WE ASK THAT COUNCILMEMBERS AND 5 00:00:40,320 --> 00:00:45,600 STAFF PLEASE MAKE SURE YOUR 6 00:00:45,600 --> 00:00:47,840 MICROPHONES ARE SET TO MUTE 7 00:00:47,840 --> 00:00:49,200 UNLESS WHEN YOU'RE SPEAKING. 8 00:00:49,200 --> 00:00:51,000 PLEASE IDENTIFY YOURSELF SO WE 9 00:00:51,000 --> 00:00:52,560 KNOW WHO'S SPEAKING AND TO 10 00:00:52,560 --> 00:00:54,640 ENSURE THE ACCURACY OF OUR 11 00:00:54,640 --> 00:00:56,160 COUNCIL RECORDS 12 00:00:56,160 --> 00:00:58,880 IF ANYONE PARTICIPATING NEEDS 13 00:00:58,880 --> 00:01:02,600 HELP WITH TECHNICAL PROBLEMS MR. TIM -- 14 00:01:02,600 --> 00:01:05,360 [ INAUDIBLE ] FROM OUR IT 15 00:01:05,360 --> 00:01:08,520 SUPPORT WILL BE AVAILABLE TO 16 00:01:08,520 --> 00:01:10,120 ASSIST YOU AND THEIR CONTACT 17 00:01:10,120 --> 00:01:11,640 INFORMATION IS IN THE CHAT BOX 18 00:01:11,640 --> 00:01:14,360 AND NOW I'M GOING TO TURN IT 19 00:01:14,360 --> 00:01:18,120 OVER TO DR. RENA DESOUZA. 20 00:01:18,120 --> 00:01:19,720 >> THANK YOU, LYNN AND GOOD 21 00:01:19,720 --> 00:01:21,760 MORNING, EVERYONE. 22 00:01:21,760 --> 00:01:24,520 WITH MANY GREETINGS FROM NIDCD 23 00:01:24,520 --> 00:01:26,520 AND ITS STAFF AND LEADERSHIP AND 24 00:01:26,520 --> 00:01:28,760 THE COMMUNITY AT NIH. 25 00:01:28,760 --> 00:01:30,880 WE HAVE VERY MUCH HELD YOU IN 26 00:01:30,880 --> 00:01:32,800 OUR HEARTS ALL OF THESE MONTHS. 27 00:01:32,800 --> 00:01:36,800 NOW SOMEONE HAS THEIR MIC ON OR 28 00:01:36,800 --> 00:01:37,080 SOMETHING. 29 00:01:37,080 --> 00:01:38,800 SO PLEASE BE CAREFUL. 30 00:01:38,800 --> 00:01:41,880 WHAT I HOPE TO DO IN THIS 31 00:01:41,880 --> 00:01:43,280 COUNCIL SESSION IS TO GIVE YOU 32 00:01:43,280 --> 00:01:47,560 AN OVERVIEW OF WHERE WE ARE 33 00:01:47,560 --> 00:01:47,760 TODAY. 34 00:01:47,760 --> 00:01:50,960 HOW WE IN AN UNSETTLED TIME HAVE 35 00:01:50,960 --> 00:01:53,280 STAYED TRUE TO OUR MISSION USING 36 00:01:53,280 --> 00:01:55,120 THE LESSONS LEARNED FROM THE 37 00:01:55,120 --> 00:01:56,560 PANDEMIC TO KEEP MOVING FORWARD 38 00:01:56,560 --> 00:02:00,120 SO THAT WOULD BE THE FIRST 39 00:02:00,120 --> 00:02:01,440 INTENT. 40 00:02:01,440 --> 00:02:06,200 OBVIOUSLY WE HAVE MANY WISHES OF 41 00:02:06,200 --> 00:02:08,120 FAREWELL AND GRATITUDE TO OUR 42 00:02:08,120 --> 00:02:09,680 LEADERS WHO HAVE SERVED US WELL 43 00:02:09,680 --> 00:02:12,560 AND HAVE LEFT THE INSTITUTE OR 44 00:02:12,560 --> 00:02:14,880 IN TRANSITION AND TO WELCOME 45 00:02:14,880 --> 00:02:15,280 NEWCOMERS. 46 00:02:15,280 --> 00:02:17,760 SO HERE FIRST OF ALL IS 47 00:02:17,760 --> 00:02:19,240 DR. FRANCIS COLLINS. 48 00:02:19,240 --> 00:02:21,360 I'M SO GRATEFUL THAT HE HIRED ME 49 00:02:21,360 --> 00:02:23,360 AND I HAD THIS YEAR PLUS OF 50 00:02:23,360 --> 00:02:24,600 WORKING WITH HIM. 51 00:02:24,600 --> 00:02:26,280 HE WAS PATIENT AND UNDERSTANDING 52 00:02:26,280 --> 00:02:28,960 AND LISTENING TO ORAL HEALTH 53 00:02:28,960 --> 00:02:30,840 ISSUES AND WAS ABSOLUTELY A 54 00:02:30,840 --> 00:02:33,600 LEGACY OF A LEADER FOR OUR 55 00:02:33,600 --> 00:02:35,360 INSTITUTION AND THE COUNTRY AND 56 00:02:35,360 --> 00:02:36,360 THE WORLD. 57 00:02:36,360 --> 00:02:39,000 I ENCOURAGE YOU TO WATCH HIS 58 00:02:39,000 --> 00:02:42,120 FAREWELL TRIBUTE WHICH IS A 59 00:02:42,120 --> 00:02:43,360 ONE-OF-A-KIND STAR-STUDDED 60 00:02:43,360 --> 00:02:44,120 TRIBUTE. 61 00:02:44,120 --> 00:02:46,520 NOT BECAUSE THE DIRECTORS HAD A 62 00:02:46,520 --> 00:02:47,920 CHANCE TO SAY SOMETHING BUT ALL 63 00:02:47,920 --> 00:02:49,960 OF THE LIVES AND PEOPLE THAT 64 00:02:49,960 --> 00:02:50,920 FRANCIS HAD TOUCHED. 65 00:02:50,920 --> 00:02:53,560 A LOT OF GOOD WISHES COME HIS 66 00:02:53,560 --> 00:02:57,200 WAY AND I KNOW HE WILL CONTINUE 67 00:02:57,200 --> 00:02:59,120 TO STAY IN TOUCH WITH HIS 68 00:02:59,120 --> 00:03:00,960 RESEARCH AND WOULD BE A 69 00:03:00,960 --> 00:03:04,520 WONDERFUL COLLEAGUE FOR ME TO 70 00:03:04,520 --> 00:03:05,360 SHARE COFFEE WITH. 71 00:03:05,360 --> 00:03:08,280 THIS IS AN UNPRECEDENTED TIME. 72 00:03:08,280 --> 00:03:10,080 THAT IS UNDER STATING THE FACT 73 00:03:10,080 --> 00:03:22,920 THAT LARR -- LARRY TABAK * DEALING 74 00:03:22,920 --> 00:03:26,960 WITH THE RETURN TO WORK ISSUES. 75 00:03:26,960 --> 00:03:31,520 I HAVE TO PINCH MYSELF -- TO 76 00:03:31,520 --> 00:03:32,440 BELIEVE THAT WE HAVE SOMEONE 77 00:03:32,440 --> 00:03:37,360 FROM OUR OWN COMMUNITY IN THE 78 00:03:37,360 --> 00:03:39,440 HIGHEST POSITION. 79 00:03:39,440 --> 00:03:40,160 CONGRATULATIONS. 80 00:03:40,160 --> 00:03:41,320 WE KNOW THAT YOU WILL BE THE 81 00:03:41,320 --> 00:03:43,280 PERSON THAT IS KEEPING US AFLOAT 82 00:03:43,280 --> 00:03:47,040 AND STEADY. 83 00:03:47,040 --> 00:03:56,760 VERY SPECIAL THANK YOU TO ALICIA 84 00:03:56,760 --> 00:03:57,160 DEMBROSKY. 85 00:03:57,160 --> 00:04:00,800 ALICIA HAS CHOSEN TO RETIRE. 86 00:04:00,800 --> 00:04:03,160 LEAVING BEHIND A VERY, VERY 87 00:04:03,160 --> 00:04:06,280 SOLID OFFICE OF DEVOTED STAFF 88 00:04:06,280 --> 00:04:07,880 AND WELL ESTABLISHED PRACTICES. 89 00:04:07,880 --> 00:04:13,160 AS YOU CAN SEE HERE ALICIA HAD 90 00:04:13,160 --> 00:04:22,920 ORGANIZED 39 COUNCILS AND 23BS 91 00:04:22,920 --> 00:04:23,760 23BSC's. 92 00:04:23,760 --> 00:04:24,960 CONGRATULATIONS. 93 00:04:24,960 --> 00:04:29,920 WE HAD A FAREWELL ACKNOWLEDGMENT 94 00:04:29,920 --> 00:04:32,640 OF ALICIA AND I HOPE YOU WILL 95 00:04:32,640 --> 00:04:34,600 CONTINUE TO SEND HER MESSAGES. 96 00:04:34,600 --> 00:04:37,360 VERY HAPPY TO WELCOME LYNN KING 97 00:04:37,360 --> 00:04:38,040 ON-BOARD. 98 00:04:38,040 --> 00:04:39,960 LYNN IS A VERY FAMILIAR FACE TO 99 00:04:39,960 --> 00:04:40,720 OUR COMMUNITY. 100 00:04:40,720 --> 00:04:42,720 HAVING REALLY CHAMPIONED 101 00:04:42,720 --> 00:04:45,120 TRAINING AND CAREER DEVELOPMENT. 102 00:04:45,120 --> 00:04:47,560 SHE BRINGS A WEALTH OF 103 00:04:47,560 --> 00:04:49,640 EXPERIENCES AND AS YOU CAN SEE 104 00:04:49,640 --> 00:04:51,720 THROUGHOUT AND IN ALL OF THE 105 00:04:51,720 --> 00:04:53,120 PORTFOLIOS INVOLVED IN THE 106 00:04:53,120 --> 00:04:54,760 DIVISION OF EXTRAMURAL 107 00:04:54,760 --> 00:04:55,680 ACTIVITIES. 108 00:04:55,680 --> 00:04:56,760 VERY EXCITED TO HAVE YOU 109 00:04:56,760 --> 00:04:59,320 ON-BOARD. 110 00:04:59,320 --> 00:05:04,760 TRULY A THRILL TO INTRODUCE 111 00:05:04,760 --> 00:05:07,680 JENNIFER WEBSTER-CYRIAQUE. 112 00:05:07,680 --> 00:05:09,000 WHO CAME FROM THE UNIVERSITY OF 113 00:05:09,000 --> 00:05:10,880 NORTH CAROLINA WHERE SHE SPENT 114 00:05:10,880 --> 00:05:13,200 MANY YEARS DEVELOPING HER 115 00:05:13,200 --> 00:05:13,600 CAREER. 116 00:05:13,600 --> 00:05:16,040 SHE IS KNOWN TO SO MANY AROUND 117 00:05:16,040 --> 00:05:20,960 THE COUNTRY AS NEUROLOGIST AND 118 00:05:20,960 --> 00:05:23,760 HOSPITAL DENTISTRY EXPERTISE AND 119 00:05:23,760 --> 00:05:26,080 I VERY TRUE PASSION FOR HEALTH 120 00:05:26,080 --> 00:05:28,760 DISPARITY RESEARCH. 121 00:05:28,760 --> 00:05:36,120 SHE WILL HAVE -- WILL BE AT MY 122 00:05:36,120 --> 00:05:52,360 RIGHT HAND -- SHE WILL ALSO HAVE 123 00:05:52,360 --> 00:05:58,000 A LAB IN NIAD BUT HOUSED IN 124 00:05:58,000 --> 00:06:00,560 NIDCD SPACE BUT UNDER JEFF COLIN 125 00:06:00,560 --> 00:06:03,880 ACE LEADERSHIP AT NIAD AND WILL 126 00:06:03,880 --> 00:06:12,320 FOCUS ON VIRAL ESPECIALLY DEE -- EPIDEMIOL OGY. 127 00:06:12,320 --> 00:06:14,760 VERY HAPPY TO HAVE YOU ON-BOARD 128 00:06:14,760 --> 00:06:16,680 JENNIFER AND I KNOW YOU WILL BE 129 00:06:16,680 --> 00:06:18,680 IN TOUCH WITH SEVERAL OF THOSE 130 00:06:18,680 --> 00:06:20,040 LISTENING TO US TODAY. 131 00:06:20,040 --> 00:06:24,160 ALSO VERY HAPPY TO INTRODUCE 132 00:06:24,160 --> 00:06:27,360 RENEE JOSKOW. 133 00:06:27,360 --> 00:06:28,120 *. 134 00:06:28,120 --> 00:06:29,560 ALSO ASKING IN THE OFFICE OF 135 00:06:29,560 --> 00:06:32,120 SCIENCE POLICY AND ANALYSIS AS 136 00:06:32,120 --> 00:06:40,240 ITS DIRECTOR. 137 00:06:40,240 --> 00:06:42,360 RENEE HAS EVERY CONTACT IN PLACE 138 00:06:42,360 --> 00:06:44,680 THAT SHE HAS DEVELOPED 139 00:06:44,680 --> 00:06:45,560 STEADFASTLY OVER THE YEARS. 140 00:06:45,560 --> 00:06:47,560 SHE BRINGS A WEALTH OF EXPERTISE 141 00:06:47,560 --> 00:06:49,960 IN MANY AREAS AND AS YOU CAN SEE 142 00:06:49,960 --> 00:06:53,200 HERE SHE WILL BE OUR AMBASSADOR 143 00:06:53,200 --> 00:06:55,480 OUR SPOKESPERSON FOR THE ORAL 144 00:06:55,480 --> 00:06:57,160 HEALTH IN AMERICA REPORT TAKING 145 00:06:57,160 --> 00:06:59,800 ITS MESSAGE TO VARIOUS 146 00:06:59,800 --> 00:07:02,000 CONSTITUENTS ACROSS THE COUNTRY 147 00:07:02,000 --> 00:07:03,680 WITH THE PURPOSE OF SHARED 148 00:07:03,680 --> 00:07:04,760 OWNERSHIP AND EVERYONE LOOKING 149 00:07:04,760 --> 00:07:06,440 TO WORK TOGETHER TO ACTUALLY 150 00:07:06,440 --> 00:07:08,800 MOVE THE NEEDLE ON HEALTH 151 00:07:08,800 --> 00:07:11,040 DISPARITIES AND/ORAL DISEASES 152 00:07:11,040 --> 00:07:12,080 AND CONDITIONS. 153 00:07:12,080 --> 00:07:15,080 SHE WILL ALSO BE WATCHING OVER 154 00:07:15,080 --> 00:07:17,600 AND ACTUALLY DIRECTING THE 155 00:07:17,600 --> 00:07:20,800 DENTAL PUBLIC HEALTH FELLOWSHIP 156 00:07:20,800 --> 00:07:24,480 TRAINING PROGRAM. 157 00:07:24,480 --> 00:07:28,320 AND SHE AS YOU CAN SEE HERE WILL 158 00:07:28,320 --> 00:07:31,800 BE INSTRUMENTAL IN SHAPING THE 159 00:07:31,800 --> 00:07:33,640 VISION AND CREATING A NOVEL 160 00:07:33,640 --> 00:07:37,920 PRESENCE FOR NIDCD IN CONNECTING 161 00:07:37,920 --> 00:07:39,720 WITH OTHER FEDERAL AGENCIES 162 00:07:39,720 --> 00:07:42,160 WHOSE COLLABORATION WE NEED FOR 163 00:07:42,160 --> 00:07:44,840 THIS MULTI-DISCIPLINARY APPROACH 164 00:07:44,840 --> 00:07:48,400 TO MORE WHOLISTIC TREATMENT. 165 00:07:48,400 --> 00:07:59,200 HAPPY TO WELCOME JACQUES NOR. 166 00:07:59,200 --> 00:08:04,560 YOU ARE THE CURRENT PRESIDENT OF 167 00:08:04,560 --> 00:08:06,440 AADOCR. 168 00:08:06,440 --> 00:08:10,120 A STRONG ALLEY AND STAKEHOLDER. 169 00:08:10,120 --> 00:08:11,080 WELCOME ON-BOARD. 170 00:08:11,080 --> 00:08:14,040 LOOK FORWARD TO WORKING WITH YOU 171 00:08:14,040 --> 00:08:16,920 AND AMY SLEP. 172 00:08:16,920 --> 00:08:19,200 WHO BRINGS REALLY DISTINGUISHED 173 00:08:19,200 --> 00:08:21,560 TRACK RECORD AND A VERY UNIQUE 174 00:08:21,560 --> 00:08:25,720 AND SPECIALIZED EXPERTISE IN THE 175 00:08:25,720 --> 00:08:37,720 AREA OF FAMILY ENVIRONMENT. 176 00:08:37,720 --> 00:08:39,800 THANK YOU FOR AGREEING TO SERVE 177 00:08:39,800 --> 00:08:42,160 AND WE'RE DELIGHTED TO HAVE YOU. 178 00:08:42,160 --> 00:08:43,400 AND WHAT BRING TO THE TABLE 179 00:08:43,400 --> 00:08:48,160 RIGHT NOW IS AN AREA THAT NIDCD 180 00:08:48,160 --> 00:08:52,960 WISHES TO FOCUS ON. 181 00:08:52,960 --> 00:08:55,440 NOW I WANT TO TURN THIS BACK TO 182 00:08:55,440 --> 00:08:56,760 LYNN WHO WILL BE PRESENTING THE 183 00:08:56,760 --> 00:08:58,360 MINUTES FROM OUR LAST COUNCIL. 184 00:08:58,360 --> 00:09:02,360 LYNN. 185 00:09:02,360 --> 00:09:03,800 >> THE FIRST ITEM OF BUSINESS IS 186 00:09:03,800 --> 00:09:06,160 THE APPROVAL OF THE MINUTES FROM 187 00:09:06,160 --> 00:09:11,680 THE PREVIOUS MEETING. 188 00:09:11,680 --> 00:09:13,800 FROM SEPTEMBER 2021 COUNCIL 189 00:09:13,800 --> 00:09:14,640 MEETING. 190 00:09:14,640 --> 00:09:16,000 AND WERE MADE AVAILABLE TO 191 00:09:16,000 --> 00:09:18,960 COUNCILMEMBERS FOR THEIR REVIEW. 192 00:09:18,960 --> 00:09:20,520 ARE THERE ANY COMMENTS OR 193 00:09:20,520 --> 00:09:21,840 CORRECTIONS TO THE 194 00:09:21,840 --> 00:09:26,400 SEPTEMBER 2021 MEETING? 195 00:09:26,400 --> 00:09:28,680 MEETING MINUTES? 196 00:09:28,680 --> 00:09:30,920 IF NOT WOULD A MEMBER OF COUNCIL 197 00:09:30,920 --> 00:09:33,040 LIKE TO MAKE A MOTION OF 198 00:09:33,040 --> 00:09:35,760 APPROVAL OF THE MINUTES? 199 00:09:35,760 --> 00:09:39,640 >> I MAKE A MOTION TO APPROVE. 200 00:09:39,640 --> 00:09:40,200 >> A SECOND. 201 00:09:40,200 --> 00:09:42,040 >> SECOND. 202 00:09:42,040 --> 00:09:43,440 >> SECOND. 203 00:09:43,440 --> 00:09:45,400 >> ALL APPROVED. 204 00:09:45,400 --> 00:09:46,800 AYE. 205 00:09:46,800 --> 00:09:48,360 >> AYE. 206 00:09:48,360 --> 00:09:52,680 >> AND ANY OPPOSED? 207 00:09:52,680 --> 00:09:52,880 OKAY. 208 00:09:52,880 --> 00:09:54,600 THANK YOU VERY MUCH. 209 00:09:54,600 --> 00:09:57,040 NOW WE'RE GOING TO DO THE ANNUAL 210 00:09:57,040 --> 00:09:58,560 REVIEW OF COUNCIL OPERATING 211 00:09:58,560 --> 00:09:59,800 PROCEDURES. 212 00:09:59,800 --> 00:10:01,520 EVERY YEAR AT THE JANUARY 213 00:10:01,520 --> 00:10:04,560 MEETING COUNCIL REVIEWERS REVIEW 214 00:10:04,560 --> 00:10:06,520 AND APPROVES THE ADVISORY 215 00:10:06,520 --> 00:10:08,080 COUNCIL OPERATING PROCEDURES AND 216 00:10:08,080 --> 00:10:10,280 MAKES RECOMMENDATIONS FOR 217 00:10:10,280 --> 00:10:12,760 REVISION WHERE APPROPRIATE. 218 00:10:12,760 --> 00:10:14,440 NADCRC IS NOT RECOMMENDING ANY 219 00:10:14,440 --> 00:10:15,840 CHANGES THIS YEAR. 220 00:10:15,840 --> 00:10:18,160 DOES ANYONE FROM COUNCIL HAVE 221 00:10:18,160 --> 00:10:20,160 SUGGESTIONS FOR CHANGES, HAVE 222 00:10:20,160 --> 00:10:24,560 COMMENTS OR ANY QUESTIONS? 223 00:10:24,560 --> 00:10:25,400 OKAY. 224 00:10:25,400 --> 00:10:27,320 WOULD A MEMBER OF COUNCIL LIKE 225 00:10:27,320 --> 00:10:29,400 TO MAKE A MOTION TO APPROVE THE 226 00:10:29,400 --> 00:10:34,760 COUNCIL OPERATING PROCEDURES? 227 00:10:34,760 --> 00:10:35,920 >> I'LL MAKE THAT MOTION. 228 00:10:35,920 --> 00:10:36,960 >> I WOULD SECOND. 229 00:10:36,960 --> 00:10:38,800 >> THANK YOU. 230 00:10:38,800 --> 00:10:42,120 ALL IN FAVOR. 231 00:10:42,120 --> 00:10:42,360 >> AYE. 232 00:10:42,360 --> 00:10:44,280 >> AND ANY OPPOSED? 233 00:10:44,280 --> 00:10:45,520 OKAY. 234 00:10:45,520 --> 00:10:45,720 GREAT. 235 00:10:45,720 --> 00:10:48,960 NOW WE'LL TURN IT OVER TO THE 236 00:10:48,960 --> 00:10:52,200 NADCRC DIRECTOR'S REPORT. 237 00:10:52,200 --> 00:10:53,440 >> THANK YOU, LYNN. 238 00:10:53,440 --> 00:10:55,640 AND AS YOU CAN SEE I LOVE THIS 239 00:10:55,640 --> 00:10:59,960 PICTURE BECAUSE IT SHOWS THE 240 00:10:59,960 --> 00:11:01,960 WAVE OF THE PANDEMIC IS STILL 241 00:11:01,960 --> 00:11:03,760 UPON US BUT WE LOOK TO THE 242 00:11:03,760 --> 00:11:05,080 FUTURE WITH MUCH HOPE AND 243 00:11:05,080 --> 00:11:05,640 PROGRAM. 244 00:11:05,640 --> 00:11:07,960 SO I WOULD LIKE TO -- IT'S A 245 00:11:07,960 --> 00:11:09,040 VERY DENSE PRESENTATION TO LET 246 00:11:09,040 --> 00:11:10,960 YOU KNOW AND REMIND YOU THAT IT 247 00:11:10,960 --> 00:11:12,600 WILL BE RECORDED AND I WILL BE 248 00:11:12,600 --> 00:11:15,080 HAPPY TO SHARE THE POWER POINT. 249 00:11:15,080 --> 00:11:18,280 TO GIVE YOU A BRIEF OVERVIEW OF 250 00:11:18,280 --> 00:11:22,360 THE NEW -- OF NEWS FROM NIH'S 251 00:11:22,360 --> 00:11:23,800 EFFORTS IN THE PANDEMIC AND HOW 252 00:11:23,800 --> 00:11:25,640 THESE INITIATIVES ARE HERE TO 253 00:11:25,640 --> 00:11:28,000 STAY PERHAPS AND COULD EASILY BE 254 00:11:28,000 --> 00:11:29,280 TRANSLATED TO WHAT WE DO. 255 00:11:29,280 --> 00:11:31,400 WE HAVE A DISTINGUISHED PANEL OF 256 00:11:31,400 --> 00:11:34,400 GUESTS AND I'M DELIGHTED THAT 257 00:11:34,400 --> 00:11:36,160 DR. -- WHO IS DIRECTOR OF THE 258 00:11:36,160 --> 00:11:38,840 NATIONAL INSTITUTES OF MINORITY 259 00:11:38,840 --> 00:11:41,160 HEALTH AND HEALTH DISPARITIES IS 260 00:11:41,160 --> 00:11:44,160 HERE AND HE WILL ILLUSTRATE ONE 261 00:11:44,160 --> 00:11:47,280 EXAMPLE ON CAMPUS THAT HAS A 262 00:11:47,280 --> 00:11:48,600 TREMENDOUS RAMIFICATION FOR THE 263 00:11:48,600 --> 00:11:49,120 FUTURE. 264 00:11:49,120 --> 00:11:51,160 I'LL GIVE YOU A BRIEF OVERVIEW 265 00:11:51,160 --> 00:11:52,760 OF THE BUDGET. 266 00:11:52,760 --> 00:11:54,960 IT'S IN CONTINUING RESOLUTION 267 00:11:54,960 --> 00:11:57,280 RIGHT NOW AND WE'RE HOPING IT 268 00:11:57,280 --> 00:11:59,040 DOES GET APPROVED BUT I'LL GIVE 269 00:11:59,040 --> 00:12:03,240 YOU AN IDEA AS TO WHERE WE ARE. 270 00:12:03,240 --> 00:12:05,760 IT WAS A YEAR THAT WAS. 271 00:12:05,760 --> 00:12:08,880 AND 21 WAS A YEAR THAT WAS 272 00:12:08,880 --> 00:12:10,840 BECAUSE WE ACCOMPLISHED TWO 273 00:12:10,840 --> 00:12:12,200 MAJOR MILESTONES THAT I WILL 274 00:12:12,200 --> 00:12:16,880 TOUCH O ON. 275 00:12:16,880 --> 00:12:18,520 THE REPORT ITSELF AND OUR 276 00:12:18,520 --> 00:12:20,520 STRATEGIC PLAN. 277 00:12:20,520 --> 00:12:24,000 I WANT TO SPECIFICALLY FOCUS ON 278 00:12:24,000 --> 00:12:27,040 HOW NIDCD IS POSITIONING TO 279 00:12:27,040 --> 00:12:29,760 REDUCE PUBLIC HEALTH BURDENS AT 280 00:12:29,760 --> 00:12:32,560 A PLACE THAT IS 281 00:12:32,560 --> 00:12:33,960 DISPROPORTIONATELY ON THIS 282 00:12:33,960 --> 00:12:39,280 SEGMENT OF THE POPULATION. 283 00:12:39,280 --> 00:12:40,560 SO, IT'S NOT JUST THE FACT THAT 284 00:12:40,560 --> 00:12:42,000 THERE ARE DISPARITIES. 285 00:12:42,000 --> 00:12:43,920 IT'S THE FACT THAT DESPITE THE 286 00:12:43,920 --> 00:12:46,240 SCIENCE AND TECHNOLOGY ADVANCES 287 00:12:46,240 --> 00:12:48,760 DESPITE THE WONDERFUL BRILLIANCE 288 00:12:48,760 --> 00:12:51,000 OF THE SCIENCE IT HAS NOT BEEN 289 00:12:51,000 --> 00:12:52,320 ENOUGH TO ACTUALLY MOVE THE 290 00:12:52,320 --> 00:12:55,120 NEEDLE IN A SIGNIFICANT WAY FOR 291 00:12:55,120 --> 00:12:56,280 MANY IN THIS COUNTRY. 292 00:12:56,280 --> 00:12:58,520 SO I'M GOING TO CHAT ABOUT THAT 293 00:12:58,520 --> 00:13:00,280 AND HOW OUR STRATEGIC PLAN 294 00:13:00,280 --> 00:13:03,320 ADDRESSES THAT SPECIFICALLY. 295 00:13:03,320 --> 00:13:05,760 VERY MUCH AT THE CENTER OF OUR 296 00:13:05,760 --> 00:13:08,360 ACTIVITIES ON CAMPUS AND WITHIN 297 00:13:08,360 --> 00:13:10,760 THE INSTITUTE IS HOW DO WE SHAPE 298 00:13:10,760 --> 00:13:13,360 OUR BIOMEDICAL WORKFORCE. 299 00:13:13,360 --> 00:13:15,640 CREATE ONE THAT REPRESENTS THE 300 00:13:15,640 --> 00:13:17,120 DEMOGRAPHICS OF OUR NATION AND 301 00:13:17,120 --> 00:13:19,120 ADDRESS THE PUBLIC HEALTH 302 00:13:19,120 --> 00:13:20,160 BURDENS OF DISEASE. 303 00:13:20,160 --> 00:13:23,160 NEW AND EXCITING SUGGESTIONS FOR 304 00:13:23,160 --> 00:13:26,840 HOW COUNCIL WILL ENGAGED FOR THE 305 00:13:26,840 --> 00:13:28,960 FUTURE AND PERHAPS A FAR MORE 306 00:13:28,960 --> 00:13:30,440 ACTIVE WAY OF THAN IN THE PAST 307 00:13:30,440 --> 00:13:32,320 BUT NOT IN MY WAY UNUSUAL 308 00:13:32,320 --> 00:13:35,360 BECAUSE MANY OF THE COUNCILS 309 00:13:35,360 --> 00:13:36,120 WORK SIMILARLY WHICH IS TO 310 00:13:36,120 --> 00:13:37,960 CREATE THE WORKING GROUPS AND 311 00:13:37,960 --> 00:13:39,440 THE CONVERSATIONS THROUGHOUT THE 312 00:13:39,440 --> 00:13:41,120 YEAR AND IN BETWEEN COUNCIL 313 00:13:41,120 --> 00:13:42,280 MEETINGS. 314 00:13:42,280 --> 00:13:44,600 AND THEN FINALLY TO INTRODUCE 315 00:13:44,600 --> 00:13:45,240 OUR GUEST. 316 00:13:45,240 --> 00:13:47,080 WE HAVE A LOT TO COVER. 317 00:13:47,080 --> 00:13:49,360 SO THIS IS WHERE WE ARE WITH THE 318 00:13:49,360 --> 00:13:51,960 RETURN TO WORK. 319 00:13:51,960 --> 00:13:53,400 AND THE FUTURE WORKPLACE 320 00:13:53,400 --> 00:13:54,240 DISCUSSION. 321 00:13:54,240 --> 00:13:56,760 NOTHING THAT IS SURPRISING TO 322 00:13:56,760 --> 00:13:57,240 YOU. 323 00:13:57,240 --> 00:13:59,160 NIH WILL MAINTAIN A VERY 324 00:13:59,160 --> 00:14:00,000 FLEXIBLE WORKPLACE. 325 00:14:00,000 --> 00:14:02,640 IT WILL LIKELY TAKE ON HYBRID 326 00:14:02,640 --> 00:14:03,320 MODES. 327 00:14:03,320 --> 00:14:04,960 AND OF COURSE AS YOU MUST KNOW 328 00:14:04,960 --> 00:14:08,040 TRAVEL AND CAMPUS WIDE MEETINGS 329 00:14:08,040 --> 00:14:10,320 RIGHT NOW DECISIONS ARE STILL 330 00:14:10,320 --> 00:14:13,200 PENDING ON THE STATUS OF THOSE 331 00:14:13,200 --> 00:14:15,240 EVENTS BECAUSE OF OMICRON 332 00:14:15,240 --> 00:14:15,640 ESSENTIALLY. 333 00:14:15,640 --> 00:14:18,200 BUT WHAT I WANT TO SAY IS THAT 334 00:14:18,200 --> 00:14:20,880 THE HYBRID STATE THAT WE'RE IN 335 00:14:20,880 --> 00:14:23,400 HAS OPENED UP TREMENDOUS DOORS 336 00:14:23,400 --> 00:14:25,840 FOR COMMUNICATION THAT COULD BE 337 00:14:25,840 --> 00:14:27,960 VIRTUAL AND THAT HAS ITS 338 00:14:27,960 --> 00:14:29,160 ADVANTAGES SOMETIMES OVER IN 339 00:14:29,160 --> 00:14:30,960 PERSON TRAVEL AND THERE ARE 340 00:14:30,960 --> 00:14:32,960 ADVANTAGES AND DISADVANTAGES ON 341 00:14:32,960 --> 00:14:35,920 BOTH ENDS BUT HAVING THE HYBRID 342 00:14:35,920 --> 00:14:38,680 MODE ALLOWS US TO CAPITALIZE AND 343 00:14:38,680 --> 00:14:42,640 IMPROVE ON HOW WE STAY CONNECTED 344 00:14:42,640 --> 00:14:43,360 THROUGHOUT THE YEAR. 345 00:14:43,360 --> 00:14:46,360 SO I THINK THAT FOR ME IS A 346 00:14:46,360 --> 00:14:47,720 WONDERFUL TAKE HOME MESSAGE 347 00:14:47,720 --> 00:14:49,960 ABOUT THE PANDEMIC. 348 00:14:49,960 --> 00:14:51,440 NOW THIS IS THE LATEST WE HAVE. 349 00:14:51,440 --> 00:14:53,920 THERE IS A LOT OF WORK BEING 350 00:14:53,920 --> 00:14:55,800 DONE ON THE IMMUNOLOGY OF THE 351 00:14:55,800 --> 00:14:58,720 VIRUS ITSELF AND THE VARIANTS. 352 00:14:58,720 --> 00:15:00,600 THE LAST BULLET INDICATES THAT 353 00:15:00,600 --> 00:15:04,000 THERE IS NEW DATA SHOWING THAT 354 00:15:04,000 --> 00:15:04,720 DURING PREGNANCY IT IS POSSIBLE 355 00:15:04,720 --> 00:15:08,360 FOR THE FETUS TO ACTUALLY 356 00:15:08,360 --> 00:15:12,560 RECEIVE OR REACT WITH 357 00:15:12,560 --> 00:15:14,360 INFLAMMATORY IMMUNE RESPONSES 358 00:15:14,360 --> 00:15:15,720 AND THAT IS BEING STUDIED. 359 00:15:15,720 --> 00:15:18,160 WE ALSO KNOW THAT ANTIBODY 360 00:15:18,160 --> 00:15:21,280 LEVELS ARE NOT THE ONLY MEASURE 361 00:15:21,280 --> 00:15:23,040 BECAUSE THERE IS THE CELLULAR 362 00:15:23,040 --> 00:15:26,640 ASPECT OF TC AND B CELL MEMORY 363 00:15:26,640 --> 00:15:28,320 RESPONSES THAT PLAY A ROLE IN 364 00:15:28,320 --> 00:15:30,720 PROTECTING US. 365 00:15:30,720 --> 00:15:34,680 NOW THE ACTIVE ARM OF NIH'S 366 00:15:34,680 --> 00:15:36,680 RESPONSE TO COVID INVOLVED MANY, 367 00:15:36,680 --> 00:15:40,040 MANY INITIATIVES. 368 00:15:40,040 --> 00:15:42,600 ACTIVE ITSELF IS VERY DEDICATED 369 00:15:42,600 --> 00:15:46,360 TO LOOKING AT THE THERAPEUTIC 370 00:15:46,360 --> 00:15:47,720 ASPECTS. 371 00:15:47,720 --> 00:15:49,800 REPURPOSED DRUGS. 372 00:15:49,800 --> 00:15:55,680 MONO CLONES. 373 00:15:55,680 --> 00:15:57,720 SINGLY OR IN UNIFORM. 374 00:15:57,720 --> 00:15:59,600 WE CAN VERY QUICKLY DETERMINE 375 00:15:59,600 --> 00:16:04,800 THE LEVEL OF PATHO GET NEWS TEE 376 00:16:04,800 --> 00:16:11,440 * OR INFECT IVITY. 377 00:16:11,440 --> 00:16:14,200 WHAT IS INTERESTING IN PREPARING 378 00:16:14,200 --> 00:16:15,960 FOR THE NEXT PANDEMIC WE HAVE 379 00:16:15,960 --> 00:16:17,360 NIH RESEARCHERS THAT ARE 380 00:16:17,360 --> 00:16:20,280 ESTABLISHING THE PLATFORMS THAT 381 00:16:20,280 --> 00:16:23,360 WILL QUICKLY OR FAST-TRACK DATA 382 00:16:23,360 --> 00:16:27,800 ON NEW VARIANTS THAT THE 383 00:16:27,800 --> 00:16:28,920 INFRASTRUCTURE FOR ACTUALLY 384 00:16:28,920 --> 00:16:31,440 MONITORING AND TESTING THESE 385 00:16:31,440 --> 00:16:34,720 VARIANTS, I DO BELIEVE THAT 386 00:16:34,720 --> 00:16:36,960 MODENA IS IN THE PROCESS OF 387 00:16:36,960 --> 00:16:40,760 PREPARING OMICRON SPECIFIC VIRUS 388 00:16:40,760 --> 00:16:43,760 VACCINE BECAUSE IT IS IN FACT A 389 00:16:43,760 --> 00:16:44,560 PECULIAR STRAIN AND PREPARE US 390 00:16:44,560 --> 00:16:46,400 TO BE AS BEST PROTECTED AS WE 391 00:16:46,400 --> 00:16:47,720 CAN. 392 00:16:47,720 --> 00:16:51,560 AND TO FORCE DISSEMINATE RAPIDLY 393 00:16:51,560 --> 00:16:53,240 AND WIDELY THROUGH THE 394 00:16:53,240 --> 00:16:54,600 COMMUNITY. 395 00:16:54,600 --> 00:16:57,360 NOW DR. -- WILL BE TALKING ABOUT 396 00:16:57,360 --> 00:17:00,200 WHAT I CONSIDER A VERY IMPORTANT 397 00:17:00,200 --> 00:17:02,960 PROGRAM THAT GREW FROM OUR 398 00:17:02,960 --> 00:17:04,360 AWARENESS FOR THE THINGS THAT 399 00:17:04,360 --> 00:17:05,480 NIH HAD DONE WELL. 400 00:17:05,480 --> 00:17:07,360 THAT OUR NATION HAD DONE WELL 401 00:17:07,360 --> 00:17:09,080 AND ALSO REALIZING AND EMBRACING 402 00:17:09,080 --> 00:17:10,520 THE NEED FOR CHANGE AND FOR 403 00:17:10,520 --> 00:17:11,760 MAKING THINGS BETTER FOR THE 404 00:17:11,760 --> 00:17:14,440 FUTURE. 405 00:17:14,440 --> 00:17:15,800 THE COMMUNITY ENGAGEMENT AND 406 00:17:15,800 --> 00:17:17,920 LEADERSHIP AND CREATING A 407 00:17:17,920 --> 00:17:23,800 DIVERSE GROUP OF -- A NETWORK OF 408 00:17:23,800 --> 00:17:25,160 OF CONTACTS WITH VARYING 409 00:17:25,160 --> 00:17:26,840 COMMUNITIES AROUND OUR COUNTRY 410 00:17:26,840 --> 00:17:29,480 IS ABSOLUTELY NECESSARY. 411 00:17:29,480 --> 00:17:32,200 AND SO AS YOU CAN SEE ON THE 412 00:17:32,200 --> 00:17:34,560 RIGHT THE OUTREACH WAS TO ALL OF 413 00:17:34,560 --> 00:17:36,640 OUR COMMUNITY LEADERS IN EVERY 414 00:17:36,640 --> 00:17:43,360 SEGMENT OF OUR POPULATION. 415 00:17:43,360 --> 00:17:45,160 THIS STUDY WHICH IS THE HUB IS 416 00:17:45,160 --> 00:17:48,200 BASED AT NYU LOOKING AT 417 00:17:48,200 --> 00:17:50,560 LONG-STANDING CONSEQUENCES OF 418 00:17:50,560 --> 00:17:54,120 COVID INFECTION OR SARS COVID 2 419 00:17:54,120 --> 00:18:01,440 INFECTION AND THAT IS VERY MUCH 420 00:18:01,440 --> 00:18:07,160 IN THE TRACK RIGHT NOW. 421 00:18:07,160 --> 00:18:08,960 KEEPING A STRONG TRACK ON. 422 00:18:08,960 --> 00:18:13,920 WE'VE HAD FOR NIDCD A ROBUST 423 00:18:13,920 --> 00:18:22,320 FORROW --ROBUST PORTFOLIO. 424 00:18:22,320 --> 00:18:24,360 AND YOU CAN SEE THAT HERE. 425 00:18:24,360 --> 00:18:28,600 I'M PLEASED TO SAY THAT THE PBRN 426 00:18:28,600 --> 00:18:31,160 HAS A RESEARCH REGISTRY CALLED 427 00:18:31,160 --> 00:18:32,760 CORE THAT IS AVAILABLE RIGHT NOW 428 00:18:32,760 --> 00:18:36,040 AND ACTIVE AND THAT WE'RE 429 00:18:36,040 --> 00:18:38,040 LOOKING AT CONDITIONS IN 430 00:18:38,040 --> 00:18:39,960 PRODUCTION OF AEROSOLS AND MANY 431 00:18:39,960 --> 00:18:42,800 OTHER CONSEQUENCES OF HOW WE 432 00:18:42,800 --> 00:18:45,600 PRACTICE OUR DENTISTRY AND 433 00:18:45,600 --> 00:18:48,040 DELIVER CARE TO POPULATIONS AT 434 00:18:48,040 --> 00:18:48,240 LARGE. 435 00:18:48,240 --> 00:18:50,640 THERE ARE MANY DENTIST THAT ARE 436 00:18:50,640 --> 00:18:52,640 ACTUALLY ENGAGED IN DELIVERING 437 00:18:52,640 --> 00:18:54,360 VACCINES AROUND THE COUNTRY. 438 00:18:54,360 --> 00:18:55,960 LIKE THE UNIVERSITY OF PACIFIC 439 00:18:55,960 --> 00:18:57,600 THAT HAVE PLAYED A VERY STRONG 440 00:18:57,600 --> 00:19:00,240 ROLE IN HELPING THE COMMUNITY. 441 00:19:00,240 --> 00:19:02,800 SO VERY PLEASED TO HEAR THAT. 442 00:19:02,800 --> 00:19:07,760 SO I'VE BEEN AROUND VIRTUALLY OF 443 00:19:07,760 --> 00:19:09,320 COURSE AND BEEN AS FAR AS I 444 00:19:09,320 --> 00:19:12,160 COULD REACHING OUT TO OUR 445 00:19:12,160 --> 00:19:13,000 STAKEHOLDER ORGANIZATIONS 446 00:19:13,000 --> 00:19:15,200 KEEPING EVERYONE ABREAST OF THE 447 00:19:15,200 --> 00:19:17,480 PROGRESS WE MADE WITH THE 448 00:19:17,480 --> 00:19:18,760 PREPARATION TO REPORT WHICH IS 449 00:19:18,760 --> 00:19:22,280 VERY EAGERLY AWAITED AND 450 00:19:22,280 --> 00:19:24,160 CONNECTING WITH GIVING YOU AS 451 00:19:24,160 --> 00:19:25,920 FAR AS POSSIBLE IN THE MOST OPEN 452 00:19:25,920 --> 00:19:31,760 AND TRANSPARENT MANNER -- OF 453 00:19:31,760 --> 00:19:32,760 WHERE WE WERE GOING WITH OUR 454 00:19:32,760 --> 00:19:34,320 MISSION AND WHERE OUR CURRENT 455 00:19:34,320 --> 00:19:35,360 CONCEPTS ARE HEADING. 456 00:19:35,360 --> 00:19:39,600 SO IS THAT A GROUP OF TALKS 457 00:19:39,600 --> 00:19:42,200 INCLUDING SOME VERY SPECIAL NIH 458 00:19:42,200 --> 00:19:44,400 WIDE CONNECTIONS THAT ARE 459 00:19:44,400 --> 00:19:45,160 EXTREMELY VALUABLE TO OUR 460 00:19:45,160 --> 00:19:48,280 MISSION. 461 00:19:48,280 --> 00:19:49,960 I'LL CONTINUE TO DO THAT OVER 462 00:19:49,960 --> 00:19:50,440 THE YEAR. 463 00:19:50,440 --> 00:19:57,200 I THINK IT WILL BE A HYBRID YEAR 464 00:19:57,200 --> 00:20:00,200 AND ALSO VIRTUAL TALKS. 465 00:20:00,200 --> 00:20:02,200 OUR BUDGET TODAY IS IN 466 00:20:02,200 --> 00:20:03,360 CONTINUING RESOLUTION. 467 00:20:03,360 --> 00:20:05,040 SO EVERYTHING IS ESTIMATED. 468 00:20:05,040 --> 00:20:08,160 YOU CAN SEE WE'VE STAYED VERY, 469 00:20:08,160 --> 00:20:10,320 VERY DIRECTED TO MEETING ALL OF 470 00:20:10,320 --> 00:20:11,720 THE ARMS OF OUR MISSION. 471 00:20:11,720 --> 00:20:14,680 AND YOU CAN SEE THAT DIVIDED 472 00:20:14,680 --> 00:20:17,400 INTO CATEGORIES AND BETTER 473 00:20:17,400 --> 00:20:18,480 REPRESENTED HERE IN THE PIE 474 00:20:18,480 --> 00:20:18,680 CHART. 475 00:20:18,680 --> 00:20:21,680 WE HAVE A HEALTHY BALANCE OF 78% 476 00:20:21,680 --> 00:20:25,520 OF OUR EXTRAMURAL BUDGET OF 477 00:20:25,520 --> 00:20:26,960 $377 MILLION GOING TOWARDS 478 00:20:26,960 --> 00:20:28,920 RESEARCH PROJECT GRANTS. 479 00:20:28,920 --> 00:20:32,680 AND NONCOMPETING RBGs STILL 480 00:20:32,680 --> 00:20:40,960 REMAIN DOMINANT WITH 19% NEW 481 00:20:40,960 --> 00:20:42,160 RPGs BEING FUNDED. 482 00:20:42,160 --> 00:20:45,600 IF YOU PUT IT IN THE CONTEXT OF 483 00:20:45,600 --> 00:20:48,640 WHAT YOU WILL SOON LEARN WE 484 00:20:48,640 --> 00:20:50,200 PERHAPS WILL BENEFIT GREATLY 485 00:20:50,200 --> 00:20:53,840 FROM INVESTING MORE HEAVILY IN 486 00:20:53,840 --> 00:20:55,160 CAREER AND TRAINING DEVELOPMENT 487 00:20:55,160 --> 00:20:57,160 AND I HOPE IN THE NEXT FEW YEARS 488 00:20:57,160 --> 00:20:58,640 THIS WILL BE REFLECTED IN THE 489 00:20:58,640 --> 00:21:01,360 PIE CHART. 490 00:21:01,360 --> 00:21:03,160 COMPARED TO THE PURCHASING POWER 491 00:21:03,160 --> 00:21:11,720 NIH IS ALSO SUBJECT TO TIN -- SUBJECT TO 492 00:21:11,720 --> 00:21:12,240 INFLATION. 493 00:21:12,240 --> 00:21:14,160 SO WE HAVE TO PAY ATTENTION TO 494 00:21:14,160 --> 00:21:14,680 THAT. 495 00:21:14,680 --> 00:21:18,120 AND YOU CAN SEE HERE IN 21 THAT 496 00:21:18,120 --> 00:21:21,320 WE ARE KIND OF A LITTLE LOWER 497 00:21:21,320 --> 00:21:23,080 THAN 20 BUT BETTER THAN PREVIOUS 498 00:21:23,080 --> 00:21:28,960 YEARS. 499 00:21:28,960 --> 00:21:39,640 OUR RPG RATE -- -- IT IS 500 00:21:39,640 --> 00:21:43,800 APPROACHING 25% FOR 21. 501 00:21:43,800 --> 00:21:46,000 NOW DENTAL SCHOOL FUNDING 502 00:21:46,000 --> 00:21:48,080 REMAINS AT ABOUT 45%. 503 00:21:48,080 --> 00:21:50,600 YOU CAN SEE IT'S NOT A NUMBER 504 00:21:50,600 --> 00:21:53,760 THAT I HOPE WILL STAY STATIC. 505 00:21:53,760 --> 00:21:56,560 WE INTEND TO VERY MUCH ENGAGE 506 00:21:56,560 --> 00:21:59,080 AND INVEST FURTHER IN RESEARCH 507 00:21:59,080 --> 00:22:01,120 THAT IS BASED ACADEMIC RESEARCH 508 00:22:01,120 --> 00:22:02,960 THAT IS BASED IN DENTAL SCHOOLS 509 00:22:02,960 --> 00:22:05,240 AND THERE IS A REASON FOR THAT. 510 00:22:05,240 --> 00:22:08,680 IN DEFINING WHAT BEST SCIENCE IS 511 00:22:08,680 --> 00:22:10,560 TODAY IS DIFFERENT THAN WHAT IT 512 00:22:10,560 --> 00:22:12,720 WAS DEFINED IN PREVIOUS YEARS. 513 00:22:12,720 --> 00:22:15,800 BECAUSE BEST SCIENCE TODAY 514 00:22:15,800 --> 00:22:17,840 RELIES VERY MUCH ON CHAIR SIDE 515 00:22:17,840 --> 00:22:19,360 OBSERVATIONS AND TRANSLATION TO 516 00:22:19,360 --> 00:22:22,040 THE BENCH OR TO COMMUNITIES AND 517 00:22:22,040 --> 00:22:24,800 FOR THAT REASON WE EMBRACE 518 00:22:24,800 --> 00:22:26,360 DENTAL SCHOOLS WHO HAVE IN THE 519 00:22:26,360 --> 00:22:29,840 PAST NOT HAD THE RESOURCES OR 520 00:22:29,840 --> 00:22:32,880 EVEN THE SUPPORT NECESSARILY TO 521 00:22:32,880 --> 00:22:34,640 DEVELOP RESEARCH INTENSE 522 00:22:34,640 --> 00:22:36,680 MISSIONS AND IT DOESN'T HAVE TO 523 00:22:36,680 --> 00:22:37,760 BE INTENSE. 524 00:22:37,760 --> 00:22:39,240 IT CAN BE SUPPORTIVE. 525 00:22:39,240 --> 00:22:42,560 WE HAVE MANY MECHANISMS IN PLACE 526 00:22:42,560 --> 00:22:44,560 TO DRAW DENTAL SCHOOLS INTO THE 527 00:22:44,560 --> 00:22:47,240 COMMUNITY OF ORAL BIOMEDICAL 528 00:22:47,240 --> 00:22:48,480 RESEARCH FOLKS AND THE REASON 529 00:22:48,480 --> 00:22:52,640 BEING IS THAT CHAIR SIDE 530 00:22:52,640 --> 00:22:55,520 OBSERVATIONS -- AND WE DO CARE 531 00:22:55,520 --> 00:22:56,240 ABOUT TRANSLATION. 532 00:22:56,240 --> 00:22:58,720 IT'S HARD NOT TO WANT TO BRAG 533 00:22:58,720 --> 00:23:02,360 ABOUT OUR INTRAMURAL PROGRAM SO 534 00:23:02,360 --> 00:23:04,760 I ASKED FOR BRAD TO SUMMARIZE 535 00:23:04,760 --> 00:23:05,720 THE HIGHLIGHTS. 536 00:23:05,720 --> 00:23:08,160 THERE WERE ABOUT 100 PAPERS BUT 537 00:23:08,160 --> 00:23:11,560 HE PICKED A FEW THAT ARE TRULY 538 00:23:11,560 --> 00:23:13,800 PARADIGM SHIFTING. 539 00:23:13,800 --> 00:23:16,160 REFLECTING THE WORK OF OUR 540 00:23:16,160 --> 00:23:16,760 RESEARCHERS. 541 00:23:16,760 --> 00:23:19,320 THEY GIVE OUR INSTITUTE MUCH 542 00:23:19,320 --> 00:23:20,680 PROMINENCE ON CAMPUS AND THE 543 00:23:20,680 --> 00:23:21,080 WORLD. 544 00:23:21,080 --> 00:23:25,760 SO I WANT TO THANK THEM AND 545 00:23:25,760 --> 00:23:27,440 APPRECIATE MATT'S LEADERSHIP IN 546 00:23:27,440 --> 00:23:31,080 GUIDING THIS GROUP OF 27 VERY 547 00:23:31,080 --> 00:23:32,120 TALENTED PRINCIPLE INVESTIGATORS 548 00:23:32,120 --> 00:23:33,920 AND YOU CAN SEE THEM AS WE GO 549 00:23:33,920 --> 00:23:34,760 THROUGH THE LIST THAT IT 550 00:23:34,760 --> 00:23:39,080 COMPANIES HAVE A BROAD RANGE OF 551 00:23:39,080 --> 00:23:41,400 TOPICS IN TOP CITED JOURNALS. 552 00:23:41,400 --> 00:23:42,120 OKAY. 553 00:23:42,120 --> 00:23:44,680 SO THE REPORT AND HOW DID IT 554 00:23:44,680 --> 00:23:50,480 COME ABOUT? 555 00:23:50,480 --> 00:23:57,160 NADCRC -- -- TOOK IT ON WITH A 556 00:23:57,160 --> 00:23:59,640 GREAT SENSE OF COMMITMENT. 557 00:23:59,640 --> 00:24:02,960 WE SHEPHERD THE REVIEW PROCESS 558 00:24:02,960 --> 00:24:03,720 IN EDITING. 559 00:24:03,720 --> 00:24:07,560 IT CAME FROM 400 CONTRACTORS WHO 560 00:24:07,560 --> 00:24:11,280 WERE LED BY TALENTED AND 561 00:24:11,280 --> 00:24:14,640 COMMITTED EDITORS. 562 00:24:14,640 --> 00:24:18,960 WE EXAMINED THE PROGRESS MADE 563 00:24:18,960 --> 00:24:26,040 SINCE 2000. 564 00:24:26,040 --> 00:24:27,920 IT WAS ORGANIZED ACROSS THE 565 00:24:27,920 --> 00:24:29,600 LIFE-SPAN LOOKING AT DISEASE 566 00:24:29,600 --> 00:24:31,040 TRENDS AND WHERE WE ARE TODAY 567 00:24:31,040 --> 00:24:34,360 AND WHAT PROGRESS WE'VE MADE AND 568 00:24:34,360 --> 00:24:36,240 DELIVERING A VERY IMPORTANT SET 569 00:24:36,240 --> 00:24:38,000 OF CAUSE FOR ACTION THAT I HOPE 570 00:24:38,000 --> 00:24:40,720 THAT WE CAN ALL TAKE SERIOUSLY. 571 00:24:40,720 --> 00:24:43,160 CALLS TO ACTION AND WORK ON SO 572 00:24:43,160 --> 00:24:45,400 THAT WE CAN REALLY HELP MOVE THE 573 00:24:45,400 --> 00:24:47,080 NEEDLE AND THE PLAN IS TO MAKE 574 00:24:47,080 --> 00:24:48,600 IT A LIVING DOCUMENT. 575 00:24:48,600 --> 00:24:51,480 ONE THAT WILL CONTINUE TO GUIDE 576 00:24:51,480 --> 00:24:54,560 BOTH NIDCD AND ALL OF OUR 577 00:24:54,560 --> 00:24:55,200 STAKEHOLDERS. 578 00:24:55,200 --> 00:24:57,200 THIS IS THE SPACE TO ACKNOWLEDGE 579 00:24:57,200 --> 00:24:58,920 THE CONTRIBUTIONS. 580 00:24:58,920 --> 00:25:02,840 WE'RE HOPING TO DO SO WITH 581 00:25:02,840 --> 00:25:04,360 INDIVIDUAL RECOGNITION. 582 00:25:04,360 --> 00:25:07,080 AND AS YOU CAN IMAGINE A 750 583 00:25:07,080 --> 00:25:08,760 PAGE REPORT COULD NOT HAVE BEEN 584 00:25:08,760 --> 00:25:10,640 PUT TOGETHER IN THAT PERIOD OF 585 00:25:10,640 --> 00:25:11,680 TIME DURING THE PANDEMIC. 586 00:25:11,680 --> 00:25:14,520 AND WITH SO MANY CHANGES IN OUR 587 00:25:14,520 --> 00:25:16,320 SYSTEM WITHOUT THE HELP OF THIS 588 00:25:16,320 --> 00:25:20,560 COMMITTED GROUP SO I WANT TO 589 00:25:20,560 --> 00:25:22,160 THANK JUDITH AND BRUCE FOR 590 00:25:22,160 --> 00:25:26,760 KEEPING EVERYTHING ON COURSE. 591 00:25:26,760 --> 00:25:28,960 BOB AND JOCELYN AND CATHERINE 592 00:25:28,960 --> 00:25:32,160 AND CHRISTIAN AND LAURI FOR YOUR 593 00:25:32,160 --> 00:25:35,280 LEADERSHIP IN DRIVING EACH OF 594 00:25:35,280 --> 00:25:37,000 THOSE SIX SECTIONS. 595 00:25:37,000 --> 00:25:45,000 THERE WAS A STAFF AS WELL AS 596 00:25:45,000 --> 00:25:46,840 INDIVIDUALS WHO CAME FORTH AND 597 00:25:46,840 --> 00:25:48,600 REALLY DEDICATED MANY HOURS OF 598 00:25:48,600 --> 00:25:52,040 WORK TO GETTING THIS THROUGH. 599 00:25:52,040 --> 00:25:52,920 THANK YOU AGAIN. 600 00:25:52,920 --> 00:25:55,760 NOW WHAT DOES THE REPORT TALK 601 00:25:55,760 --> 00:25:55,960 ABOUT? 602 00:25:55,960 --> 00:25:58,160 IN THE LAST 20 YEARS WE HAVE TO 603 00:25:58,160 --> 00:26:01,000 ADMIT THE DEMOGRAPHICS OF THIS 604 00:26:01,000 --> 00:26:02,120 NATION HAVE CHANGED. 605 00:26:02,120 --> 00:26:06,320 THAT WE MOVED INTO THIS 606 00:26:06,320 --> 00:26:09,160 DIGITIZATION AGE NOT JUST IN OUR 607 00:26:09,160 --> 00:26:10,960 PRACTICES BUT THE WAY THAT WE 608 00:26:10,960 --> 00:26:12,520 DELIVER OUR CARE AND EVEN 609 00:26:12,520 --> 00:26:13,680 ANALYZE OUR DATA. 610 00:26:13,680 --> 00:26:16,160 SO AT THE DELIVERY OF OUR 611 00:26:16,160 --> 00:26:18,080 SERVICES THAT HAVE CHANGED. 612 00:26:18,080 --> 00:26:20,280 DENTISTRY AND TELEHEALTH AND 613 00:26:20,280 --> 00:26:22,760 TELEMEDICINE CAN WORK. 614 00:26:22,760 --> 00:26:24,600 BUT ALSO THINKING OF THE LARGE 615 00:26:24,600 --> 00:26:26,240 DENTAL SERVICES ORGANIZATIONS 616 00:26:26,240 --> 00:26:28,040 THAT HAVE MOVED THE NEED EL ON 617 00:26:28,040 --> 00:26:32,760 THE MEASUREMENTS OF OUTCOMES. 618 00:26:32,760 --> 00:26:39,520 OUAND THE RISING HPV CANCERS THAT 619 00:26:39,520 --> 00:26:43,280 ARE THE MOST DOMINANT OF ALL HPV 620 00:26:43,280 --> 00:26:45,080 CANCERS AND ALSO DOMINATING IN 621 00:26:45,080 --> 00:26:48,600 THE FIELD OF HEAD AND NEXT 622 00:26:48,600 --> 00:26:49,120 CARCINOMAS. 623 00:26:49,120 --> 00:26:50,880 OUR DISCOVERIES HAVE BEEN 624 00:26:50,880 --> 00:26:54,200 AMAZING AND WORTH NOTING BUT WE 625 00:26:54,200 --> 00:26:56,760 CONTINUE TO EXIST -- THE DIVIDES 626 00:26:56,760 --> 00:27:00,160 AND BARRIERS AND DETERMINANTS OF 627 00:27:00,160 --> 00:27:01,520 HEALTH. 628 00:27:01,520 --> 00:27:04,760 I WAS THINKING OF ALL OF THE 629 00:27:04,760 --> 00:27:07,560 Ds. 630 00:27:07,560 --> 00:27:11,160 SO WHEN I THOUGHT OF WHAT THE 631 00:27:11,160 --> 00:27:12,760 CAUSE TO ACTION WOULD BE I 632 00:27:12,760 --> 00:27:13,680 THOUGHT OF THIS LIST. 633 00:27:13,680 --> 00:27:17,200 THAT WE NEED THAT RESEARCH 634 00:27:17,200 --> 00:27:18,680 ENTERPRISE THAT WILL SIMPLY 635 00:27:18,680 --> 00:27:19,960 CREATE THE EVIDENCE THAT HAD 636 00:27:19,960 --> 00:27:23,200 WILL DRIVE REFORMS AND POLICY 637 00:27:23,200 --> 00:27:28,800 CHANGES. 638 00:27:28,800 --> 00:27:30,160 NADCRC CAN PROVIDE THE RESEARCH 639 00:27:30,160 --> 00:27:31,440 THAT DRIVES THE EVIDENCE. 640 00:27:31,440 --> 00:27:33,800 WE CLEARLY CAN BE INVOLVED 641 00:27:33,800 --> 00:27:35,840 THROUGH OUR IMPLEMENTATION 642 00:27:35,840 --> 00:27:38,160 SCIENCES AND STRATEGIES AND OUR 643 00:27:38,160 --> 00:27:39,960 POPULATIONS TO HELP REDUCE THE 644 00:27:39,960 --> 00:27:42,040 NEGATIVE IMPACT OF UPSTREAM 645 00:27:42,040 --> 00:27:42,760 DETERMINANTS. 646 00:27:42,760 --> 00:27:46,840 THE NEED TO FIGURE THE DELIVERY 647 00:27:46,840 --> 00:27:48,840 AND CONFIGURE WHAT WORKS BEST 648 00:27:48,840 --> 00:27:50,560 FOR WHICH POPULATION. 649 00:27:50,560 --> 00:27:53,360 TO REIMAGINE DENTAL EDUCATION IN 650 00:27:53,360 --> 00:27:55,160 THIS CHANGING UNIVERSE TO BE 651 00:27:55,160 --> 00:27:56,560 MORE INTEGRATED AND MORE 652 00:27:56,560 --> 00:27:59,840 AFFORDABLE. 653 00:27:59,840 --> 00:28:01,520 AND THEN ALL OF THIS TOGETHER 654 00:28:01,520 --> 00:28:06,160 WOULD HELP REDUCE OR ELIMINATE 655 00:28:06,160 --> 00:28:10,840 THE SOCIO AND ECONOMIC. 656 00:28:10,840 --> 00:28:12,400 THIS REQUIRES US COMING TOGETHER 657 00:28:12,400 --> 00:28:13,160 WITH A PLAN. 658 00:28:13,160 --> 00:28:15,160 SO HERE IS AN EXAMPLE OF THE 659 00:28:15,160 --> 00:28:17,520 IMPACT THAT WE HOPE THE REPORT 660 00:28:17,520 --> 00:28:18,040 WILL HAVE. 661 00:28:18,040 --> 00:28:20,240 AS YOU CAN SEE IT WAS WELL 662 00:28:20,240 --> 00:28:21,160 RECEIVED. 663 00:28:21,160 --> 00:28:22,600 IT WAS QUITE ROBUST. 664 00:28:22,600 --> 00:28:24,760 THE RESPONSE TO THE WEBINAR 665 00:28:24,760 --> 00:28:31,560 ITSELF AND ALL THAT FOLLOWED AND 666 00:28:31,560 --> 00:28:33,960 JDE's DEPARTMENT KEEPS -- THEY 667 00:28:33,960 --> 00:28:36,040 WATCH THESE TRENDS AS THEY'VE 668 00:28:36,040 --> 00:28:36,840 GROWN. 669 00:28:36,840 --> 00:28:42,880 WE HAVE PUBLISHED TWO ARTICLES. 670 00:28:42,880 --> 00:28:44,280 IT'S STAGGERED SO WE BRING 671 00:28:44,280 --> 00:28:46,400 ATTENTION TO THE REPORT AT 672 00:28:46,400 --> 00:28:47,240 DIFFERENT TIMES. 673 00:28:47,240 --> 00:28:49,280 WE DECIDED THAT TARGETED 674 00:28:49,280 --> 00:28:50,960 ARTICLES THAT WOULD BE OF 675 00:28:50,960 --> 00:28:52,760 INTEREST TO FOCUS GROUPS WOULD 676 00:28:52,760 --> 00:28:56,760 BE PUBLISHED IN THE JOURNAL OF 677 00:28:56,760 --> 00:28:57,040 EDUCATION. 678 00:28:57,040 --> 00:28:58,840 JADA AND OF COURSE THE JOURNAL 679 00:28:58,840 --> 00:29:01,640 OF DENTAL RESEARCH AND CREATING 680 00:29:01,640 --> 00:29:03,920 WITHIN US THIS SHARED OWNERSHIP. 681 00:29:03,920 --> 00:29:05,760 THE SENSE OF SHARED OWNERSHIP. 682 00:29:05,760 --> 00:29:07,760 THAT IS ESSENTIAL FOR 683 00:29:07,760 --> 00:29:08,760 FOLLOW-UPS. 684 00:29:08,760 --> 00:29:10,880 RIGHT. 685 00:29:10,880 --> 00:29:13,400 RENEE AND JENNIFER AND MYSELF 686 00:29:13,400 --> 00:29:15,360 AND OTHERS WILL OUTREACH TO 687 00:29:15,360 --> 00:29:17,880 STAKEHOLDER GROUPS ACROSS THE 688 00:29:17,880 --> 00:29:18,400 NATION. 689 00:29:18,400 --> 00:29:22,400 AN EXAMPLE IS THE AADOCR WEBINAR 690 00:29:22,400 --> 00:29:24,760 THAT WILL FOCUS SPECIFICALLY ON 691 00:29:24,760 --> 00:29:27,480 THE RESEARCH OPPORTUNITIES THAT 692 00:29:27,480 --> 00:29:29,040 THE REPORT SUGGEST AND THAT WILL 693 00:29:29,040 --> 00:29:32,280 BE FOLLOWED BY OTHER WEBINAR AND 694 00:29:32,280 --> 00:29:36,360 OTHER FORUMS FROM ADA AND DENTAL 695 00:29:36,360 --> 00:29:38,200 PUBLIC HEALTH. 696 00:29:38,200 --> 00:29:40,400 AND I WANT TO SAY THAT EVEN 697 00:29:40,400 --> 00:29:42,200 THOUGH WE TALK ABOUT THE BURDENS 698 00:29:42,200 --> 00:29:44,760 OF DISEASE THAT IT'S IMPORTANT 699 00:29:44,760 --> 00:29:45,880 TO CELEBRATE THE RESEARCH 700 00:29:45,880 --> 00:29:46,840 ADVANCES SO FAR. 701 00:29:46,840 --> 00:29:49,320 THERE IS A LOT MORE TO BE DONE. 702 00:29:49,320 --> 00:29:50,880 IT JUST GIVES US THAT REASON TO 703 00:29:50,880 --> 00:29:53,080 EXIST. 704 00:29:53,080 --> 00:29:54,960 SO I WANTED TO PUT UP THIS 705 00:29:54,960 --> 00:29:57,960 MESSAGE BECAUSE IT ACTUALLY 706 00:29:57,960 --> 00:30:00,360 SUMMARIZES THE HEART THAT BEATS 707 00:30:00,360 --> 00:30:03,880 SO STRONGLY AS WE WORK TOWARDS 708 00:30:03,880 --> 00:30:05,240 MEETING THE GOALS WE REPORT AND 709 00:30:05,240 --> 00:30:07,960 IT'S VERY WELL STATED IN THIS 710 00:30:07,960 --> 00:30:08,240 COVERLETTER. 711 00:30:08,240 --> 00:30:11,080 WITH THE ENDORSEMENT OF THE 712 00:30:11,080 --> 00:30:13,120 SURGEON GENERAL OF FRANCIS 713 00:30:13,120 --> 00:30:14,960 COLLINS AT THAT TIME SO PLEASE 714 00:30:14,960 --> 00:30:15,760 READ IT. 715 00:30:15,760 --> 00:30:20,560 THE EXECUTIVE SUMMARY IS A NICE 716 00:30:20,560 --> 00:30:22,680 ENCOUNTER OF WHAT IS IN THE 717 00:30:22,680 --> 00:30:23,080 REPORT. 718 00:30:23,080 --> 00:30:25,840 WE WERE GUIDED BY WHAT THE 719 00:30:25,840 --> 00:30:27,760 REPORT WAS SUGGESTING BUT WE 720 00:30:27,760 --> 00:30:29,520 DIDN'T HAVE THE REPORT READY AT 721 00:30:29,520 --> 00:30:31,520 THE TIME WE BEGAN PLANNING FOR 722 00:30:31,520 --> 00:30:34,000 OUR NEXT FIVE YEARS. 723 00:30:34,000 --> 00:30:35,480 NOW THE PREVIOUS DIRECTOR AND 724 00:30:35,480 --> 00:30:37,560 HER TEAM HAD INITIATED THE 725 00:30:37,560 --> 00:30:40,760 PROCESS AND WE HAD RECEIVED 726 00:30:40,760 --> 00:30:47,000 RESPONSES TO TH CALL. 727 00:30:47,000 --> 00:30:49,440 WE ALMOST HAD TO LOOK AT OUR 728 00:30:49,440 --> 00:30:52,600 FUTURE WITH A NEW SET OF LENSES 729 00:30:52,600 --> 00:30:54,560 BECAUSE THE WORLD HAD IN FACT 730 00:30:54,560 --> 00:30:56,320 CHANGED AND THERE WERE THREE 731 00:30:56,320 --> 00:30:58,120 PRINCIPLES THAT I WANT YOU TO 732 00:30:58,120 --> 00:31:00,800 THINK ABOUT. 733 00:31:00,800 --> 00:31:04,160 AND ASSOCIATE WITHIN NIDCD AND 734 00:31:04,160 --> 00:31:07,160 TAKE INTO YOUR OWN ECOSYSTEM. 735 00:31:07,160 --> 00:31:10,920 THE NEED TO TRANSLATE ACROSS THE 736 00:31:10,920 --> 00:31:12,600 SPECTRUMS MORE CRITICAL THAN 737 00:31:12,600 --> 00:31:13,000 EVER. 738 00:31:13,000 --> 00:31:16,240 THE FACT THAT WE CREATE A SENSE 739 00:31:16,240 --> 00:31:18,960 OF EQUITABLE DIVERSE AND 740 00:31:18,960 --> 00:31:20,520 INCLUSIVITY IN EVERYTHING THAT 741 00:31:20,520 --> 00:31:22,720 WE DO AND TO FOCUS ON MEASURING 742 00:31:22,720 --> 00:31:25,080 WHAT WE DO SUCH THAT WE CAN KNOW 743 00:31:25,080 --> 00:31:26,720 WHAT THE RETURN OF INVESTMENT 744 00:31:26,720 --> 00:31:27,160 IS. 745 00:31:27,160 --> 00:31:29,400 WHAT WORKS AND WHAT DOESN'T 746 00:31:29,400 --> 00:31:30,400 WORK. 747 00:31:30,400 --> 00:31:32,960 AND BE ALWAYS GUIDED BY OUR CORE 748 00:31:32,960 --> 00:31:34,840 VALUES WHICH WILL BE EMPHASIZED 749 00:31:34,840 --> 00:31:36,560 AGAIN IN A FEW MINUTES. 750 00:31:36,560 --> 00:31:37,760 I PUT THIS ON. 751 00:31:37,760 --> 00:31:39,320 THESE ARE OUR STRATEGIC 752 00:31:39,320 --> 00:31:39,840 PRIORITIES. 753 00:31:39,840 --> 00:31:41,720 NOW NOTE HERE THAT IN THE CENTER 754 00:31:41,720 --> 00:31:44,040 ON THE LEFT SCHEMATIC IS THE 755 00:31:44,040 --> 00:31:44,760 PATIENT. 756 00:31:44,760 --> 00:31:51,440 AVENUE THAT EVERY ONE OF OUR 757 00:31:51,440 --> 00:31:52,360 RESEARCH EXPERT COUNTS. 758 00:31:52,360 --> 00:31:54,920 ARE SOME FURTHER ALONG THAN 759 00:31:54,920 --> 00:31:55,160 OTHERS. 760 00:31:55,160 --> 00:31:58,920 IT'S THE NATURE OF THE WAY WE'VE 761 00:31:58,920 --> 00:31:59,520 DEVELOPED. 762 00:31:59,520 --> 00:32:01,000 BUT AS YOU CAN SEE IT'S ALL 763 00:32:01,000 --> 00:32:01,440 IMPORTANT. 764 00:32:01,440 --> 00:32:03,760 IT'S NOT ONE THAT YOU CAN COUNT 765 00:32:03,760 --> 00:32:06,640 ON AS BEING THE DRIVING ONE BUT 766 00:32:06,640 --> 00:32:08,360 THAT BASIC AND FOUNDATIONAL 767 00:32:08,360 --> 00:32:12,640 RESEARCH AND SCIENCES WILL FEED 768 00:32:12,640 --> 00:32:13,880 HYPOTHESIS THAT CAN BE TESTED 769 00:32:13,880 --> 00:32:15,880 AND THAT OUR PUBLIC HEALTH 770 00:32:15,880 --> 00:32:22,360 OBJECTIO--OBSERVATION IS VERY POSSIBLE 771 00:32:22,360 --> 00:32:22,760 TODAY. 772 00:32:22,760 --> 00:32:25,160 THE FIRST GOAL AND I'LL SAY THIS 773 00:32:25,160 --> 00:32:27,040 EVEN THOUGH WE DESCRIBED IT A 774 00:32:27,040 --> 00:32:30,040 COUPLE OF COUNCIL AGO IS TO ADD 775 00:32:30,040 --> 00:32:31,880 THE MEAT TO THE BONES OF 776 00:32:31,880 --> 00:32:33,160 UNDERSTANDING THE DISEASE 777 00:32:33,160 --> 00:32:36,680 PROCESSES THAT WE ARE CONCERNED 778 00:32:36,680 --> 00:32:40,840 ABOUT. 779 00:32:40,840 --> 00:32:44,760 AND IF WE DON'T KNOW THE 780 00:32:44,760 --> 00:32:46,160 PATHOGENESIS COMPLETELY THAT THE 781 00:32:46,160 --> 00:32:48,160 DEEP PHENOTYPING ASSOCIATED WITH 782 00:32:48,160 --> 00:32:50,760 THESE DISEASES WE CANNOT MAKE 783 00:32:50,760 --> 00:32:53,000 THOSE CONNECTIONS TO SYSTEMATIC 784 00:32:53,000 --> 00:32:54,760 DISEASES SO WE NEED TO DO BOTH 785 00:32:54,760 --> 00:32:56,440 AT THE SAME TIME AND WE DO KNOW 786 00:32:56,440 --> 00:32:57,560 THERE IS AN ASSOCIATION. 787 00:32:57,560 --> 00:33:00,160 THERE IS IS NOT DOUBT ABOUT 788 00:33:00,160 --> 00:33:00,360 THAT. 789 00:33:00,360 --> 00:33:04,360 PUTTING THE CELLULAR AND 790 00:33:04,360 --> 00:33:06,720 MOLECULAR DETERMINANTS ON THAT 791 00:33:06,720 --> 00:33:10,480 HYPOTHESIS TO GIVE IT MORE 792 00:33:10,480 --> 00:33:10,760 CREDENCE. 793 00:33:10,760 --> 00:33:13,480 RECOGNIZING THE UNIQUENESS IS 794 00:33:13,480 --> 00:33:15,080 VERY IMPORTANT FOR US TO 795 00:33:15,080 --> 00:33:17,960 EVALUATE THE KINDS OF 796 00:33:17,960 --> 00:33:19,040 TREATMENTS, THE SUCCESSES AND 797 00:33:19,040 --> 00:33:20,360 WHAT WORKS AND WHAT DOESN'T 798 00:33:20,360 --> 00:33:22,480 WORK. 799 00:33:22,480 --> 00:33:27,560 TRANSLATING IN GOAL THREE THE 800 00:33:27,560 --> 00:33:30,160 IMPLEMENTATIONAL SCIENCE IS 801 00:33:30,160 --> 00:33:32,520 CRITICAL AS TRAINING THE FUTURE 802 00:33:32,520 --> 00:33:34,320 GENERATIONS AND EXPANDING NEW 803 00:33:34,320 --> 00:33:39,760 PARTNERSHIPS. 804 00:33:39,760 --> 00:33:41,600 NOW WHAT IS GOING TO DRIVE A LOT 805 00:33:41,600 --> 00:33:43,600 OF OUR THINKING IS HOW WE 806 00:33:43,600 --> 00:33:44,840 MEASURE OUR SUCCESS AND AS YOU 807 00:33:44,840 --> 00:33:47,960 CAN SEE HERE VERY WELL 808 00:33:47,960 --> 00:33:50,360 ILLUSTRATED IN THIS SCHEMATIC 809 00:33:50,360 --> 00:33:52,160 THAT DRAWING FROM THE PANDEMIC 810 00:33:52,160 --> 00:33:54,280 TAKING THIS DATA INTO HAND AND 811 00:33:54,280 --> 00:33:56,760 DRIVING NEW INVESTMENTS IS VERY 812 00:33:56,760 --> 00:33:58,040 CRITICAL FOR OUR FUTURE. 813 00:33:58,040 --> 00:34:01,560 SO NOW I WANT TO GO INTO WHAT I 814 00:34:01,560 --> 00:34:06,800 CONSIDER ARE THE TRANS PARADIGM 815 00:34:06,800 --> 00:34:08,840 SHIFTING. 816 00:34:08,840 --> 00:34:13,040 NO DOUBT DATA SCIENCE IS WHERE 817 00:34:13,040 --> 00:34:16,200 -- IS THE FUTURE. 818 00:34:16,200 --> 00:34:17,680 THERE ARE MANY PROGRAMS THAT ARE 819 00:34:17,680 --> 00:34:23,080 GOING TO GIVE US NADCRC A HOME 820 00:34:23,080 --> 00:34:25,160 TO LAUNCH FROM AND YOU'LL HEAR 821 00:34:25,160 --> 00:34:28,160 IT'S ONE AREA THAT WE INTEND TO 822 00:34:28,160 --> 00:34:30,120 PRIORITIZE AND WE CERTAINLY HAVE 823 00:34:30,120 --> 00:34:31,760 THE FOUNDATION PIECES IN PLACE 824 00:34:31,760 --> 00:34:33,680 RIGHT NOW. 825 00:34:33,680 --> 00:34:35,480 AS YOU CAN SEE THROUGH THESE 826 00:34:35,480 --> 00:34:36,440 VARIOUS PROGRAMS. 827 00:34:36,440 --> 00:34:42,560 7 WE ALSO HAVE A VARIETY OF 828 00:34:42,560 --> 00:34:47,520 TRANS NIH PROGRAMS THAT FOCUS ON 829 00:34:47,520 --> 00:34:49,520 PAIN MANAGEMENT OR MISUSE 830 00:34:49,520 --> 00:34:52,000 DISORDERS VERY IMPORTANT 831 00:34:52,000 --> 00:34:53,000 ESPECIALLY DURING THE PANDEMIC. 832 00:34:53,000 --> 00:34:59,040 I WANT TO FOCUS ON HEEL. 833 00:34:59,040 --> 00:35:00,160 -- HEAL. 834 00:35:00,160 --> 00:35:01,360 WE WERE ABLE TO COME TOGETHER 835 00:35:01,360 --> 00:35:04,520 AND I WANT TO THANK LYNN WHO'S A 836 00:35:04,520 --> 00:35:06,360 DIRECTOR OF THE CENTER FOR 837 00:35:06,360 --> 00:35:08,360 COMPLIMENTARY -- OF HEALTH WHO 838 00:35:08,360 --> 00:35:10,320 DROVE THIS INITIATIVE AND 839 00:35:10,320 --> 00:35:12,120 LOOKING TO COME TOGETHER WITH 840 00:35:12,120 --> 00:35:16,280 THE NATIONAL INSTITUTE OF NIAMS 841 00:35:16,280 --> 00:35:19,320 AND A FEW OTHERS TO FOCUS ON 842 00:35:19,320 --> 00:35:22,160 JOINT -- THE PATHOGENESIS OF 843 00:35:22,160 --> 00:35:24,160 JOINT DISEASE AND THERE ARE TWO 844 00:35:24,160 --> 00:35:28,360 MAJOR JOINTS THAT IS THE FOCUS. 845 00:35:28,360 --> 00:35:32,440 LOOKING TO SEE HOW NEURAL OR HOW 846 00:35:32,440 --> 00:35:34,720 INNOVATION JOINED CAN AFFECT THE 847 00:35:34,720 --> 00:35:36,280 NORMAL FUNCTION AND ALSO ITSELF 848 00:35:36,280 --> 00:35:39,960 DISEASE AND PROGRESS AND 849 00:35:39,960 --> 00:35:40,200 DISEASE. 850 00:35:40,200 --> 00:35:42,760 TRACKING NERVES DOWN GIVES US A 851 00:35:42,760 --> 00:35:44,560 SENSE OF WHERE SYMPTOMS ARE 852 00:35:44,560 --> 00:35:46,360 LIKELY TO EMERGE. 853 00:35:46,360 --> 00:35:50,160 SO THIS INITIATIVE IS CALLED 854 00:35:50,160 --> 00:35:52,360 REJOIN AND IT'S NEW TREATMENTS 855 00:35:52,360 --> 00:35:55,000 FOR JOINT PAIN AND THAT RFA IS 856 00:35:55,000 --> 00:35:57,240 OUT AND I ENCOURAGE YOU TO TAKE 857 00:35:57,240 --> 00:35:59,480 NOTE OF THAT AND EVEN IF YOU'RE 858 00:35:59,480 --> 00:36:02,000 NOT WORKING IN THE AREA. 859 00:36:02,000 --> 00:36:04,160 IF YOU HAVE INSIGHTS INTO 860 00:36:04,160 --> 00:36:06,680 INNOVATION AND PATHOGENESIS THIS 861 00:36:06,680 --> 00:36:08,760 IS AN AREA TO INVEST IN. 862 00:36:08,760 --> 00:36:12,960 VERY FORTUNATELY WE ARE HOPEFUL 863 00:36:12,960 --> 00:36:15,160 THAT THERE WILL BE APPROVAL OF 864 00:36:15,160 --> 00:36:19,360 AN INCREASE IN BUDGET OF WHICH 865 00:36:19,360 --> 00:36:21,360 NADCRC WILL GET $18 MILLION THAT 866 00:36:21,360 --> 00:36:22,800 WILL BE DEDICATED TO PAIN 867 00:36:22,800 --> 00:36:23,440 RESEARCH. 868 00:36:23,440 --> 00:36:26,040 WE'RE WAITING FOR THE APPROVAL 869 00:36:26,040 --> 00:36:29,960 TO COME THROUGH AND WE'RE SHOVEL 870 00:36:29,960 --> 00:36:32,880 READY. 871 00:36:32,880 --> 00:36:36,840 AN EXAMPLE IN ONE OF THE 872 00:36:36,840 --> 00:36:40,600 INITIATIVES WOULD BE CREATING A 873 00:36:40,600 --> 00:36:42,160 BRAINSTORMING GROUP ON CAMPUS 874 00:36:42,160 --> 00:36:44,040 THAT ACTUALLY IS HAPPENING RIGHT 875 00:36:44,040 --> 00:36:50,520 NOW TO REALLY MOVE THE FIELD. 876 00:36:50,520 --> 00:36:55,800 IT IS VERY DEBILITATING AND A 877 00:36:55,800 --> 00:36:58,360 COMPLEX DISORDER AS YOU KNOW. 878 00:36:58,360 --> 00:37:00,240 BUT I THINK IT'S THAT COMING 879 00:37:00,240 --> 00:37:03,920 TOGETHER THE HOLISTIC 880 00:37:03,920 --> 00:37:04,880 MULTI-DISCIPLINARY COMING 881 00:37:04,880 --> 00:37:06,360 TOGETHER THAT WILL MAKE THE 882 00:37:06,360 --> 00:37:10,280 BIGGER DIFFERENCE. 883 00:37:10,280 --> 00:37:13,360 AMP IS ONE OF THE MOST EXCITING 884 00:37:13,360 --> 00:37:16,560 PROGRAMS IN A PRIVATE PUBLIC 885 00:37:16,560 --> 00:37:17,720 PARTNERSHIP FOCUSED ON THESE 886 00:37:17,720 --> 00:37:20,240 VARIOUS CONDITIONS ALL OF WHICH 887 00:37:20,240 --> 00:37:22,880 THAT HAVE ADVANCED IN AMAZING 888 00:37:22,880 --> 00:37:24,800 WAYS AND HAS GIVEN RISE TO THE 889 00:37:24,800 --> 00:37:27,320 HOPE THAT THE INFORMATION GAINED 890 00:37:27,320 --> 00:37:33,360 FROM SAY SYSTEMATIC LUPUS AND 891 00:37:33,360 --> 00:37:35,240 RHEUMATOID ARTHRITIS COULD BE 892 00:37:35,240 --> 00:37:39,040 APPLIED TO CHILDREN'S SYNDROME. 893 00:37:39,040 --> 00:37:46,160 WE DO INTEND TO FUND A PROGRAM 894 00:37:46,160 --> 00:37:48,760 AND NADCRC WILL ADMINISTER THAT 895 00:37:48,760 --> 00:37:49,000 PROGRAM. 896 00:37:49,000 --> 00:37:57,200 SO WE EXPECT A LOT OF PROGRESS. 897 00:37:57,200 --> 00:38:03,160 I WANTED TO BRING COUPLES 898 00:38:03,160 --> 00:38:07,840 ANOTHER -- TO DEVELOP A PROGRAM 899 00:38:07,840 --> 00:38:11,080 FOR GENE THERAPY. 900 00:38:11,080 --> 00:38:13,200 THIS WILL BE APPROVED BY FDA 901 00:38:13,200 --> 00:38:15,200 AHEAD OF TIME AND BE MADE 902 00:38:15,200 --> 00:38:17,080 AVAILABLE SO YOU CAN PUT THE 903 00:38:17,080 --> 00:38:18,600 GENE OF INTEREST AND TARGET IT 904 00:38:18,600 --> 00:38:20,760 TO THE TISSUE OF INTEREST. 905 00:38:20,760 --> 00:38:23,760 NOW MOST OF US IN OUR FIELD ARE 906 00:38:23,760 --> 00:38:28,520 DEALING WITH CANIAL FACIAL 907 00:38:28,520 --> 00:38:32,120 DISORDERS THAT ARE DEVELOPING IN 908 00:38:32,120 --> 00:38:32,520 UTERO. 909 00:38:32,520 --> 00:38:35,040 IT IS NOT TECHNOLOGY THAT WE CAN 910 00:38:35,040 --> 00:38:36,560 READILY ACCESS RIGHT NOW. 911 00:38:36,560 --> 00:38:38,760 BUT THERE ARE OTHER CONDITION 912 00:38:38,760 --> 00:38:41,040 THAT'S THIS COULD BE APPLIED TO. 913 00:38:41,040 --> 00:38:42,600 SO PLEASE BE AWARE OF THIS 914 00:38:42,600 --> 00:38:43,000 INITIATIVE. 915 00:38:43,000 --> 00:38:46,320 I WANT TO TIE THIS ALL UP TO SAY 916 00:38:46,320 --> 00:38:49,640 THAT AS AMP EVOLVED WHAT I 917 00:38:49,640 --> 00:38:52,160 CONSIDER CORE PROCESSES THAT IF 918 00:38:52,160 --> 00:38:53,960 WE UNDERSTOOD BETTER WE WOULD 919 00:38:53,960 --> 00:38:56,160 MAKE SO MUCH OF A DIFFERENCE FOR 920 00:38:56,160 --> 00:39:00,560 MANY DISEASES AND ONE IS 921 00:39:00,560 --> 00:39:01,320 INFLAMMATION. 922 00:39:01,320 --> 00:39:03,560 TAKING A SYSTEM'S APPROACH TO 923 00:39:03,560 --> 00:39:06,160 UNDERSTANDING THE INFLAMMATORY 924 00:39:06,160 --> 00:39:06,920 PROCESS. 925 00:39:06,920 --> 00:39:09,480 WATCHING IT CLOSELY BECAUSE 926 00:39:09,480 --> 00:39:11,360 PARODONTAL DISEASE AND SEVERAL 927 00:39:11,360 --> 00:39:14,760 CONDITIONS -- INVOLVE 928 00:39:14,760 --> 00:39:17,440 INFLAMMATION INCLUDING THE 929 00:39:17,440 --> 00:39:19,760 DOWNSTREAM CONSEQUENCES. 930 00:39:19,760 --> 00:39:21,960 IT'S A VERY STEP WISE PROCESS. 931 00:39:21,960 --> 00:39:23,760 IT'S JUST BEGINNING AND IT'S 932 00:39:23,760 --> 00:39:25,800 GOING TO SCALE UP MANY EFFORTS 933 00:39:25,800 --> 00:39:29,560 ACROSS OUR CAMPUS. 934 00:39:29,560 --> 00:39:34,160 NOW WHEN I FIRST STARTED BEFORE 935 00:39:34,160 --> 00:39:36,360 IT WAS AFTER GEORGE FLOYD AND 936 00:39:36,360 --> 00:39:39,160 THE NATIONAL RESPONSE TO THAT 937 00:39:39,160 --> 00:39:41,560 VERY TRAGIC DEATH THAT WE ALL 938 00:39:41,560 --> 00:39:42,960 PAID ATTENTION TO THIS. 939 00:39:42,960 --> 00:39:46,080 AND NIH WAS NO EXCEPTION. 940 00:39:46,080 --> 00:39:47,920 SINCE THEN THIS PROGRAM UNITE 941 00:39:47,920 --> 00:39:49,760 THAT WORKS WITH ALL OF THE OTHER 942 00:39:49,760 --> 00:39:52,000 PROGRAMS ON OUR CAMPUS HAS 943 00:39:52,000 --> 00:39:55,160 PUBLISHED EXTENSIVELY AND YOU 944 00:39:55,160 --> 00:39:57,320 CAN SEE THESE KEY PAPERS 945 00:39:57,320 --> 00:40:00,040 DESCRIBING HOW NIH IS GOING TO 946 00:40:00,040 --> 00:40:01,840 TAKE THIS SERIOUSLY AND HOW 947 00:40:01,840 --> 00:40:02,880 WE'RE GOING TO MOVE OUR 948 00:40:02,880 --> 00:40:03,400 PROGRAMS. 949 00:40:03,400 --> 00:40:06,200 THIS THINKING HAS REALLY 950 00:40:06,200 --> 00:40:07,400 PENETRATED ALL OF OUR PROGRAMS 951 00:40:07,400 --> 00:40:10,160 RIGHT NOW. 952 00:40:10,160 --> 00:40:15,560 AND REALLY AM SO INSPIRED. 953 00:40:15,560 --> 00:40:18,840 THESE ARE JUST A FEW EXAMPLES OF 954 00:40:18,840 --> 00:40:22,160 THE ONGOING INITIATIVES AND ALSO 955 00:40:22,160 --> 00:40:26,400 VISIBLE OFF CAMPUS ARE TRIBUTES 956 00:40:26,400 --> 00:40:28,520 TO UNDER REPRESENTED GROUPS ON 957 00:40:28,520 --> 00:40:30,120 OUR CAMPUS AND LEADERS AS YOU 958 00:40:30,120 --> 00:40:30,800 CAN SEE HERE. 959 00:40:30,800 --> 00:40:36,080 WE HAVE OUR OWN JIMMY DO WHO HAS 960 00:40:36,080 --> 00:40:38,360 PLAYED A VERY IMPORTANT ROLE ON 961 00:40:38,360 --> 00:40:40,520 OUR CAMPUS AND CONTINUES TO BE A 962 00:40:40,520 --> 00:40:40,760 LEADER. 963 00:40:40,760 --> 00:40:42,760 SO WE HAVE CHANGES IN OUR 964 00:40:42,760 --> 00:40:44,640 PHYSICAL WORKPLACE AND AS 965 00:40:44,640 --> 00:40:47,200 JENNIFER DESCRIBES IN THE SLIDE 966 00:40:47,200 --> 00:40:50,000 SHE PUT TOGETHER A WORKFORCE IN 967 00:40:50,000 --> 00:40:54,120 DENSITY IS AND THE ORAL HEALTH 968 00:40:54,120 --> 00:40:57,520 SCIENCES -- PRESENTS A GOOD 969 00:40:57,520 --> 00:40:58,760 OPPORTUNITY FOR MAKING A 970 00:40:58,760 --> 00:40:59,680 DIFFERENCE. 971 00:40:59,680 --> 00:41:02,360 AND YOU CAN LOOK AT THESE 972 00:41:02,360 --> 00:41:04,120 STATISTICS. 973 00:41:04,120 --> 00:41:06,720 NONE OF WHICH WOULD SURPRISE 974 00:41:06,720 --> 00:41:07,120 YOU. 975 00:41:07,120 --> 00:41:08,920 THIS WAS PRESENTED IN THE REPORT 976 00:41:08,920 --> 00:41:12,760 TO SHOW THE PERCENTAGE OF OUR 977 00:41:12,760 --> 00:41:14,480 FUNDED INDIVIDUALS IN EACH OF 978 00:41:14,480 --> 00:41:17,040 THE MECHANISMS THAT WE FUND AND 979 00:41:17,040 --> 00:41:19,640 YOU CAN SEE THAT WE HAVE A LOT 980 00:41:19,640 --> 00:41:24,720 OF WORK TO DO. 981 00:41:24,720 --> 00:41:27,000 SO HOW WE ARE BEGINNING TO 982 00:41:27,000 --> 00:41:27,960 ADDRESS THIS? 983 00:41:27,960 --> 00:41:31,760 AND THERE HAS BEEN A BIT OF A 984 00:41:31,760 --> 00:41:34,640 LAG PERIOD BECAUSE OF TRANS NIH 985 00:41:34,640 --> 00:41:36,800 POLICIES HAVE TO BE IN PLACE 986 00:41:36,800 --> 00:41:39,600 BEFORE NADCRC COULD LAUNCH ANY 987 00:41:39,600 --> 00:41:40,680 INITIATIVE IN THIS AREA. 988 00:41:40,680 --> 00:41:43,960 WE HAVE INTENTIONAL STRATEGIES. 989 00:41:43,960 --> 00:41:47,160 WE HAVE -- LOOKING AT OUR 990 00:41:47,160 --> 00:41:49,760 DATASETS AND DEVELOPING A 991 00:41:49,760 --> 00:41:50,360 PUBLIC/PRIVATE PARTNERSHIP WHICH 992 00:41:50,360 --> 00:41:52,640 WILL BE ONE OF THE WORKFORCE 993 00:41:52,640 --> 00:41:54,440 INITIATIVES TO REALLY BRING 994 00:41:54,440 --> 00:41:56,760 TOGETHER THE GROUP OF 995 00:41:56,760 --> 00:41:58,080 INDIVIDUALS WHO CAN INFLUENCE 996 00:41:58,080 --> 00:42:01,040 WHO WE TRAIN, WHO WE ADMIT 997 00:42:01,040 --> 00:42:01,800 >>> DENTAL SCHOOLS. 998 00:42:01,800 --> 00:42:03,680 HOW MANY GRADUATE TRAINEES WE 999 00:42:03,680 --> 00:42:06,280 INVEST IN. 1000 00:42:06,280 --> 00:42:09,200 AND NIDCD CANNOT DO THIS ALONE. 1001 00:42:09,200 --> 00:42:15,760 WE HAVE TO HAVE THE HELP OF A DA 1002 00:42:15,760 --> 00:42:19,280 AND OTHER ORGANIZATIONS. 1003 00:42:19,280 --> 00:42:22,760 EXPANDING THE WORKFORCE. 1004 00:42:22,760 --> 00:42:24,320 THESE ARE THE GRANTS THAT WE 1005 00:42:24,320 --> 00:42:27,960 FUNDED THAT ARE VERY MUCH 1006 00:42:27,960 --> 00:42:29,720 TARGETED TO ENRICHING OUR 1007 00:42:29,720 --> 00:42:31,320 PIPELINE FOR THE FUTURE. 1008 00:42:31,320 --> 00:42:35,840 AND THIS INCLUDES THE SUCCESSFUL 1009 00:42:35,840 --> 00:42:39,280 AADOCR -- PROGRAM. 1010 00:42:39,280 --> 00:42:41,320 THERE IS A NEED FOR US TO 1011 00:42:41,320 --> 00:42:43,200 ACTUALLY USE ALL OF OUR 1012 00:42:43,200 --> 00:42:45,240 RESOURCES TO INFLUENCE HEALTH 1013 00:42:45,240 --> 00:42:47,200 DISPARITIES TO GATHER THE DATA 1014 00:42:47,200 --> 00:42:49,280 AND TO MAKE A DIFFERENCE IN 1015 00:42:49,280 --> 00:42:51,880 TERMS OF CREATING OR ELIMINATING 1016 00:42:51,880 --> 00:42:55,400 OR REDUCING ANY BIASES AND 1017 00:42:55,400 --> 00:42:57,320 STRUCTURAL BARRIERS THAT EXIST 1018 00:42:57,320 --> 00:42:58,880 IN OUR COMMUNITY AND YOU CAN SEE 1019 00:42:58,880 --> 00:43:00,960 THAT THESE ARE REFLECTED HERE 1020 00:43:00,960 --> 00:43:02,160 WITH THESE PARTICULAR 1021 00:43:02,160 --> 00:43:09,440 MECHANISMS. 1022 00:43:09,440 --> 00:43:10,720 THESE ARE THE VERY NEW 1023 00:43:10,720 --> 00:43:12,120 ANNOUNCEMENTS. 1024 00:43:12,120 --> 00:43:14,000 THE FOAs AND NOTICES THAT ARE 1025 00:43:14,000 --> 00:43:16,560 OUT RIGHT NOW AND VERY SPECIFIC 1026 00:43:16,560 --> 00:43:20,160 AND VERY TARGETED TOPIC AREAS. 1027 00:43:20,160 --> 00:43:22,880 TO GAIN YOUR INPUT AND ALSO FOR 1028 00:43:22,880 --> 00:43:26,160 US TO BE ABLE TO INITIATE FROM 1029 00:43:26,160 --> 00:43:28,600 THESE DIFFERENT GRANT 1030 00:43:28,600 --> 00:43:29,560 OPPORTUNITIES OR FUNDING 1031 00:43:29,560 --> 00:43:34,560 OPPORTUNITIES. 1032 00:43:34,560 --> 00:43:36,760 NOTE THAT THE RESIDENCY AND 1033 00:43:36,760 --> 00:43:38,400 FELLOWSHIP IS OFF TO A GOOD 1034 00:43:38,400 --> 00:43:40,840 START AND THAT WE NOW HAVE 1035 00:43:40,840 --> 00:43:42,400 SELECTED THE CLASS FOR NEXT YEAR 1036 00:43:42,400 --> 00:43:43,760 AND THE PROGRAM WILL OPERATE 1037 00:43:43,760 --> 00:43:46,760 WITH ONE YEAR OF DENTAL PUBLIC 1038 00:43:46,760 --> 00:43:49,400 HEALTH FOCUSED CURRICULUM SO 1039 00:43:49,400 --> 00:43:52,520 FOLKS GET CERTIFIED AND THEN 1040 00:43:52,520 --> 00:43:59,200 MOVE ON TO A VERY FOCUSED TWO 1041 00:43:59,200 --> 00:44:00,680 TWO-YEAR EXPERIENCE. 1042 00:44:00,680 --> 00:44:07,520 AND AS YOU CAN SEE I'M 1043 00:44:07,520 --> 00:44:08,760 MENTIONING -- THE MIND THE 1044 00:44:08,760 --> 00:44:09,440 FUTURE AGAIN. 1045 00:44:09,440 --> 00:44:11,880 THEY ARE TARGETED TOWARDS 1046 00:44:11,880 --> 00:44:14,120 DEVELOPING A MORE COMMITTED 1047 00:44:14,120 --> 00:44:17,840 PIPELINE OF DENTIST SCIENTIST. 1048 00:44:17,840 --> 00:44:19,560 WE'RE STILL NOT THROUGH BUT IT'S 1049 00:44:19,560 --> 00:44:21,240 THE BEGINNING OF THE 1050 00:44:21,240 --> 00:44:23,040 TRANSFORMATION FOR THE TRAINING 1051 00:44:23,040 --> 00:44:25,160 OF SCIENTISTS FOR OUR 1052 00:44:25,160 --> 00:44:27,400 PROFESSION. 1053 00:44:27,400 --> 00:44:29,640 JANICE LEE WILL SOON MENTION THE 1054 00:44:29,640 --> 00:44:31,320 CLINICAL TRAINING RESEARCH 1055 00:44:31,320 --> 00:44:33,520 FELLOWSHIP THAT HER PROGRAM 1056 00:44:33,520 --> 00:44:34,840 RUNS. 1057 00:44:34,840 --> 00:44:36,440 THE DEADLINE IS THE 15th OF 1058 00:44:36,440 --> 00:44:37,880 SEPTEMBER AND IT'S BEEN 1059 00:44:37,880 --> 00:44:39,920 REMARKABLE TO SEE HOW THAT 1060 00:44:39,920 --> 00:44:42,400 PROGRAM HAS SHAPED UP UNDER 1061 00:44:42,400 --> 00:44:43,640 JANICE'S LEADERSHIP AND THE 1062 00:44:43,640 --> 00:44:46,320 IMPACT OF OUR TRAINEES NOW IN 1063 00:44:46,320 --> 00:44:47,440 DIFFERENT INSTITUTIONS ACROSS 1064 00:44:47,440 --> 00:44:52,200 THE COUNTRY AS THEY ARE PLACED 1065 00:44:52,200 --> 00:44:55,760 IN FACULTY POSITIONS. 1066 00:44:55,760 --> 00:44:59,520 IN 21 WE FUNDED THESE RFAs AND 1067 00:44:59,520 --> 00:45:00,880 AWARDS IN ALL OF THESE 1068 00:45:00,880 --> 00:45:04,320 CATEGORIES. 1069 00:45:04,320 --> 00:45:07,760 AND IN 22 WE HAVE RFAs OUT 1070 00:45:07,760 --> 00:45:10,160 HERE THAT ALSO COVER A DIVERSE 1071 00:45:10,160 --> 00:45:13,200 SET OF TOPICS. 1072 00:45:13,200 --> 00:45:20,760 THAT FOCUS BOTH ON -- HEALTH 1073 00:45:20,760 --> 00:45:24,960 DISPARITIES -- AS WELL AND WILL 1074 00:45:24,960 --> 00:45:29,080 BE FUNDING AWARDEES IN THIS 1075 00:45:29,080 --> 00:45:29,560 CYCLE. 1076 00:45:29,560 --> 00:45:32,120 WE ARE IN THE PAST HAVE APPROVED 1077 00:45:32,120 --> 00:45:35,520 COUNCIL -- THESE FOLLOWING 1078 00:45:35,520 --> 00:45:37,280 APPROACHES -- CONCEPTS. 1079 00:45:37,280 --> 00:45:39,200 THEY ARE ALL THERE. 1080 00:45:39,200 --> 00:45:41,080 AND AGAIN VERY DIVERSE. 1081 00:45:41,080 --> 00:45:45,320 AND WE ALSO HAVE NEW CONCEPT 1082 00:45:45,320 --> 00:45:50,200 CLEARANCES TODAY THAT EACH ONE 1083 00:45:50,200 --> 00:45:51,800 -- WHICH IS EXCITING AND I HOPE 1084 00:45:51,800 --> 00:45:56,120 YOU WILL BE ENCOURAGED BY THESE 1085 00:45:56,120 --> 00:45:57,800 EFFORTS TO MOVE OUR PORTFOLIO IN 1086 00:45:57,800 --> 00:45:59,200 POSITIVE WAYS. 1087 00:45:59,200 --> 00:46:01,640 SO NOW WHEN WE LOOK AT WHAT WE 1088 00:46:01,640 --> 00:46:06,240 HAVE IN TERMS OF THE SCIENCE AND 1089 00:46:06,240 --> 00:46:08,160 TECHNOLOGY -- GIFTS OF SCIENCE 1090 00:46:08,160 --> 00:46:09,760 AND TECHNOLOGY WE HAVE TO BE 1091 00:46:09,760 --> 00:46:10,400 THINKING OF THE OPPORTUNITIES 1092 00:46:10,400 --> 00:46:14,040 AND THIS CAME FROM TARA -- TALK 1093 00:46:14,040 --> 00:46:15,120 TO US. 1094 00:46:15,120 --> 00:46:18,560 WHERE CHEF TALKED ABOUT ART 8 1095 00:46:18,560 --> 00:46:21,400 AND THE CHALLENGES -- WHAT CAN 1096 00:46:21,400 --> 00:46:25,760 WE DO TO ACCELERATE THE GREAT 1097 00:46:25,760 --> 00:46:26,320 TRUTHS. 1098 00:46:26,320 --> 00:46:28,000 WE NEED THEM. 1099 00:46:28,000 --> 00:46:32,240 HOW CAN WE REVOLUTIONIZE THE 1100 00:46:32,240 --> 00:46:32,440 COUGS. 1101 00:46:32,440 --> 00:46:35,200 AND TRANSFORM HEALTH CARE AND 1102 00:46:35,200 --> 00:46:36,720 REDUCE HEALTH DISPARITIES. 1103 00:46:36,720 --> 00:46:38,600 THESE ARE GOALS THAT ARE NOT IN 1104 00:46:38,600 --> 00:46:44,760 ANY WAY FOREIGN TO US AT NADCRC. 1105 00:46:44,760 --> 00:46:46,320 WE'RE WELL ALIGNED WITH THESE 1106 00:46:46,320 --> 00:46:49,160 BROADER VISIONARY GOALS. 1107 00:46:49,160 --> 00:46:53,000 SHE ASKED WHAT IF WE COULD 1108 00:46:53,000 --> 00:47:00,160 DEVELOP mRNA VACCINES. 1109 00:47:00,160 --> 00:47:00,440 ZIP CODES. 1110 00:47:00,440 --> 00:47:02,000 WHAT ABOUT THE PLATFORM BASED 1111 00:47:02,000 --> 00:47:03,720 TECHNOLOGIES THAT WOULD ALLOW US 1112 00:47:03,720 --> 00:47:08,120 QUICKLY TO ASSESS CONDITIONS OR 1113 00:47:08,120 --> 00:47:12,440 LOOKING AT THE PROGRESS. 1114 00:47:12,440 --> 00:47:14,360 COULD WE HAVE INTERVENTIONS THAT 1115 00:47:14,360 --> 00:47:17,520 ADDRESS HEALTH INEQUITIES. 1116 00:47:17,520 --> 00:47:22,320 NONE ARE IMPOSSIBLE TO ACHIEVE. 1117 00:47:22,320 --> 00:47:26,560 AND THEN FINALLY SHE HAD THE 1118 00:47:26,560 --> 00:47:28,000 PATIENT CENTERED OR PATIENT 1119 00:47:28,000 --> 00:47:29,560 CONTROLLED TECHNOLOGIES THAT WE 1120 00:47:29,560 --> 00:47:32,280 IN DENTISTRY AND/ORAL HEALTH 1121 00:47:32,280 --> 00:47:35,320 VALUE TREMENDOUSLY. 1122 00:47:35,320 --> 00:47:38,320 NOW I WANT TO SAY THAT THE 1123 00:47:38,320 --> 00:47:40,160 VISION THAT I WOULD HAVE IS AS 1124 00:47:40,160 --> 00:47:43,400 WE INVEST -- WE'VE GOT THREE 1125 00:47:43,400 --> 00:47:51,080 MAJOR INITIATIVES. 1126 00:47:51,080 --> 00:47:55,360 IT WOULD BE LOVELY THAT IF THE 1127 00:47:55,360 --> 00:48:00,000 INITIATIVE -- ARE CREATING 1128 00:48:00,000 --> 00:48:01,120 REGENERATIVE STRATEGIES. 1129 00:48:01,120 --> 00:48:03,600 ONCE WE ADVANCE OUR BASIC 1130 00:48:03,600 --> 00:48:05,440 UNDERSTANDING OF OUR DISEASES 1131 00:48:05,440 --> 00:48:07,760 AND MAKE THE CONNECTIONS TO 1132 00:48:07,760 --> 00:48:12,160 SYSTEMATIC DISEASES THIS -- 1133 00:48:12,160 --> 00:48:14,160 THERAPIES AND CURES TARGETED TO 1134 00:48:14,160 --> 00:48:16,400 TISSUE REGENERATION CAN ACTUALLY 1135 00:48:16,400 --> 00:48:19,320 PERHAPS BE TESTED IN THE PDRN 1136 00:48:19,320 --> 00:48:22,160 BUT IN THE MEANTIME HAS GROWN IN 1137 00:48:22,160 --> 00:48:24,800 ENROLLING DIVERSE POPULATION OF 1138 00:48:24,800 --> 00:48:28,120 PATIENTS AND PRACTITIONERS AND 1139 00:48:28,120 --> 00:48:30,560 ALMOST BEING READY TO BE 1140 00:48:30,560 --> 00:48:32,440 MOBILIZED SHOULD WE HAVE ANOTHER 1141 00:48:32,440 --> 00:48:33,160 PANDEMIC. 1142 00:48:33,160 --> 00:48:36,400 SO THESE ARE THE PARTS THAT WE 1143 00:48:36,400 --> 00:48:37,960 HAVE. 1144 00:48:37,960 --> 00:48:40,880 COULD -- FACE BASE MAKE IT ONE 1145 00:48:40,880 --> 00:48:43,880 THAT IS HOLISTIC IN NATURE WITH 1146 00:48:43,880 --> 00:48:45,960 DEEP PHENOTYPING DATA THAT 1147 00:48:45,960 --> 00:48:48,600 COVERS THE SPAN OF DISEASE 1148 00:48:48,600 --> 00:48:50,640 ACROSS THE LIFE-SPAN SO THAT A 1149 00:48:50,640 --> 00:48:53,080 CLINICIAN WANTING TO KNOW MORE 1150 00:48:53,080 --> 00:48:54,960 ABOUT A CERTAIN CONDITION -- 1151 00:48:54,960 --> 00:48:57,640 COULD ACTUALLY GET GUIDANCE AND 1152 00:48:57,640 --> 00:49:00,080 WE COULD THEN BE DRIVEN TO 1153 00:49:00,080 --> 00:49:00,760 THERAPIES. 1154 00:49:00,760 --> 00:49:07,280 THAT IS HOW I WOULD SECRETARY -- I WOULD C ONNECT 1155 00:49:07,280 --> 00:49:11,160 AS WE THINK ABOUT THE FUTURE. 1156 00:49:11,160 --> 00:49:14,480 I WOULD LIKE TO ENGAGE COUNCIL 1157 00:49:14,480 --> 00:49:16,320 -- THIS IT IS THE RIGHT HAND OF 1158 00:49:16,320 --> 00:49:18,200 THE DIRECTOR IN MANY WAYS. 1159 00:49:18,200 --> 00:49:23,160 I WATCHED HOW FRANCIS COLLINS SO 1160 00:49:23,160 --> 00:49:25,880 WELL ENGAGED HIS ADVISORY 1161 00:49:25,880 --> 00:49:28,120 COUNCIL AND ON VERY KEY 1162 00:49:28,120 --> 00:49:29,480 SOMETIMES CONTROVERSIAL 1163 00:49:29,480 --> 00:49:31,880 INITIATIVES TO GET THEIR 1164 00:49:31,880 --> 00:49:33,960 FEEDBACK TO TAKE SERIOUSLY THE 1165 00:49:33,960 --> 00:49:35,960 RECOMMENDATIONS. 1166 00:49:35,960 --> 00:49:39,160 THAT IS HOW THEY FORMULATED. 1167 00:49:39,160 --> 00:49:40,960 I WOULD LIKE TO SET UP WORKING 1168 00:49:40,960 --> 00:49:42,440 GROUPS ON COUNCIL DRIVEN BY 1169 00:49:42,440 --> 00:49:42,960 COUNCIL MEMBERS. 1170 00:49:42,960 --> 00:49:45,000 THERE IS A STRICT PROTOCOL THAT 1171 00:49:45,000 --> 00:49:47,360 WE NEED TO FOLLOW AND WE WILL. 1172 00:49:47,360 --> 00:49:49,480 AND IN LOOKING AT THE LONG LIST 1173 00:49:49,480 --> 00:49:51,800 I CAME UP WITH THESE THREE THAT 1174 00:49:51,800 --> 00:49:53,480 SEEMED ABSOLUTELY CRITICAL RIGHT 1175 00:49:53,480 --> 00:49:54,240 NOW. 1176 00:49:54,240 --> 00:49:56,800 DATA SCIENCE FOR ORAL HEALTH 1177 00:49:56,800 --> 00:49:57,200 RESEARCH. 1178 00:49:57,200 --> 00:50:02,760 THE INTEGRATE OF TRAINING FOR 1179 00:50:02,760 --> 00:50:05,880 ORAL HEALTH PROFESSIONALS OF THE 1180 00:50:05,880 --> 00:50:09,320 FUTURE AND ENHANCING EDI FOR OUR 1181 00:50:09,320 --> 00:50:10,760 WORKFORCE AND THESE THREE 1182 00:50:10,760 --> 00:50:16,160 WORKING GROUPS WILL ENGAGE AND 1183 00:50:16,160 --> 00:50:19,720 BRING TO COUNCIL HOPEFULLY IN 1184 00:50:19,720 --> 00:50:21,840 MAY AND MAYBE SEPTEMBER COUNCIL. 1185 00:50:21,840 --> 00:50:25,400 A FIRM PLAN OF DIRECTORS THAT WE 1186 00:50:25,400 --> 00:50:26,640 CAN CONSIDER AS A GROUP. 1187 00:50:26,640 --> 00:50:31,560 SO, THAT IS ONE NEW CHANGE THAT 1188 00:50:31,560 --> 00:50:32,760 PEOPLE SEE FOR THE FUTURE. 1189 00:50:32,760 --> 00:50:34,880 WE ARE ALSO FINDING A LOT OF 1190 00:50:34,880 --> 00:50:39,480 VALUE IN ENGAGING THINK TANKS IN 1191 00:50:39,480 --> 00:50:41,280 AREAS OF EMERGING INTEREST AND 1192 00:50:41,280 --> 00:50:44,760 CONCERN. 1193 00:50:44,760 --> 00:50:51,720 ONE IS HPV. 1194 00:50:51,720 --> 00:50:54,200 SO WE DID GET A GROUP TOGETHER 1195 00:50:54,200 --> 00:50:56,200 LAST WEEK OF FUNDED RESEARCHERS 1196 00:50:56,200 --> 00:50:59,360 WHO ARE LEADING THE FIELD ALONG 1197 00:50:59,360 --> 00:51:02,360 WITH NED WHO KICKED IT OFF AND 1198 00:51:02,360 --> 00:51:06,040 VERY GRATEFUL TO -- WHO HAS BEEN 1199 00:51:06,040 --> 00:51:09,440 STEADFAST IN HIS SUPPORT OF 1200 00:51:09,440 --> 00:51:11,560 NADCRC'S PROGRAM AND WAS 1201 00:51:11,560 --> 00:51:12,520 INVOLVED IN THE ORGANIZATION OF 1202 00:51:12,520 --> 00:51:15,360 THE THINK TANK ALONG WITH JOHN 1203 00:51:15,360 --> 00:51:18,160 CHEN AND AMANDA -- AND LILLIAN 1204 00:51:18,160 --> 00:51:18,560 SHUN. 1205 00:51:18,560 --> 00:51:20,680 SO WE HAVE A SET OF 1206 00:51:20,680 --> 00:51:21,680 RECOMMENDATIONS VERY PRODUCTIVE 1207 00:51:21,680 --> 00:51:23,880 AND THAT WILL BE NOW PROCESSED 1208 00:51:23,880 --> 00:51:26,120 MORE DEEPLY SUCH THAT WE DO HAVE 1209 00:51:26,120 --> 00:51:28,360 A PLAN FOR ACTION IN A FEW 1210 00:51:28,360 --> 00:51:30,240 MONTHS AND YOU CAN IMAGINE HOW 1211 00:51:30,240 --> 00:51:33,760 MANY WORKING GROUP WELL THINK 1212 00:51:33,760 --> 00:51:35,680 TANKS CAN HAPPEN VIRTUALLY 1213 00:51:35,680 --> 00:51:35,880 RIGHT? 1214 00:51:35,880 --> 00:51:38,720 IN A MANNER THAT IS CONVENIENT 1215 00:51:38,720 --> 00:51:40,360 AND PRODUCTIVE FOR ALL OF US. 1216 00:51:40,360 --> 00:51:42,200 THAT IS ONE OF THE WAYS THAT WE 1217 00:51:42,200 --> 00:51:43,160 MOVE THROUGH. 1218 00:51:43,160 --> 00:51:46,480 SO I WANT TO THANK YOU STAFF FOR 1219 00:51:46,480 --> 00:51:48,560 YOUR AMAZING SUPPORT. 1220 00:51:48,560 --> 00:51:50,360 YOU MAKE EVERY DAY FOR ME AN 1221 00:51:50,360 --> 00:51:53,840 HONOR AND PRIVILEGE TO SERVE. 1222 00:51:53,840 --> 00:51:57,480 I HAVE MANY OF THE EXECUTIVES -- 1223 00:51:57,480 --> 00:52:00,400 ALL OF THEM TO THANK PERSONALLY 1224 00:52:00,400 --> 00:52:02,000 AND YOU KNOW WHO YOU ARE AND YOU 1225 00:52:02,000 --> 00:52:04,200 KNOW THAT WE AS A TEAM ARE 1226 00:52:04,200 --> 00:52:04,960 UNBEATABLE. 1227 00:52:04,960 --> 00:52:08,160 AND THAT WE WILL BRING TO NADCRC 1228 00:52:08,160 --> 00:52:10,320 AND THE COMMUNITY THIS 1229 00:52:10,320 --> 00:52:12,400 UNWAVERING COMMITMENT FOR 1230 00:52:12,400 --> 00:52:13,560 SCIENTIFIC EXCELLENCE AND ALL 1231 00:52:13,560 --> 00:52:15,920 THAT WE STAND AS TRUTH. 1232 00:52:15,920 --> 00:52:21,560 SO THANK YOU VERY MUCH. 1233 00:52:21,560 --> 00:52:24,360 I WANT NOW TO INTRODUCE WITH 1234 00:52:24,360 --> 00:52:32,160 GREAT PRIDE A FELLOW COLLEAGUE 1235 00:52:32,160 --> 00:52:35,480 ELISEO -- PEREZ-STABLE: COMES 1236 00:52:35,480 --> 00:52:37,720 TO US WITH AGREEING TO TALK 1237 00:52:37,720 --> 00:52:41,480 ABOUT HIS INSTITUTE AND THE 1238 00:52:41,480 --> 00:52:44,360 INITIATIVES ESPECIALLY THE ONES 1239 00:52:44,360 --> 00:52:55,040 INITIATED DURING THE PANDEMIC. 1240 00:52:55,040 --> 00:52:58,760 ELISEO BRINGS EXPERTISE THAT 1241 00:52:58,760 --> 00:53:00,720 SPANS DECADES. 1242 00:53:00,720 --> 00:53:04,720 HAS DEVOTED HIS RESEARCH TO MANY 1243 00:53:04,720 --> 00:53:06,120 AREAS THAT INVOLVE CANCER AND 1244 00:53:06,120 --> 00:53:10,000 WILL HEALTH CARE IN GENERAL AND 1245 00:53:10,000 --> 00:53:11,880 OF COURSE HIS SERVICE JUST OVER 1246 00:53:11,880 --> 00:53:19,480 THE LAST YEAR -- WAS 1247 00:53:19,480 --> 00:53:21,720 ACKNOWLEDGED. 1248 00:53:21,720 --> 00:53:24,960 SO FOLLOWING ELISEO WHO WILL 1249 00:53:24,960 --> 00:53:27,200 TALK ABOUT THIS INITIATIVE AND 1250 00:53:27,200 --> 00:53:28,560 FROM WHICH WE COULD BE INSPIRED 1251 00:53:28,560 --> 00:53:30,800 TO DO SIMILAR THINGS IN THE NEAR 1252 00:53:30,800 --> 00:53:33,040 FUTURE. 1253 00:53:33,040 --> 00:53:34,960 WE HAVE THREE WONDERFUL 1254 00:53:34,960 --> 00:53:37,600 COLLEAGUES AND LEADERS. 1255 00:53:37,600 --> 00:53:40,080 MICHELLE CULP WHO SOME OF YOU 1256 00:53:40,080 --> 00:53:40,560 MIGHT KNOW. 1257 00:53:40,560 --> 00:53:43,160 SHE WAS PART OF OUR LEADERSHIP A 1258 00:53:43,160 --> 00:53:47,240 FEW YEARS AGO. 1259 00:53:47,240 --> 00:53:51,560 SHE HAD A BROADER PICTURE AND 1260 00:53:51,560 --> 00:53:53,960 WHAT NIH IS WATCHING FOR. 1261 00:53:53,960 --> 00:53:56,160 THERE WERE SO MANY QUESTIONS 1262 00:53:56,160 --> 00:53:58,960 RAISED ABOUT THE NEED FOR 1263 00:53:58,960 --> 00:54:01,320 [ INAUDIBLE ] IN TIMES OF 1264 00:54:01,320 --> 00:54:01,800 EMERGENCY. 1265 00:54:01,800 --> 00:54:07,880 IT'S NOT A TOPIC BUT MADE ME 1266 00:54:07,880 --> 00:54:09,960 THINK THAT PERHAPS WE COULD 1267 00:54:09,960 --> 00:54:12,040 CREATE THAT. 1268 00:54:12,040 --> 00:54:13,800 JANICE LEE WHO YOU KNOW HAS MADE 1269 00:54:13,800 --> 00:54:15,440 REMARKABLE CHANGES IN THE 1270 00:54:15,440 --> 00:54:17,160 PROGRAM AND HAS DEVELOPED IT TO 1271 00:54:17,160 --> 00:54:18,680 A POINT OF NATIONAL IMPACT. 1272 00:54:18,680 --> 00:54:21,000 JANICE WILL TALK ABOUT THAT 1273 00:54:21,000 --> 00:54:26,520 PROGRAM AND ANNA NICHOLSON HAS 1274 00:54:26,520 --> 00:54:29,640 HER OWN OFFICE THAT REALLY 1275 00:54:29,640 --> 00:54:30,960 EXTENDS THROUGHOUT THE COUNTRY. 1276 00:54:30,960 --> 00:54:34,160 SO I THANK ALL THREE OF YOU A 1277 00:54:34,160 --> 00:54:36,360 AMAZING WOMEN WHO I AM REALLY 1278 00:54:36,360 --> 00:54:39,760 THRILLED TO INVITE TO THE 1279 00:54:39,760 --> 00:54:39,960 SESSION. 1280 00:54:39,960 --> 00:54:42,160 SO WITH THAT DONE I DON'T KNOW 1281 00:54:42,160 --> 00:54:49,080 HOW WE'VE DONE TIMEWISE CAN WE 1282 00:54:49,080 --> 00:54:51,720 GET ELISEO ON-BOARD 1283 00:54:51,720 --> 00:54:55,760 >> I'M HERE. 1284 00:54:55,760 --> 00:54:56,320 >> WONDERFUL PRESENTATION. 1285 00:54:56,320 --> 00:55:00,520 THANK YOU FOR THE INTRODUCTION 1286 00:55:00,520 --> 00:55:03,040 AND IS A PRIVILEGE TO LISTEN TO 1287 00:55:03,040 --> 00:55:04,400 ANOTHER DIRECTOR PRESENT AT 1288 00:55:04,400 --> 00:55:04,920 COUNCIL. 1289 00:55:04,920 --> 00:55:06,920 BECAUSE WE DON'T GET THOSE 1290 00:55:06,920 --> 00:55:08,960 OPPORTUNITIES TOO OFTEN. 1291 00:55:08,960 --> 00:55:11,320 I WAS GLAD I WAS ABLE TO MAKE 1292 00:55:11,320 --> 00:55:12,840 THE TIME AND THANK YOU FOR THE 1293 00:55:12,840 --> 00:55:16,760 INVITATION. 1294 00:55:16,760 --> 00:55:18,160 GOOD IDEAS FOR MY COUNCIL NEXT 1295 00:55:18,160 --> 00:55:18,880 WEEK. 1296 00:55:18,880 --> 00:55:21,960 I WILL SHARE THE SCREEN AND MOVE 1297 00:55:21,960 --> 00:55:28,200 AND ADVANCE MY SLIDES. 1298 00:55:28,200 --> 00:55:55,400 METROPOLITAN LET ME 1299 00:55:55,400 --> 00:56:00,040 >> I HAD NOT MET RENA IN PERSON. 1300 00:56:00,040 --> 00:56:02,960 THAT IS INTERESTING. 1301 00:56:02,960 --> 00:56:05,760 YOU'RE ALWAYS REFERRED TO THE 1302 00:56:05,760 --> 00:56:08,120 COVID DIRECTORS AND CLEARLY WE 1303 00:56:08,120 --> 00:56:10,280 DID HAVE A ZOOM INTERVIEW. 1304 00:56:10,280 --> 00:56:12,320 I WAS PRIVILEGED TO DO 1305 00:56:12,320 --> 00:56:14,000 INTERVIEWS IN THE THIRD PHASE. 1306 00:56:14,000 --> 00:56:17,880 SO I'M DELIGHTED TO BE AND NIH 1307 00:56:17,880 --> 00:56:20,760 AND PARTNER WITH ALL OF US TO 1308 00:56:20,760 --> 00:56:24,520 MOVE THE AGENDA FORWARD. 1309 00:56:24,520 --> 00:56:27,560 SO AFTER I WAS ASKED TO TALK 1310 00:56:27,560 --> 00:56:29,760 ABOUT RADx BUT I THOUGHT I 1311 00:56:29,760 --> 00:56:36,000 WOULD GIVE A GENERAL OVERVIEW OF 1312 00:56:36,000 --> 00:56:38,280 NIMHD WITH SOME OVERLAPS THAT WE 1313 00:56:38,280 --> 00:56:39,800 HAVE WITH THE AGENDA. 1314 00:56:39,800 --> 00:56:41,720 I'LL START WITH OUR DEFINITIONS 1315 00:56:41,720 --> 00:56:43,960 OF POPULATIONS WITH HEALTH 1316 00:56:43,960 --> 00:56:44,240 DISPARITIES. 1317 00:56:44,240 --> 00:56:45,720 THE FIRST THREE BULLETS ON THE 1318 00:56:45,720 --> 00:56:48,040 SLIDE WAS IN OUR ORIGINAL 1319 00:56:48,040 --> 00:56:50,160 LEGISLATION IN THE YEAR 2000. 1320 00:56:50,160 --> 00:56:52,840 SO ALL RACIAL AND ETHNIC 1321 00:56:52,840 --> 00:56:55,360 MINORITY GROUPS AS DEFINED BY 1322 00:56:55,360 --> 00:56:59,840 THE CENSUS SO THAT COULD EVOLVE. 1323 00:56:59,840 --> 00:57:04,080 THIS IS REFERENCE TO ALL POOR 1324 00:57:04,080 --> 00:57:05,360 PEOPLE OF ANY COLOR. 1325 00:57:05,360 --> 00:57:11,160 WE ARE NOT INTERESTED IN -- 1326 00:57:11,160 --> 00:57:13,520 INTERESTED IN POOR WHITES. 1327 00:57:13,520 --> 00:57:15,760 SO THE SOCIO ECONOMIC STATUS IS 1328 00:57:15,760 --> 00:57:18,400 IMPORTANT AND THEN RURAL 1329 00:57:18,400 --> 00:57:19,240 RESIDENTS. 1330 00:57:19,240 --> 00:57:20,840 WE QUALIFIED THAT AS THE 1331 00:57:20,840 --> 00:57:21,800 UNDERSERVED. 1332 00:57:21,800 --> 00:57:24,120 WE DECLARED SEXUAL AND GENDER 1333 00:57:24,120 --> 00:57:28,800 MINORITIES AS A POPULATION FOR 1334 00:57:28,800 --> 00:57:31,160 HEALTH DISPARITIES AFTER SEVERAL 1335 00:57:31,160 --> 00:57:32,120 YEARS OF WORK. 1336 00:57:32,120 --> 00:57:36,360 LED BY LARRY DAY BACK. 1337 00:57:36,360 --> 00:57:41,920 *. 1338 00:57:41,920 --> 00:57:43,800 WE EMBRACED A NOTION IS THAT ALL 1339 00:57:43,800 --> 00:57:47,080 OF THESE POPULATIONS SHARE A 1340 00:57:47,080 --> 00:57:48,160 SOCIAL DISADVANTAGE THAT RESULTS 1341 00:57:48,160 --> 00:57:50,120 FROM HAVING BEEN SUBJECT TO 1342 00:57:50,120 --> 00:57:52,200 DISCRIMINATION OR RACISM AND 1343 00:57:52,200 --> 00:57:53,440 BEING UNDERSERVED IN HEALTH 1344 00:57:53,440 --> 00:57:54,240 CARE. 1345 00:57:54,240 --> 00:57:56,040 SO A HEALTH OUTCOME THAT IS 1346 00:57:56,040 --> 00:57:57,960 WORSE IN ONE OF THESE 1347 00:57:57,960 --> 00:58:00,280 POPULATIONS IN COMPARISON TO A 1348 00:58:00,280 --> 00:58:02,600 REFERENCE GROUP IS WHAT WE USE 1349 00:58:02,600 --> 00:58:06,240 AS A DEFINITION FOR HEALTH 1350 00:58:06,240 --> 00:58:06,520 DISPARITY. 1351 00:58:06,520 --> 00:58:10,000 NOW A SECOND IMPORTANT POINT IS 1352 00:58:10,000 --> 00:58:12,760 THAT RACE AND ETHNICITY AS A 1353 00:58:12,760 --> 00:58:15,200 SOCIAL CONSTRUCT SELF-IDENTIFIED 1354 00:58:15,200 --> 00:58:17,400 SOCIAL CONSTRUCT AND 1355 00:58:17,400 --> 00:58:20,160 SOCIOECONOMIC STATUS AS A 1356 00:58:20,160 --> 00:58:23,320 MEASURED OUTCOME OR VARIABLE ARE 1357 00:58:23,320 --> 00:58:25,920 FUNDAMENTAL IN INFLUENCING 1358 00:58:25,920 --> 00:58:27,240 HEALTH. 1359 00:58:27,240 --> 00:58:28,800 THERE ARE MANY DATA THAT 1360 00:58:28,800 --> 00:58:30,280 INDICATE THIS AND BECAUSE OF 1361 00:58:30,280 --> 00:58:32,760 THIS I WOULD SAY THAT IN ALL 1362 00:58:32,760 --> 00:58:34,480 CLINICAL RESEARCH OR ALL 1363 00:58:34,480 --> 00:58:36,440 RESEARCH RELATED TO HUMAN BEINGS 1364 00:58:36,440 --> 00:58:39,120 AND ALL CLINICAL SERVICES WITH 1365 00:58:39,120 --> 00:58:41,000 HUMAN BEINGS SHOULD MEASURE 1366 00:58:41,000 --> 00:58:42,760 THESE AND AT LEAST CONSIDER THEM 1367 00:58:42,760 --> 00:58:44,280 AS INFLUENCING OUTCOMES. 1368 00:58:44,280 --> 00:58:49,000 WE KNOW THAT RACE ETHNICITY AND 1369 00:58:49,000 --> 00:58:53,760 SOCIAL ECONOMIC -- HAS LIFE -- 1370 00:58:53,760 --> 00:58:56,080 AND MORTALITY THAT ARE NOT FULLY 1371 00:58:56,080 --> 00:58:57,280 EXPLAINED. 1372 00:58:57,280 --> 00:59:00,240 AFRICAN-AMERICANS IN THE REGARD 1373 00:59:00,240 --> 00:59:03,440 STUDY SAME AGE -- HAD TWO TIMES 1374 00:59:03,440 --> 00:59:05,560 THE NUMBER OF INCIDENT STROKES 1375 00:59:05,560 --> 00:59:08,120 WHEN COMPARED TO THE WHITE 1376 00:59:08,120 --> 00:59:10,960 COUNTERPARTS FOR THE EXACT SAME 1377 00:59:10,960 --> 00:59:15,560 LEVEL OF BLOOD PRESSURE UNDER 1378 00:59:15,560 --> 00:59:15,720 160. 1379 00:59:15,720 --> 00:59:17,880 ALMOST ALL CHRONIC DISEASES ARE 1380 00:59:17,880 --> 00:59:19,880 MORE COMMON IN PEOPLE WHO ARE 1381 00:59:19,880 --> 00:59:22,000 POOR AND YET THIS IS NOT REALLY 1382 00:59:22,000 --> 00:59:23,920 BECAUSE OF BAD BEHAVIOR. 1383 00:59:23,920 --> 00:59:28,160 THERE ARE MANY STRUCTURE -- 1384 00:59:28,160 --> 00:59:30,360 ISSUES AND WITHIN A COMMON 1385 00:59:30,360 --> 00:59:34,800 DISEASE SUCH AS TYPE II DIABETES 1386 00:59:34,800 --> 00:59:35,760 -- 1387 00:59:35,760 --> 00:59:37,640 [ INAUDIBLE ] PERSONS FROM ANY 1388 00:59:37,640 --> 00:59:39,960 RACIAL AND ETHNIC MINORITY GROUP 1389 00:59:39,960 --> 00:59:43,760 HAD LESS HEART DISEASE BY 30% 1390 00:59:43,760 --> 00:59:46,640 AND MORE END STAGE RENAL DISEASE 1391 00:59:46,640 --> 00:59:49,960 WHEN COMPARED TO THEIR WHITE 1392 00:59:49,960 --> 00:59:52,120 COUNTERPARTS AT 10 YEARS OF 1393 00:59:52,120 --> 00:59:52,360 FOLLOW-UP. 1394 00:59:52,360 --> 00:59:53,480 WE ALSO ACKNOWLEDGE THAT THERE 1395 00:59:53,480 --> 00:59:57,000 ARE MANY SOCIAL DETERMINANTS OF 1396 00:59:57,000 --> 00:59:57,880 HEALTH. 1397 00:59:57,880 --> 01:00:00,320 WE LIKE TO CALL THE INDIVIDUAL 1398 01:00:00,320 --> 01:00:02,440 SOCIAL DETERMINANTS OF HEALTH 1399 01:00:02,440 --> 01:00:04,760 INCLUDING DEMOGRAPHICS AND 1400 01:00:04,760 --> 01:00:06,160 FAMILY BACKGROUND. 1401 01:00:06,160 --> 01:00:07,640 WHERE YOU LIVE. 1402 01:00:07,640 --> 01:00:10,200 CULTURAL IDENTITY. 1403 01:00:10,200 --> 01:00:10,560 SPIRITUALITY. 1404 01:00:10,560 --> 01:00:12,760 LANGUAGE PROFICIENCY AND HEALTH 1405 01:00:12,760 --> 01:00:16,080 LITERACY PARTICULARLY IMPORTANT 1406 01:00:16,080 --> 01:00:17,560 AND HEALTH FUME SEE WHICH HAS 1407 01:00:17,560 --> 01:00:21,160 NOT BEEN STUDIED AS MUCH. 1408 01:00:21,160 --> 01:00:23,680 *. 1409 01:00:23,680 --> 01:00:25,560 IT HAS COME VERY MUCH TO 1410 01:00:25,560 --> 01:00:27,360 ATTENTION NOW IN PART TRIGGERED 1411 01:00:27,360 --> 01:00:29,800 BY THE COVID-19 PANDEMIC BUT 1412 01:00:29,800 --> 01:00:31,800 PRECEDING THAT AND YOU CAN SEE 1413 01:00:31,800 --> 01:00:34,280 HOUSING, GREEN SPACE AND ACCESS 1414 01:00:34,280 --> 01:00:35,560 TO BROADBAND. 1415 01:00:35,560 --> 01:00:37,720 ISN'T IS THAT IMPORTANT. 1416 01:00:37,720 --> 01:00:39,160 ECONOMIC OPPORTUNITY THAT IS 1417 01:00:39,160 --> 01:00:41,840 ACCESSIBLE TO WHERE YOU LIVE. 1418 01:00:41,840 --> 01:00:44,760 TRANSPORTATION, SCHOOLS OF HIGH 1419 01:00:44,760 --> 01:00:46,880 QUALITY. 1420 01:00:46,880 --> 01:00:48,240 HEALTHY FOOD. 1421 01:00:48,240 --> 01:00:50,080 AND ISSUES AROUND PUBLIC SAFETY 1422 01:00:50,080 --> 01:00:54,920 AND CRIMINAL JUSTICE. 1423 01:00:54,920 --> 01:00:57,760 IN 2018 OR 19 WE UNDERTOOK A 1424 01:00:57,760 --> 01:01:01,400 PROCESS THAT THROUGH THE PHOENIX 1425 01:01:01,400 --> 01:01:03,080 TOOLKIT PROCESS WHICH IS A 1426 01:01:03,080 --> 01:01:04,000 WEBSITE. 1427 01:01:04,000 --> 01:01:07,560 THE LINK IS LISTED THERE TO VET 1428 01:01:07,560 --> 01:01:09,360 WHAT WE CALLED STANDARDIZED 1429 01:01:09,360 --> 01:01:10,680 MEASURES OF SOCIAL DETERMINANTS 1430 01:01:10,680 --> 01:01:12,160 OF HEALTH. 1431 01:01:12,160 --> 01:01:14,880 WE GATHERED WHAT WAS ON THE 1432 01:01:14,880 --> 01:01:16,040 WEBSITE MOSTLY INDIVIDUAL, WE 1433 01:01:16,040 --> 01:01:17,600 WENT THROUGH A YEAR AND A HALF 1434 01:01:17,600 --> 01:01:19,720 EXPERT COMMITTEE PROCESS TO 1435 01:01:19,720 --> 01:01:21,600 REVIEW THESE AND WENT THROUGH AN 1436 01:01:21,600 --> 01:01:24,760 INITIAL PHASE I THAT WE LAUNCHED 1437 01:01:24,760 --> 01:01:26,920 IN MAY 2020. 1438 01:01:26,920 --> 01:01:28,360 WE'RE NOW UNDERGOING A SECOND 1439 01:01:28,360 --> 01:01:30,160 PHASE TO CONTINUE TO EXPAND THIS 1440 01:01:30,160 --> 01:01:32,560 LIST AND WE'RE ENCOURAGING ALL 1441 01:01:32,560 --> 01:01:35,560 OF OUR INVESTIGATORS THROUGH --- 1442 01:01:35,560 --> 01:01:38,040 [ INAUDIBLE ] TO REFER TO THIS 1443 01:01:38,040 --> 01:01:40,760 WEBSITE TO USE THOSE MEASURES 1444 01:01:40,760 --> 01:01:41,680 THAT WE HAVE. 1445 01:01:41,680 --> 01:01:43,240 WE ALSO DEVELOPED A RESEARCH 1446 01:01:43,240 --> 01:01:44,800 FRAMEWORK FOR MINORITY HEALTH 1447 01:01:44,800 --> 01:01:47,360 AND HEALTH DISPARITIES MODELED 1448 01:01:47,360 --> 01:01:50,160 IN PART ON ONE THAT I WORKED ON 1449 01:01:50,160 --> 01:01:51,720 WHEN I WAS ON THE NATIONAL 1450 01:01:51,720 --> 01:01:53,920 INSTITUTE OF AGING COUNCIL ALONG 1451 01:01:53,920 --> 01:01:56,760 WITH MARIE BERNARD AND CARL HILL 1452 01:01:56,760 --> 01:01:59,120 AND NORMAN KAPLAN. 1453 01:01:59,120 --> 01:02:02,640 AND IT INCLUDES NOT ONLY THE 1454 01:02:02,640 --> 01:02:04,040 BIOLOGICAL COMPONENTS THAT HAVE 1455 01:02:04,040 --> 01:02:05,720 EXPLODED IN THE LAST TWO DECADES 1456 01:02:05,720 --> 01:02:08,240 BUT ALSO THE PHYSICAL BUILT IN 1457 01:02:08,240 --> 01:02:09,560 ENVIRONMENT COMPONENTS THAT ALSO 1458 01:02:09,560 --> 01:02:11,720 EXPLODED IN THE LAST TWO DECADES 1459 01:02:11,720 --> 01:02:14,720 AS WELL AS TRADITIONAL 1460 01:02:14,720 --> 01:02:17,760 BEHAVIORAL ISSUES AND SOCIAL 1461 01:02:17,760 --> 01:02:18,200 CULTURAL ENVIRONMENT. 1462 01:02:18,200 --> 01:02:20,680 I THINK THE HEALTH CARE SYSTEM 1463 01:02:20,680 --> 01:02:22,560 IS CRITICALLY IMPORTANT IN 1464 01:02:22,560 --> 01:02:24,200 INFLUENCING DISPARITIES AND 1465 01:02:24,200 --> 01:02:27,760 OUTCOMES PARTICULARLY FOR THAT 1466 01:02:27,760 --> 01:02:29,400 20%-30% OF THE U.S. POPULATION 1467 01:02:29,400 --> 01:02:31,640 THAT HAS CHRONIC DISEASES THAT 1468 01:02:31,640 --> 01:02:33,760 NEEDS TO SEE CLINICIANS ON A 1469 01:02:33,760 --> 01:02:34,480 REGULAR BASES. 1470 01:02:34,480 --> 01:02:37,120 THIS FRAMEWORK IS NOT MEANT TO 1471 01:02:37,120 --> 01:02:40,000 BE CAUTION ALL OR COMPREHENSIVE 1472 01:02:40,000 --> 01:02:43,760 BUT TO GIVE A SENSE OF THE AREA 1473 01:02:43,760 --> 01:02:46,640 THAT THEY ARE WORKING ON THAT 1474 01:02:46,640 --> 01:02:48,240 MIGHT INFLUENCE HEALTH OUTCOMES 1475 01:02:48,240 --> 01:02:50,440 IN POPULATIONS WITH HEALTH 1476 01:02:50,440 --> 01:02:51,320 DISPARITIES. 1477 01:02:51,320 --> 01:02:53,560 IT WOULD GO FROM RIGHT TO LEFT. 1478 01:02:53,560 --> 01:02:55,880 AND WE'RE COMING ON A TIME WHERE 1479 01:02:55,880 --> 01:02:58,560 WE WANT TO REVIEW WHETHER OR NOT 1480 01:02:58,560 --> 01:03:00,440 THIS MAY NEED TO BE UPDATED TO 1481 01:03:00,440 --> 01:03:02,160 INCLUDE OTHER COMPONENTS. 1482 01:03:02,160 --> 01:03:04,560 TURNING TO COVID THIS IS AN A 1483 01:03:04,560 --> 01:03:12,840 UNANIMOUS SIS DON--ANALYSIS DONE TO LOOK A T THE 1484 01:03:12,840 --> 01:03:14,520 PRELIMINARY CAUSE OF DEATH FOR 1485 01:03:14,520 --> 01:03:16,560 THE YEAR 2020. 1486 01:03:16,560 --> 01:03:21,160 THERE WERE 477,000 EXCESS DEATHS 1487 01:03:21,160 --> 01:03:23,760 IN THE CALENDAR YEAR 2020. 1488 01:03:23,760 --> 01:03:26,080 THIS IS QUITE STAGGERING. 1489 01:03:26,080 --> 01:03:28,200 WE ALL KNEW IT BUT TO SEE THE 1490 01:03:28,200 --> 01:03:31,560 QUANTIFICATION IS STAGGERING. 1491 01:03:31,560 --> 01:03:32,320 ABOUT THREE QUARTERS ARE 1492 01:03:32,320 --> 01:03:33,600 DIRECTLY RELATED TO COVID. 1493 01:03:33,600 --> 01:03:35,600 YOU CAN SEE ABOUT A QUARTER OF 1494 01:03:35,600 --> 01:03:38,720 THE EXCESS DEATHS MAY NOT BE 1495 01:03:38,720 --> 01:03:42,040 DIRECTLY RELATED TO COVID BUT 1496 01:03:42,040 --> 01:03:43,560 CONSEQUENTIAL FROM THE PANDEMIC. 1497 01:03:43,560 --> 01:03:46,760 YOU CAN SEE THAT MALES HAD MORE 1498 01:03:46,760 --> 01:03:48,760 DEATHS THAN FEMALES. 1499 01:03:48,760 --> 01:03:52,360 AND PROPORTIONATELY LATINOS, 1500 01:03:52,360 --> 01:03:53,560 AFRICAN-AMERICANS, AMERICAN 1501 01:03:53,560 --> 01:03:56,040 INDIAN AND ALASKA NATIVES HAD 1502 01:03:56,040 --> 01:03:58,560 MUCH HIGHER RATES OF EXCESS 1503 01:03:58,560 --> 01:03:59,600 DEATHS PARTICULARLY FOR THE MEN 1504 01:03:59,600 --> 01:04:01,840 BUT ALSO FOR THE WELCOME PARED 1505 01:04:01,840 --> 01:04:03,520 TO THEIR WHITE AND 1506 01:04:03,520 --> 01:04:04,680 ASIAN-AMERICAN COUNTERPARTS. 1507 01:04:04,680 --> 01:04:07,120 AND THIS WAS IN THE ANNALS OF 1508 01:04:07,120 --> 01:04:07,960 INTERNAL MEDICINE. 1509 01:04:07,960 --> 01:04:11,320 BACK IN MAY OF 2020. 1510 01:04:11,320 --> 01:04:17,480 MONICA WEB HOOPER AND I 1511 01:04:17,480 --> 01:04:20,440 PUBLISHED A COMMENTARY IN JAMA 1512 01:04:20,440 --> 01:04:22,360 HIGHLIGHTING THE ISSUES OF 1513 01:04:22,360 --> 01:04:23,440 DISPARITIES. 1514 01:04:23,440 --> 01:04:25,920 THIS IS AFTER DR. FAUCI 1515 01:04:25,920 --> 01:04:28,360 MENTIONED IN ONE OF THE EVENING 1516 01:04:28,360 --> 01:04:29,680 PRESS CONFERENCES THAT WERE 1517 01:04:29,680 --> 01:04:32,800 BEING HELD IN LATE MARCH 2020. 1518 01:04:32,800 --> 01:04:35,040 LOOKING BACK 22 MONTHS LATER NOT 1519 01:04:35,040 --> 01:04:37,880 MUCH HAS CHANGED. 1520 01:04:37,880 --> 01:04:38,960 ALTHOUGH SOME PROGRESS HAS BEEN 1521 01:04:38,960 --> 01:04:40,040 MADE. 1522 01:04:40,040 --> 01:04:41,520 CASE RATES, HOSPITALIZATIONS AND 1523 01:04:41,520 --> 01:04:43,640 DEATHS FOR LATINOS, 1524 01:04:43,640 --> 01:04:45,520 AFRICAN-AMERICANS AND AMERICAN 1525 01:04:45,520 --> 01:04:48,040 INDIAN AND ALASKA NATIVES ARE 1526 01:04:48,040 --> 01:04:49,960 SOMEWHERE TWO TO THREE TIMES 1527 01:04:49,960 --> 01:04:52,920 THAT OF WHITES. 1528 01:04:52,920 --> 01:04:55,040 THESE ARE AND IT'S CONSISTENT 1529 01:04:55,040 --> 01:04:56,880 ACROSS THE WAY. 1530 01:04:56,880 --> 01:04:58,520 THE REASON CASE RATES ARE HIGHER 1531 01:04:58,520 --> 01:05:01,360 IS THERE IS MORE EXPOSURE AND 1532 01:05:01,360 --> 01:05:03,400 THE RISK IS DUE TO SOCIAL 1533 01:05:03,400 --> 01:05:05,640 CONDITIONS AND JOBS. 1534 01:05:05,640 --> 01:05:08,640 EARLY ON IN THE PANDEMIC A LOT 1535 01:05:08,640 --> 01:05:10,560 WAS MADE ABOUT OBESITY AND 1536 01:05:10,560 --> 01:05:12,600 DIABETES AND HEART DISEASE. 1537 01:05:12,600 --> 01:05:15,600 THOSE LEAD TO A HIGHER RATE OF 1538 01:05:15,600 --> 01:05:17,800 COMPLICATIONS BUT ABOUT 40% OF 1539 01:05:17,800 --> 01:05:19,280 LATINOS OR AFRICAN-AMERICANS 1540 01:05:19,280 --> 01:05:21,720 ACTUALLY HAVE TO WORK IN PUBLIC 1541 01:05:21,720 --> 01:05:25,200 FACING JOBS AND DO NOT HAVE THE 1542 01:05:25,200 --> 01:05:27,200 PRIVILEGE TO ISOLATOR WORK FROM 1543 01:05:27,200 --> 01:05:28,520 HOME. 1544 01:05:28,520 --> 01:05:30,600 AND SO WE NEED TO CONSIDER THAT 1545 01:05:30,600 --> 01:05:34,800 THIS EXPOSURE AND ECONOMIC AND 1546 01:05:34,800 --> 01:05:36,720 STRUCTURAL FACTORS ARE THE MAIN 1547 01:05:36,720 --> 01:05:37,120 CAUSE. 1548 01:05:37,120 --> 01:05:40,000 WE TALKED ABOUT LIFE EXPECTANCY 1549 01:05:40,000 --> 01:05:43,840 AND WHEN THE VACCINE CAME OUT 1550 01:05:43,840 --> 01:05:44,480 AFRICAN-AMERICAN COMMUNITIES HAD 1551 01:05:44,480 --> 01:05:47,440 THE HIGHEST RATE OF HESITANCY IN 1552 01:05:47,440 --> 01:05:48,040 THIS COUNTRY. 1553 01:05:48,040 --> 01:05:49,160 THAT CHANGED. 1554 01:05:49,160 --> 01:05:51,880 I'LL COME BACK TO THAT WITH THE 1555 01:05:51,880 --> 01:05:54,560 CEAL PROGRAM AND THE KINDS OF 1556 01:05:54,560 --> 01:05:58,160 SURVEY IN SEPTEMBER OF 2021 1557 01:05:58,160 --> 01:06:04,600 SHOWED THAT 70% OF BLACKS AND 1558 01:06:04,600 --> 01:06:08,280 71% OF WHITES AND 73% OF LATINOS 1559 01:06:08,280 --> 01:06:10,120 HAD RECEIVED WINDOWS. 1560 01:06:10,120 --> 01:06:11,560 RURAL AMERICANS AND LESS 1561 01:06:11,560 --> 01:06:16,120 EDUCATION AND LESS IN COLLEGE 1562 01:06:16,120 --> 01:06:17,960 FOR SURE ARE LEAST LIKELY 1563 01:06:17,960 --> 01:06:19,560 PERSONS TO RECEIVE VACCINES AS 1564 01:06:19,560 --> 01:06:21,560 WE WELL KNOW. 1565 01:06:21,560 --> 01:06:30,200 RADx WAS A HUGE PROGRAM OF 1566 01:06:30,200 --> 01:06:32,160 SUPPLEMENTARY PROGRAMS. 1567 01:06:32,160 --> 01:06:37,200 $1.4 BILLION WAS ALLOCATED TO 1568 01:06:37,200 --> 01:06:37,880 NIH. 1569 01:06:37,880 --> 01:06:41,800 THE HUGE SUCCESS OF THIS PROCESS 1570 01:06:41,800 --> 01:06:44,760 AND DEVELOPING THE TESTING 1571 01:06:44,760 --> 01:06:46,680 TECHNOLOGY LED BY THE NATIONAL 1572 01:06:46,680 --> 01:06:50,960 INSTITUTE OF BIOMEDICAL ENGINEER 1573 01:06:50,960 --> 01:06:55,240 AND BRUCE'S TEAM RECEIVED OVER 1574 01:06:55,240 --> 01:06:55,640 $500 MILLION. 1575 01:06:55,640 --> 01:06:58,600 THERE IS ALSO A PLATFORM FOR 1576 01:06:58,600 --> 01:07:00,280 TECHNOLOGY THAT WAS MORE READY 1577 01:07:00,280 --> 01:07:01,440 TO BE IMPLEMENTED. 1578 01:07:01,440 --> 01:07:02,920 YOU'VE PROBABLY HEARD THIS 1579 01:07:02,920 --> 01:07:03,960 BEFORE. 1580 01:07:03,960 --> 01:07:05,160 AND ALSO WHAT IS RADICAL AND 1581 01:07:05,160 --> 01:07:06,480 WHAT IS OUT THERE. 1582 01:07:06,480 --> 01:07:08,760 WHAT CAN WE DO THAT IS 1583 01:07:08,760 --> 01:07:09,160 DIFFERENT. 1584 01:07:09,160 --> 01:07:13,640 A TEST TO BE USED OR WASTEWATER. 1585 01:07:13,640 --> 01:07:15,120 ADVANCING THE WASTEWATER 1586 01:07:15,120 --> 01:07:16,280 TECHNOLOGY. 1587 01:07:16,280 --> 01:07:19,200 DR. COLLINS DECIDED THAT ABOUT 1588 01:07:19,200 --> 01:07:21,360 $500 MILLION OF THE ALLOCATION 1589 01:07:21,360 --> 01:07:25,080 TO NIH WOULD GO TO RADx 1590 01:07:25,080 --> 01:07:27,360 UNDERSERVED POPULATIONS TO 1591 01:07:27,360 --> 01:07:29,200 ADDRESS DISPARITIES AND THIS WAS 1592 01:07:29,200 --> 01:07:32,360 A REMARKABLE ACHIEVEMENT ON OUR 1593 01:07:32,360 --> 01:07:35,520 PART AND WE HAVE SINCE APRIL OF 1594 01:07:35,520 --> 01:07:37,040 2020 BEEN WORKING ON THIS 1595 01:07:37,040 --> 01:07:37,680 NONSTOP. 1596 01:07:37,680 --> 01:07:41,680 I COCHAIRED THIS PROGRAM WITH 1597 01:07:41,680 --> 01:07:50,560 DR. RICHARD HODES. 1598 01:07:50,560 --> 01:07:54,040 ANWE CONTINUE TO WORK ON THIS. 1599 01:07:54,040 --> 01:07:57,800 THE GOAL WAS TO ENHANCE COVID-19 1600 01:07:57,800 --> 01:07:58,320 TESTING. 1601 01:07:58,320 --> 01:08:00,880 THIS IS ALL APPROPRIATIONS FOR 1602 01:08:00,880 --> 01:08:01,400 TESTING. 1603 01:08:01,400 --> 01:08:04,520 SO WE HAVE TO STAY IN THAT LANE 1604 01:08:04,520 --> 01:08:07,160 AMONG UNDERSERVED AND VULNERABLE 1605 01:08:07,160 --> 01:08:08,760 POPULATIONS ACROSS THE U.S. 1606 01:08:08,760 --> 01:08:12,280 WE BASED IT ON A CONSORTIUM OF 1607 01:08:12,280 --> 01:08:13,120 COMMUNITY ENGAGED RESEARCH 1608 01:08:13,120 --> 01:08:15,200 PROJECTS SO THEY COULD IMPLEMENT 1609 01:08:15,200 --> 01:08:16,560 TESTING INTERVENTIONS KNOWING 1610 01:08:16,560 --> 01:08:19,000 THAT THEY HAD ESTABLISHED 1611 01:08:19,000 --> 01:08:20,760 RELATIONSHIPS WITH THEIR 1612 01:08:20,760 --> 01:08:21,960 COMMUNITIES. 1613 01:08:21,960 --> 01:08:24,240 WE WANT TO STRENGTHEN THE DATA 1614 01:08:24,240 --> 01:08:25,480 AVAILABLE AND IDENTIFY 1615 01:08:25,480 --> 01:08:27,840 STRATEGIES TO REDUCE DISPARITIES 1616 01:08:27,840 --> 01:08:29,600 AND SEE WHAT WE COULD DO IN THIS 1617 01:08:29,600 --> 01:08:31,120 AREA. 1618 01:08:31,120 --> 01:08:32,760 KEEP IN MIND THAT WE LAUNCHED 1619 01:08:32,760 --> 01:08:34,480 THIS BEFORE THE VACCINES WERE 1620 01:08:34,480 --> 01:08:35,840 BEING TESTED. 1621 01:08:35,840 --> 01:08:37,600 THAT YOU REMEMBER ALL OF THE 1622 01:08:37,600 --> 01:08:39,840 CHALLENGES THAT WE HAD AS A 1623 01:08:39,840 --> 01:08:46,840 COUNTRY INITIALLY OR -- IN 1624 01:08:46,840 --> 01:08:48,760 GETTING THE TESTING RIGHT. 1625 01:08:48,760 --> 01:08:50,960 BUT FORTUNATELY I THINK THOSE 1626 01:08:50,960 --> 01:08:52,160 THINGS HAVE BEEN MOSTLY WORKED 1627 01:08:52,160 --> 01:08:52,680 OUT. 1628 01:08:52,680 --> 01:08:54,920 WE HAVE NOW GONE THROUGH PHASE I 1629 01:08:54,920 --> 01:08:55,560 AND PHASE II. 1630 01:08:55,560 --> 01:08:58,440 PHASE II IS BEING LAUNCHED ON 1631 01:08:58,440 --> 01:09:00,720 FRIDAY OF THIS WEEK. 1632 01:09:00,720 --> 01:09:04,760 WITH SMALLER PROGRAM THAN WE HAD 1633 01:09:04,760 --> 01:09:07,560 IN PHASE I. 1634 01:09:07,560 --> 01:09:10,920 WE FUNDED A COORDINATION AND 1635 01:09:10,920 --> 01:09:12,240 DATA COLLECTION CENTER AT DUKE 1636 01:09:12,240 --> 01:09:14,440 NORTH CAROLINA. 1637 01:09:14,440 --> 01:09:17,760 AND THIS HAS BEEN AN INCREDIBLY 1638 01:09:17,760 --> 01:09:19,360 USEFUL RESOURCE FOR THIS 1639 01:09:19,360 --> 01:09:19,560 PROJECT. 1640 01:09:19,560 --> 01:09:23,840 IT IS LED BY THREE CO-PRINCIPLE 1641 01:09:23,840 --> 01:09:24,240 INVESTIGATORS. 1642 01:09:24,240 --> 01:09:26,920 AND WE'RE FOCUSED ON BOTH THE 1643 01:09:26,920 --> 01:09:28,760 TECHNICAL SUPPORT FOR TESTING 1644 01:09:28,760 --> 01:09:30,360 AND MONITORING EMERGING 1645 01:09:30,360 --> 01:09:35,480 TECHNOLOGIES AND FUNDING 1646 01:09:35,480 --> 01:09:35,760 RERESEARCH. 1647 01:09:35,760 --> 01:09:39,160 AND BY STATISTICS COMPONENT BY 1648 01:09:39,160 --> 01:09:44,040 WARREN WHO USED TO BE HERE. 1649 01:09:44,040 --> 01:09:48,120 A OF PROGRAM LED BY CORBY AT THE 1650 01:09:48,120 --> 01:09:49,160 UNIVERSITY OF NORTH CAROLINA. 1651 01:09:49,160 --> 01:09:51,560 SOME INNOVATIVE APPROACHES TO 1652 01:09:51,560 --> 01:09:54,320 THE EQUITY EVIDENCE ACADEMY 1653 01:09:54,320 --> 01:09:55,240 BEING ONE. 1654 01:09:55,240 --> 01:09:56,360 CREATING A COMMUNITY OF 1655 01:09:56,360 --> 01:09:56,960 PRACTICE. 1656 01:09:56,960 --> 01:10:00,960 TO GO ALONG WITH NOW NEARLY 100 1657 01:10:00,960 --> 01:10:04,800 PROJECTS THAT WE'VE FUNDED AND 1658 01:10:04,800 --> 01:10:05,560 THE COORDINATION WITH THE 1659 01:10:05,560 --> 01:10:07,320 ADMINISTRATION. 1660 01:10:07,320 --> 01:10:10,320 THE CONTACT PRINCIPLE 1661 01:10:10,320 --> 01:10:14,040 INVESTIGATOR MICKEY -- IS A 1662 01:10:14,040 --> 01:10:18,000 LATINO INFECTIOUS DISEASE 1663 01:10:18,000 --> 01:10:21,880 PEDIATRICIAN AND CORBY IS AN 1664 01:10:21,880 --> 01:10:22,280 AFRICAN-AMERICAN. 1665 01:10:22,280 --> 01:10:24,760 WE LOVE TO USE THESE MAPS. 1666 01:10:24,760 --> 01:10:27,160 WE ARE IN THE ENTIRE COUNTRY NOT 1667 01:10:27,160 --> 01:10:31,200 SQUARES IN EVERY STATE BUT -- 1668 01:10:31,200 --> 01:10:32,000 RECRUITING INDIVIDUALS FROM 1669 01:10:32,000 --> 01:10:34,040 EVERY STATE SO THAT EXPLAINS WHY 1670 01:10:34,040 --> 01:10:35,560 WE LIST OVER 50. 1671 01:10:35,560 --> 01:10:39,360 WE DO NOTICE THAT WE'RE GOING 1672 01:10:39,360 --> 01:10:40,440 FROM HAWAII TO PUERTO RICO. 1673 01:10:40,440 --> 01:10:43,960 WE HAVE THE SOUTH PACIFIC 1674 01:10:43,960 --> 01:10:45,400 TERRITORIES INCLUDED FROM AWARDS 1675 01:10:45,400 --> 01:10:48,960 MADE IN HAWAII AND CALIFORNIA. 1676 01:10:48,960 --> 01:10:52,040 ABOUT 10 OF THESE AWARDS ARE 1677 01:10:52,040 --> 01:10:55,560 FOCUSED ON AMERICAN INDIAN AND 1678 01:10:55,560 --> 01:10:57,840 ALASKA NATIVE POPULATIONS. 1679 01:10:57,840 --> 01:10:59,840 AND WE'RE PROUD OF HOW THIS HAS 1680 01:10:59,840 --> 01:11:00,280 BEEN DISPLAYED. 1681 01:11:00,280 --> 01:11:02,520 IT'S A CHALLENGE TO GET ALL OF 1682 01:11:02,520 --> 01:11:04,160 THESE INVESTIGATORS USED TO 1683 01:11:04,160 --> 01:11:05,400 DOING WHAT THEY WANT. 1684 01:11:05,400 --> 01:11:06,920 ONCE THEY GET A GRANT TO WORK 1685 01:11:06,920 --> 01:11:08,760 TOGETHER AND TO DO THINGS 1686 01:11:08,760 --> 01:11:09,000 TOGETHER. 1687 01:11:09,000 --> 01:11:12,480 AND WE HAVE I THINK MADE HUGE 1688 01:11:12,480 --> 01:11:14,560 PROGRESS BUT OF COURSE THE 1689 01:11:14,560 --> 01:11:18,200 REALITIES NOT EVER 100% SO WE'RE 1690 01:11:18,200 --> 01:11:20,520 ASKING FOR COMMON DATA 1691 01:11:20,520 --> 01:11:21,960 ALLOCATION AND COMPLETE DATA 1692 01:11:21,960 --> 01:11:25,760 SHARING OF ALL OF THEIR DATA ON 1693 01:11:25,760 --> 01:11:27,640 A TIMELY BASES SO PROVIDING 1694 01:11:27,640 --> 01:11:30,400 UPLOADS EVERY WEEK OF DATA TO 1695 01:11:30,400 --> 01:11:32,120 THE COORDINATING CENTER AND ALSO 1696 01:11:32,120 --> 01:11:35,200 FOR THE REMAINING DATA AT A 1697 01:11:35,200 --> 01:11:36,640 DIFFERENT CADENCE. 1698 01:11:36,640 --> 01:11:38,160 THESE ARE THE TOTAL NUMBER OF 1699 01:11:38,160 --> 01:11:40,200 PROJECTS WE'VE FUNDED TO DATE. 1700 01:11:40,200 --> 01:11:43,880 WE HAVE A PHASE THREE THAT IS 1701 01:11:43,880 --> 01:11:47,880 BEING LAUNCHED SHORTLY. 1702 01:11:47,880 --> 01:11:48,200 *. 1703 01:11:48,200 --> 01:11:49,480 HOPEFULLY BY THE FIRST WEEK IN 1704 01:11:49,480 --> 01:11:51,400 FEBRUARY. 1705 01:11:51,400 --> 01:11:53,960 WE HAVE 1.2 MILLION TEST 1706 01:11:53,960 --> 01:11:55,720 DISTRIBUTED AND THE DATA IS MORE 1707 01:11:55,720 --> 01:11:56,760 UP-TO-DATE. 1708 01:11:56,760 --> 01:12:01,680 THIS IS AS OF JANUARY OF 2022. 1709 01:12:01,680 --> 01:12:03,480 WE'RE IN ALL 50 STATES AND 1710 01:12:03,480 --> 01:12:08,000 TERRITORIES AND THE DISTRICT. 1711 01:12:08,000 --> 01:12:08,600 OVER 1.3 MILLION PARTICIPANTS 1712 01:12:08,600 --> 01:12:09,960 HAVE BEEN ENROLLED INCLUDING 1713 01:12:09,960 --> 01:12:13,040 PEOPLE ABSTRACTED FROM 1714 01:12:13,040 --> 01:12:14,400 ELECTRONIC HEALTH RECORDS AND 1715 01:12:14,400 --> 01:12:17,160 THE CDC HAS CONTINUED TO GO UP 1716 01:12:17,160 --> 01:12:20,360 AND FUNDED SOME PILOT GRANTS AND 1717 01:12:20,360 --> 01:12:22,720 HAVE LISTED 48 JOURNAL ARTICLES 1718 01:12:22,720 --> 01:12:28,240 THAT HAVE CONDITIONA ACKNOWLEDGED THIS 1719 01:12:28,240 --> 01:12:29,200 FUNDING MECHANISM. 1720 01:12:29,200 --> 01:12:31,880 WE GET THIS UPDATE AT LEAST ON A 1721 01:12:31,880 --> 01:12:34,560 MONTHLY BASES. 1722 01:12:34,560 --> 01:12:37,560 OF CONCERN YOU CAN SEE HERE 1723 01:12:37,560 --> 01:12:39,960 JANUARY OF 2022 THE POSITIVITY 1724 01:12:39,960 --> 01:12:41,160 RATE HAS GONE UP. 1725 01:12:41,160 --> 01:12:43,760 THIS IS THE OMICRON SURGE. 1726 01:12:43,760 --> 01:12:46,040 REMEMBER THESE ARE COMMUNITY 1727 01:12:46,040 --> 01:12:48,840 ENGAGED PROJECTS MOSTLY NOT 1728 01:12:48,840 --> 01:12:49,440 SYSTEMATIC. 1729 01:12:49,440 --> 01:12:51,640 ALTHOUGH SOME OF THE 1730 01:12:51,640 --> 01:12:56,440 PARTICIPANTS ARE BEING -- ARE 1731 01:12:56,440 --> 01:13:00,240 SYMPTOMATIC. 1732 01:13:00,240 --> 01:13:04,640 AND THESE WERE UPDATED AS OF 1733 01:13:04,640 --> 01:13:05,160 JANUARY 11. 1734 01:13:05,160 --> 01:13:07,560 THE COMMUNITY ENGAGEMENT 1735 01:13:07,560 --> 01:13:08,720 EXPERIENCE HAS BEEN SOMETHING 1736 01:13:08,720 --> 01:13:11,160 YOU SNEAK ABOUT THIS PROGRAM AS 1737 01:13:11,160 --> 01:13:12,240 NIH HAS SUPPORTED IT. 1738 01:13:12,240 --> 01:13:16,320 WE HAD MANY PARTICIPANTS IN THE 1739 01:13:16,320 --> 01:13:20,760 UNIVERSITY OF NORTH CAROLINA LED 1740 01:13:20,760 --> 01:13:26,040 EQUITY ACADEMY EVENT. 1741 01:13:26,040 --> 01:13:28,120 MANY BREAST PRACTICES GUIDANCE 1742 01:13:28,120 --> 01:13:29,040 DOCUMENTS. 1743 01:13:29,040 --> 01:13:30,600 THE COMMUNITY COLLABORATION 1744 01:13:30,600 --> 01:13:31,880 GRANTS AND CHANNELS FOR 1745 01:13:31,880 --> 01:13:33,000 COMMUNITY OF PRACTICE. 1746 01:13:33,000 --> 01:13:35,160 WE HAVE COMMUNITY-BASED LEADERS 1747 01:13:35,160 --> 01:13:37,080 AT THE TABLE FROM THE BEGINNING 1748 01:13:37,080 --> 01:13:39,960 AND I'LL COME BACK TO THIS AS I 1749 01:13:39,960 --> 01:13:42,760 TALK ABOUT CEAL. 1750 01:13:42,760 --> 01:13:44,240 DEPLOYING THESE PROJECTS DURING 1751 01:13:44,240 --> 01:13:47,680 A PANDEMIC DOES REQUIRE ROBUST 1752 01:13:47,680 --> 01:13:49,680 AND TRUSTED AND EFFECTIVE 1753 01:13:49,680 --> 01:13:50,800 COMMUNITY PARTNERSHIPS AND I 1754 01:13:50,800 --> 01:13:53,280 WILL COME TO A CONCLUSION ON 1755 01:13:53,280 --> 01:13:55,680 THIS OR A RECOMMENDATION THAT 1756 01:13:55,680 --> 01:13:57,720 GARY AND RICHARD AND OTHERS WILL 1757 01:13:57,720 --> 01:14:01,000 PUSH FOR AS WE MOVE FORWARD IN 1758 01:14:01,000 --> 01:14:02,640 THE CURRENT FISCAL YEAR. 1759 01:14:02,640 --> 01:14:04,400 THESE ARE SOME OF THE WORK 1760 01:14:04,400 --> 01:14:06,160 GROUPS THAT HAVE BEEN 1761 01:14:06,160 --> 01:14:06,440 ESTABLISHED. 1762 01:14:06,440 --> 01:14:10,760 AS YOU CAN SEE THIS IS 1763 01:14:10,760 --> 01:14:13,000 SPONTANEOUS WORK FORCE THAT HAVE 1764 01:14:13,000 --> 01:14:14,520 FORMED. 1765 01:14:14,520 --> 01:14:18,280 LET ME SAY A FEW WORDS ABOUT 1766 01:14:18,280 --> 01:14:19,000 CEAL. 1767 01:14:19,000 --> 01:14:23,440 I WANT TO EMPHASIZE WHAT A GAME 1768 01:14:23,440 --> 01:14:25,880 CHANGER THIS HAS BEEN. 1769 01:14:25,880 --> 01:14:28,960 THIS AROSE SOMEWHAT 1770 01:14:28,960 --> 01:14:30,960 SPONTANEOUSLY OUT OF THE NEED TO 1771 01:14:30,960 --> 01:14:33,960 HAVE MORE INCLUSIVE 1772 01:14:33,960 --> 01:14:36,760 PARTICIPATION IN OUR CLINICAL 1773 01:14:36,760 --> 01:14:39,120 TRIALS PARTICULARLY WITH MODENA 1774 01:14:39,120 --> 01:14:40,760 BUT ALL OF THE VACCINE TRIALS IN 1775 01:14:40,760 --> 01:14:44,200 THE SUMMER OF 2020. 1776 01:14:44,200 --> 01:14:48,400 GARY GIBBONS AND A LONG WITH 1777 01:14:48,400 --> 01:14:54,120 FRANCIS COLLINS AND FAUCI AND 1778 01:14:54,120 --> 01:14:56,440 FRANCIS COLLINS MET EVERY 1779 01:14:56,440 --> 01:14:57,560 SATURDAY FOR ABOUT THREE AND A 1780 01:14:57,560 --> 01:15:00,240 HALF MONTHS TO MONITOR WHAT 1781 01:15:00,240 --> 01:15:01,360 MODENA WAS DOING. 1782 01:15:01,360 --> 01:15:05,080 OUT OF THAT CAME CEAL. 1783 01:15:05,080 --> 01:15:07,400 WE GAVE ADVICE AND THEY ENDED UP 1784 01:15:07,400 --> 01:15:10,160 WITH 37% OF MINORITIES IN THEIR 1785 01:15:10,160 --> 01:15:12,520 CLINICAL TRIAL FOR THE mRNA 1786 01:15:12,520 --> 01:15:13,760 VACCINE. 1787 01:15:13,760 --> 01:15:15,680 WE STOOD CEAL UP WITH MONEY THAT 1788 01:15:15,680 --> 01:15:18,720 WE GOT FROM DIFFERENT ICs. 1789 01:15:18,720 --> 01:15:20,480 MOSTLY FROM THE OFFICE OF THE 1790 01:15:20,480 --> 01:15:21,600 DIRECTOR AND OPERATION WARP 1791 01:15:21,600 --> 01:15:24,280 SPEED YOU CAN SEE THE ADDITIONS 1792 01:15:24,280 --> 01:15:24,960 IN 2021 HERE. 1793 01:15:24,960 --> 01:15:28,960 WE HAVE ONE IN THE DC MARYLAND 1794 01:15:28,960 --> 01:15:30,320 VIRGINIA AREA. 1795 01:15:30,320 --> 01:15:32,960 THESE ARE BEING DONE AND MANAGED 1796 01:15:32,960 --> 01:15:36,160 BY SNAP HEART AND LUNG 1797 01:15:36,160 --> 01:15:36,920 INSTITUTE. 1798 01:15:36,920 --> 01:15:39,160 WE MEET WITH OUR TEAM EVERY 1799 01:15:39,160 --> 01:15:40,560 OTHER WEEK. 1800 01:15:40,560 --> 01:15:42,760 THIS IS PRIMARILY SETTING UP 1801 01:15:42,760 --> 01:15:44,720 THIS COMMUNITY ENGAGED NETWORK 1802 01:15:44,720 --> 01:15:48,000 THAT WE SEE AS A MECHANISM A 1803 01:15:48,000 --> 01:15:50,160 PLATFORM THAT WE CAN LEVERAGE 1804 01:15:50,160 --> 01:15:51,480 FOR OTHER ISSUES. 1805 01:15:51,480 --> 01:15:54,440 NOT JUST PANDEMICS. 1806 01:15:54,440 --> 01:15:56,760 AND HOW THIS NETWORK THIS 1807 01:15:56,760 --> 01:15:58,040 PLATFORM WON'T DO EVERYTHING BUT 1808 01:15:58,040 --> 01:15:59,760 WHETHER OR NOT WE'LL SET UP 1809 01:15:59,760 --> 01:16:01,280 SOMETHING SIMILAR. 1810 01:16:01,280 --> 01:16:04,360 ADD A CLINICAL COMPONENT WHICH 1811 01:16:04,360 --> 01:16:05,680 WE'RE PLANNING TO DO NOW AT 1812 01:16:05,680 --> 01:16:06,880 LEAST TO PILOT IT. 1813 01:16:06,880 --> 01:16:09,080 WE STILL HAVE TO SECURE MORE 1814 01:16:09,080 --> 01:16:13,240 SOLID FUNDING AND THE 1815 01:16:13,240 --> 01:16:16,080 APPROPRIATIONS WILL BE CRUCIAL 1816 01:16:16,080 --> 01:16:17,680 SINCE THERE IS LANGUAGE IN THE 1817 01:16:17,680 --> 01:16:19,360 HOUSE AND SENATE LANGUAGE TO 1818 01:16:19,360 --> 01:16:21,480 SUPPORT THIS COMMUNITY 1819 01:16:21,480 --> 01:16:25,560 ENGAGEMENT THROUGH AN HLBI. 1820 01:16:25,560 --> 01:16:27,760 THIS IS BASED ON THE NOTION OF 1821 01:16:27,760 --> 01:16:28,720 PARTNERSHIP. 1822 01:16:28,720 --> 01:16:31,360 SO WE DON'T START ALWAYS WITH 1823 01:16:31,360 --> 01:16:33,960 THE ASK SIMIC HEALTH CENTER 1824 01:16:33,960 --> 01:16:35,600 RESEARCHER BUT WE BRING LEADERS 1825 01:16:35,600 --> 01:16:37,800 TO THE TABLE TO BEGIN WITH. 1826 01:16:37,800 --> 01:16:42,320 AND WE HAVE SET UP COMMITTEES 1827 01:16:42,320 --> 01:16:44,080 THAT ARE NOT IN THE FUNDED 1828 01:16:44,080 --> 01:16:46,000 PROJECTS THAT PROVIDE OVERSIGHT 1829 01:16:46,000 --> 01:16:50,960 OVER THE RESEARCH OF THE 1830 01:16:50,960 --> 01:16:52,200 INCLUSIVE PARTICIPATION OF THE 1831 01:16:52,200 --> 01:16:56,000 COMMUNITY ENGAGEMENT. 1832 01:16:56,000 --> 01:16:57,760 AND REALLY EMPHASIZES TRUST. 1833 01:16:57,760 --> 01:16:59,320 TRUST IN SCIENCE. 1834 01:16:59,320 --> 01:17:02,040 AND WHO DELIVERS THAT MESSAGE. 1835 01:17:02,040 --> 01:17:04,440 WE NEED TRUSTED MESSENGERS. 1836 01:17:04,440 --> 01:17:07,640 WE'RE STILL WELL BEHIND IN THE 1837 01:17:07,640 --> 01:17:10,320 COMMUNICATION SCIENCE FIELD. 1838 01:17:10,320 --> 01:17:11,320 WE'VE SEEN WHAT HAPPENED. 1839 01:17:11,320 --> 01:17:13,960 WE HAVE BUILT A GREAT VACCINE. 1840 01:17:13,960 --> 01:17:16,040 WE HAVE BUILT THIS WONDERFUL 1841 01:17:16,040 --> 01:17:16,720 HOUSE. 1842 01:17:16,720 --> 01:17:18,280 PEOPLE WILL COME AND GET IT. 1843 01:17:18,280 --> 01:17:20,320 MANY DID BUT MANY DIDN'T AND 1844 01:17:20,320 --> 01:17:22,720 THAT IS BECAUSE WE LET OUR GUARD 1845 01:17:22,720 --> 01:17:26,160 DOWN ON WHAT THE ABILITY OF THIS 1846 01:17:26,160 --> 01:17:29,160 INFORMATION TO REALLY CREATE 1847 01:17:29,160 --> 01:17:30,240 DISTRUST IN SCIENCE. 1848 01:17:30,240 --> 01:17:31,680 SOMETHING THAT WE WERE NOT USED 1849 01:17:31,680 --> 01:17:32,320 TO SEEING. 1850 01:17:32,320 --> 01:17:34,600 THIS IS NOT A SHORT-TERM EFFORT. 1851 01:17:34,600 --> 01:17:36,880 THIS IS FOR THE LONG-TERM AS WE 1852 01:17:36,880 --> 01:17:38,400 KNOW. 1853 01:17:38,400 --> 01:17:40,760 WE'RE STARTING YEAR THREE. 1854 01:17:40,760 --> 01:17:43,120 CEAL HAS HAD A SPECIAL IMPACT IN 1855 01:17:43,120 --> 01:17:51,640 OUR COMMUNICATION METRI MET -- MET 1856 01:17:51,640 --> 01:17:52,600 RIX. 1857 01:17:52,600 --> 01:17:56,480 * IT HAS WORKED HARD TO PROMOTE 1858 01:17:56,480 --> 01:17:58,240 AND TO COUNTER THE 1859 01:17:58,240 --> 01:17:58,600 MISINFORMATION. 1860 01:17:58,600 --> 01:18:01,760 WE NEED IS TO DO MORE IN THE 1861 01:18:01,760 --> 01:18:02,920 COUNTER MESSAGING THAT WE HAVE 1862 01:18:02,920 --> 01:18:05,800 NOT YET DONE AS MUCH ABOUT. 1863 01:18:05,800 --> 01:18:08,760 LET ME TURN TO ANOTHER TOPIC 1864 01:18:08,760 --> 01:18:11,240 THAT RENA TOUCHED ON WHICH IS 1865 01:18:11,240 --> 01:18:15,040 RELATED TO RACISM AND I SHOW 1866 01:18:15,040 --> 01:18:17,640 THIS SLIDE AT MANY TALKS. 1867 01:18:17,640 --> 01:18:20,640 THIS IS FROM 2015 AND IN THE 1868 01:18:20,640 --> 01:18:23,040 LAST 30 DAYS WERE YOU TREATED 1869 01:18:23,040 --> 01:18:25,960 UNFAIRLY BECAUSE OF RACE OR 1870 01:18:25,960 --> 01:18:26,400 ETHNIC BACKGROUND. 1871 01:18:26,400 --> 01:18:27,960 AND THIS IS FROM THE KAISER 1872 01:18:27,960 --> 01:18:29,480 FAMILY FOUNDATION. 1873 01:18:29,480 --> 01:18:32,800 ASIANS ARE NOT INCLUDED IN THE 1874 01:18:32,800 --> 01:18:34,240 RANDOM SAMPLE. 1875 01:18:34,240 --> 01:18:36,520 LATINOS ABOUT 36%. 1876 01:18:36,520 --> 01:18:37,640 AFRICAN-AMERICANS OVER HALF SAID 1877 01:18:37,640 --> 01:18:39,000 YES. 1878 01:18:39,000 --> 01:18:41,600 AND THEN IN HEALTH CARE IT 1879 01:18:41,600 --> 01:18:43,960 SHOULD BE AND IS MUCH LOWER. 1880 01:18:43,960 --> 01:18:48,320 SO WE HAVE A PROBLEM AND THIS 1881 01:18:48,320 --> 01:18:49,760 PRECEDED GEORGE FLOYD AND THE 1882 01:18:49,760 --> 01:18:50,840 PANDEMIC AND THIS IS A PROBLEM 1883 01:18:50,840 --> 01:18:52,560 THAT I THINK WE NEED TO 1884 01:18:52,560 --> 01:18:54,440 ACKNOWLEDGE AND RECKON WITH AND 1885 01:18:54,440 --> 01:18:56,400 BEGIN TO MANAGE MORE ACTIVELY AS 1886 01:18:56,400 --> 01:18:59,720 A COUNTRY AND I'M PLEASED THAT 1887 01:18:59,720 --> 01:19:01,280 WE'RE DOING IT ALTHOUGH THERE IS 1888 01:19:01,280 --> 01:19:03,640 A LOT OF RESISTANCE TO IT. 1889 01:19:03,640 --> 01:19:06,240 WHAT DO WE DO? 1890 01:19:06,240 --> 01:19:08,560 MOST OF THE WORK IS IS IN THIS 1891 01:19:08,560 --> 01:19:11,280 INTERPERSONAL NATURAL PHASE. 1892 01:19:11,280 --> 01:19:12,760 GOOD MEASURES AND THEY ARE ON 1893 01:19:12,760 --> 01:19:13,960 THE WEBSITE. 1894 01:19:13,960 --> 01:19:15,360 AND OTHER INVESTIGATORS HAVE 1895 01:19:15,360 --> 01:19:15,880 DONE THIS. 1896 01:19:15,880 --> 01:19:18,160 THE ASSOCIATIONS HAVE BEEN 1897 01:19:18,160 --> 01:19:19,760 ESTABLISHED MOSTLY WITH 1898 01:19:19,760 --> 01:19:22,080 BEHAVIORAL OR SUBSTANCE ABUSE 1899 01:19:22,080 --> 01:19:24,520 OUTCOMES AND SOME WITH 1900 01:19:24,520 --> 01:19:27,960 CARDIOVASCULAR DISEASE AND OTHER 1901 01:19:27,960 --> 01:19:29,320 CONDITIONS. 1902 01:19:29,320 --> 01:19:33,560 EARN TURN NATURALIZED RACISM. 1903 01:19:33,560 --> 01:19:58,160 THEY'VE INTERNALIZE EDIT -- * 1904 01:19:58,160 --> 01:20:01,520 THIS IS THE MODEL THAT APPLIES. 1905 01:20:01,520 --> 01:20:03,920 PERCEIVED SOCIETAL 1906 01:20:03,920 --> 01:20:05,200 DISCRIMINATION IS ANOTHER WAY OF 1907 01:20:05,200 --> 01:20:09,600 LOOKING AT IT. 1908 01:20:09,600 --> 01:20:11,320 AND THEN SECONDHAND EFFECTS OF 1909 01:20:11,320 --> 01:20:14,520 RACISM IS HARDLY BEEN STUDIED. 1910 01:20:14,520 --> 01:20:17,280 IF YOU GREW UP AROUND SOMEONE 1911 01:20:17,280 --> 01:20:19,920 WHO HAS BEEN HEAVILY IMPACTED BY 1912 01:20:19,920 --> 01:20:22,160 RACISM AND WHAT DOES THAT DO TO 1913 01:20:22,160 --> 01:20:23,320 YOUR HEALTH. 1914 01:20:23,320 --> 01:20:24,480 STRUCTURAL RACISM. 1915 01:20:24,480 --> 01:20:26,600 THE IDEA THAT THERE IS A HISTORY 1916 01:20:26,600 --> 01:20:30,320 AND CULTURE OF INSTITUTIONS. 1917 01:20:30,320 --> 01:20:34,200 AND PROMOTING AN IDEOLOGY. 1918 01:20:34,200 --> 01:20:37,160 THE CIVIL WAR DID NOT END IN 1919 01:20:37,160 --> 01:20:40,120 1865 AND JIM CROW DID NOT END IN 1920 01:20:40,120 --> 01:20:40,560 1965. 1921 01:20:40,560 --> 01:20:42,440 I THINK WE'RE STILL LIVING THE 1922 01:20:42,440 --> 01:20:44,520 CONSEQUENCES OF OUR HISTORY AND 1923 01:20:44,520 --> 01:20:47,320 THERE IS NO FINGER-POINTING OR 1924 01:20:47,320 --> 01:20:47,960 BLAME HERE. 1925 01:20:47,960 --> 01:20:49,400 THIS IS A MATTER OF 1926 01:20:49,400 --> 01:20:50,760 ACKNOWLEDGING AND PROCESSING AND 1927 01:20:50,760 --> 01:20:52,320 HOW CAN WE WORK TOGETHER TO MAKE 1928 01:20:52,320 --> 01:20:54,280 IT BETTER. 1929 01:20:54,280 --> 01:20:57,560 AND RESIDENTIAL SEGREGATION IS 1930 01:20:57,560 --> 01:20:58,960 ACORNER STONE OF THIS SYSTEM. 1931 01:20:58,960 --> 01:21:05,400 THIS IS A POLICY THAT WAS 1932 01:21:05,400 --> 01:21:08,520 IMPLEMENTED IN THE 1930s AND 1933 01:21:08,520 --> 01:21:11,680 PLAYED OUT AFTER WORLD WAR II 1934 01:21:11,680 --> 01:21:15,200 WITH THE RETURN OF DEMOBILIZED 1935 01:21:15,200 --> 01:21:16,440 ARMED SERVICES THAT PARTICIPATED 1936 01:21:16,440 --> 01:21:19,400 IN THE WAR. 1937 01:21:19,400 --> 01:21:20,440 REDLINING OF NEIGHBORHOODS AND 1938 01:21:20,440 --> 01:21:22,440 NOT ALLOW AFRICAN-AMERICANS AND 1939 01:21:22,440 --> 01:21:24,480 LATINO FAMILIES TO BUILD EQUITY 1940 01:21:24,480 --> 01:21:27,840 WHICH IS THE PRIMARY WAY 1941 01:21:27,840 --> 01:21:28,800 FAMILIES GROW WEALTH IN THE 1942 01:21:28,800 --> 01:21:31,320 UNITED STATES IS BY PURCHASING 1943 01:21:31,320 --> 01:21:32,680 PROPERTY AND HAVING THAT 1944 01:21:32,680 --> 01:21:34,040 PROPERTY GROW IN VALUE. 1945 01:21:34,040 --> 01:21:36,960 WE HELD A WORKSHOP IN 2017 WHERE 1946 01:21:36,960 --> 01:21:39,600 REALLY I WAS QUESTIONING CAN WE 1947 01:21:39,600 --> 01:21:41,400 REALLY STUDY STRUCTURAL RACISM 1948 01:21:41,400 --> 01:21:47,280 OR IS IT MORE OF AN -- 1949 01:21:47,280 --> 01:21:49,320 ORGANIZATIONAL CONCEPT. 1950 01:21:49,320 --> 01:21:54,400 NOW IS THE TIME AND -- -- 1951 01:21:54,400 --> 01:21:56,440 SUPPORTED BY ALMOST ALL 1952 01:21:56,440 --> 01:21:58,320 INSTITUTES AT NIH WILL BE MAKING 1953 01:21:58,320 --> 01:22:01,080 RECOMMENDATIONS TO OUR COUNCIL 1954 01:22:01,080 --> 01:22:03,600 NEXT WEEK ABOUT FUNDING 1955 01:22:03,600 --> 01:22:04,160 DECISIONS. 1956 01:22:04,160 --> 01:22:07,720 WE GOT A ROBUST RESPONSE AND I 1957 01:22:07,720 --> 01:22:14,320 SUSPECT WE THE AGENCY SOMEWHERE 1958 01:22:14,320 --> 01:22:21,440 BETWEEN -- 20-30RO1s THIS 1959 01:22:21,440 --> 01:22:33,080 YEAR. 1960 01:22:33,080 --> 01:22:36,280 THESE ARE TO GIVE YOU AN EXAMPLE 1961 01:22:36,280 --> 01:22:40,440 OF COMMUNITY DRIVEN 1962 01:22:40,440 --> 01:22:40,760 INTERVENTIONS. 1963 01:22:40,760 --> 01:22:43,000 PROBABLY THE MOVING TO 1964 01:22:43,000 --> 01:22:44,280 OPPORTUNITY STUDY IS ONE OF THE 1965 01:22:44,280 --> 01:22:48,320 BETTER KNOWN AND MOST EFFECTIVE 1966 01:22:48,320 --> 01:22:50,680 GIVING SINGLE MOMS A VOUCHER TO 1967 01:22:50,680 --> 01:22:53,560 MOVE TO A BETTER NEIGHBORHOOD 1968 01:22:53,560 --> 01:22:55,640 NOT INTENDED AS A HEALTH 1969 01:22:55,640 --> 01:22:57,880 INTERVENTION BUT IT RESULTED IN 1970 01:22:57,880 --> 01:23:06,320 LOWER A1Cs AND LOWER BMIs. 1971 01:23:06,320 --> 01:23:08,120 NIMHD, LET ME LEAVE YOU WITH 1972 01:23:08,120 --> 01:23:09,560 THESE TWO LESSONS. 1973 01:23:09,560 --> 01:23:12,000 HOW DO WE REDUCE DISPARITIES IN 1974 01:23:12,000 --> 01:23:13,160 HEALTH CARE. 1975 01:23:13,160 --> 01:23:15,640 NUMBER ONE IS EXPANDING ACCESS. 1976 01:23:15,640 --> 01:23:20,720 I KNOW THIS COMMUNITY AT NIDCR 1977 01:23:20,720 --> 01:23:23,160 IS KEENLY AWARE OF THIS. 1978 01:23:23,160 --> 01:23:25,040 BECAUSE DENTAL CARE HAS NOT BEEN 1979 01:23:25,040 --> 01:23:27,080 COVERED UNDERSTAND HEALTH CARE 1980 01:23:27,080 --> 01:23:27,320 COVERAGE. 1981 01:23:27,320 --> 01:23:28,600 THIS NEEDS TO CHANGE. 1982 01:23:28,600 --> 01:23:30,840 JUST LIKE THE EXPERIMENTED HAS 1983 01:23:30,840 --> 01:23:31,960 SHOWN BENEFITS. 1984 01:23:31,960 --> 01:23:35,520 WE KNOW THAT IF YOU GET 1985 01:23:35,520 --> 01:23:38,480 PREVENTIVE DENTAL CARE YOU WILL 1986 01:23:38,480 --> 01:23:39,040 DO BETTER. 1987 01:23:39,040 --> 01:23:41,400 TREATMENT OF HYPERTENSION. 1988 01:23:41,400 --> 01:23:45,520 WE COULD SAY FLUORIDE VARNISH IN 1989 01:23:45,520 --> 01:23:46,160 CHILDREN. 1990 01:23:46,160 --> 01:23:49,080 THERE ARE SIMILAR PARALLELS. 1991 01:23:49,080 --> 01:23:52,760 PREVENTING TOOTH DECAY AND 1992 01:23:52,760 --> 01:23:59,480 PREVENTS -- COORDINATING CARE. 1993 01:23:59,480 --> 01:24:01,000 PATIENT CENTERED CARE. 1994 01:24:01,000 --> 01:24:04,200 AND FOCUSED ON PRIMARY CARE AND 1995 01:24:04,200 --> 01:24:05,160 SECONDARY HOMES. 1996 01:24:05,160 --> 01:24:07,480 NOT JUST THE PRIMARY CARE HOME 1997 01:24:07,480 --> 01:24:10,960 BUT ALSO THE SECONDARY HOME. 1998 01:24:10,960 --> 01:24:13,400 LEVERAGING I.T. AND ELECTRONIC 1999 01:24:13,400 --> 01:24:17,120 HEALTH RECORDS TO ADDRESS 2000 01:24:17,120 --> 01:24:17,800 EQUITY. 2001 01:24:17,800 --> 01:24:19,880 THE MORE TECHNOLOGY THE MORE 2002 01:24:19,880 --> 01:24:23,560 DIGITAL THAT YOU COULD 2003 01:24:23,560 --> 01:24:24,480 MARGINALIZE POPULATIONS AND 2004 01:24:24,480 --> 01:24:27,680 WORSEN DISPARITIES. 2005 01:24:27,680 --> 01:24:28,960 PERFORMANCE MEASUREMENT AND RISK 2006 01:24:28,960 --> 01:24:31,760 NEED AND EQUITY I THINK HEALTH 2007 01:24:31,760 --> 01:24:33,800 CARE SYSTEMS NEED TO LOOK AT 2008 01:24:33,800 --> 01:24:36,040 WHAT THEIR PROFILE IS. 2009 01:24:36,040 --> 01:24:38,760 NOT JUST SAY DID WE DO ALL OF 2010 01:24:38,760 --> 01:24:39,160 THE MAMMOGRAMS. 2011 01:24:39,160 --> 01:24:40,960 DID WE GET THE PATIENTS OUT OF 2012 01:24:40,960 --> 01:24:42,520 THE HOSPITAL IN TWO OR THREE 2013 01:24:42,520 --> 01:24:43,080 DAYS. 2014 01:24:43,080 --> 01:24:46,720 BUT ALSO HOW WE'RE DOING ACROSS 2015 01:24:46,720 --> 01:24:48,560 AN EQUITY MEASURE. 2016 01:24:48,560 --> 01:24:50,240 ETHNICITY COULD BE ONE. 2017 01:24:50,240 --> 01:24:51,720 INSURANCE STATUS COULD BE 2018 01:24:51,720 --> 01:24:51,960 ANOTHER. 2019 01:24:51,960 --> 01:24:53,160 AND THIS IS SOMETHING THAT I 2020 01:24:53,160 --> 01:24:56,040 THINK I HOPE THAT CMS WILL BE 2021 01:24:56,040 --> 01:24:57,480 THINKING ABOUT IMPLEMENTING OR 2022 01:24:57,480 --> 01:25:00,560 AT LEAST THROUGH A PILOT 2023 01:25:00,560 --> 01:25:01,760 PROGRAM. 2024 01:25:01,760 --> 01:25:04,760 THE OTHER IS THE COMMUNITY 2025 01:25:04,760 --> 01:25:06,160 ENGAGED PLATFORM. 2026 01:25:06,160 --> 01:25:08,080 THIS HAS BEEN AROUND FOR A LONG 2027 01:25:08,080 --> 01:25:08,840 TIME. 2028 01:25:08,840 --> 01:25:11,800 MY CAREER BEGAN AS A 2029 01:25:11,800 --> 01:25:13,960 COMMUNITY-BASED INTERVENTION IN 2030 01:25:13,960 --> 01:25:16,160 TOBACCO CESSATION. 2031 01:25:16,160 --> 01:25:18,200 AT A TIME WHEN I DIDN'T KNOW 2032 01:25:18,200 --> 01:25:18,960 WHAT THAT WAS. 2033 01:25:18,960 --> 01:25:21,400 I WORKED WITH PSYCHOLOGIST AND 2034 01:25:21,400 --> 01:25:21,800 COMMUNITIES. 2035 01:25:21,800 --> 01:25:24,560 BUT WE'VE LEARNED A LOT IN THE 2036 01:25:24,560 --> 01:25:25,960 LAST 40 YEARS ABOUT WHAT IT 2037 01:25:25,960 --> 01:25:27,280 TAKES TO DO THIS. 2038 01:25:27,280 --> 01:25:29,520 AND I THINK THAT THE TIME IS NOW 2039 01:25:29,520 --> 01:25:33,040 FOR REALLY MAKING THIS A ROBUST 2040 01:25:33,040 --> 01:25:36,320 PLATFORM THAT CAN BE LEVERAGED 2041 01:25:36,320 --> 01:25:38,160 BY CLINICIAN AND TRANSLATIONAL 2042 01:25:38,160 --> 01:25:40,520 SCIENTIST ACROSS THE NIH FAMILY 2043 01:25:40,520 --> 01:25:42,800 AND THE COUNTRY. 2044 01:25:42,800 --> 01:25:44,160 EQUAL PARTNERSHIP IS A STARTING 2045 01:25:44,160 --> 01:25:44,760 POINT. 2046 01:25:44,760 --> 01:25:46,880 WE CANNOT HAVE SCIENTIST TELLING 2047 01:25:46,880 --> 01:25:48,120 COMMUNITY PEOPLE WHAT TO DO. 2048 01:25:48,120 --> 01:25:49,320 THEY HAVE TO WORK TOGETHER FROM 2049 01:25:49,320 --> 01:25:51,560 THE BEGINNING AND THAT WILL HELP 2050 01:25:51,560 --> 01:25:56,760 AND THEN HAVE THIS PARTNERSHIP 2051 01:25:56,760 --> 01:25:57,400 PUBLIC SUSTAINABLE. 2052 01:25:57,400 --> 01:25:58,600 LONG-TERM AND TRUSTING. 2053 01:25:58,600 --> 01:26:00,720 IT DOESN'T MEAN THAT YOU'RE 2054 01:26:00,720 --> 01:26:02,480 ALWAYS INTERACTING BECAUSE THE 2055 01:26:02,480 --> 01:26:04,520 OTHER ACTIVITIES INTERVENE OR 2056 01:26:04,520 --> 01:26:06,880 THERE IS LESS FUNDING BUT ONCE 2057 01:26:06,880 --> 01:26:07,920 YOU ESTABLISH THESE 2058 01:26:07,920 --> 01:26:10,200 RELATIONSHIPS THEY ARE 2059 01:26:10,200 --> 01:26:11,760 SUSTAINABLE. 2060 01:26:11,760 --> 01:26:14,360 I'M A FIRM BELIEVER THAT WE 2061 01:26:14,360 --> 01:26:16,720 SHOULD SHIFT TO POPULATIONS OF 2062 01:26:16,720 --> 01:26:17,200 HEALTH. 2063 01:26:17,200 --> 01:26:19,880 BASED ON STRONG PRIMARY CARE 2064 01:26:19,880 --> 01:26:22,280 INCLUDING DENTAL CARE. 2065 01:26:22,280 --> 01:26:23,560 RECOGNIZING THE RESPONSIBLE OF 2066 01:26:23,560 --> 01:26:27,080 HEALTH AND NOT JUST HEALTH CARE. 2067 01:26:27,080 --> 01:26:29,160 ENGAGE COMMUNITY RESOURCES IN 2068 01:26:29,160 --> 01:26:31,080 PROMOTING HEALTH AND THE ACCESS 2069 01:26:31,080 --> 01:26:33,240 TO REAL FOOD AND SAFE PLACES FOR 2070 01:26:33,240 --> 01:26:35,160 PEOPLE TO WALK AND EXERCISE AND 2071 01:26:35,160 --> 01:26:36,560 CONGREGATE. 2072 01:26:36,560 --> 01:26:42,240 AND NOT BE FEARFUL OF VIOLENCE 2073 01:26:42,240 --> 01:26:44,440 OR -- CONDITIONS. 2074 01:26:44,440 --> 01:26:48,040 MANAGING STRUCTURAL AND 2075 01:26:48,040 --> 01:26:49,800 INTERPERSONAL NATURAL RACES. 2076 01:26:49,800 --> 01:26:52,560 I WANTED TO TURN TO SOME OF THE 2077 01:26:52,560 --> 01:26:55,760 ORAL HEALTH DISPARITY ISSUES 2078 01:26:55,760 --> 01:26:57,440 THAT WE ACKNOWLEDGE AND TODAY 2079 01:26:57,440 --> 01:27:01,320 LISTEN TO RENA I WONDER ABOUT 2080 01:27:01,320 --> 01:27:02,560 TMJ DYSFUNCTION AND SOMETHING 2081 01:27:02,560 --> 01:27:05,200 THAT WE SHOULD SPEND SOME TIME 2082 01:27:05,200 --> 01:27:07,240 ON AT NIMHD. 2083 01:27:07,240 --> 01:27:12,080 THE CAVITY RATES ARE DIFFERENT. 2084 01:27:12,080 --> 01:27:14,520 MINORITY KIDS HAVE MUCH MORE 2085 01:27:14,520 --> 01:27:15,640 CAVITIES. 2086 01:27:15,640 --> 01:27:18,760 MORE THAN 40% OF LOW-INCOME AND 2087 01:27:18,760 --> 01:27:21,080 AFRICAN-AMERICAN HAVE UNTREATED 2088 01:27:21,080 --> 01:27:25,000 TOOTH DECAY WHICH LEADS TO MORE 2089 01:27:25,000 --> 01:27:38,640 EXTRACTIONSES. 2090 01:27:38,640 --> 01:27:42,480 AMERICAN INDIAN OR ALASKA NATIVE 2091 01:27:42,480 --> 01:27:46,160 HAVE THE WORSE ORAL HEALTH. 2092 01:27:46,160 --> 01:27:47,840 AND THIS IS AN AREA THAT WE 2093 01:27:47,840 --> 01:27:49,920 WOULD FOCUS ON. 2094 01:27:49,920 --> 01:27:53,400 ORAL CANCER ALSO AMONG 2095 01:27:53,400 --> 01:27:55,040 AFRICAN-AMERICANS HAVE WORSE 2096 01:27:55,040 --> 01:27:56,760 SURVIVAL THAN WHITES AND THEN 2097 01:27:56,760 --> 01:28:00,320 DENTAL THERAPEUTIC CARE IS 2098 01:28:00,320 --> 01:28:00,560 COSTLY. 2099 01:28:00,560 --> 01:28:02,320 PREVENTIVE CARE IS AFFORDABLE. 2100 01:28:02,320 --> 01:28:04,760 BUT MANY PEOPLE DON'T HAVE IT. 2101 01:28:04,760 --> 01:28:07,560 UP TO 30% OF AMERICANS AT LEAST 2102 01:28:07,560 --> 01:28:10,000 -- LACK DENTAL INSURANCE. 2103 01:28:10,000 --> 01:28:13,840 WITHOUT GOING INTO DETAILS WE DO 2104 01:28:13,840 --> 01:28:19,840 FUND PROJECTS IN THE DENTAL 2105 01:28:19,840 --> 01:28:39,200 HEALTH ORAL HEALTH DISPARITIES. 2106 01:28:39,200 --> 01:28:41,400 THIS IS PARTICULARLY REGARDING 2107 01:28:41,400 --> 01:28:45,160 THE ASSOCIATION OF PERIODONTAL 2108 01:28:45,160 --> 01:28:46,000 DISEASE. 2109 01:28:46,000 --> 01:28:48,240 THIS IS ONE EXAMPLE THAT WAS 2110 01:28:48,240 --> 01:28:49,640 RELATED. 2111 01:28:49,640 --> 01:28:50,800 ACTUALLY AN INVESTIGATOR LOOKING 2112 01:28:50,800 --> 01:28:55,400 AT CHANGES IN RATES OF CODEINE 2113 01:28:55,400 --> 01:28:56,960 AND OPIOID PRESCRIPTION AFTER 2114 01:28:56,960 --> 01:29:02,560 THE BLACK BOX WARNING BETWEEN 2115 01:29:02,560 --> 01:29:05,200 2011-2016 AND IS THIS WARNING 2116 01:29:05,200 --> 01:29:07,560 WAS ASSOCIATED WITH IMMEDIATE 2117 01:29:07,560 --> 01:29:10,640 DROP BUT DID NOT CHANGE 2118 01:29:10,640 --> 01:29:16,560 ALTERNATIVE OPIOID PRESCRIPTION 2119 01:29:16,560 --> 01:29:18,160 FILLING. 2120 01:29:29,960 --> 01:29:32,200 I BELIEVE THIS WAS AN R21 THAT 2121 01:29:32,200 --> 01:29:33,160 WE FUNDED. 2122 01:29:33,160 --> 01:29:35,760 LET ME FINISH WITH A PLUG. 2123 01:29:35,760 --> 01:29:38,000 WE STARTED THIS IN 2016. 2124 01:29:38,000 --> 01:29:40,040 IT WAS A TRANSITION FROM WHAT 2125 01:29:40,040 --> 01:29:42,040 USED TO BE A COURSE THAT WAS 2126 01:29:42,040 --> 01:29:42,480 OFFERED. 2127 01:29:42,480 --> 01:29:43,960 IT IS FREE. 2128 01:29:43,960 --> 01:29:46,280 ALTHOUGH THE TRAVEL WE WOULD 2129 01:29:46,280 --> 01:29:48,040 SUPPORT WHEN PEOPLE ARE 2130 01:29:48,040 --> 01:29:48,320 TRAVELING. 2131 01:29:48,320 --> 01:29:52,800 WE'VE HAD IT NOW VIRTUALLY AND 2132 01:29:52,800 --> 01:29:56,520 WE'LL WAIT TO SEE WHAT HAPPENS 2133 01:29:56,520 --> 01:29:57,680 IN 2022. 2134 01:29:57,680 --> 01:29:59,160 WE TARGET EARLY STAGE 2135 01:29:59,160 --> 01:30:01,360 INVESTIGATORS AND POSTDOCTORAL 2136 01:30:01,360 --> 01:30:03,160 FELLOWS WHO COMMIT TO SAYING IN 2137 01:30:03,160 --> 01:30:06,040 THEIR APPLICATION THAT THEY 2138 01:30:06,040 --> 01:30:12,480 WOULD BE WRITING A GRANT. 2139 01:30:12,480 --> 01:30:17,240 THE FEW LECTURES THAT FOCUSED ON 2140 01:30:17,240 --> 01:30:19,000 THE THREE THEMES OF OUR 2141 01:30:19,000 --> 01:30:23,840 INSTITUTE THE INTEGRATED 2142 01:30:23,840 --> 01:30:27,160 BIOLOGICAL SCIENCE AND 2143 01:30:27,160 --> 01:30:29,640 POPULATION SCIENCE AND HEALTH 2144 01:30:29,640 --> 01:30:29,920 SCIENCES. 2145 01:30:29,920 --> 01:30:32,240 THEY GET A MOCK INTERVIEW. 2146 01:30:32,240 --> 01:30:33,920 WE USE REAL GRANTS WITH 2147 01:30:33,920 --> 01:30:36,240 PERMISSION AND THIS IS A 2148 01:30:36,240 --> 01:30:37,320 TREMENDOUS WAY TO TEACH. 2149 01:30:37,320 --> 01:30:40,320 AND I WISH I HAD HAD THAT BACK 2150 01:30:40,320 --> 01:30:41,920 IN THE DAY. 2151 01:30:41,920 --> 01:30:42,920 MEETINGS WITH STAFF. 2152 01:30:42,920 --> 01:30:45,120 THIS IS ALLOWING THEM TO NETWORK 2153 01:30:45,120 --> 01:30:48,200 NOT JUST PROGRAM STAFF FROM 2154 01:30:48,200 --> 01:30:50,480 NIMHD BUT ACROSS THE AGENCY. 2155 01:30:50,480 --> 01:30:52,800 THEY ALSO GET INDIVIDUALIZED 2156 01:30:52,800 --> 01:30:54,280 CONSULTATIONS ON THEIR RESEARCH 2157 01:30:54,280 --> 01:30:57,520 INTEREST WHETHER IT BE A 2158 01:30:57,520 --> 01:30:59,320 PROPOSAL FOR THE APPLICATION. 2159 01:30:59,320 --> 01:31:03,400 WE DO A WRITING HALF DAY WITH 2160 01:31:03,400 --> 01:31:05,000 HELP FROM WAMC. 2161 01:31:05,000 --> 01:31:08,760 YOU CAN SEE THAT WE'VE HAD ABOUT 2162 01:31:08,760 --> 01:31:10,440 332 PARTICIPANTS OVER THE SIX 2163 01:31:10,440 --> 01:31:11,520 YEARS. 2164 01:31:11,520 --> 01:31:16,720 60% WHO HAVE COME TO OUR HEALTH 2165 01:31:16,720 --> 01:31:19,480 DISPARITIES RESEARCH INSTITUTE. 2166 01:31:19,480 --> 01:31:21,960 I DID NOT CHECK HOW MANY ARE 2167 01:31:21,960 --> 01:31:23,040 DENTIST. 2168 01:31:23,040 --> 01:31:24,760 I LOVE THIS PHOTO. 2169 01:31:24,760 --> 01:31:28,400 THE SCREEN SHOTS OF ZOOM 2170 01:31:28,400 --> 01:31:28,680 MEETINGS. 2171 01:31:28,680 --> 01:31:31,400 THEY DO GIVE US SOME NEW IMAGES 2172 01:31:31,400 --> 01:31:34,440 THAT ARE REALLY QUITE NICE. 2173 01:31:34,440 --> 01:31:37,320 AND LET ME JUST END WITH THIS 2174 01:31:37,320 --> 01:31:39,640 LIST OF SOME OF OUR CURRENT 2175 01:31:39,640 --> 01:31:40,440 FUNDING OPPORTUNITY 2176 01:31:40,440 --> 01:31:40,960 ANNOUNCEMENTS. 2177 01:31:40,960 --> 01:31:42,960 THESE ARE NOT SET ASIDE FOR THE 2178 01:31:42,960 --> 01:31:45,120 MOST PART. 2179 01:31:45,120 --> 01:31:50,280 THEY ARE -- THAT WE TRY TO 2180 01:31:50,280 --> 01:31:51,440 STIMULATE THE COMMUNITY. 2181 01:31:51,440 --> 01:31:54,200 THIS IS A SECOND ITERATION OF 2182 01:31:54,200 --> 01:31:55,600 THIS. 2183 01:31:55,600 --> 01:31:56,920 PATIENT CLINICIAN COMMUNICATION. 2184 01:31:56,920 --> 01:31:58,560 THIS JUST CAME OUT AND IT'S 2185 01:31:58,560 --> 01:32:00,520 BROAD. 2186 01:32:00,520 --> 01:32:04,200 SOCIAL ESPECIALLY GENOMICS. 2187 01:32:04,200 --> 01:32:07,160 WE * FUNDED ABOUT 21 GRANTS. 2188 01:32:07,160 --> 01:32:08,360 SLEEP DISPARITIES. 2189 01:32:08,360 --> 01:32:11,200 LIVER CANCER AND CHRONIC LIVER 2190 01:32:11,200 --> 01:32:11,560 DISEASE. 2191 01:32:11,560 --> 01:32:16,760 FUNDED SOME INTERESTING RO1s. 2192 01:32:16,760 --> 01:32:20,080 LUNG CANCER AND SCREENING AND 2193 01:32:20,080 --> 01:32:21,440 CARE. 2194 01:32:21,440 --> 01:32:22,760 HEALTH INFORMATION TECHNOLOGIES 2195 01:32:22,760 --> 01:32:25,000 AND HEALTH DISPARITIES. 2196 01:32:25,000 --> 01:32:28,760 THE STRUCTURAL RACISM AND 2197 01:32:28,760 --> 01:32:29,160 DISCRIMINATION. 2198 01:32:29,160 --> 01:32:31,400 WE HAD SET ASIDE AND HAVE NOT 2199 01:32:31,400 --> 01:32:33,440 DECIDED WHAT THE FOLLOW-UP ON 2200 01:32:33,440 --> 01:32:34,360 THAT IS. 2201 01:32:34,360 --> 01:32:35,800 I'M SURE MORE WILL COME. 2202 01:32:35,800 --> 01:32:38,160 THE MANAGEMENT OF DIABETES. 2203 01:32:38,160 --> 01:32:40,840 CARE OF PATIENTS WITH MULTIPLE 2204 01:32:40,840 --> 01:32:43,640 CHRONIC DISEASES. 2205 01:32:43,640 --> 01:32:45,160 AN IMPORTANT TOPIC. 2206 01:32:45,160 --> 01:32:48,120 AND THE ROLE OF WORK AND HEALTH 2207 01:32:48,120 --> 01:32:49,240 DISPARITIES AS WELL. 2208 01:32:49,240 --> 01:32:51,680 WE ALSO HAD A STRATEGIC PLAN 2209 01:32:51,680 --> 01:32:57,080 WHICH PUBLISHED LAST YEAR FOR 2210 01:32:57,080 --> 01:32:57,760 2021-2025. 2211 01:32:57,760 --> 01:32:59,360 THIS IS A STRATEGIC PLAN THAT 2212 01:32:59,360 --> 01:33:00,800 WE'RE CHARGED WITH PUTTING 2213 01:33:00,800 --> 01:33:02,680 TOGETHER FOR THE ENTIRE NIH. 2214 01:33:02,680 --> 01:33:04,120 THIS IS IN OUR STATUTORY 2215 01:33:04,120 --> 01:33:05,080 LANGUAGE. 2216 01:33:05,080 --> 01:33:08,760 THIS WAS CONTRIBUTED TO BY EVERY 2217 01:33:08,760 --> 01:33:12,040 INSTITUTE AT NIH. 2218 01:33:12,040 --> 01:33:14,360 WE HAD VERY GOOD PARTICIPATION 2219 01:33:14,360 --> 01:33:18,200 AND CONTRIBUTION FROM NIDCR TO 2220 01:33:18,200 --> 01:33:18,480 THIS PLAN. 2221 01:33:18,480 --> 01:33:20,920 SO THANK YOU FOR YOUR ATTENTION. 2222 01:33:20,920 --> 01:33:25,160 IF RENA LETS ME I'M HAPPY TO 2223 01:33:25,160 --> 01:33:26,560 ANSWER SOME QUESTIONS AND IF YOU 2224 01:33:26,560 --> 01:33:30,320 HAVE TIME. 2225 01:33:30,320 --> 01:33:33,240 >> THANK YOU, ELISEO. 2226 01:33:33,240 --> 01:33:37,480 IS THAT WAS INSPIRATIONAL. 2227 01:33:37,480 --> 01:33:40,520 I OFFER YOU HONORARY MEMBERSHIP. 2228 01:33:40,520 --> 01:33:42,760 THAT WAS SO INSPIRATIONAL AND 2229 01:33:42,760 --> 01:33:44,720 THERE ARE QUESTIONS ABOUT THE 2230 01:33:44,720 --> 01:33:46,600 INFRASTRUCTURE THAT YOU'VE 2231 01:33:46,600 --> 01:33:50,160 ESTABLISHED IN CEAL THAT IS 2232 01:33:50,160 --> 01:33:51,720 GROWING AND EXPERIENCING GROWING 2233 01:33:51,720 --> 01:33:52,760 PAINS. 2234 01:33:52,760 --> 01:33:55,560 COULD ORAL HEALTH BE INTEGRATED 2235 01:33:55,560 --> 01:33:57,000 THERE BOTH IN THE RECORD 2236 01:33:57,000 --> 01:33:59,040 GATHERING AND THE ACTUAL 2237 01:33:59,040 --> 01:34:00,680 PROGRAMS OR INITIATIVES THAT 2238 01:34:00,680 --> 01:34:01,800 FLOW OUT OF THIS. 2239 01:34:01,800 --> 01:34:04,360 >> ABSOLUTELY. 2240 01:34:04,360 --> 01:34:06,960 GARY GIBBONS AND I HAVE ALWAYS 2241 01:34:06,960 --> 01:34:11,840 HAD THESE CONVERSATIONS AND 2242 01:34:11,840 --> 01:34:17,880 NIHBLI IS THE BIG FELLA. 2243 01:34:17,880 --> 01:34:20,320 IT HAS BEEN AN ALL STAFF EFFORT 2244 01:34:20,320 --> 01:34:22,320 AND I COULDN'T THANK ALL OF THE 2245 01:34:22,320 --> 01:34:23,920 STAFF THAT HAVE BEEN INVOLVED IN 2246 01:34:23,920 --> 01:34:26,600 THIS IN A WAY THAT WAS 2247 01:34:26,600 --> 01:34:27,320 UNPREDICTED. 2248 01:34:27,320 --> 01:34:29,000 THIS JUST KIND OF HAPPENED AND 2249 01:34:29,000 --> 01:34:30,160 EVERYBODY STEPPED UP TO THE 2250 01:34:30,160 --> 01:34:30,640 PLATE. 2251 01:34:30,640 --> 01:34:33,760 IT HAS TO BE SUSTAINED. 2252 01:34:33,760 --> 01:34:35,680 WE WOULD LIKE TO SEE DEVELOPMENT 2253 01:34:35,680 --> 01:34:40,760 OF A CLINICAL COMPONENT AND THAT 2254 01:34:40,760 --> 01:34:42,320 MEANS FUNDING SITES THAT 2255 01:34:42,320 --> 01:34:44,440 COORDINATE WHAT WOULD BE THE 2256 01:34:44,440 --> 01:34:46,560 EQUIVALENT OF COMMUNITY-BASED 2257 01:34:46,560 --> 01:34:48,920 CLINICS THAT WOULD BE ABLE TO DO 2258 01:34:48,920 --> 01:34:54,080 A TEST, ADMINISTER A VACCINE, 2259 01:34:54,080 --> 01:34:56,200 AROUND THIS COVID PANDEMIC OF 2260 01:34:56,200 --> 01:34:57,320 COURSE. 2261 01:34:57,320 --> 01:35:00,120 AND SORT OF IN THE FUTURE HAVE 2262 01:35:00,120 --> 01:35:01,240 THAT BE LEVERAGED AS WELL FOR 2263 01:35:01,240 --> 01:35:02,440 OTHER FACTORS. 2264 01:35:02,440 --> 01:35:05,880 SO I SEE NO PROBLEM WITH 2265 01:35:05,880 --> 01:35:08,960 INCORPORATING ORAL HEALTH 2266 01:35:08,960 --> 01:35:11,760 COMPONENT IN THE FUTURE BUT CEAL 2267 01:35:11,760 --> 01:35:14,040 CAN'T DO EVERYTHING. 2268 01:35:14,040 --> 01:35:16,720 WE'RE NOT EVERYWHERE. 2269 01:35:16,720 --> 01:35:19,000 SO WE'RE MISSING CHUNKS OF THE 2270 01:35:19,000 --> 01:35:21,320 COUNTRY PARTICULARLY IN THE MORE 2271 01:35:21,320 --> 01:35:24,200 REMOTE RURAL AREAS IN THE WEST. 2272 01:35:24,200 --> 01:35:26,640 BUT I DO EXPECT THAT MORE WILL 2273 01:35:26,640 --> 01:35:28,760 BE FORTHCOMING AND WE WILL 2274 01:35:28,760 --> 01:35:30,760 PARTNER WITH OTHER INSTITUTES ON 2275 01:35:30,760 --> 01:35:31,960 THIS AS THESE COME UP. 2276 01:35:31,960 --> 01:35:34,640 WE HOPE THAT THE APPROPRIATIONS 2277 01:35:34,640 --> 01:35:36,760 WILL GIVE US SOME SO LID 2278 01:35:36,760 --> 01:35:40,200 INDICATION OF FUNDING *. 2279 01:35:40,200 --> 01:35:43,320 I WOULD COMMIT SIGNIFICANT FUNDS 2280 01:35:43,320 --> 01:35:46,640 TO CEAL AND THEN THERE IS 2281 01:35:46,640 --> 01:35:49,520 APPROPRIATION LANGUAGE -- TO 2282 01:35:49,520 --> 01:35:53,280 HAVE SUSTAINED COMMUNITY ENGAGED 2283 01:35:53,280 --> 01:35:53,680 ACTIVITY. 2284 01:35:53,680 --> 01:35:59,560 YOU CAN SEE MATERNAL HEALTH BE 2285 01:35:59,560 --> 01:36:01,680 ANOTHER BENEFICIARY. 2286 01:36:01,680 --> 01:36:03,760 WE'RE CAUTIOUSLY OPTIMISTIC 2287 01:36:03,760 --> 01:36:05,760 ABOUT THIS AS A PLATFORM FOR THE 2288 01:36:05,760 --> 01:36:05,960 FUTURE 2289 01:36:05,960 --> 01:36:07,600 >> THANK YOU. 2290 01:36:07,600 --> 01:36:12,280 I INVITE QUESTIONS. 2291 01:36:12,280 --> 01:36:13,800 JEN. 2292 01:36:13,800 --> 01:36:25,320 CAN'T HEAR YOU. 2293 01:36:25,320 --> 01:36:28,240 ANYONE ELSE? 2294 01:36:28,240 --> 01:36:29,920 THERE IS RAUL. 2295 01:36:29,920 --> 01:36:31,120 >> THANK YOU. 2296 01:36:31,120 --> 01:36:33,640 I WANT TO MAKE A COMMENT THAT 20 2297 01:36:33,640 --> 01:36:36,480 YEARS AGO HIS INSTITUTE AND HE 2298 01:36:36,480 --> 01:36:40,320 WASN'T THERE THEN BUT NIMHD WAS 2299 01:36:40,320 --> 01:36:44,360 ONE OF THE CO-FOUNDERS OF -- 2300 01:36:44,360 --> 01:36:48,560 ORAL HEALTH DISPARITIES RESEARCH 2301 01:36:48,560 --> 01:36:50,960 CENTERS THAT HAD TWO -- SEVEN 2302 01:36:50,960 --> 01:36:53,040 YEAR ROUNDS OF FUNDING. 2303 01:36:53,040 --> 01:37:02,200 BY BUILDING A CADRE OF 2304 01:37:02,200 --> 01:37:02,600 SCIENTISTS. 2305 01:37:02,600 --> 01:37:06,160 I WAS REALLY HAPPY TO SEE A VERY 2306 01:37:06,160 --> 01:37:09,160 SIMILAR APPROACH THAT YOU'VE 2307 01:37:09,160 --> 01:37:12,120 TAKEN NOW -- CASTING A BROAD NET 2308 01:37:12,120 --> 01:37:13,440 TRYING TO ENGAGE MANY 2309 01:37:13,440 --> 01:37:14,360 COMMUNITIES AND I HOPE 2310 01:37:14,360 --> 01:37:16,040 CONTINUING TO HAVE A STRONG 2311 01:37:16,040 --> 01:37:18,160 PARTNERSHIP WITH OUR INSTITUTE 2312 01:37:18,160 --> 01:37:20,400 AND MOVING FORWARD. 2313 01:37:20,400 --> 01:37:21,680 A TREMENDOUS OPPORTUNITY FOR 2314 01:37:21,680 --> 01:37:23,560 ORAL HEALTH DISPARITY RESEARCH 2315 01:37:23,560 --> 01:37:25,880 TO INFORM YOUR OVER-ALL MISSION 2316 01:37:25,880 --> 01:37:27,920 AS WELL AS TO BENEFIT THE ORAL 2317 01:37:27,920 --> 01:37:28,520 HEALTH OF AMERICANS. 2318 01:37:28,520 --> 01:37:30,840 THANK YOU FOR WHAT YOU'RE DOING 2319 01:37:30,840 --> 01:37:32,320 AND APPRECIATE YOUR TALK 2320 01:37:32,320 --> 01:37:34,000 >> I DID BENEFIT FROM THE CENTER 2321 01:37:34,000 --> 01:37:37,560 THAT WAS AT UCSF AND WE 2322 01:37:37,560 --> 01:37:38,760 COLLABORATED AND SHARED SOME 2323 01:37:38,760 --> 01:37:40,680 FACULTY AND COLLABORATED ON A 2324 01:37:40,680 --> 01:37:41,800 NUMBER OF THINGS. 2325 01:37:41,800 --> 01:37:42,880 THANK YOU. 2326 01:37:42,880 --> 01:37:44,480 YES. 2327 01:37:44,480 --> 01:37:46,520 WE'LL CONTINUE TO WORK ACROSS 2328 01:37:46,520 --> 01:37:48,360 THE ENTIRE INSTITUTE AND 2329 01:37:48,360 --> 01:37:51,080 ESPECIALLY I HAVE TO SHOUT OUT 2330 01:37:51,080 --> 01:37:54,760 TO -- MARTHA WAS TERRIFIC BUT 2331 01:37:54,760 --> 01:37:58,440 THE NEW WAVE OF NIH INSTITUTE 2332 01:37:58,440 --> 01:38:00,320 DIRECTORS HAVE REALLY ENGAGED 2333 01:38:00,320 --> 01:38:03,760 EVERY ASPECT ACROSS THE BOARD. 2334 01:38:03,760 --> 01:38:06,840 SO DISPARITIES IS ON EVERYONE'S 2335 01:38:06,840 --> 01:38:07,880 CONSIDERATION. 2336 01:38:07,880 --> 01:38:09,040 SO I THINK THAT IS REALLY 2337 01:38:09,040 --> 01:38:10,320 IMPORTANT. 2338 01:38:10,320 --> 01:38:13,800 >> JUST TO SAY THAT JANE -- CEAL 2339 01:38:13,800 --> 01:38:17,240 PROGRAM ACTUALLY BECAME PART OF 2340 01:38:17,240 --> 01:38:18,760 THE STATEWIDE MANDATE. 2341 01:38:18,760 --> 01:38:20,760 RIGHT. 2342 01:38:20,760 --> 01:38:23,240 SO IT WAS VERY TRANSFORMATIVE 2343 01:38:23,240 --> 01:38:23,840 PROGRAM. 2344 01:38:23,840 --> 01:38:26,040 THANK YOU AND WE HAVE RENEE AND 2345 01:38:26,040 --> 01:38:27,320 JENNIFER. 2346 01:38:27,320 --> 01:38:29,840 WHOEVER CAN TALK OR WANTS TO. 2347 01:38:29,840 --> 01:38:32,240 ANYONE? 2348 01:38:32,240 --> 01:38:34,400 NOPE. 2349 01:38:34,400 --> 01:38:36,320 >> AXIL HAS HIS HAND UP. 2350 01:38:36,320 --> 01:38:37,240 >> YEAH. 2351 01:38:37,240 --> 01:38:39,440 FIRST OF ALL THANK YOU FOR THIS 2352 01:38:39,440 --> 01:38:40,000 OUTSTANDING PRESENTATION. 2353 01:38:40,000 --> 01:38:43,880 7 DEPRESSING ANDINGS STATIONAL 2354 01:38:43,880 --> 01:38:45,640 AT THE SAME TIME. 2355 01:38:45,640 --> 01:38:47,040 BUT POINTING OUT THE WORK THAT 2356 01:38:47,040 --> 01:38:48,600 STILL NEEDS TO BE DONE BUT ALSO 2357 01:38:48,600 --> 01:38:52,320 TO SEE THE FANTASTIC EFFORTS. 2358 01:38:52,320 --> 01:38:55,320 NOW I HAVE A MORE GENERAL 2359 01:38:55,320 --> 01:38:57,200 QUESTION WHICH IS -- I'M 2360 01:38:57,200 --> 01:38:58,960 THINKING ABOUT ALL OF THESE 2361 01:38:58,960 --> 01:39:00,480 DISPARITIES THAT YOU SHOWED. 2362 01:39:00,480 --> 01:39:03,160 SOME OF THEM PRIMARILY HAVE 2363 01:39:03,160 --> 01:39:06,160 THEIR CAUSE IN REAL MEDICAL 2364 01:39:06,160 --> 01:39:09,920 DIFFERENCES THAT ARE DRIVEN BY 2365 01:39:09,920 --> 01:39:11,080 GENETICS. 2366 01:39:11,080 --> 01:39:12,160 HYPERTENSION. 2367 01:39:12,160 --> 01:39:14,320 YOU SHOWED AN EXAMPLE AND THERE 2368 01:39:14,320 --> 01:39:15,080 ARE MORE. 2369 01:39:15,080 --> 01:39:18,320 AS A RESEARCHER I THINK YOU 2370 01:39:18,320 --> 01:39:20,600 WOULD ADDRESS THROUGH STUDY 2371 01:39:20,600 --> 01:39:24,320 DESIGNS LIKE YOU HIGHLIGHTED AND 2372 01:39:24,320 --> 01:39:24,960 DEVELOPED -- 2373 01:39:24,960 --> 01:39:26,120 [ INAUDIBLE ] TREATMENT 2374 01:39:26,120 --> 01:39:28,200 APPROACHES THAT YOU TAKE THIS 2375 01:39:28,200 --> 01:39:30,280 INTO ACCOUNT. 2376 01:39:30,280 --> 01:39:34,520 AND OTHERS AS A RESULT OF THE 2377 01:39:34,520 --> 01:39:36,320 SOCIO ECONOMIC DIFFERENCES AND 2378 01:39:36,320 --> 01:39:38,760 MANY IN BETWEEN. 2379 01:39:38,760 --> 01:39:41,760 HOW IMPORTANT DO YOU THINK IT IS 2380 01:39:41,760 --> 01:39:45,160 TO REALLY TRY HARD AND 2381 01:39:45,160 --> 01:39:48,360 DISENTANGLE WHAT IS DRIVEN BY 2382 01:39:48,360 --> 01:39:49,760 GENETICS VERSUS ENVIRONMENTAL 2383 01:39:49,760 --> 01:39:52,720 FACTORS IN ORDER TO ADDRESS THEM 2384 01:39:52,720 --> 01:39:53,000 SEPARATELY. 2385 01:39:53,000 --> 01:39:54,760 IS THAT SOMETHING THAT IS HIGH 2386 01:39:54,760 --> 01:39:58,320 ON YOUR LIST OR DO YOU HAVE AN 2387 01:39:58,320 --> 01:40:01,040 APPROACH WHERE YOU SAY WELL WE 2388 01:40:01,040 --> 01:40:03,520 CAN CHANGE IT ANY WAY. 2389 01:40:03,520 --> 01:40:04,760 SOMETHING THAT SOCIETY NEEDS TO 2390 01:40:04,760 --> 01:40:06,160 CHANGE AT LARGE. 2391 01:40:06,160 --> 01:40:08,640 IT WON'T CHANGE IMMEDIATELY SO 2392 01:40:08,640 --> 01:40:10,200 SINCE WE CANNOT SEPARATE IT 2393 01:40:10,200 --> 01:40:12,400 WE'RE BETTER OFF TAKING A 2394 01:40:12,400 --> 01:40:14,920 HOLISTIC APPROACH. 2395 01:40:14,920 --> 01:40:16,000 TELL US ABOUT YOUR THINKING 2396 01:40:16,000 --> 01:40:16,760 HERE. 2397 01:40:16,760 --> 01:40:17,920 >> THANK YOU FOR THAT QUESTION. 2398 01:40:17,920 --> 01:40:21,920 AND I THINK YOU HIT ON THE -- 2399 01:40:21,920 --> 01:40:23,120 THE FRAMEWORK WHICH WE'VE TRIED 2400 01:40:23,120 --> 01:40:25,520 TO CAPTURE THIS IDEA IS THAT 2401 01:40:25,520 --> 01:40:27,640 THERE IS NOT ONE CAUSE OF 2402 01:40:27,640 --> 01:40:28,040 ANYTHING. 2403 01:40:28,040 --> 01:40:30,320 WE KNOW THAT FROM CLINICAL 2404 01:40:30,320 --> 01:40:32,120 MEDICINE. 2405 01:40:32,120 --> 01:40:34,520 BUT YOU SEE THESE INTERACTIONS. 2406 01:40:34,520 --> 01:40:36,960 YOU MENTIONED HYPERTENSION BUT 2407 01:40:36,960 --> 01:40:39,400 IN REALITY -- I'VE GOT 2408 01:40:39,400 --> 01:40:41,760 COLLEAGUES THAT ARGUE IT'S NOT 2409 01:40:41,760 --> 01:40:42,640 GENETICS. 2410 01:40:42,640 --> 01:40:44,000 IT'S THE SOCIAL ENVIRONMENT OR 2411 01:40:44,000 --> 01:40:46,440 THE SALT THAT PEOPLE ARE EATING 2412 01:40:46,440 --> 01:40:49,320 THAT TRIGGERS OTHER BIOLOGICAL 2413 01:40:49,320 --> 01:40:50,920 MECHANISMS THAT LEAD TO THIS. 2414 01:40:50,920 --> 01:40:53,280 IT'S A DISCOVERY ISSUE AS WELL. 2415 01:40:53,280 --> 01:40:55,760 I THINK WE NEED TO BE OPEN TO 2416 01:40:55,760 --> 01:40:57,960 WHAT COULD BE INFLUENCED BY 2417 01:40:57,960 --> 01:41:00,040 BIOLOGY BY BEHAVIOR AND BY OUR 2418 01:41:00,040 --> 01:41:02,560 ENVIRONMENT AND TO ACKNOWLEDGE 2419 01:41:02,560 --> 01:41:04,480 THAT THE HISTORY OF THE 2420 01:41:04,480 --> 01:41:07,160 STRUCTURAL ISSUES THAT ALSO 2421 01:41:07,160 --> 01:41:08,880 WEIGH IN ON THESE FACTORS. 2422 01:41:08,880 --> 01:41:12,080 WE'RE NOT CONCEDING THAT FIELD 2423 01:41:12,080 --> 01:41:14,760 SO DISCOVERING MECHANISMS IS 2424 01:41:14,760 --> 01:41:16,080 CRITICAL AND I'M ALL FOR THAT 2425 01:41:16,080 --> 01:41:17,920 AND PART OF OUR RESEARCH. 2426 01:41:17,920 --> 01:41:21,320 BUT WE'RE NOT CONCEDING THE 2427 01:41:21,320 --> 01:41:23,320 STRUCTURAL FACTORS OR CHANGING 2428 01:41:23,320 --> 01:41:25,120 THEM AS A WAY OF INTERVENTION 2429 01:41:25,120 --> 01:41:27,400 AND THAT IS WHAT THE COMMON FUND 2430 01:41:27,400 --> 01:41:29,760 IS ALL ABOUT AND THAT COMMITMENT 2431 01:41:29,760 --> 01:41:32,160 FROM FRANCIS COLLINS TO SAY 2432 01:41:32,160 --> 01:41:34,400 WE'LL DO A COMMON FUND PROGRAM. 2433 01:41:34,400 --> 01:41:36,120 AND OTHERS GOT THAT GOING. 2434 01:41:36,120 --> 01:41:38,960 THEY ASKED ME TO JOIN WHEN THEY 2435 01:41:38,960 --> 01:41:49,840 SAW A WINDOW OF OPPORTUNITY. 2436 01:41:49,840 --> 01:41:53,560 SO I'M OPTIMISTIC THAT IF YOU 2437 01:41:53,560 --> 01:41:54,160 DEMONSTRATE STRUCTURAL CHANGE 2438 01:41:54,160 --> 01:41:56,560 AND THE MODEL OF A HEALTHY 2439 01:41:56,560 --> 01:41:58,880 COMMUNITY CAN BE REPLICATED. 2440 01:41:58,880 --> 01:42:00,560 OR WITHIN A HEALTH CARE SYSTEM. 2441 01:42:00,560 --> 01:42:03,000 YOU CAN HAVE EQUITABLE CARE 2442 01:42:03,000 --> 01:42:04,800 WITHIN A HEALTH CARE SYSTEM THAT 2443 01:42:04,800 --> 01:42:07,400 YOU CAN MAKE A DIFFERENCE IN 2444 01:42:07,400 --> 01:42:09,440 MANY OF THESE DISPARITIES AND 2445 01:42:09,440 --> 01:42:11,960 MANAGE THE INEQUALITIES AND WHEN 2446 01:42:11,960 --> 01:42:13,560 THERE IS BIOLOGY INVOLVED WE 2447 01:42:13,560 --> 01:42:16,240 HAVE TOOLS FOR THAT TOO. 2448 01:42:16,240 --> 01:42:17,160 CONTROLLING BLOOD PRESSURE. 2449 01:42:17,160 --> 01:42:19,560 AS A PRIMARY CARE DOCTOR IT WAS 2450 01:42:19,560 --> 01:42:23,560 A MATTER OF USING DRUGS AND THIS 2451 01:42:23,560 --> 01:42:27,280 THERAPEUTIC INERTIA BUT WHEN YOU 2452 01:42:27,280 --> 01:42:28,760 SEE BLACK AMERICANS HAVE THE 2453 01:42:28,760 --> 01:42:31,320 HIGHEST RATE OF STROKES BECAUSE 2454 01:42:31,320 --> 01:42:33,640 OF POORLY CONTAINED 2455 01:42:33,640 --> 01:42:35,800 HYPERTENSION. 2456 01:42:35,800 --> 01:42:38,160 YOU SAY WHY DON'T WE DO BETTER 2457 01:42:38,160 --> 01:42:41,160 FOR THE PEOPLE AT MOST RISK. 2458 01:42:41,160 --> 01:42:44,400 SOME IS IMPLEMENTATION SCIENCE. 2459 01:42:44,400 --> 01:42:46,000 WHAT CAN WE DO BETTER IN THAT 2460 01:42:46,000 --> 01:42:46,560 REGARD. 2461 01:42:46,560 --> 01:42:48,360 IT'S A FASCINATING FIELD. 2462 01:42:48,360 --> 01:42:49,720 EVERYTHING THAT YOU CAN THINK OF 2463 01:42:49,720 --> 01:42:52,360 AND IT'S A MATTER OF BEING 2464 01:42:52,360 --> 01:42:53,760 SCIENTIFIC ABOUT THE APPROACH 2465 01:42:53,760 --> 01:42:56,840 AND DOING MEASURES AND VARIABLES 2466 01:42:56,840 --> 01:42:59,120 AND BEING OPEN MINDED BY WHAT IS 2467 01:42:59,120 --> 01:43:01,440 THE CAUSAL PATHWAY AND NOT SET 2468 01:43:01,440 --> 01:43:02,600 ON NO. 2469 01:43:02,600 --> 01:43:04,760 THIS HAS GOT TO BE THIS OR THAT 2470 01:43:04,760 --> 01:43:05,480 THE. 2471 01:43:05,480 --> 01:43:07,000 >> BUT I THINK WHAT WOULD BE 2472 01:43:07,000 --> 01:43:08,760 INTERESTING TO INCORPORATE WITH 2473 01:43:08,760 --> 01:43:11,400 THE FRESH PERSPECTIVES THAT THE 2474 01:43:11,400 --> 01:43:13,880 ORAL CAVITY SERVES AS THE PORTAL 2475 01:43:13,880 --> 01:43:16,720 FOR ALL OF THESE THREATS. 2476 01:43:16,720 --> 01:43:18,560 WHETHER WHAT TAKE IN -- IN YOUR 2477 01:43:18,560 --> 01:43:20,800 DIET WHAT YOU'RE SMOKING OR 2478 01:43:20,800 --> 01:43:21,400 INHALING. 2479 01:43:21,400 --> 01:43:23,120 IT'S THE PORTAL TO THE REST OF 2480 01:43:23,120 --> 01:43:26,360 THE BODY AND YET IN ORAL HEALTH 2481 01:43:26,360 --> 01:43:30,160 IS SO DISCONNECTED AND WE NEED 2482 01:43:30,160 --> 01:43:31,760 TO BRING THAT CLOSER. 2483 01:43:31,760 --> 01:43:36,440 I'LL GIVE YOU ONE EXAMPLE. 2484 01:43:36,440 --> 01:43:39,760 MEDICAID WAS ACCEPTED BY A FEW 2485 01:43:39,760 --> 01:43:44,560 STATES THAT OFFERED CHILDREN 0-3 2486 01:43:44,560 --> 01:43:46,320 FREE DENTAL EXAMS. 2487 01:43:46,320 --> 01:43:49,960 50% REDUCTION IN CARRIES AND 50% 2488 01:43:49,960 --> 01:43:52,760 OF REDUCTION IN CARRIES FOR 2489 01:43:52,760 --> 01:43:53,920 LOW-INCOME FAMILIES BENEFITING 2490 01:43:53,920 --> 01:43:55,320 THE MOST. 2491 01:43:55,320 --> 01:44:01,000 IT BROUGHT PEDIATRIC PHYSICIANS 2492 01:44:01,000 --> 01:44:01,680 ALONG. 2493 01:44:01,680 --> 01:44:03,880 WE LOOK AT THE OLDER AGE GROUPS 2494 01:44:03,880 --> 01:44:08,040 AND IT'S BACK UP AS BEING THE 2495 01:44:08,040 --> 01:44:09,680 MOST COMMON REASON TO MISS 2496 01:44:09,680 --> 01:44:09,920 SCHOOLS. 2497 01:44:09,920 --> 01:44:12,680 TO GO TO THE ER AND GET DRUGS 2498 01:44:12,680 --> 01:44:14,920 AND THEN KIND OF FALL OFF. 2499 01:44:14,920 --> 01:44:17,280 IT'S A BAND DAY APPROACH SO IT 2500 01:44:17,280 --> 01:44:20,480 TELLS US IS HOW CAN ONE SUSTAIN 2501 01:44:20,480 --> 01:44:21,800 THE ENGAGEMENT SO THAT YOU MAKE 2502 01:44:21,800 --> 01:44:23,720 A DIFFERENCE THROUGH THE 2503 01:44:23,720 --> 01:44:25,120 LIFE-SPAN AND CREATE THE HEALTH 2504 01:44:25,120 --> 01:44:28,000 CHANGES THAT YOU NEED AND THE 2505 01:44:28,000 --> 01:44:30,360 BEHAVIORAL CHANGES GENERATION 2506 01:44:30,360 --> 01:44:32,600 AFTER GENERATION. 2507 01:44:32,600 --> 01:44:34,040 >> I COULDN'T AGREE WITH YOU 2508 01:44:34,040 --> 01:44:35,080 MORE. 2509 01:44:35,080 --> 01:44:37,640 IT HAS TO BE INTEGRATED AND 2510 01:44:37,640 --> 01:44:40,720 CLEARLY BEING A PEER EVENT AND 2511 01:44:40,720 --> 01:44:42,640 ALSO HAVING TAKEN CARE OF SO 2512 01:44:42,640 --> 01:44:44,840 MANY OLDER ADULTS I CAN SEE HOW 2513 01:44:44,840 --> 01:44:46,720 MUCH ORAL HEALTH CAN IMPACT 2514 01:44:46,720 --> 01:44:49,320 QUALITY OF LIFE, NUTRITION AND 2515 01:44:49,320 --> 01:44:51,600 IN ADDITION TO THE ISSUES AROUND 2516 01:44:51,600 --> 01:44:53,160 CHRONIC PAIN THAT YOU ALREADY 2517 01:44:53,160 --> 01:44:53,760 MENTIONED. 2518 01:44:53,760 --> 01:44:56,320 WE HAVE WORK TO DO FOR MORE 2519 01:44:56,320 --> 01:44:56,960 INTEGRATION. 2520 01:44:56,960 --> 01:45:00,600 AND I THINK LARRY TABEK WAS THE 2521 01:45:00,600 --> 01:45:03,560 ONE THAT TOLD ME THAT IT WAS THE 2522 01:45:03,560 --> 01:45:05,840 SECOND OLDEST INSTITUTE 2523 01:45:05,840 --> 01:45:12,760 >> WE'RE GOING TO CELEBRATE OUR 2524 01:45:12,760 --> 01:45:17,960 75th NEXT YEAR. 2525 01:45:17,960 --> 01:45:19,360 NOT HEARING ANY MORE FROM 2526 01:45:19,360 --> 01:45:22,160 COUNCIL I DON'T SEE ANY HANDS 2527 01:45:22,160 --> 01:45:24,760 RAISED WE THANK YOU FOR YOUR 2528 01:45:24,760 --> 01:45:28,760 TIME AND LOTS OF FOLLOW-UP AND 2529 01:45:28,760 --> 01:45:31,760 CONNECTIONS THAT WILL ENSUE FROM 2530 01:45:31,760 --> 01:45:32,760 THIS 2531 01:45:32,760 --> 01:45:35,200 >> THANK YOU FOR THE INVITATION 2532 01:45:35,200 --> 01:45:36,800 AND CONGRATULATIONS ON YOUR NEW 2533 01:45:36,800 --> 01:45:38,960 DEPUTY AND ALSO PLEASE SHARE MY 2534 01:45:38,960 --> 01:45:39,480 SLIDES. 2535 01:45:39,480 --> 01:45:41,320 THERE IS NOTHING SECRET IN ANY 2536 01:45:41,320 --> 01:45:42,320 OF THEM. 2537 01:45:42,320 --> 01:45:44,760 >> THANK YOU. 2538 01:45:44,760 --> 01:45:45,040 SALUTE. 2539 01:45:45,040 --> 01:45:48,160 >> LOOK FORWARD TO THAT DINNER. 2540 01:45:48,160 --> 01:45:48,760 >> YES. 2541 01:45:48,760 --> 01:45:53,120 AND RAUL YOU'RE A FELLOW CUBAN. 2542 01:45:53,120 --> 01:45:56,160 RURAL IS COMING TO TOWN AND WE 2543 01:45:56,160 --> 01:45:57,120 WILL HIT THAT RESTAURANT THAT 2544 01:45:57,120 --> 01:45:59,560 YOU RECOMMENDED. 2545 01:45:59,560 --> 01:45:59,920 >> TAKE CARE. 2546 01:45:59,920 --> 01:46:01,960 THANK YOU. 2547 01:46:01,960 --> 01:46:04,360 >> AND NOW A REAL PLEASURE TO 2548 01:46:04,360 --> 01:46:05,960 INTRODUCE MICHELLE CULP. 2549 01:46:05,960 --> 01:46:08,720 THE PRIVILEGE AND HONOR AND IT'S 2550 01:46:08,720 --> 01:46:10,320 BEEN SO MUCH FUN INTERACTING 2551 01:46:10,320 --> 01:46:12,640 WITH YOU MICHELLE IN THESE PAST 2552 01:46:12,640 --> 01:46:14,600 FEW MONTHS ON THE WORKFORCE. 2553 01:46:14,600 --> 01:46:17,880 THE CLINICAL TRIALS STEWARDSHIP. 2554 01:46:17,880 --> 01:46:19,960 WE LOOK FORWARD TO HEARING YOU 2555 01:46:19,960 --> 01:46:20,960 CAST THAT BROAD NET. 2556 01:46:20,960 --> 01:46:26,520 YOUR VISION FOR THE FUTURE. 2557 01:46:26,520 --> 01:46:29,120 >> THANK YOU RENA AND THANK YOU 2558 01:46:29,120 --> 01:46:30,480 FOR INVITING ME. 2559 01:46:30,480 --> 01:46:32,560 IT'S NICE TO SEE ON THE 2560 01:46:32,560 --> 01:46:35,040 PARTICIPANT LIST A FEW FAMILIAR 2561 01:46:35,040 --> 01:46:37,880 NUMBERS. 2562 01:46:37,880 --> 01:46:40,560 NADCRC WAS ONE OF THE INSTITUTES 2563 01:46:40,560 --> 01:46:42,960 I WORKED FOR A FEW YEARS AGO SO, 2564 01:46:42,960 --> 01:46:44,360 ITS NICE TO COME BACK. 2565 01:46:44,360 --> 01:46:46,560 THANK YOU FOR THE INVITATION. 2566 01:46:46,560 --> 01:46:48,320 I WILL BE TALKING ABOUT CLINICAL 2567 01:46:48,320 --> 01:46:50,320 TRIALS AND POLICY AND WHAT 2568 01:46:50,320 --> 01:46:56,560 EFFORTS ARE ONGOING. 2569 01:46:56,560 --> 01:47:00,080 SO LITTLE I GUESS HISTORY OR A 2570 01:47:00,080 --> 01:47:02,160 TIME LINE REFRESHER ABOUT WHAT 2571 01:47:02,160 --> 01:47:04,760 THINGS THE NIH HAS BEEN DOING TO 2572 01:47:04,760 --> 01:47:06,320 MAINTAIN AND IMPROVE THE QUALITY 2573 01:47:06,320 --> 01:47:11,120 OF CLINICAL TRIALS ACROSS THE 2574 01:47:11,120 --> 01:47:12,800 ENTERPRISE AT THE NIH FROM THE 2575 01:47:12,800 --> 01:47:15,760 POINT OF IDEA AND CONCEPT OF THE 2576 01:47:15,760 --> 01:47:17,520 WAY THROUGH PUBLICATION. 2577 01:47:17,520 --> 01:47:22,440 ROLLING BACK THE CLOCK TO 2578 01:47:22,440 --> 01:47:24,960 APRIL 2010. 2579 01:47:24,960 --> 01:47:26,960 THERE WAS AN COURT THAT MADE 2580 01:47:26,960 --> 01:47:29,840 SOME RECOMMENDATION THAT'S WERE 2581 01:47:29,840 --> 01:47:32,520 SPECIFIC TO THE NCI AND THEIR 2582 01:47:32,520 --> 01:47:33,240 COOPERATIVE GROUPS. 2583 01:47:33,240 --> 01:47:35,880 THEY MADE A NUMBER OF 2584 01:47:35,880 --> 01:47:39,440 RECOMMENDATIONS AND AT THE TIME 2585 01:47:39,440 --> 01:47:41,320 DR. COLLINS WAS OUR DIRECTOR 2586 01:47:41,320 --> 01:47:43,960 SAID WHY LIMIT THEM JUST TO THE 2587 01:47:43,960 --> 01:47:44,560 NCI. 2588 01:47:44,560 --> 01:47:47,240 MAYBE WE SHOULD DO MORE AND HOW 2589 01:47:47,240 --> 01:47:52,520 THEY CAN BE IN ARE CORPORATE -- 2590 01:47:52,520 --> 01:47:54,000 INCORPORATED ACROSS THE NIH. 2591 01:47:54,000 --> 01:47:55,560 THEY PUT TOGETHER A SMALL 2592 01:47:55,560 --> 01:47:57,000 WORKING GROUP THAT LOOKED AT 2593 01:47:57,000 --> 01:47:58,760 WHAT THINGS THEY COULD DO AND 2594 01:47:58,760 --> 01:48:00,440 HOW THEY COULD IMPROVE THINGS 2595 01:48:00,440 --> 01:48:01,760 AND MADE SOME RECOMMENDATIONS 2596 01:48:01,760 --> 01:48:04,480 THAT I WILL TALK ABOUT IN THE 2597 01:48:04,480 --> 01:48:07,560 NEXT COMING SLIDES. 2598 01:48:07,560 --> 01:48:10,680 ONE OF THE THINGS AT THE END OF 2599 01:48:10,680 --> 01:48:12,640 THE TIME LINE IS NOT ONLY A 2600 01:48:12,640 --> 01:48:15,160 STATEMENT FROM THEN VICE 2601 01:48:15,160 --> 01:48:17,160 PRESIDENT JOE BIDEN ABOUT 2602 01:48:17,160 --> 01:48:19,600 RESULTS REPORTING IS THAT HE 2603 01:48:19,600 --> 01:48:21,880 STATED THAT PUBLIC FUNDS SHOULD 2604 01:48:21,880 --> 01:48:24,200 SUPPORT THE DISSEMINATION OF 2605 01:48:24,200 --> 01:48:25,960 RESULTS AND THOSE PEOPLE WHO ARE 2606 01:48:25,960 --> 01:48:27,760 PARTICIPATING IN CLINICAL 2607 01:48:27,760 --> 01:48:29,200 RESEARCH SHOULD HAVE THEIR DATA 2608 01:48:29,200 --> 01:48:30,440 MADE AVAILABLE. 2609 01:48:30,440 --> 01:48:33,240 SO THIS TIME LINE COVERS THE 2610 01:48:33,240 --> 01:48:36,320 WHOLE LIFE CYCLE OF CLINICAL 2611 01:48:36,320 --> 01:48:40,560 TRIAL DEVELOPMENT. 2612 01:48:40,560 --> 01:48:43,560 BACK THEN WE LOOKED AT HOW MUCH 2613 01:48:43,560 --> 01:48:46,080 MONEY THE NIH WAS SPENDING ON 2614 01:48:46,080 --> 01:48:47,640 RESEARCH AND SPECIFICALLY 2615 01:48:47,640 --> 01:48:48,760 CLINICAL TRIALS. 2616 01:48:48,760 --> 01:48:52,800 SO BACK IN 2013 THE NIH HAD 2617 01:48:52,800 --> 01:48:54,240 QUITE A LARGE BUDGET. 2618 01:48:54,240 --> 01:48:57,160 YOU'LL SEE HERE THAT WE SPENT 2619 01:48:57,160 --> 01:49:01,880 ABOUT 12% OF THE BUDGET, 2620 01:49:01,880 --> 01:49:03,200 $3.15 BILLION ON CLINICAL 2621 01:49:03,200 --> 01:49:04,600 TRIALS. 2622 01:49:04,600 --> 01:49:06,160 24 OUT OF 27 INSTITUTES AND 2623 01:49:06,160 --> 01:49:07,760 CENTERS THAT SUPPORTED CLINICAL 2624 01:49:07,760 --> 01:49:08,960 TRIALS. 2625 01:49:08,960 --> 01:49:12,760 AND WE HAD A TOTAL OF OVER 5,000 2626 01:49:12,760 --> 01:49:14,680 AWARDS THAT FUNDED CLINICAL 2627 01:49:14,680 --> 01:49:15,200 TRIALS. 2628 01:49:15,200 --> 01:49:17,840 SO WE REALIZED IT WAS A HUGE 2629 01:49:17,840 --> 01:49:20,080 INVESTMENT OF TAXPAYER DOLLARS 2630 01:49:20,080 --> 01:49:21,760 GOING INTO CLINICAL TRIALS AND 2631 01:49:21,760 --> 01:49:25,480 FELT WE HAD AND OBLIGATION TO 2632 01:49:25,480 --> 01:49:27,360 KEEP THE QUALITY OF CLINICAL 2633 01:49:27,360 --> 01:49:29,760 TRIALS HIGH AND TO CONTINUE TO 2634 01:49:29,760 --> 01:49:35,760 EXCEL. 2635 01:49:35,760 --> 01:49:37,760 SO THIS WORKING GROUP WAS PUT 2636 01:49:37,760 --> 01:49:43,920 TOGETHER BACK IN 2013 TO THINK 2637 01:49:43,920 --> 01:49:45,560 ABOUT WHAT THINGS COULD BE DONE 2638 01:49:45,560 --> 01:49:52,720 TO ADDRESS THAT REPORT BACK IN 2639 01:49:52,720 --> 01:49:56,160 2010 AND OTHER ISSUES THAT WERE 2640 01:49:56,160 --> 01:49:56,800 RECOMMENDED. 2641 01:49:56,800 --> 01:49:59,120 THIS WORKING GROUP PRODUCED 8 2642 01:49:59,120 --> 01:50:00,040 RECOMMENDATIONS. 2643 01:50:00,040 --> 01:50:01,720 THE FIRST AT THAT TIME WAS TO 2644 01:50:01,720 --> 01:50:03,720 DEVELOP A CLEAR AND 2645 01:50:03,720 --> 01:50:05,160 OPERATIONALLY USEFUL DEFINITION 2646 01:50:05,160 --> 01:50:05,960 OF THE CLINICAL TRIAL. 2647 01:50:05,960 --> 01:50:08,200 I THINK MOST OF YOU ARE PROBABLY 2648 01:50:08,200 --> 01:50:11,200 AWARE NOW THAT NIH DOES HAVE A 2649 01:50:11,200 --> 01:50:12,680 CLINICAL TRIAL DEFINITION. 2650 01:50:12,680 --> 01:50:15,400 ON THE OER WEBSITE THERE IS A 2651 01:50:15,400 --> 01:50:16,680 NICE GRAPHIC THAT DESCRIBES IT 2652 01:50:16,680 --> 01:50:18,240 AND THERE ARE SOME QUESTIONS 2653 01:50:18,240 --> 01:50:22,080 THAT HELP LEAD RESEARCHERS TO 2654 01:50:22,080 --> 01:50:23,160 UNDERSTAND WHETHER THEIR STUDY 2655 01:50:23,160 --> 01:50:25,960 IS A CLINICAL TRIAL. 2656 01:50:25,960 --> 01:50:27,960 THE OTHER THE SECOND 2657 01:50:27,960 --> 01:50:30,320 RECOMMENDATION WAS TO IMPROVE 2658 01:50:30,320 --> 01:50:33,960 THE EFFICIENCY OF IRB REVIEW. 2659 01:50:33,960 --> 01:50:36,640 AT THAT TIME WE MULTIPLE IRBs 2660 01:50:36,640 --> 01:50:41,880 WERE LOOKING AT A SINGLE 2661 01:50:41,880 --> 01:50:43,920 CLINICAL TRIAL OR CLINICAL STUDY 2662 01:50:43,920 --> 01:50:48,080 AND WE WERE GETTING MULTIPLE IRB 2663 01:50:48,080 --> 01:50:49,000 REVIEWS SO THE RECOMMEND IS TO 2664 01:50:49,000 --> 01:50:51,560 LOOK AT EFFICIENCIES AND THE 2665 01:50:51,560 --> 01:50:54,240 RESULTS WERE A SINGLE IRB 2666 01:50:54,240 --> 01:50:54,480 POLICY. 2667 01:50:54,480 --> 01:50:56,520 THE THIRD RECOMMENDATION WAS TO 2668 01:50:56,520 --> 01:51:00,120 ENHANCE THE RELEVANCE AND 2669 01:51:00,120 --> 01:51:02,280 FEASIBILITY OF NIH FUNDED 2670 01:51:02,280 --> 01:51:02,920 CLINICAL TRIALS. 2671 01:51:02,920 --> 01:51:05,320 THE FOURTH WAS INCREASE 2672 01:51:05,320 --> 01:51:06,560 KNOWLEDGE AMONG INVESTIGATORS 2673 01:51:06,560 --> 01:51:07,800 AND TAFF. 2674 01:51:07,800 --> 01:51:10,160 A POLICY WAS GENERATED FROM 2675 01:51:10,160 --> 01:51:10,320 THAT. 2676 01:51:10,320 --> 01:51:10,760 *. 2677 01:51:10,760 --> 01:51:13,880 ALSO TO ENHANCE THE INFORMATION 2678 01:51:13,880 --> 01:51:15,200 COLLECTED IN PROGRESS REPORTS. 2679 01:51:15,200 --> 01:51:17,200 AND YOU PROBABLY ARE AWARE OF 2680 01:51:17,200 --> 01:51:19,480 SOME OF THOSE ENHANCEMENT MADE 2681 01:51:19,480 --> 01:51:22,720 IN THE FORMS THAT OER HAS PUT 2682 01:51:22,720 --> 01:51:23,240 OUT. 2683 01:51:23,240 --> 01:51:26,320 THE 6th WAS TO DEVELOP 2684 01:51:26,320 --> 01:51:27,440 SOPHISTICATED WEB BASED TOOLS 2685 01:51:27,440 --> 01:51:28,760 FOR MONITORING. 2686 01:51:28,760 --> 01:51:32,760 THIS REQUIRED A LOT OF IT 2687 01:51:32,760 --> 01:51:34,320 SUPPORT AND ADDING ADDITIONAL 2688 01:51:34,320 --> 01:51:40,080 FORMS AND DATABASES TO HELP THE 2689 01:51:40,080 --> 01:51:42,280 NIH AND RESEARCHERS TO TRACK AND 2690 01:51:42,280 --> 01:51:43,560 MONITOR CLINICAL TRIALS. 2691 01:51:43,560 --> 01:51:46,200 WE HAVE WANTED TO ENHANCE 2692 01:51:46,200 --> 01:51:47,760 CLINICAL TRIAL RESULTS AND 2693 01:51:47,760 --> 01:51:48,560 MAKING SURE THAT THE RESULTS 2694 01:51:48,560 --> 01:51:50,560 THAT CAME FROM CLINICAL TRIALS 2695 01:51:50,560 --> 01:51:52,320 WERE MADE AVAILABLE TO THE 2696 01:51:52,320 --> 01:51:52,760 PUBLIC. 2697 01:51:52,760 --> 01:51:55,440 AND LASTLY WAS TO HAVE A MORE 2698 01:51:55,440 --> 01:52:00,560 RIGOROUS PIE -- PEER REVIEW AND HAVE 2699 01:52:00,560 --> 01:52:03,640 MORE DETAIL. 2700 01:52:03,640 --> 01:52:07,120 SO WHAT THE GOALS OF THE 2016 2701 01:52:07,120 --> 01:52:08,680 STEWARDSHIP REFORM POLICIES WERE 2702 01:52:08,680 --> 01:52:10,280 TO IMPROVE THE QUALITY AND 2703 01:52:10,280 --> 01:52:12,520 EFFICIENCY OF CLINICAL TRIALS. 2704 01:52:12,520 --> 01:52:20,720 WE WANTED TO SUPPORT TRIALS 2705 01:52:20,720 --> 01:52:22,880 INVESTIGATING -- MISSION 2706 01:52:22,880 --> 01:52:24,400 RELEVANT QUESTIONS AND HIGH 2707 01:52:24,400 --> 01:52:24,760 PRIORITY. 2708 01:52:31,760 --> 01:52:35,080 JUST TALKING ABOUT WHAT THOSE 2709 01:52:35,080 --> 01:52:38,560 FORMS MEANT WITH REGARD TO THE 2710 01:52:38,560 --> 01:52:42,960 LIFE CYCLE. 2711 01:52:42,960 --> 01:52:44,800 TAKING THIS LIFE CYCLE OR 2712 01:52:44,800 --> 01:52:47,120 JOURNEY APPROACH WE THOUGHT 2713 01:52:47,120 --> 01:52:50,240 ABOUT THE WAY IDEAS ARE 2714 01:52:50,240 --> 01:52:52,760 CONCEIVED AND HOW AN IDEA COMES 2715 01:52:52,760 --> 01:52:55,720 IN AND IN ORDER TO IMPROVE HOW 2716 01:52:55,720 --> 01:52:56,960 WE'RE THINKING ABOUT CLINICAL 2717 01:52:56,960 --> 01:52:59,080 TRIALS AND MANAGING IT WE FELT 2718 01:52:59,080 --> 01:53:01,120 THAT BEING SURE THAT 2719 01:53:01,120 --> 01:53:02,440 INVESTIGATORS AND THOSE MANAGING 2720 01:53:02,440 --> 01:53:04,440 CLINICAL TRIALS HAD A BETTER 2721 01:53:04,440 --> 01:53:06,080 UNDERSTANDING OF CLINICAL 2722 01:53:06,080 --> 01:53:06,920 TRIALS. 2723 01:53:06,920 --> 01:53:09,880 THUS WE DEVELOPED A POLICY THAT 2724 01:53:09,880 --> 01:53:11,000 REQUIRES GOOD CLINICAL PRACTICE 2725 01:53:11,000 --> 01:53:13,040 TRAINING. 2726 01:53:13,040 --> 01:53:16,160 WE ALSO INSTITUTED A POLICY FOR 2727 01:53:16,160 --> 01:53:17,960 CLINICAL TRIAL FUNDING 2728 01:53:17,960 --> 01:53:21,120 OPPORTUNITY A NOUNSMENTS AND 2729 01:53:21,120 --> 01:53:22,480 HAVE SENSE REQUIRED THAT 2730 01:53:22,480 --> 01:53:24,400 CLINICAL TRIALS COME IN THROUGH 2731 01:53:24,400 --> 01:53:26,880 A SPECIFIC FUNDING OPPORTUNITY 2732 01:53:26,880 --> 01:53:30,080 AND THAT THOSE APPLICATIONS HAVE 2733 01:53:30,080 --> 01:53:32,080 SPECIFIC ITEMS IN IT SO THAT 2734 01:53:32,080 --> 01:53:34,360 REVIEWERS CAN BETTER EVALUATE 2735 01:53:34,360 --> 01:53:36,000 THE CLINICAL TRIAL. 2736 01:53:36,000 --> 01:53:38,440 ON THE FLIP SIDE THERE ARE 2737 01:53:38,440 --> 01:53:40,760 ADDITIONAL CLINICAL TRIAL REVIEW 2738 01:53:40,760 --> 01:53:43,040 CRITERIA THAT PANELS MUST 2739 01:53:43,040 --> 01:53:46,960 FOLLOW. 2740 01:53:46,960 --> 01:53:47,520 WE INSTITUTED A SINGLE IRB 2741 01:53:47,520 --> 01:53:51,480 POLICY. 2742 01:53:51,480 --> 01:53:56,520 ---STATES THAT MULTI SITE 2743 01:53:56,520 --> 01:53:58,760 CLINICAL TRIALS OR STUDIES WILL 2744 01:53:58,760 --> 01:54:01,320 USE A SINGLE IRB. 2745 01:54:01,320 --> 01:54:04,000 WE ALSO RELEASED A PROTOCOL 2746 01:54:04,000 --> 01:54:05,800 TEMPLATE WHICH WAS NOT REALLY 2747 01:54:05,800 --> 01:54:09,400 PART OF THE REFORMS BUT THE 2748 01:54:09,400 --> 01:54:11,080 TIMING WAS SUCH THAT IT PROVIDED 2749 01:54:11,080 --> 01:54:13,280 A RESOURCE TO HELP INVESTIGATORS 2750 01:54:13,280 --> 01:54:16,000 DEVELOP CLINICAL TRIAL PROTOCOLS 2751 01:54:16,000 --> 01:54:20,800 IN ACCORDANCE WITH ICH6. 2752 01:54:20,800 --> 01:54:23,720 INCLUDING ALL OF THE LIMITS 2753 01:54:23,720 --> 01:54:25,280 NECESSARY. 2754 01:54:25,280 --> 01:54:28,600 WE ALSO RELEASED THE POLICY FOR 2755 01:54:28,600 --> 01:54:30,160 CLINICAL TRIAL REGISTRATION OR 2756 01:54:30,160 --> 01:54:32,080 RESULTS REPORTINGS WHICH MEANS 2757 01:54:32,080 --> 01:54:35,960 THAT ALL NIH FUNDED CLINICAL 2758 01:54:35,960 --> 01:54:38,760 TRIALS MUST REGISTER AND THAT 2759 01:54:38,760 --> 01:54:42,040 RESULTS MUST BE REPORTED TO 2760 01:54:42,040 --> 01:54:45,360 CLINICAL TRIALS.GOV WITHIN 12 2761 01:54:45,360 --> 01:54:48,000 MONTHS OF THE TRIAL'S PRIMARY 2762 01:54:48,000 --> 01:54:48,880 COMPLETION DATE. 2763 01:54:48,880 --> 01:54:52,760 SO THAT COVERS FROM THE LIFE 2764 01:54:52,760 --> 01:54:55,720 CYCLE OF CLINICAL TRIAL IDEA ALL 2765 01:54:55,720 --> 01:54:57,520 THE WAY THROUGH CLINICAL TRIAL 2766 01:54:57,520 --> 01:55:01,520 REGISTRATION AND REPORTING. 2767 01:55:01,520 --> 01:55:04,520 SO THIS IS JUST A LITTLE BIT 2768 01:55:04,520 --> 01:55:07,960 MORE CLARITY ON THE POLICIES 2769 01:55:07,960 --> 01:55:10,160 THAT HAVE -- WERE RELEASED BACK 2770 01:55:10,160 --> 01:55:12,000 IN 2016 BUT A NUMBER OF THEM 2771 01:55:12,000 --> 01:55:16,760 WERE NOT EFFECTIVE UNTIL 2017 OR 2772 01:55:16,760 --> 01:55:17,160 EARLY 2018. 2773 01:55:17,160 --> 01:55:19,600 I HOPE MOST OF YOU ARE AWARE OF 2774 01:55:19,600 --> 01:55:22,080 THEM AND IF YOU'VE SUBMITTED 2775 01:55:22,080 --> 01:55:23,320 CLINICAL TRIALS HAVE FOLLOWED 2776 01:55:23,320 --> 01:55:25,480 THOSE POLICIES AND ARE WELL 2777 01:55:25,480 --> 01:55:27,680 INFORMED I'M HAPPY TO TALK ABOUT 2778 01:55:27,680 --> 01:55:29,760 THEM IN GREATER DETAIL IF YOU'RE 2779 01:55:29,760 --> 01:55:30,840 INTERESTED. 2780 01:55:30,840 --> 01:55:34,240 NEXT SLIDE. 2781 01:55:34,240 --> 01:55:37,000 SO WHEN WE THINK ABOUT RESULTS 2782 01:55:37,000 --> 01:55:39,920 REPORTING FRANCIS COLLINS AND 2783 01:55:39,920 --> 01:55:43,200 THE NIH ARE VERY COMMITTED TO 2784 01:55:43,200 --> 01:55:45,120 BEING SURE IS THAT RESULTS OF 2785 01:55:45,120 --> 01:55:47,960 STUDIES ARE MADE AVAILABLE 2786 01:55:47,960 --> 01:55:48,760 QUICKLY. 2787 01:55:48,760 --> 01:55:51,960 WHILE THE CLINICAL TRIALS 2788 01:55:51,960 --> 01:55:54,200 DISSEMINATION POLICY STATES THAT 2789 01:55:54,200 --> 01:55:56,640 RESULTS MUST BE REPORTED WITHIN 2790 01:55:56,640 --> 01:55:58,680 ONE YEAR OF THE PRIMARY 2791 01:55:58,680 --> 01:56:00,240 COMPLETION DATE OF CLINICAL 2792 01:56:00,240 --> 01:56:03,000 TRIALS IN NOVEMBER OF 2020 2793 01:56:03,000 --> 01:56:07,000 DR. COLLINS WAS REALLY EMPHATIC 2794 01:56:07,000 --> 01:56:10,120 ABOUT ENSURING THAT RESULTS OF 2795 01:56:10,120 --> 01:56:12,080 COVID STUDIES WOULD BE REPORTED 2796 01:56:12,080 --> 01:56:13,400 AS QUICKLY AS POSSIBLE. 2797 01:56:13,400 --> 01:56:15,720 THIS WAS NOT A REQUIREMENT 2798 01:56:15,720 --> 01:56:17,600 CHANGE BUT A PLEA TO THOSE 2799 01:56:17,600 --> 01:56:19,880 RESEARCHERS WORKING ON COVID 2800 01:56:19,880 --> 01:56:21,960 STUDIES TO QUICKLY REPORT 2801 01:56:21,960 --> 01:56:24,920 RESULTS TO CLINICAL TRIALS.GOV 2802 01:56:24,920 --> 01:56:26,440 SO OTHER RESEARCHERS WOULD BE 2803 01:56:26,440 --> 01:56:28,560 AWARE AND THE PUBLIC WOULD HAVE 2804 01:56:28,560 --> 01:56:29,960 THE LATEST RESULTS INFORMATION. 2805 01:56:29,960 --> 01:56:32,760 SO THIS IS JUST AN EXAMPLE OF 2806 01:56:32,760 --> 01:56:34,640 NIH'S COMMITMENT TO RESULTS 2807 01:56:34,640 --> 01:56:38,440 REPORTING. 2808 01:56:38,440 --> 01:56:42,400 AS WE MOVE FORWARD BECAUSE WE 2809 01:56:42,400 --> 01:56:44,840 HAVE PUT OUT A NUMBER OF REFORMS 2810 01:56:44,840 --> 01:56:49,960 IN THE LAST FIVE YEARS 2811 01:56:49,960 --> 01:56:52,480 DR. COLLINS CONTINUED TO SUPPORT 2812 01:56:52,480 --> 01:56:53,600 STEWARDSHIP AND WANTED TO BE 2813 01:56:53,600 --> 01:56:55,600 SURE IS THAT WE WERE DOING ALL 2814 01:56:55,600 --> 01:56:57,840 THAT WE COULD BE IN ENSURING THE 2815 01:56:57,840 --> 01:56:59,760 QUALITY OF CLINICAL TRIALS AND 2816 01:56:59,760 --> 01:57:01,640 SEE IF THERE ARE OTHER EFFORTS 2817 01:57:01,640 --> 01:57:02,640 THAT COULD BE DONE. 2818 01:57:02,640 --> 01:57:04,600 CERTAINLY COVID HIGHLIGHTED A 2819 01:57:04,600 --> 01:57:06,760 NUMBER OF AREAS WHERE 2820 01:57:06,760 --> 01:57:07,600 IMPROVEMENTS COULD BE MADE BUT 2821 01:57:07,600 --> 01:57:10,280 LOOKING AT THE FUNDING OVER THE 2822 01:57:10,280 --> 01:57:12,520 LAST SEVERAL YEARS YOU'LL SEE 2823 01:57:12,520 --> 01:57:14,800 WHEN WE STARTED THE REFORMS IN 2824 01:57:14,800 --> 01:57:15,880 2013 AND THINKING ABOUT OUR 2825 01:57:15,880 --> 01:57:17,520 BUDGET AT $3 BILLION WHEN YOU 2826 01:57:17,520 --> 01:57:21,400 LOOK AT THE ESTIMATED BUDGET OF 2827 01:57:21,400 --> 01:57:23,360 2021 THE NIH BUDGET HAS DOUBLED 2828 01:57:23,360 --> 01:57:24,720 SINCE THEN. 2829 01:57:24,720 --> 01:57:28,160 AND SO WE FEEL THAT WE HAD A 2830 01:57:28,160 --> 01:57:29,640 CONTINUED NEED TO BE SURE IS 2831 01:57:29,640 --> 01:57:32,560 THAT WE WERE PROVIDING THE BEST 2832 01:57:32,560 --> 01:57:34,640 STEWARDSHIP FOR CLINICAL TRIALS 2833 01:57:34,640 --> 01:57:36,360 IN KEEPING THOSE TRIALS OF THE 2834 01:57:36,360 --> 01:57:40,360 HIGHEST QUALITY. 2835 01:57:40,360 --> 01:57:47,160 SO WITH THAT THIS CLINICAL TRIAL 2836 01:57:47,160 --> 01:57:47,880 STEWARDSHIP EFFORT CONTINUES AND 2837 01:57:47,880 --> 01:57:50,360 WITH THE TASK FORCE FORMED LAST 2838 01:57:50,360 --> 01:57:52,760 SUMMER RENA IS ONE OF THE TASK 2839 01:57:52,760 --> 01:57:55,000 FORCE MEMBERS AS IS JANICE LEE 2840 01:57:55,000 --> 01:57:58,200 SO WE'RE ABLE TO GET INPUT FROM 2841 01:57:58,200 --> 01:57:59,560 HIGH LEVEL LEADERSHIP ACROSS THE 2842 01:57:59,560 --> 01:58:02,760 NIH THAT INCLUDES BOTH 2843 01:58:02,760 --> 01:58:06,760 EXTRAMURAL AND INTERMURAL INPUTS 2844 01:58:06,760 --> 01:58:09,200 WHERE WE CAN ASSESS THE POLICIES 2845 01:58:09,200 --> 01:58:11,680 THAT WERE DEVELOPED IN 2016 ARE 2846 01:58:11,680 --> 01:58:12,720 MEETING THE INITIAL GOALS AND 2847 01:58:12,720 --> 01:58:14,960 ALSO TO LOOK TO SEE HOW WE MAY 2848 01:58:14,960 --> 01:58:17,960 BE ABLE TO IMPROVE OR FIND GAP 2849 01:58:17,960 --> 01:58:20,520 AREAS FOR AND WHAT MORE WE MIGHT 2850 01:58:20,520 --> 01:58:24,160 BE ABLE TO DO TO IMPROVE 2851 01:58:24,160 --> 01:58:28,600 CLINICAL TRIALS. 2852 01:58:28,600 --> 01:58:31,160 SO I JUST WANTED TO IN CLOSING 2853 01:58:31,160 --> 01:58:33,120 WITH THE STEWARDSHIP IT'S 2854 01:58:33,120 --> 01:58:35,000 ONGOING TO SEE THAT WE'RE 2855 01:58:35,000 --> 01:58:36,760 IMPROVING CLINICAL TRIALS AND 2856 01:58:36,760 --> 01:58:37,800 PULLING TOGETHER RECOMMENDATIONS 2857 01:58:37,800 --> 01:58:40,000 FROM A NUMBER OF AREAS AND I 2858 01:58:40,000 --> 01:58:42,360 GUESS STAY TUNED TO SEE WHAT 2859 01:58:42,360 --> 01:58:44,000 THOSE RECOMMENDATIONS WILL BE 2860 01:58:44,000 --> 01:58:47,760 AND HOW WE CAN TAKE ACTION ON 2861 01:58:47,760 --> 01:58:49,120 THEM ACROSS THE ENTERPRISE. 2862 01:58:49,120 --> 01:58:52,320 I WANT TO SHIFT GEARS A LITTLE 2863 01:58:52,320 --> 01:58:55,000 BIT BECAUSE LISTENING ABOUT THE 2864 01:58:55,000 --> 01:58:57,320 CEAL INITIATIVE AS WELL AS 2865 01:58:57,320 --> 01:58:59,440 HEARING CONTINUES ACROSS THE 2866 01:58:59,440 --> 01:59:01,760 CLINICAL TRIAL EVENT SURPRISE 2867 01:59:01,760 --> 01:59:04,160 ABOUT WHAT * THINGS WE MIGHT 2868 01:59:04,160 --> 01:59:06,800 DOING IMPROVE CLINICAL TRIALS. 2869 01:59:06,800 --> 01:59:09,920 WE PULLED TOGETHER SOME LESSONS 2870 01:59:09,920 --> 01:59:13,560 LEARNED FROM A NUMBER OF SOURCES 2871 01:59:13,560 --> 01:59:16,080 INCLUDING THE INSTITUTE THAT PUT 2872 01:59:16,080 --> 01:59:18,600 OUT A PUBLICATION -- THE 2873 01:59:18,600 --> 01:59:20,720 NATIONAL ACADEMIES HAS HAD A 2874 01:59:20,720 --> 01:59:26,480 DIRECT FORUM SERIES. 2875 01:59:26,480 --> 01:59:32,400 AND THEN OPERATIONAL WARP SPEED 2876 01:59:32,400 --> 01:59:35,280 AS WELL AS SOME OTHER GROUPS DID 2877 01:59:35,280 --> 01:59:39,160 A PRESENTATION AT THE REAGAN 2878 01:59:39,160 --> 01:59:42,000 UDAL FOUNDATION TALKING ABOUT 2879 01:59:42,000 --> 01:59:43,720 LESSONS LEARNED. 2880 01:59:43,720 --> 01:59:45,840 SO I JUST WANTED TO HIGHLIGHT 2881 01:59:45,840 --> 01:59:50,400 SOME OF SHOWS LESSONS LEARNED. 2882 01:59:50,400 --> 01:59:57,880 7 START WITH CLINICAL TRIAL 2883 01:59:57,880 --> 01:59:59,920 DESIGN WHICH IS AT THE BEGINNING 2884 01:59:59,920 --> 02:00:02,560 OF THE CLINICAL TRIAL LIFE 2885 02:00:02,560 --> 02:00:03,000 CYCLE. 2886 02:00:03,000 --> 02:00:05,160 WHAT ARE THE THINGS THAT WE 2887 02:00:05,160 --> 02:00:07,560 COULD DO AND HOW WE CAN 2888 02:00:07,560 --> 02:00:09,280 CO-DESIGN CLINICAL TRIALS WITH 2889 02:00:09,280 --> 02:00:12,160 PATIENT ADVOCATES AND UNDER 2890 02:00:12,160 --> 02:00:13,960 REPRESENTED COMMUNITIES SO THEIR 2891 02:00:13,960 --> 02:00:20,520 NEEDS ARE BASKETBAL BETTER A LINED. 2892 02:00:20,520 --> 02:00:23,560 WE WOULD LIKE TO SEE IS THAT 2893 02:00:23,560 --> 02:00:25,680 CLINICAL TRIAL DESIGN ARE 2894 02:00:25,680 --> 02:00:27,880 IMPROVED TO ELIMINATE UNDER 2895 02:00:27,880 --> 02:00:29,920 POWER TRIALS THAT DO NOT 2896 02:00:29,920 --> 02:00:31,000 CONTRIBUTE TO ADVANCING 2897 02:00:31,000 --> 02:00:33,360 KNOWLEDGE AND TO USE METHODS TO 2898 02:00:33,360 --> 02:00:35,760 LIMIT CONDUCT OF CLINICAL TRIALS 2899 02:00:35,760 --> 02:00:38,960 THAT ARE NOT DESIGNED TO PRODUCE 2900 02:00:38,960 --> 02:00:41,520 ROBUST DATA. 2901 02:00:41,520 --> 02:00:45,400 AND THE FOA POLICY THAT'S AN 2902 02:00:45,400 --> 02:00:46,960 AREA THAT WE'RE TRYING TO BE 2903 02:00:46,960 --> 02:00:48,360 SURE IS THAT CLINICAL TRIALS 2904 02:00:48,360 --> 02:00:51,080 THAT ARE FUNDED CAN PRODUCE 2905 02:00:51,080 --> 02:00:52,680 ROBUST DATA. 2906 02:00:52,680 --> 02:00:55,080 THINKING ABOUT DESIGN AGAIN WAYS 2907 02:00:55,080 --> 02:00:58,680 IN WHICH WE CAN USE MORE -- 2908 02:00:58,680 --> 02:01:02,320 ADAPTIVE TRIAL DESIGNS IN WHICH 2909 02:01:02,320 --> 02:01:03,760 PATIENTS ARE SUBJECTED AND THEN 2910 02:01:03,760 --> 02:01:07,520 TO PROMOTE THE DEVELOPMENT AND 2911 02:01:07,520 --> 02:01:10,480 OPERATIONAL -- OPERATIONS OF 2912 02:01:10,480 --> 02:01:22,720 EFFICIENT LARGE SCALE LYNN CAL -- SCALE 2913 02:01:22,720 --> 02:01:32,240 CLINICAL TRIALS NETWORK. 2914 02:01:35,080 --> 02:01:41,160 I THINK THAT ELISEO TOUCHED ON 2915 02:01:41,160 --> 02:01:45,040 THIS BUT HE IS NOT ALONE. 2916 02:01:45,040 --> 02:01:46,840 THEY'VE MADE RECOMMENDATIONS ON 2917 02:01:46,840 --> 02:01:48,960 HOW WE MIGHT BE ABLE TO INVEST 2918 02:01:48,960 --> 02:01:51,920 IN COMMUNITY OUTREACH AND 2919 02:01:51,920 --> 02:01:53,440 ENGAGEMENT EARLY IN THE CLINICAL 2920 02:01:53,440 --> 02:01:54,000 TRIAL PROCESS. 2921 02:01:54,000 --> 02:01:55,760 THIS IS NOT ASKING FOR 2922 02:01:55,760 --> 02:01:57,360 ENGAGEMENT WHEN THE TRIAL IS 2923 02:01:57,360 --> 02:01:58,560 FAILING TO RECRUIT. 2924 02:01:58,560 --> 02:02:00,880 BUT EARLY IN THE STAGES OF 2925 02:02:00,880 --> 02:02:02,440 DESIGNING THE TRIAL SO THAT 2926 02:02:02,440 --> 02:02:04,120 THEIR NEEDS ARE ADDRESSED AND 2927 02:02:04,120 --> 02:02:07,240 THAT THEY CAN BE AWARE OF 2928 02:02:07,240 --> 02:02:09,360 CLINICAL TRIALS -- HE SAID THAT 2929 02:02:09,360 --> 02:02:13,200 WE MOVE AT THE SPEED OF TRUST SO 2930 02:02:13,200 --> 02:02:21,760 BY CULTIVATING WE CAN IMPROVE ON 2931 02:02:21,760 --> 02:02:23,520 THE TRUST. 2932 02:02:23,520 --> 02:02:26,600 THEY ARE AT THE TABLE AND SEEN 2933 02:02:26,600 --> 02:02:30,360 AS A PARTNER WHERE THEIR INPUT 2934 02:02:30,360 --> 02:02:34,400 IS VIEWED AS EQUAL TO THE OTHER 2935 02:02:34,400 --> 02:02:36,880 TEAM MEMBERS IN DEVELOPING IDEAS 2936 02:02:36,880 --> 02:02:38,920 THAT ADDRESS THE COMMUNITY'S 2937 02:02:38,920 --> 02:02:42,440 NEEDS AND TO ENGAGE A DIVERSE 2938 02:02:42,440 --> 02:02:45,120 CLINICAL RESEARCH TEAM MEMBERS 2939 02:02:45,120 --> 02:02:47,160 THAT REPRESENT THE POPULATIONS 2940 02:02:47,160 --> 02:02:49,960 AND HAVE ALL TEAM MEMBERS BE 2941 02:02:49,960 --> 02:02:52,720 REPRESENTATIVE SO THAT WE ARE 2942 02:02:52,720 --> 02:02:57,240 SURE THAT THE DIFFERENT ROLES 2943 02:02:57,240 --> 02:03:05,600 CAPTURE DIFFERENT POPULATIONS. 2944 02:03:05,600 --> 02:03:07,360 MORE ABOUT DIVERSITY. 2945 02:03:07,360 --> 02:03:09,960 WE WANT TO IMPROVE THE DIVERSITY 2946 02:03:09,960 --> 02:03:10,720 IN CLINICAL TRIALS. 2947 02:03:10,720 --> 02:03:12,760 THERE ARE POLICIES THAT THE NIH 2948 02:03:12,760 --> 02:03:14,600 HAS ABOUT INCLUSION OF WOMEN AND 2949 02:03:14,600 --> 02:03:15,240 CHILDREN. 2950 02:03:15,240 --> 02:03:16,840 RACIAL ETHNIC MINORITIES AND 2951 02:03:16,840 --> 02:03:18,840 INCLUSION OF PARTICIPANTS ACROSS 2952 02:03:18,840 --> 02:03:20,520 THE LIFE-SPAN BUT THIS IS REALLY 2953 02:03:20,520 --> 02:03:22,400 ALSO TO DETERMINE THE BEST 2954 02:03:22,400 --> 02:03:24,240 PRACTICES FOR INCREASING 2955 02:03:24,240 --> 02:03:26,480 PARTICIPATION IN CLINICAL TRIALS 2956 02:03:26,480 --> 02:03:27,360 FROM UNDER REPRESENTED 2957 02:03:27,360 --> 02:03:29,360 COMMUNITIES AND TO CREATE ACTION 2958 02:03:29,360 --> 02:03:31,960 PLANS FOR IMPROVING DIVERSITY IN 2959 02:03:31,960 --> 02:03:34,640 CLINICAL TRIALS. 2960 02:03:34,640 --> 02:03:36,120 RECOMMENDATIONS INCLUDED 2961 02:03:36,120 --> 02:03:38,120 ENSURING DIVERSE FACULTY 2962 02:03:38,120 --> 02:03:39,000 PROMOTION. 2963 02:03:39,000 --> 02:03:41,240 EQUITABLE AND INCLUSIVE 2964 02:03:41,240 --> 02:03:43,360 WORKFORCE TRAINING PROGRAMS AND 2965 02:03:43,360 --> 02:03:44,520 PROFESSIONAL DEVELOPMENT 2966 02:03:44,520 --> 02:03:45,600 OPPORTUNITIES FOR DIVERSE 2967 02:03:45,600 --> 02:03:48,760 POPULATIONS. 2968 02:03:48,760 --> 02:03:51,560 ANOTHER THOUGHT ABOUT DIVERSE IN 2969 02:03:51,560 --> 02:03:53,280 CLINICAL TRIALS IS MAKING 2970 02:03:53,280 --> 02:03:58,160 TELEHEALTH OR TELL RESEARCH AND 2971 02:03:58,160 --> 02:04:02,840 ELECTRONIC VISITS MORE VISIBLE 2972 02:04:02,840 --> 02:04:04,680 INCLUDING NOVEL AND EQUITABLE 2973 02:04:04,680 --> 02:04:07,200 DATA COLLECTION METHODS AND 2974 02:04:07,200 --> 02:04:08,680 ACTUALLY SOMEWHAT CURIOUS ABOUT 2975 02:04:08,680 --> 02:04:12,320 HOW THE DENTAL COMMUNITY IS ABLE 2976 02:04:12,320 --> 02:04:14,600 TO INTEGRATE ELECTRONIC HEALTH 2977 02:04:14,600 --> 02:04:15,880 RECORDS INTO RESEARCH AND TO BE 2978 02:04:15,880 --> 02:04:19,280 ABLE TO UTILIZE TELL RESEARCHER, 2979 02:04:19,280 --> 02:04:28,760 TELEHEALTH IN CLINICAL TRIALS. 2980 02:04:28,760 --> 02:04:31,320 SO DECENTRALIZED CLINICAL TRIALS 2981 02:04:31,320 --> 02:04:33,760 HAS GOTTEN A LOT OF BUZZ. 2982 02:04:33,760 --> 02:04:37,560 IT CAN TAKE ON A NUMBER OF 2983 02:04:37,560 --> 02:04:39,960 DIFFERENT DEFINITIONS WHETHER 2984 02:04:39,960 --> 02:04:42,320 THEY BE TELEMEDICINE OR 2985 02:04:42,320 --> 02:04:45,040 TELEHEALTH TYPE OF TRIALS OR 2986 02:04:45,040 --> 02:04:46,960 PRAGMATIC CLINICAL TRIALS BUT 2987 02:04:46,960 --> 02:04:48,400 THINKING THAT WE NEED TO THINK 2988 02:04:48,400 --> 02:04:52,160 ABOUT WAYS TO REMOVE BARRIERS 2989 02:04:52,160 --> 02:04:54,760 EXPAND ADOPTION OF THESE TRIALS 2990 02:04:54,760 --> 02:04:56,640 SO THAT PATIENTS ARE NOT ALWAYS 2991 02:04:56,640 --> 02:04:59,160 HAVING TO COME INTO AN ACADEMIC 2992 02:04:59,160 --> 02:05:02,480 HEALTH CENTER TO GET THEIR STUDY 2993 02:05:02,480 --> 02:05:03,800 VISITS COMPLETED. 2994 02:05:03,800 --> 02:05:06,160 AND TO THINK ABOUT WAYS IN WHICH 2995 02:05:06,160 --> 02:05:08,720 WE CAN MONITOR CLINICAL TRIALS 2996 02:05:08,720 --> 02:05:09,880 MORE REMOTELY. 2997 02:05:09,880 --> 02:05:12,920 HOW WE CAN ALIGN REMOTE DATA 2998 02:05:12,920 --> 02:05:15,080 COLLECTION STANDARDS SO THAT 2999 02:05:15,080 --> 02:05:16,360 DATA CAN BE PULLED FROM OTHER 3000 02:05:16,360 --> 02:05:18,200 SOURCES NOT JUST THE SINGLE 3001 02:05:18,200 --> 02:05:20,360 RESEARCH SITE. 3002 02:05:20,360 --> 02:05:24,160 EXTEND TELEMEDICINE IN REMOTE 3003 02:05:24,160 --> 02:05:26,840 MONITORING FOR FLEXIBILITIES AND 3004 02:05:26,840 --> 02:05:28,040 REIMBURSEMENT BEYOND PUBLIC 3005 02:05:28,040 --> 02:05:28,760 HEALTH EMERGENCY. 3006 02:05:28,760 --> 02:05:30,800 WE SAW A LOT OF THAT CHANGE 3007 02:05:30,800 --> 02:05:32,760 DURING COVID WHERE PEOPLE HAD TO 3008 02:05:32,760 --> 02:05:36,400 MAKE THOSE CHANGES BECAUSE THEY 3009 02:05:36,400 --> 02:05:38,200 WERE NOT ABLE TO COME IN FOR 3010 02:05:38,200 --> 02:05:40,680 THEIR VISITS AND THEY HAD TO BE 3011 02:05:40,680 --> 02:05:42,080 DONE THROUGH OTHER TECHNOLOGIES. 3012 02:05:42,080 --> 02:05:44,360 HOW CAN WE SUSTAIN THOSE TYPES 3013 02:05:44,360 --> 02:05:45,800 OF TECH SNEAKS AND METHODS IN 3014 02:05:45,800 --> 02:05:47,160 THE FUTURE FOR ANY CLINICAL 3015 02:05:47,160 --> 02:05:49,000 TRIAL. 3016 02:05:49,000 --> 02:05:52,120 DEMONSTRATE THAT CONDUCTING 3017 02:05:52,120 --> 02:05:55,960 CLINICAL TRIAL -- CONDUCT 3018 02:05:55,960 --> 02:05:59,520 TECHNOLOGY ABLED DECENTRALIZED 3019 02:05:59,520 --> 02:06:03,440 TRIALS -- WE WERE FORCED TO DO 3020 02:06:03,440 --> 02:06:05,400 THESE THINGS BUT LOOKING AT HOW 3021 02:06:05,400 --> 02:06:07,600 WE CAN BE SURETY HIGHEST DATA 3022 02:06:07,600 --> 02:06:10,440 QUALITY AND THE VALIDITY OF THE 3023 02:06:10,440 --> 02:06:11,360 DATA WE RECEIVED. 3024 02:06:11,360 --> 02:06:14,200 THAT'S AN AREA THAT WE NEED TO 3025 02:06:14,200 --> 02:06:20,200 THINK ABOUT. 3026 02:06:20,200 --> 02:06:22,880 SO THIS LEADS INTO THE DIGITAL 3027 02:06:22,880 --> 02:06:24,360 RESEARCH TECHNOLOGIES AND WAYS 3028 02:06:24,360 --> 02:06:25,880 IN WHICH WE CAN USE TECHNOLOGIES 3029 02:06:25,880 --> 02:06:28,000 TO SUPPORT CLINICAL TRIALS. 3030 02:06:28,000 --> 02:06:31,880 AND APPLY THOSE TECHNOLOGIES TO 3031 02:06:31,880 --> 02:06:33,760 SIMPLIFY CLINICAL TRIALS AND 3032 02:06:33,760 --> 02:06:37,560 IMPROVE THE PATIENT EXPERIENCE 3033 02:06:37,560 --> 02:06:38,960 USING DIGITAL HEALTH 3034 02:06:38,960 --> 02:06:40,480 TECHNOLOGIES TO ENABLE DIRECT 3035 02:06:40,480 --> 02:06:42,360 INTERACTION WITH PATIENTS AND 3036 02:06:42,360 --> 02:06:44,640 POTENTIAL TRIAL PARTICIPANTS TO 3037 02:06:44,640 --> 02:06:46,760 GAIN THEIR INPUT NOT ONLY ON 3038 02:06:46,760 --> 02:06:49,560 THEIR IDEAS FOR DEVELOPING 3039 02:06:49,560 --> 02:06:51,040 CLINICAL TRIAL RESEARCH 3040 02:06:51,040 --> 02:06:53,280 QUESTIONS BUT ALSO TO HELP 3041 02:06:53,280 --> 02:06:55,120 PROVIDE THE DATA. 3042 02:06:55,120 --> 02:06:58,400 SO THERE IS THEN EXPERIENCE IN 3043 02:06:58,400 --> 02:07:00,120 USING CROWD SOURCING AND OTHER 3044 02:07:00,120 --> 02:07:02,360 TECHNOLOGIES TO GATHER INPUT OR 3045 02:07:02,360 --> 02:07:04,120 COMMUNITY ENGAGEMENT IN PATIENT 3046 02:07:04,120 --> 02:07:06,120 INPUT ON TRIAL DESIGN BUT HOW 3047 02:07:06,120 --> 02:07:07,960 CAN WE ALSO USE THOSE TYPES OF 3048 02:07:07,960 --> 02:07:09,920 TECHNOLOGIES TO GATHER CLINICAL 3049 02:07:09,920 --> 02:07:12,640 DATA FOR THE STUDIES. 3050 02:07:12,640 --> 02:07:16,120 USING SELF-REPORTED DATA 3051 02:07:16,120 --> 02:07:17,640 COLLECTION TOOLS IS ANOTHER WAY 3052 02:07:17,640 --> 02:07:19,200 IN WHICH WE CAN USE RESEARCH 3053 02:07:19,200 --> 02:07:20,040 TECHNOLOGIES. 3054 02:07:20,040 --> 02:07:22,280 AND THEN UTILIZING ANALYTICS AND 3055 02:07:22,280 --> 02:07:24,440 ARTIFICIAL INTELLIGENCE, MACHINE 3056 02:07:24,440 --> 02:07:29,320 LEARNING TO GENERATE FASTER AND 3057 02:07:29,320 --> 02:07:32,120 MORE RIGOROUS SYSTEMATIC 3058 02:07:32,120 --> 02:07:32,960 REVIEWS. 3059 02:07:32,960 --> 02:07:36,240 THEY ARE USING ELECTRONIC 3060 02:07:36,240 --> 02:07:39,080 SOURCES TO ANSWER RESEARCH 3061 02:07:39,080 --> 02:07:39,360 QUESTIONS. 3062 02:07:39,360 --> 02:07:40,760 THERE ARE OTHER INITIATIVES 3063 02:07:40,760 --> 02:07:43,320 ACROSS THE NIH THAT ARE USING 3064 02:07:43,320 --> 02:07:44,560 ARTIFICIAL INTELLIGENCE AND 3065 02:07:44,560 --> 02:07:51,840 SYNTHETIC DATA TO ANSWER. 3066 02:07:51,840 --> 02:07:53,520 THESE ARE TECHNOLOGIES THAT 3067 02:07:53,520 --> 02:07:55,400 COULD HELP ADVANCE THE WAY THAT 3068 02:07:55,400 --> 02:07:57,760 WE DO CLINICAL TRIALS TO 3069 02:07:57,760 --> 02:08:00,960 PRESERVE OUR RESOURCES IN AREAS 3070 02:08:00,960 --> 02:08:04,760 SO THAT WE CAN IMPROVE QUALITY 3071 02:08:04,760 --> 02:08:06,560 AND IMPROVE THE DESIGN OF 3072 02:08:06,560 --> 02:08:07,200 CLINICAL RESEARCH. 3073 02:08:07,200 --> 02:08:16,760 .AND THEN LASTLY DATA COLLECTION 3074 02:08:16,760 --> 02:08:23,440 AND DATA TRANSPARENCY. 3075 02:08:23,440 --> 02:08:26,960 USING REAL WORLD DATA OR REAL 3076 02:08:26,960 --> 02:08:32,760 WORLD EVIDENCE TO EXPLORE HEALTH 3077 02:08:32,760 --> 02:08:35,560 INEQUITIES. 3078 02:08:35,560 --> 02:08:37,040 ENSURING EQUITABLE DATA 3079 02:08:37,040 --> 02:08:38,480 COLLECTION AT CLINICAL TRIAL 3080 02:08:38,480 --> 02:08:44,640 SITES AND MAKING USE OF REAL 3081 02:08:44,640 --> 02:08:45,120 WORLD EVIDENCE. 3082 02:08:59,400 --> 02:09:00,760 SO THAT WE ARE UNDERSTANDING 3083 02:09:00,760 --> 02:09:02,520 WHAT THE JOURNAL EDUCATORS ARE 3084 02:09:02,520 --> 02:09:06,160 LOOKING FOR AND THAT THEY CAN 3085 02:09:06,160 --> 02:09:08,760 HELP FACILITATE PUBLICATION OF 3086 02:09:08,760 --> 02:09:10,800 TRIAL RESULT DATA NOT JUST THE 3087 02:09:10,800 --> 02:09:14,560 SUMMARY DATA BUT ALSO SUPPORTING 3088 02:09:14,560 --> 02:09:17,280 THE DATASET AND PUBLICATION OF 3089 02:09:17,280 --> 02:09:20,760 THE DATA. 3090 02:09:20,760 --> 02:09:23,400 SO THOSE ARE JUST SOME THOUGHTS 3091 02:09:23,400 --> 02:09:25,320 ON WAYS IN WHICH WE CAN BE 3092 02:09:25,320 --> 02:09:27,960 THINKING ABOUT TECHNOLOGY AND 3093 02:09:27,960 --> 02:09:29,520 OTHER LESSONS LEARNED THROUGH 3094 02:09:29,520 --> 02:09:31,840 THE LAST TWO YEARS TO IMPROVE 3095 02:09:31,840 --> 02:09:34,360 THE CLINICAL TRIAL ENTERPRISE. 3096 02:09:34,360 --> 02:09:39,960 I'M HAPPY TO TAKE QUESTIONS OR 3097 02:09:39,960 --> 02:09:40,840 AND THANK YOU FOR YOUR 3098 02:09:40,840 --> 02:09:41,240 ATTENTION. 3099 02:09:41,240 --> 02:09:42,320 7 3100 02:09:42,320 --> 02:09:43,960 >> THANK YOU, MICHELLE. 3101 02:09:43,960 --> 02:09:48,760 THAT WAS AGAIN SO WELL INFORMED 3102 02:09:48,760 --> 02:09:50,320 AND INFORMATIVE FOR US. 3103 02:09:50,320 --> 02:09:53,760 THIS IS AN AREA THAT WE HAVE 3104 02:09:53,760 --> 02:09:54,680 MULTIPLE OPPORTUNITIES TO 3105 02:09:54,680 --> 02:09:55,200 ADVANCE? 3106 02:09:55,200 --> 02:10:00,360 AND I CAN SEE THAT FROM ELISEO'S 3107 02:10:00,360 --> 02:10:02,800 MODEL AND PERHAPS I'LL BE BOLD 3108 02:10:02,800 --> 02:10:04,560 TO SUGGEST CREATING A NATION 3109 02:10:04,560 --> 02:10:07,880 WIDE NETWORK OF COMMUNITY 3110 02:10:07,880 --> 02:10:09,720 ENGAGEMENT SUCH THAT CLINICAL 3111 02:10:09,720 --> 02:10:12,040 TRIALS CAN BE HELD IN LARGER 3112 02:10:12,040 --> 02:10:15,320 SCALE TO YOU GIVING US A STATUS 3113 02:10:15,320 --> 02:10:18,560 OF THE SCIENCE OF WHERE WE 3114 02:10:18,560 --> 02:10:20,560 SHOULD BE GOING AS THE PANDEMIC 3115 02:10:20,560 --> 02:10:24,360 HAS POINTED TO US HAS BEEN VERY 3116 02:10:24,360 --> 02:10:24,600 VALUABLE. 3117 02:10:24,600 --> 02:10:27,160 I SNOW THERE WILL BE PEOPLE 3118 02:10:27,160 --> 02:10:28,960 ASKING QUESTIONS BUT ORAL HEALTH 3119 02:10:28,960 --> 02:10:31,920 RECORDS IN GENERAL ARE NOT WELL 3120 02:10:31,920 --> 02:10:34,560 INTEGRATED RIGHT NOW. 3121 02:10:34,560 --> 02:10:36,800 WE HAVE INTERFACE PROGRAMS 3122 02:10:36,800 --> 02:10:38,560 WORKING IN SOME AREAS. 3123 02:10:38,560 --> 02:10:40,520 CERTAINLY ACADEMIC INSTITUTIONS 3124 02:10:40,520 --> 02:10:41,920 ARE TRYING AND LEADING THE 3125 02:10:41,920 --> 02:10:43,560 EFFORT BUT THERE IS LOTS OF ROOM 3126 02:10:43,560 --> 02:10:45,920 IN TERMS OF INTEGRATING NOT JUST 3127 02:10:45,920 --> 02:10:47,960 HEALTH CARE PRACTICES BUT 3128 02:10:47,960 --> 02:10:50,000 SHARING DATA ON PATIENTS SO WE 3129 02:10:50,000 --> 02:10:52,960 HAVE A MORE HOLISTIC APPROACH 3130 02:10:52,960 --> 02:10:56,440 AVAILABLE FOR OUR CLINICAL 3131 02:10:56,440 --> 02:10:56,800 TRIALS RESEARCH. 3132 02:10:56,800 --> 02:10:58,960 SO I INVITE ANYONE FROM COUNCIL 3133 02:10:58,960 --> 02:11:01,680 WHO HAVE ANY QUESTIONS TO ASK 3134 02:11:01,680 --> 02:11:05,760 MICHELLE SPECIFICALLY AS WE GOES 3135 02:11:05,760 --> 02:11:12,280 INTO THE MORE NADCRC TOPICS. 3136 02:11:12,280 --> 02:11:16,160 8 JENNIFER, ARE YOU HOOKED ON? 3137 02:11:16,160 --> 02:11:17,720 NO. 3138 02:11:17,720 --> 02:11:19,240 >> CAN YOU HEAR ME? 3139 02:11:19,240 --> 02:11:24,680 >> YES. 3140 02:11:24,680 --> 02:11:25,080 >> OKAY. 3141 02:11:25,080 --> 02:11:27,720 I AGREE WITH RENA AND I VERY 3142 02:11:27,720 --> 02:11:29,560 MUCH APPRECIATE YOUR TALK. 3143 02:11:29,560 --> 02:11:32,000 THERE IS A WISDOM MODULE WITHIN 3144 02:11:32,000 --> 02:11:33,920 EPIC BUT THAT IS GOING TO TAKE 3145 02:11:33,920 --> 02:11:34,680 SOME TIME. 3146 02:11:34,680 --> 02:11:36,960 THE UP TAKE HAS IS NOT BEEN HUGE 3147 02:11:36,960 --> 02:11:38,560 YET BUT IT IS COMING DOWN THE 3148 02:11:38,560 --> 02:11:40,560 ROAD SO THAT MAY OFFER A 3149 02:11:40,560 --> 02:11:43,120 SIGNIFICANT AREA OF OPPORTUNITY. 3150 02:11:43,120 --> 02:11:45,600 >> YES. 3151 02:11:45,600 --> 02:11:48,800 >> RENA I THINK THAT IN SOME 3152 02:11:48,800 --> 02:11:52,720 WAYS NIDCR HAS A UNIQUE 3153 02:11:52,720 --> 02:11:53,880 OPPORTUNITY TO ENGAGE THE 3154 02:11:53,880 --> 02:11:56,040 COMMUNITY THROUGH YOUR PRACTICE 3155 02:11:56,040 --> 02:11:58,600 BASED RESEARCH NETWORK WHO ARE 3156 02:11:58,600 --> 02:12:01,920 ENGAGED IN I GUESS PRAGMATIC 3157 02:12:01,920 --> 02:12:04,680 CLINICAL TRIALS SIMPLE TRIAL 3158 02:12:04,680 --> 02:12:08,240 DESIGNS BUT BEING ABLE TO INFORM 3159 02:12:08,240 --> 02:12:09,800 THEIR COMMUNITY ABOUT RESEARCH 3160 02:12:09,800 --> 02:12:14,760 AND ALSO TO HELP INFORM YOUR 3161 02:12:14,760 --> 02:12:16,960 PRACTITIONERS ABOUT RESEARCH SO 3162 02:12:16,960 --> 02:12:18,160 THAT RESEARCH BECOMES PART OF 3163 02:12:18,160 --> 02:12:20,120 THE HEALTH CARE SYSTEM AND THAT 3164 02:12:20,120 --> 02:12:21,920 RESEARCH IS SEEN AS QUALITY 3165 02:12:21,920 --> 02:12:24,360 IMPROVEMENT AND QUALITY CARE NOT 3166 02:12:24,360 --> 02:12:26,160 I THINK AN EXPERIMENT. 3167 02:12:26,160 --> 02:12:28,560 BUT SOMETHING WHERE ALL OF THOSE 3168 02:12:28,560 --> 02:12:29,960 PRACTITIONERS AND THE PATIENTS 3169 02:12:29,960 --> 02:12:32,120 IN THE PRACTICES CAN FEEL THAT 3170 02:12:32,120 --> 02:12:33,080 THEY ARE CONTRIBUTING TO 3171 02:12:33,080 --> 02:12:35,280 ADVANCES IN SCIENCE AND IMPROVES 3172 02:12:35,280 --> 02:12:36,000 HEALTH CARE 3173 02:12:36,000 --> 02:12:38,560 >> AND PARALLEL TO THAT IS THE 3174 02:12:38,560 --> 02:12:40,360 EVOLUTION OF OUR DIGITAL 3175 02:12:40,360 --> 02:12:42,280 TECHNOLOGY WHERE WE HAVE 3-D 3176 02:12:42,280 --> 02:12:44,920 PRINTING AND SCANS THAT WOULD 3177 02:12:44,920 --> 02:12:47,120 MAKE PROCEDURES MOVE FASTER FOR 3178 02:12:47,120 --> 02:12:49,920 PATIENTS THAT ARE ALL DIGITAL 3179 02:12:49,920 --> 02:12:52,320 RECORDS THAT COULD BE MINED IF 3180 02:12:52,320 --> 02:12:53,920 WE DID HAVE AN INTEGRATED 3181 02:12:53,920 --> 02:12:54,880 SYSTEM. 3182 02:12:54,880 --> 02:12:57,080 ANYONE FROM COUNCIL WITH 3183 02:12:57,080 --> 02:12:58,880 ADDITIONAL COMMENTS OR QUESTIONS 3184 02:12:58,880 --> 02:13:06,160 OF MICHELLE. 3185 02:13:06,160 --> 02:13:09,680 I'M LOOKING AT THE GUESTS. 3186 02:13:09,680 --> 02:13:12,880 WE HAVE A WHOLE HOST OF 3187 02:13:12,880 --> 02:13:16,560 LISTENERS AND IF THERE ARE ANY 3188 02:13:16,560 --> 02:13:16,760 YOU. 3189 02:13:16,760 --> 02:13:18,120 THANK YOU VERY MUCH FOR TAKING 3190 02:13:18,120 --> 02:13:19,720 THE TIME TO DO THIS. 3191 02:13:19,720 --> 02:13:21,840 VERY VALUABLE INDEED. 3192 02:13:21,840 --> 02:13:22,800 >> YOU'RE WELCOMED. 3193 02:13:22,800 --> 02:13:23,920 THANK YOU. 3194 02:13:23,920 --> 02:13:27,840 >> AND NOW IT'S GREAT TO MOVE ON 3195 02:13:27,840 --> 02:13:34,040 TO WHERE NIDCD IS RIGHT NOW OF 3196 02:13:34,040 --> 02:13:35,840 PATIENT ORIENTED CARE AND IT'S A 3197 02:13:35,840 --> 02:13:38,280 GREAT PLEASURE FOR ME TO 3198 02:13:38,280 --> 02:13:40,960 INTRODUCE JANICE LEE WHO WILL 3199 02:13:40,960 --> 02:13:41,720 SHORTLY HAVE HER PRESENTATION 3200 02:13:41,720 --> 02:13:43,320 UP. 3201 02:13:43,320 --> 02:13:49,120 JANICE AS YOU KNOW -- SHE CAME 3202 02:13:49,120 --> 02:13:51,400 TO NIDCD ABOUT SIX OR SEVEN 3203 02:13:51,400 --> 02:13:54,880 YEARS AGO. 3204 02:13:54,880 --> 02:14:00,720 SEVEN TO EIGHT YEARS AGO. 3205 02:14:00,720 --> 02:14:04,720 SHE IS AN ORAL SURGEON AND MD 3206 02:14:04,720 --> 02:14:10,880 AND DDS WITH A MASTERS DEGREE. 3207 02:14:10,880 --> 02:14:12,320 AND JANICE CAME? 3208 02:14:12,320 --> 02:14:14,760 TO A SYSTEM THAT WAS NOT VERY 3209 02:14:14,760 --> 02:14:16,240 WELL DEVELOPED AT THE TIME AND 3210 02:14:16,240 --> 02:14:18,360 HAS REALLY TRANSFORMED THE 3211 02:14:18,360 --> 02:14:21,400 OFFICE OF THE CLINICAL DIRECTOR. 3212 02:14:21,400 --> 02:14:23,160 HER PRESENCE IS TRULY 3213 02:14:23,160 --> 02:14:25,800 TRANSFORMATIVE FOR OF THE CAMPUS 3214 02:14:25,800 --> 02:14:28,440 BECAUSE SHE IN ADDITION TO THIS 3215 02:14:28,440 --> 02:14:37,760 ROLE WIT NIDCR IS INVOLVED CAMPUS 3216 02:14:37,760 --> 02:14:42,320 WIDE DEPARTMENT OF CLINICAL 3217 02:14:42,320 --> 02:14:42,560 CARE. 3218 02:14:42,560 --> 02:14:44,760 JANICE IS ASSOCIATE DIRECTOR AND 3219 02:14:44,760 --> 02:14:47,880 WORKED WITH MIKE AND IS 3220 02:14:47,880 --> 02:14:51,320 EXTREMELY VALUED AND RECOGNIZED 3221 02:14:51,320 --> 02:14:53,160 ACROSS CAMPUS. 3222 02:14:53,160 --> 02:14:55,680 THANK YOU JANICE AND PLEASURE 3223 02:14:55,680 --> 02:15:00,080 WILL BE -- NICE TO HEAR YOU AND 3224 02:15:00,080 --> 02:15:00,640 YOUR OVERVIEW. 3225 02:15:00,640 --> 02:15:02,640 >> THANK YOU. 3226 02:15:02,640 --> 02:15:04,720 ANNA DID YOU WANT TO PUT UP OUR 3227 02:15:04,720 --> 02:15:05,560 SLIDES? 3228 02:15:05,560 --> 02:15:08,720 >> THAT WOULD BE GOOD. 3229 02:15:08,720 --> 02:15:09,400 >> A CORRECTION. 3230 02:15:09,400 --> 02:15:11,360 I DID PUT SECOND OF FEBRUARY AS 3231 02:15:11,360 --> 02:15:16,240 THE DATE FOR THE AADOC WEBINAR. 3232 02:15:16,240 --> 02:15:18,920 IT IS MEANT TO BE THE FIRST OF 3233 02:15:18,920 --> 02:15:19,560 FEBRUARY. 3234 02:15:19,560 --> 02:15:21,720 THE SECOND OF FEBRUARY IS MY 3235 02:15:21,720 --> 02:15:23,760 WEDDING ANNIVERSARY. 3236 02:15:23,760 --> 02:15:25,600 SO APOLOGIES. 3237 02:15:25,600 --> 02:15:27,360 IT IS THE FIRST OF FEBRUARY AND 3238 02:15:27,360 --> 02:15:28,680 THERE IS INFORMATION ABOUT THE 3239 02:15:28,680 --> 02:15:33,320 WEBINAR ON THE WEBSITE. 3240 02:15:33,320 --> 02:15:35,200 >> GREAT. 3241 02:15:35,200 --> 02:15:41,920 THANK YOU VERY MUCH. 3242 02:15:41,920 --> 02:15:47,200 DR. D DESOUZA. 3243 02:15:47,200 --> 02:15:50,040 THANK YOU FOR INVITING ANN AND 3244 02:15:50,040 --> 02:15:51,440 MYSELF TO PRESENT TO YOU ABOUT 3245 02:15:51,440 --> 02:15:53,560 SOME OF THE OPPORTUNITIES AND 3246 02:15:53,560 --> 02:15:55,560 SUCCESSFUL IMPLEMENTATION. 3247 02:15:55,560 --> 02:15:57,160 IT'S IN KEEPING WITH THE 3248 02:15:57,160 --> 02:15:59,680 PREVIOUS THEME OF CLINICAL 3249 02:15:59,680 --> 02:16:03,880 TRIALS AND IT'S A PLEASURE TO BE 3250 02:16:03,880 --> 02:16:07,400 SANDWICHED BETWEEN MICHELLE AND 3251 02:16:07,400 --> 02:16:08,120 ANN. 3252 02:16:08,120 --> 02:16:11,080 I THINK WHAT I'M GOING TO DO IS 3253 02:16:11,080 --> 02:16:14,520 PULL BACK THE CURTAIN FOR THE 3254 02:16:14,520 --> 02:16:16,160 COUNCIL AND FOR THE AUDIENCE TO 3255 02:16:16,160 --> 02:16:18,520 SEE EXACTLY HOW ARE WE ABLE TO 3256 02:16:18,520 --> 02:16:19,120 DO THIS? 3257 02:16:19,120 --> 02:16:21,560 AND I'M REALLY PLEASED THAT I 3258 02:16:21,560 --> 02:16:23,680 HAVE THIS COORDINATED 3259 02:16:23,680 --> 02:16:25,560 PARTNERSHIP WITH ANNA BECAUSE IF 3260 02:16:25,560 --> 02:16:27,880 IT WAS NOT FOR THIS COORDINATED 3261 02:16:27,880 --> 02:16:29,960 PARTNERSHIP I DON'T THINK WE 3262 02:16:29,960 --> 02:16:31,520 COULD SUCCESSFULLY IMPLEMENT AND 3263 02:16:31,520 --> 02:16:34,960 AGAIN MICHELLE AND JIM BEFORE US 3264 02:16:34,960 --> 02:16:36,840 ARE TO THANK FOR THE FOUNDATION 3265 02:16:36,840 --> 02:16:40,200 THAT THEY'VE LAID BEFORE US. 3266 02:16:40,200 --> 02:16:43,560 SO YOU DID HEAR FROM DR. DESOUZA 3267 02:16:43,560 --> 02:16:47,160 THE STRATEGIC PRIORITIES OF THE 3268 02:16:47,160 --> 02:16:49,200 NIDCD. 3269 02:16:49,200 --> 02:17:03,560 WOULD -- NIDCR. 3270 02:17:03,560 --> 02:17:07,480 SHE TOO GAVE US A VISION FOR THE 3271 02:17:07,480 --> 02:17:08,760 PROGRAM DURING A RECENT TOWN 3272 02:17:08,760 --> 02:17:09,240 HALL. 3273 02:17:09,240 --> 02:17:11,800 WHAT I DO WANT TO POINT OUT THE 3274 02:17:11,800 --> 02:17:14,960 KEY WORDS IN STRATEGIC PRIORITY 3275 02:17:14,960 --> 02:17:20,720 3 WORDS LIKE ACCELERATE AND 3276 02:17:20,720 --> 02:17:24,240 WE'VE TRIED TO REDUCE EVERY 3277 02:17:24,240 --> 02:17:27,760 BARRIER POSSIBLE TO ALLOW US TO 3278 02:17:27,760 --> 02:17:29,240 ACCELERATE BECAUSE THAT IS WHAT 3279 02:17:29,240 --> 02:17:30,600 WE'RE USING TO TRANSLATE. 3280 02:17:30,600 --> 02:17:32,520 TAKING THINGS FROM THE BENCH TO 3281 02:17:32,520 --> 02:17:34,360 THE CHAIR SIDE. 3282 02:17:34,360 --> 02:17:36,840 WE ALSO WANT TO BE SURE THAT 3283 02:17:36,840 --> 02:17:38,800 WE'RE IMPLEMENTING THE HIGHEST 3284 02:17:38,800 --> 02:17:41,160 QUALITY RESEARCH AS WELL AS 3285 02:17:41,160 --> 02:17:42,160 REPRODUCIBLE STUDIES. 3286 02:17:42,160 --> 02:17:44,560 SO MY OFFICE THE OFFICE OF 3287 02:17:44,560 --> 02:17:47,560 CLINICAL DIRECTOR OF OCD OUR 3288 02:17:47,560 --> 02:17:50,680 VISION AS IT RELATES TO THE 3289 02:17:50,680 --> 02:17:52,160 PROGRAM IS TO LEAD IN THE 3290 02:17:52,160 --> 02:17:55,040 DISCOVERY OF MECHANISMS, 3291 02:17:55,040 --> 02:17:56,840 TREATMENT AND CURES FOR DISEASES 3292 02:17:56,840 --> 02:18:04,760 OF THE DENTAL ORAL CANE OHIO 3293 02:18:04,760 --> 02:18:08,040 FACIAL. 3294 02:18:08,040 --> 02:18:10,640 -- COMPLEX. 3295 02:18:10,640 --> 02:18:10,840 *. 3296 02:18:10,840 --> 02:18:13,520 AND WE FOCUS ON THESE FOUR 3297 02:18:13,520 --> 02:18:13,720 AREAS. 3298 02:18:13,720 --> 02:18:15,520 IF YOU CAN GO TO THE NEXT SLIDE 3299 02:18:15,520 --> 02:18:17,920 PLEASE. 3300 02:18:17,920 --> 02:18:19,920 WHILE WE OFTEN TALK ABOUT 3301 02:18:19,920 --> 02:18:21,120 PATIENT CENTERED RESEARCH I'M 3302 02:18:21,120 --> 02:18:23,560 ONLY GOING TO TALK ABOUT IT 3303 02:18:23,560 --> 02:18:28,400 BRIEFLY. 3304 02:18:28,400 --> 02:18:32,520 WE WILL BE FOCUSING ON AGAIN THE 3305 02:18:32,520 --> 02:18:34,520 ACCELERATION OF DISCOVERY AND 3306 02:18:34,520 --> 02:18:34,760 THERAPIES. 3307 02:18:34,760 --> 02:18:36,840 WE USE THE SAME WORD 3308 02:18:36,840 --> 02:18:38,120 ACCELERATION IN OUR MISSION AND 3309 02:18:38,120 --> 02:18:41,360 THAT IS BECAUSE IN OUR VIEW 3310 02:18:41,360 --> 02:18:43,760 HAVING THE INFRASTRUCTURE IS 3311 02:18:43,760 --> 02:18:45,880 ABSOLUTELY NECESSARY AND THAT 3312 02:18:45,880 --> 02:18:47,960 INFRASTRUCTURE DOES INCLUDE HIGH 3313 02:18:47,960 --> 02:18:49,760 QUALITY RESEARCH NURSING 3314 02:18:49,760 --> 02:18:52,200 SUPPORT, ACTIVE PATIENT 3315 02:18:52,200 --> 02:18:55,400 RECRUITMENT, ENHANCED TECHNOLOGY 3316 02:18:55,400 --> 02:18:56,720 AND TRANSFER CAPABILITIES. 3317 02:18:56,720 --> 02:18:59,800 OUR ABILITY TO ADMINISTER 3318 02:18:59,800 --> 02:19:01,480 SUPPORT FOR REGULATED STUDIES 3319 02:19:01,480 --> 02:19:06,560 AND OUR COORDINATION WITH IRB. 3320 02:19:06,560 --> 02:19:07,880 AND HOW THE EXCELLENCE IN 3321 02:19:07,880 --> 02:19:09,560 CLINICAL CARE TIES 3322 02:19:09,560 --> 02:19:12,960 >>> THIS MISSION. 3323 02:19:12,960 --> 02:19:16,520 AND AS DR. DESOUZA HAS SAID OUR 3324 02:19:16,520 --> 02:19:19,120 RESEARCH SPECIFICALLY IN THE 3325 02:19:19,120 --> 02:19:21,360 INTERMURAL IS PATIENT STORIED 3326 02:19:21,360 --> 02:19:23,400 AND YOU CAN SEE THAT THESE ARE 3327 02:19:23,400 --> 02:19:25,720 THE AREAS OF CURRENT CLINICAL 3328 02:19:25,720 --> 02:19:25,960 RESEARCH. 3329 02:19:25,960 --> 02:19:29,360 AND IF YOU COULD GENTLY CAP -- 3330 02:19:29,360 --> 02:19:30,840 THESE ARE THE INVESTIGATORS THAT 3331 02:19:30,840 --> 02:19:32,440 ARE INVOLVED IN THESE AREAS. 3332 02:19:32,440 --> 02:19:34,000 AND YOU CAN APPRECIATE THAT WE 3333 02:19:34,000 --> 02:19:36,560 HAVE BOTH CLINICIANS, CLINICAL 3334 02:19:36,560 --> 02:19:37,160 INVESTIGATORS. 3335 02:19:37,160 --> 02:19:39,760 WE HAVE BASIC SCIENTIST? 3336 02:19:39,760 --> 02:19:40,680 TRANSLATING THEIR WORK AND IT'S 3337 02:19:40,680 --> 02:19:42,720 A DEMONSTRATION THAT WE'RE NOW 3338 02:19:42,720 --> 02:19:45,560 MOVING THE ENTIRE SPECTRUM FROM 3339 02:19:45,560 --> 02:19:46,760 BENCH TO BEDSIDE. 3340 02:19:46,760 --> 02:19:48,920 I DO WANT TO POINT OUT ONE OTHER 3341 02:19:48,920 --> 02:19:51,760 GROUP AND THAT IS THE LIGHT RED 3342 02:19:51,760 --> 02:19:52,840 GROUP. 3343 02:19:52,840 --> 02:19:54,800 CLINICAL SCIENCE GROUP BECAUSE 3344 02:19:54,800 --> 02:19:57,040 THEY ARE EXPANDING OUR REACH BY 3345 02:19:57,040 --> 02:19:59,800 THEIR COLLABORATION WITH OTHER 3346 02:19:59,800 --> 02:20:01,600 INTERMURAL INVESTIGATORS AND 3347 02:20:01,600 --> 02:20:03,960 USING THINGS LIKE ORAL HEALTH 3348 02:20:03,960 --> 02:20:04,760 DETERMINANTS. 3349 02:20:04,760 --> 02:20:06,480 ONE GROUP, THE ALCOHOL USE 3350 02:20:06,480 --> 02:20:08,160 DISORDERS UNIT WILL BE WORKING 3351 02:20:08,160 --> 02:20:10,160 WITH OUR CLINICAL TEAM TO START 3352 02:20:10,160 --> 02:20:12,320 LOOKING AT SOCIAL DETERMINANTS 3353 02:20:12,320 --> 02:20:14,240 IN ORAL HEALTH DETERMINANTS AND 3354 02:20:14,240 --> 02:20:15,960 HOW THEY RELATE TO THE CONDITION 3355 02:20:15,960 --> 02:20:19,200 OF ALCOHOL ABUSE. 3356 02:20:19,200 --> 02:20:21,160 WE ARE ALSO GOING TO USE THAT 3357 02:20:21,160 --> 02:20:23,080 PLATFORM TO WORK CLOSELY WITH 3358 02:20:23,080 --> 02:20:25,200 RENEE AND THE DENTAL PUBLIC 3359 02:20:25,200 --> 02:20:28,760 HEALTH RESIDENCY AND FELLOWSHIP 3360 02:20:28,760 --> 02:20:30,760 TO INCORPORATE THEIR SKILL SETS 3361 02:20:30,760 --> 02:20:35,240 >>> THIS DEVELOPED PROTOCOL. 3362 02:20:35,240 --> 02:20:38,760 SO I WANTED TO SHOW YOU THE 3363 02:20:38,760 --> 02:20:39,760 PROTOCOL ACTIVITY OF THE 3364 02:20:39,760 --> 02:20:40,680 PROGRAM. 3365 02:20:40,680 --> 02:20:43,680 WE HAVE 17 PROTOCOLS. 3366 02:20:43,680 --> 02:20:47,640 50% ARE NATURAL HISTORY OR 3367 02:20:47,640 --> 02:20:50,880 OBSERVATIONAL STUDY AND 42% ARE 3368 02:20:50,880 --> 02:20:51,600 CLINICAL TRIALS. 3369 02:20:51,600 --> 02:20:53,400 17 IS IS NOT A LOT. 3370 02:20:53,400 --> 02:20:56,360 BUT I WANT YOU TO FOCUS ON THE 3371 02:20:56,360 --> 02:20:57,760 GREEN AND RED LINE BELOW AND 3372 02:20:57,760 --> 02:20:59,320 THAT IS BECAUSE THAT IS ACTUALLY 3373 02:20:59,320 --> 02:21:00,320 THE ACTIVITY. 3374 02:21:00,320 --> 02:21:02,720 OF ALL OF OUR CLINICAL TRIALS SO 3375 02:21:02,720 --> 02:21:05,520 YOU CAN IMAGINE WE OPEN AND 3376 02:21:05,520 --> 02:21:07,720 CLOSE MULTITUDE OF STUDIES 3377 02:21:07,720 --> 02:21:09,000 ALMOST EVERY TWO YEARS. 3378 02:21:09,000 --> 02:21:12,000 IS THAT IS MUCH HARDER THAN 3379 02:21:12,000 --> 02:21:13,560 FOLLOWING A NATURAL HISTORY 3380 02:21:13,560 --> 02:21:16,400 STUDY OVER 20 YEARS BECAUSE WE 3381 02:21:16,400 --> 02:21:19,640 NEED THE PERSONNEL TO STAND UP 3382 02:21:19,640 --> 02:21:20,720 TRIALS AND TO CLOSE TRIALS AND 3383 02:21:20,720 --> 02:21:24,960 THIS IS EXACTLY WHAT ANNA WILL 3384 02:21:24,960 --> 02:21:25,600 TALK ABOUT. 3385 02:21:25,600 --> 02:21:27,320 THROUGH A TIME LINE ALL OF THE 3386 02:21:27,320 --> 02:21:28,760 STEPS THAT WE HAVE TO GO THROUGH 3387 02:21:28,760 --> 02:21:31,560 AND WHY DID WE USE A TIME LINE? 3388 02:21:31,560 --> 02:21:34,840 WE USED THE LIFE CYCLE OF A 3389 02:21:34,840 --> 02:21:37,160 PROTOCOL AND FOR US IT'S WITHIN 3390 02:21:37,160 --> 02:21:39,720 A CONCEPT IS CONCEIVED TO THE 3391 02:21:39,720 --> 02:21:41,400 POINT WHERE A STUDY IS STARTED 3392 02:21:41,400 --> 02:21:42,240 AND INITIATED. 3393 02:21:42,240 --> 02:21:45,680 NOT THE PATIENT ENROLLMENT YET. 3394 02:21:45,680 --> 02:21:48,160 THIS WOULD LOOK AT OUR 3395 02:21:48,160 --> 02:21:48,680 OPERATIONS. 3396 02:21:48,680 --> 02:21:50,200 SPECIFICALLY THE OFFICE OF THE 3397 02:21:50,200 --> 02:21:53,120 CLINICAL DIRECTOR AND AS WELL AS 3398 02:21:53,120 --> 02:21:55,120 -- AND IF WE CAN DEMONSTRATE 3399 02:21:55,120 --> 02:22:01,000 THAT OCD AND -- TOGETHER ARE 3400 02:22:01,000 --> 02:22:03,120 IMPROVING THE TIME LINES THIS 3401 02:22:03,120 --> 02:22:05,120 WILL EXPLAIN WHY WE'RE ABLE TO 3402 02:22:05,120 --> 02:22:07,880 DO THIS MANY TRIALS OPEN AND 3403 02:22:07,880 --> 02:22:15,920 CLOSE IN SUCH A SHORT TIME. 3404 02:22:15,920 --> 02:22:19,560 SO WE OBVIOUSLY FOCUS ON OUR 3405 02:22:19,560 --> 02:22:21,240 METRICS BECAUSE AS AN OFFICE 3406 02:22:21,240 --> 02:22:27,440 THAT FOCUSES -- WE HAVE 3407 02:22:27,440 --> 02:22:28,520 CONSTITUENTS TO CONSIDER. 3408 02:22:28,520 --> 02:22:31,960 ONE OF THE METRICS IS HOW 3409 02:22:31,960 --> 02:22:33,720 QUICKLY CAN WE START THE STUDIES 3410 02:22:33,720 --> 02:22:36,280 AND THE AVERAGE TIME HAS BEEN 3411 02:22:36,280 --> 02:22:37,960 1.8 YEARS AND YOU THINK THAT IS 3412 02:22:37,960 --> 02:22:38,760 NOT THAT GREAT. 3413 02:22:38,760 --> 02:22:40,080 IT'S NOT. 3414 02:22:40,080 --> 02:22:41,560 BUT WE HAVE TO BE CLEAR AND 3415 02:22:41,560 --> 02:22:43,160 HONEST WITH WHAT WE'RE DOING. 3416 02:22:43,160 --> 02:22:46,440 WHEN WE TAKE AWAY IS THAT ONE 3417 02:22:46,440 --> 02:22:49,160 OUTLIER IT'S DOWN TO 1.4 YEARS 3418 02:22:49,160 --> 02:22:51,760 BUT WHEN WE START TO LOOK AT THE 3419 02:22:51,760 --> 02:22:52,040 BREAKDOWN. 3420 02:22:52,040 --> 02:22:53,480 YOU CAN SEE THOSE STUDIES IN 3421 02:22:53,480 --> 02:22:55,960 YELLOW ARE ACTUALLY OUR SIGNAL 3422 02:22:55,960 --> 02:22:57,720 HISTORY STUDIES. 3423 02:22:57,720 --> 02:22:59,240 THE OBSERVATION STUDIES SO WE 3424 02:22:59,240 --> 02:23:00,920 SNOW WE'RE QUITE EFFECTIVE IN 3425 02:23:00,920 --> 02:23:02,480 STARTING THE STUDIES AND YOU CAN 3426 02:23:02,480 --> 02:23:05,560 SEE THE FIRST STUDY IS OUR 3427 02:23:05,560 --> 02:23:07,560 COVID-19 STUDY WHICH WE STOOD UP 3428 02:23:07,560 --> 02:23:08,400 IN A MONTH. 3429 02:23:08,400 --> 02:23:10,400 FOUR WEEKS IN THE MIDDLE OF A 3430 02:23:10,400 --> 02:23:12,280 PANDEMIC AND THANKS ONLY BECAUSE 3431 02:23:12,280 --> 02:23:15,120 THE FOUNDATION THAT MICHELLE AND 3432 02:23:15,120 --> 02:23:18,280 JIM PUT DOWN FOR US WE WERE ABLE 3433 02:23:18,280 --> 02:23:20,320 TO BRING THESE PROCESSES AND 3434 02:23:20,320 --> 02:23:21,440 OPERATIONS TOGETHER TO STAND 3435 02:23:21,440 --> 02:23:23,040 THAT STUDY UP. 3436 02:23:23,040 --> 02:23:28,080 CAN WE THEN LOOK AT THE REST 6 3437 02:23:28,080 --> 02:23:32,760 OF OUR OPERATION. 3438 02:23:32,760 --> 02:23:41,960 THE PE HETEROGENEITY -- THEY ARE 3439 02:23:41,960 --> 02:23:43,880 FDA REGULATED. 3440 02:23:43,880 --> 02:23:47,120 WE USE SPONSORS IN SUPPORT FROM 3441 02:23:47,120 --> 02:23:50,160 PHARMA AND ONE OF THOSE TRIALS 3442 02:23:50,160 --> 02:23:53,480 DEMONSTRATED IS WITH BAYLOR 3443 02:23:53,480 --> 02:23:55,880 USING A U54 MECHANISM. 3444 02:23:55,880 --> 02:23:57,640 WE HAVE TO BE NIMBLE AND 3445 02:23:57,640 --> 02:24:00,040 PREPARED TO REACH ACROSS AISLES 3446 02:24:00,040 --> 02:24:01,760 SO THAT WE CAN EFFECTIVELY GET 3447 02:24:01,760 --> 02:24:03,320 OUR OPERATIONS TOGETHER AND 3448 02:24:03,320 --> 02:24:04,920 QUICKLY AND EFFICIENCY START 3449 02:24:04,920 --> 02:24:06,600 THESE STUDIES AND CLOSE THEM AS 3450 02:24:06,600 --> 02:24:07,640 WELL. 3451 02:24:07,640 --> 02:24:09,720 SO I DO WANT TO POINT THIS OUT. 3452 02:24:09,720 --> 02:24:12,920 AND AT THIS TIME WE ARE TAKING 3453 02:24:12,920 --> 02:24:16,360 LESSONS FROM THE COVID-19 3454 02:24:16,360 --> 02:24:18,360 EXPERIENCE. 3455 02:24:18,360 --> 02:24:20,440 ANNA WILL TELL YOU MORE ABOUT 3456 02:24:20,440 --> 02:24:20,880 THAT. 3457 02:24:20,880 --> 02:24:24,440 SHE IS GOING TO PRESENT THE 3458 02:24:24,440 --> 02:24:26,000 ACTUAL LIFE CYCLE AND HOW WE'VE 3459 02:24:26,000 --> 02:24:28,560 BEEN ABLE TO FOCUS OUR ATTENTION 3460 02:24:28,560 --> 02:24:40,720 ON AREAS OF OUR WEAKNESS. 3461 02:24:40,720 --> 02:24:41,240 >> THANKS. 3462 02:24:41,240 --> 02:24:43,960 SO I DO ALSO WANT TO THANK 3463 02:24:43,960 --> 02:24:46,880 COUNCIL AND DR. DESOUZA AND 3464 02:24:46,880 --> 02:24:49,840 DR. LEE THE OPPORTUNITY TO 3465 02:24:49,840 --> 02:24:51,360 CONTRIBUTE TO THIS TOPIC. 3466 02:24:51,360 --> 02:24:53,200 I WILL BE PROVIDING AN OVERVIEW 3467 02:24:53,200 --> 02:24:55,480 OF THE RESPONSIBILITIES WITHIN 3468 02:24:55,480 --> 02:24:57,920 THE NIDCR'S OFFICE OF CLINICAL 3469 02:24:57,920 --> 02:24:59,800 TRIALS OF OPERATIONS AND 3470 02:24:59,800 --> 02:25:04,760 MANAGEMENT ALSO REFERRED TO AT 3471 02:25:04,760 --> 02:25:10,120 OTOM AND SOME OF THE SPECIFIC 3472 02:25:10,120 --> 02:25:14,760 FUNCTIONS -- *. 3473 02:25:14,760 --> 02:25:18,160 THE MISSION OF OCTOM BEING TO 3474 02:25:18,160 --> 02:25:19,960 PROTECT THE RIGHTS AND WELFARE 3475 02:25:19,960 --> 02:25:23,720 OF NIDCR'S RESEARCH VOLUNTEERS. 3476 02:25:23,720 --> 02:25:29,920 AND THAT BEING THE DRIVING FORCE 3477 02:25:29,920 --> 02:25:32,120 OF RESPONSIBILITIES AND SINCE 3478 02:25:32,120 --> 02:25:36,960 ADVANCES OF HUMAN AND HEALTH 3479 02:25:36,960 --> 02:25:39,760 WELFARE AND ENSURING THE 3480 02:25:39,760 --> 02:25:41,640 PROTECTIONS ARE UPHELD IN THE 3481 02:25:41,640 --> 02:25:43,360 HIGHEST STANDARD TO THE HIGHEST 3482 02:25:43,360 --> 02:25:45,120 STANDARD WHICH PROMOTES THE 3483 02:25:45,120 --> 02:25:48,240 SCIENTIFIC RIGOR AND RESEARCH 3484 02:25:48,240 --> 02:25:52,040 ETHICS AND IN ORDER TO ACHIEVE 3485 02:25:52,040 --> 02:25:54,320 THIS MISSION AS JANICE WAS 3486 02:25:54,320 --> 02:25:56,680 MENTIONING WE RECOGNIZE THAT 3487 02:25:56,680 --> 02:25:58,440 OCTOM MUST WORK TOGETHER WITH 3488 02:25:58,440 --> 02:26:00,560 THOSE INVOLVED IN THE 3489 02:26:00,560 --> 02:26:01,800 DEVELOPMENT CONDUCT AND THOSE 3490 02:26:01,800 --> 02:26:02,880 WHO SERVE? 3491 02:26:02,880 --> 02:26:05,880 AN OVERSIGHT CAPACITY OF NIDCR 3492 02:26:05,880 --> 02:26:07,360 SUPPORTED CLINICAL RESEARCH. 3493 02:26:07,360 --> 02:26:12,800 SO WE'RE FOCUSING TODAY ON THE 3494 02:26:12,800 --> 02:26:15,600 INTERMURAL DIVISION BUT I WOULD 3495 02:26:15,600 --> 02:26:19,040 LIKE TO EMPHASIZE THAT OCTOM 3496 02:26:19,040 --> 02:26:20,520 RESIDES UNDER THE OFFICE OF THE 3497 02:26:20,520 --> 02:26:24,560 DIRECTOR AND PROVIDES SUPPORT TO 3498 02:26:24,560 --> 02:26:25,960 BOTH DIVISIONS AND THEIR 3499 02:26:25,960 --> 02:26:27,440 RESEARCH TEAMS IN SIMILAR 3500 02:26:27,440 --> 02:26:29,160 CAPACITIES. 3501 02:26:29,160 --> 02:26:34,960 SO YOU SEE HERE THAT OCTOM'S 3502 02:26:34,960 --> 02:26:37,200 MISSION IS ACHIEVED BY PROVIDING 3503 02:26:37,200 --> 02:26:39,200 OPERATIONAL AND MANAGEMENT AND 3504 02:26:39,200 --> 02:26:41,200 OVERSIGHT SUPPORT THROUGHOUT THE 3505 02:26:41,200 --> 02:26:43,640 LIFE CYCLE OF THE CLINICAL 3506 02:26:43,640 --> 02:26:44,240 RESEARCH. 3507 02:26:44,240 --> 02:26:44,600 OKAY TOMORROW. 3508 02:26:54,320 --> 02:26:54,400 -- 3509 02:26:56,760 --> 02:26:59,040 AND SOME OF THE SUPPORT INCLUDES 3510 02:26:59,040 --> 02:27:01,360 ASSISTING STAFF AND THE 3511 02:27:01,360 --> 02:27:02,640 INVESTIGATIVE TEAM WITH 3512 02:27:02,640 --> 02:27:04,640 UNDERSTANDING POLICIES AND 3513 02:27:04,640 --> 02:27:06,320 EXPECTATIONS WITH HUMAN SUBJECTS 3514 02:27:06,320 --> 02:27:08,200 RESEARCH THAT ARE UNIQUE TO NIH 3515 02:27:08,200 --> 02:27:12,960 AS THEY EVOLVE AND AS MICHELLE 3516 02:27:12,960 --> 02:27:15,160 CULP MENTIONED NIH IS EMBARKING 3517 02:27:15,160 --> 02:27:17,200 AND CONTINUES TO EMBARK ON MANY 3518 02:27:17,200 --> 02:27:21,960 REFORMS AND POLICY AND AS 3519 02:27:21,960 --> 02:27:24,920 DR. DESOUZA AND DR. PEREZ-STABLE 3520 02:27:24,920 --> 02:27:28,320 MENTIONED EARLIER MANY 3521 02:27:28,320 --> 02:27:29,000 INITIATIVES. 3522 02:27:29,000 --> 02:27:32,160 SO ANOTHER CHARGE TO OCTOM IS 3523 02:27:32,160 --> 02:27:33,680 DEVELOPING RESEARCH TOOLS AND 3524 02:27:33,680 --> 02:27:35,160 TEMPLATES AND OTHER RESOURCES 3525 02:27:35,160 --> 02:27:37,720 SUCH AS PROCESS DOCUMENTS FOR 3526 02:27:37,720 --> 02:27:40,440 TRAINING AND REFERENCE AND MANY 3527 02:27:40,440 --> 02:27:42,360 OF THESE ARE ON THE PUBLIC 3528 02:27:42,360 --> 02:27:44,200 FACING WEBSITE AND REALLY ARE 3529 02:27:44,200 --> 02:27:46,640 DESIGNED TO PROMOTE CONSISTENCY 3530 02:27:46,640 --> 02:27:49,280 AND STANDARDIZATION OF BEST 3531 02:27:49,280 --> 02:27:51,240 PRACTICES. 3532 02:27:51,240 --> 02:27:52,360 ANOTHER RESPONSIBILITY IS 3533 02:27:52,360 --> 02:27:55,040 MANAGING THE CLINICAL RESEARCH 3534 02:27:55,040 --> 02:27:56,680 OPERATIONS AND MANAGEMENT 3535 02:27:56,680 --> 02:27:59,880 SUPPORT CONTRACT OTHERWISE 3536 02:27:59,880 --> 02:28:05,160 REFERRED TO AS CROM. 3537 02:28:05,160 --> 02:28:11,120 AND LASTLY MANAGING THE CLINICAL 3538 02:28:11,120 --> 02:28:13,360 RESEARCH SYSTEM THAT WAS 3539 02:28:13,360 --> 02:28:15,640 LAUNCHED EARLIER THIS YEAR. 3540 02:28:15,640 --> 02:28:17,960 AND I'LL PROVIDE A BRIEF 3541 02:28:17,960 --> 02:28:19,680 OVERVIEW OF ITS CAPABILITIES. 3542 02:28:19,680 --> 02:28:20,600 HERE IS THE TEAM. 3543 02:28:20,600 --> 02:28:22,840 WE HAVE A RELATIVELY SMALL STAFF 3544 02:28:22,840 --> 02:28:25,600 AND AS I MENTIONED WE WORK 3545 02:28:25,600 --> 02:28:30,560 ACROSS INTERMURAL AND EXTRAMURAL 3546 02:28:30,560 --> 02:28:32,520 DIVISIONS. 3547 02:28:32,520 --> 02:28:37,360 I SERVE AS THE DIRECTOR. 3548 02:29:33,560 --> 02:29:35,760 AND AGAIN THE FOCUS TODAY IS ON 3549 02:29:35,760 --> 02:29:38,040 OUR PARTNERSHIP WITH INTERMURAL 3550 02:29:38,040 --> 02:29:40,160 BUT I ALWAYS WANT TO HIGHLIGHT 3551 02:29:40,160 --> 02:29:42,960 THE FACT THAT WE DO CROSSCUT 3552 02:29:42,960 --> 02:29:47,920 ACROSS THE INSTITUTE IN SIMILAR 3553 02:29:47,920 --> 02:29:49,920 CAPACITY AND ARE TAILORED TO 3554 02:29:49,920 --> 02:29:53,560 EACH DIVISION'S NEEDS. 3555 02:29:53,560 --> 02:29:55,600 SO AS DR. LEE MENTIONED HERE IS 3556 02:29:55,600 --> 02:30:01,200 THE TIME LINE WHICH DEMONSTRATES 3557 02:30:01,200 --> 02:30:03,400 THE LIFE CYCLE OF A CLINICAL 3558 02:30:03,400 --> 02:30:04,720 STUDY. 3559 02:30:04,720 --> 02:30:05,920 MOSTLY CONCENTRATING ON THE 3560 02:30:05,920 --> 02:30:07,920 REVIEW AND APPROVALS INVOLVED 3561 02:30:07,920 --> 02:30:09,960 WITH LAUNCHING IS THE STUDY. 3562 02:30:09,960 --> 02:30:14,640 SO FROM STUDY CONCEPT SUBMISSION 3563 02:30:14,640 --> 02:30:15,800 TO INITIATION AND YOU CAN SEE 3564 02:30:15,800 --> 02:30:18,040 THE MULTIPLE LAYERS AN 3565 02:30:18,040 --> 02:30:19,840 INVESTIGATOR HAS TO UNDERGO JUST 3566 02:30:19,840 --> 02:30:23,960 TO GET STARTED. 3567 02:30:23,960 --> 02:30:26,320 CONCEPT REVIEW IF THERE ARE 3568 02:30:26,320 --> 02:30:28,080 PARTNERSHIPS OUTSIDE THE NIH 3569 02:30:28,080 --> 02:30:30,080 PUTTING TOGETHER CLINICAL TRIAL 3570 02:30:30,080 --> 02:30:30,720 AGREEMENTS. 3571 02:30:30,720 --> 02:30:33,400 THE EXTERNAL SCIENTIFIC REVIEW. 3572 02:30:33,400 --> 02:30:35,400 THERE IS DATA AND SAFETY 3573 02:30:35,400 --> 02:30:37,120 MONITORING REVIEW. 3574 02:30:37,120 --> 02:30:41,120 AND THE FDA AND THE IRB THOSE 3575 02:30:41,120 --> 02:30:45,000 ARE NOTED HERE AS CONTINUUM. 3576 02:30:45,000 --> 02:30:47,960 SOMETIMES ONE AFFECTS THE OTHER 3577 02:30:47,960 --> 02:30:49,960 SO THEY MIGHT HAVE TO GO THROUGH 3578 02:30:49,960 --> 02:30:52,160 MULTIPLE REVIEWS. 3579 02:30:52,160 --> 02:30:56,320 OF COURSE, GETTING IRB APPROVAL 3580 02:30:56,320 --> 02:30:59,080 NOT ANNIES EASE TASK FOR SOME 3581 02:30:59,080 --> 02:31:00,160 TRIALS AND STUDIES. 3582 02:31:00,160 --> 02:31:03,760 AND THIS IS REALLY PROBABLY 3583 02:31:03,760 --> 02:31:07,360 DOESN'T CATCH ALL OF THE REVIEWS 3584 02:31:07,360 --> 02:31:09,480 ESPECIALLY IF ONE IS UNDERTAKING 3585 02:31:09,480 --> 02:31:11,600 A GENE THERAPY OR STEM-CELL 3586 02:31:11,600 --> 02:31:13,680 STUDY. 3587 02:31:13,680 --> 02:31:15,680 BUT YOU SEE HERE IS THAT QUITE 3588 02:31:15,680 --> 02:31:17,720 INVOLVED. 3589 02:31:17,720 --> 02:31:22,160 AND SO -- I DID WANT TO 3590 02:31:22,160 --> 02:31:25,840 EMPHASIZE THAT WE HAVE AND ARE 3591 02:31:25,840 --> 02:31:29,320 MAKING MARKED IMPROVEMENTS IN 3592 02:31:29,320 --> 02:31:30,840 COMPARISON TO PRIOR YEARS AND 3593 02:31:30,840 --> 02:31:33,360 HAVE SHORTENED THAT WINDOW AND 3594 02:31:33,360 --> 02:31:36,360 IMPROVED IN EFFICIENCIES IN THAT 3595 02:31:36,360 --> 02:31:38,560 START UP PERIOD. 3596 02:31:38,560 --> 02:31:39,760 THESE IMPROVED EFFICIENCIES COME 3597 02:31:39,760 --> 02:31:41,680 FROM NOT ONLY IDENTIFYING 3598 02:31:41,680 --> 02:31:43,440 DEFICIENCIES AND IMPROVING OUR 3599 02:31:43,440 --> 02:31:46,120 PROCESSES AND MAKING SHIFTS IN 3600 02:31:46,120 --> 02:31:47,760 THE WAY THAT WE OPERATE BUT ALSO 3601 02:31:47,760 --> 02:31:50,720 HAVING A CHAMPION AT THE OCD 3602 02:31:50,720 --> 02:31:53,200 LEVEL AND AT THE OCTOM LEVEL WHO 3603 02:31:53,200 --> 02:31:54,440 WORK TOGETHER WITH THE 3604 02:31:54,440 --> 02:31:57,760 INVESTIGATIVE TEAMS TO HELP 3605 02:31:57,760 --> 02:32:00,200 SHEPHERD THESE PROCESSES AND 3606 02:32:00,200 --> 02:32:00,760 WORKFLOWS. 3607 02:32:00,760 --> 02:32:07,560 WHILE WE'VE EVALUATED EVERY STEP 3608 02:32:07,560 --> 02:32:11,720 AN NIDCR INVESTIGATOR MUST GO WE 3609 02:32:11,720 --> 02:32:16,920 WILL CONTINUE TO EVALUATE THEM, 3610 02:32:16,920 --> 02:32:18,680 EXTENUATING CIRCUMSTANCES SUCH 3611 02:32:18,680 --> 02:32:20,360 AS THE PANDEMIC AFFECT THEM IN 3612 02:32:20,360 --> 02:32:22,360 DIFFERENT WAYS SO THIS 3613 02:32:22,360 --> 02:32:23,760 COORDINATION BETWEEN OFFICES IS 3614 02:32:23,760 --> 02:32:25,560 CRITICAL. 3615 02:32:25,560 --> 02:32:27,960 I ALSO WANT TO EMPHASIZE THAT AS 3616 02:32:27,960 --> 02:32:32,360 WE LOOK TO THE FUTURE AND AS THE 3617 02:32:32,360 --> 02:32:33,800 INTERMURAL PORTFOLIO CHANGES AND 3618 02:32:33,800 --> 02:32:35,920 HAS CHANGED AND WILL CONTINUE TO 3619 02:32:35,920 --> 02:32:36,960 CHANGE WE'RE DOING THINGS AND 3620 02:32:36,960 --> 02:32:39,160 PUTTING THINGS IN PLACE TO MEET 3621 02:32:39,160 --> 02:32:40,560 THOSE CHANGES. 3622 02:32:40,560 --> 02:32:43,520 WE'RE LOOKING AT WAYS TO IMPROVE 3623 02:32:43,520 --> 02:32:44,760 INFRASTRUCTURE BECAUSE IT'S NOT 3624 02:32:44,760 --> 02:32:51,560 ENOUGH JUST TO GET A STUDY 3625 02:32:51,560 --> 02:32:51,800 STARTED. 3626 02:32:51,800 --> 02:32:53,640 BUT ONGOING MONITORING IS 3627 02:32:53,640 --> 02:32:56,520 CRITICAL TO ENSURE THE 3628 02:32:56,520 --> 02:32:58,280 SCIENTIFIC AND ETHICAL 3629 02:32:58,280 --> 02:32:58,760 INTEGRITY. 3630 02:32:58,760 --> 02:33:00,560 WE HAVE INFRASTRUCTURE IN PLACE 3631 02:33:00,560 --> 02:33:03,440 TO MONITOR THE QUALITY AND 3632 02:33:03,440 --> 02:33:03,880 SAFETY AND? 3633 02:33:03,880 --> 02:33:06,320 WE'RE LOOKING AT HOW DO WE 3634 02:33:06,320 --> 02:33:07,440 LEVERAGE OUR CURRENT 3635 02:33:07,440 --> 02:33:09,920 INFRASTRUCTURE TO INVEST IN 3636 02:33:09,920 --> 02:33:13,440 RECRUITMENT AND ENROLLMENT PLANS 3637 02:33:13,440 --> 02:33:18,720 EARLY AND TO MONITOR PROGRESS 3638 02:33:18,720 --> 02:33:20,640 AND ENSURE EFFICIENT TIMELY 3639 02:33:20,640 --> 02:33:23,840 RESEARCH WHILE BALANCING THIS 3640 02:33:23,840 --> 02:33:25,040 INTEGRITY AND QUALITY AND SO 3641 02:33:25,040 --> 02:33:26,840 WE'RE LOOKING AT THINGS THROUGH 3642 02:33:26,840 --> 02:33:29,040 A LENS OF SYSTEM BASED 3643 02:33:29,040 --> 02:33:30,400 INFRASTRUCTURE AND CAPABILITIES 3644 02:33:30,400 --> 02:33:34,200 MOVING FORWARD. 3645 02:33:34,200 --> 02:33:35,920 SO WHEN WE TALK ABOUT 3646 02:33:35,920 --> 02:33:39,960 INFRASTRUCTURE I DO WANT TO 3647 02:33:39,960 --> 02:33:42,320 HIGHLIGHT THAT PART OF THE 3648 02:33:42,320 --> 02:33:43,960 NIDCR'S INFRASTRUCTURE INCLUDES 3649 02:33:43,960 --> 02:33:45,680 THE CLINICAL RESEARCH OPERATIONS 3650 02:33:45,680 --> 02:33:49,240 AND MANAGEMENT SUPPORT CONTRACT. 3651 02:33:49,240 --> 02:33:53,680 REFERRED TO AS CROMS. 3652 02:33:53,680 --> 02:33:57,440 THE CLEARANCE WENT TO COUNCIL IN 3653 02:33:57,440 --> 02:34:00,360 MAY OF 2018. 3654 02:34:00,360 --> 02:34:11,680 8 THE KEY AREAS ARE LISTED HERE. 3655 02:34:11,680 --> 02:34:13,360 STUDY DOCUMENTATION SUPPORT. 3656 02:34:13,360 --> 02:34:15,360 DATA AND SAFETY MONITORING 3657 02:34:15,360 --> 02:34:18,800 SUPPORT OF THE CLINICAL SITE 3658 02:34:18,800 --> 02:34:21,440 MONITORING. 3659 02:34:21,440 --> 02:34:25,360 REGULATORY SUPPORT AND DATA 3660 02:34:25,360 --> 02:34:27,720 MANAGEMENT SERVICES AND KEY TO 3661 02:34:27,720 --> 02:34:31,520 THIS LAST ITERATION WAS THE 3662 02:34:31,520 --> 02:34:33,040 DEVELOPMENT AND MAINTENANCE OF 3663 02:34:33,040 --> 02:34:36,560 THE NIDCR CLINICAL RESEARCH 3664 02:34:36,560 --> 02:34:39,440 MANAGEMENT SYSTEM. 3665 02:34:39,440 --> 02:34:40,800 THE CROMS AND WHILE THERE ARE 3666 02:34:40,800 --> 02:34:44,760 MANY AREAS OF SUPPORT I WANTED 3667 02:34:44,760 --> 02:34:46,360 TO HIGHLIGHT TWO AREAS THAT 3668 02:34:46,360 --> 02:34:48,320 SPEAK TO THE FUTURE OF OUR 3669 02:34:48,320 --> 02:34:51,680 EFFICIENCY AND INFRASTRUCTURE 3670 02:34:51,680 --> 02:34:51,960 IMPROVEMENT. 3671 02:34:51,960 --> 02:34:54,880 SO TRAINING AND CLINICAL 3672 02:34:54,880 --> 02:34:58,240 RESEARCH MANAGEMENT SYSTEM. 3673 02:34:58,240 --> 02:35:03,560 SO HERE STARTING WITH THE CRMS 3674 02:35:03,560 --> 02:35:06,560 -- I'LL HIGHLIGHT THE SYSTEM 3675 02:35:06,560 --> 02:35:08,200 CAPABILITIES, THE SYSTEM 3676 02:35:08,200 --> 02:35:12,360 LAUNCHED IN FEBRUARY OF 2021. 3677 02:35:12,360 --> 02:35:15,360 IT PROVIDES AN NIDCR ENTERPRISE 3678 02:35:15,360 --> 02:35:16,960 SYSTEM WITH SEVERAL MODULES TO 3679 02:35:16,960 --> 02:35:20,720 TRACK THE MONITORING OF THE 3680 02:35:20,720 --> 02:35:22,200 NIDCR CLINICAL RESEARCH. 3681 02:35:22,200 --> 02:35:25,160 SO IN BRIEF IT TRACKS OUR HUMAN 3682 02:35:25,160 --> 02:35:26,520 SUBJECTS RESEARCH AT THE GRANT 3683 02:35:26,520 --> 02:35:29,080 LEVEL AND STUDY LEVEL STORING 3684 02:35:29,080 --> 02:35:30,760 STUDY ATTRIBUTES AND DOCUMENTS 3685 02:35:30,760 --> 02:35:33,640 AND MANAGING THE NIDCR OVERSIGHT 3686 02:35:33,640 --> 02:35:34,760 ASSESSMENT FLOW. 3687 02:35:34,760 --> 02:35:37,360 IT PROVIDES A TRACKING SYSTEM 3688 02:35:37,360 --> 02:35:38,920 FOR OUR SAFETY OVERSIGHT 3689 02:35:38,920 --> 02:35:39,960 COMMITTEES INCLUDING MANAGING 3690 02:35:39,960 --> 02:35:41,840 THE NUMBER OF CONFLICT OF 3691 02:35:41,840 --> 02:35:45,360 INTEREST FLOW AND PROVIDING A 3692 02:35:45,360 --> 02:35:46,920 SECURE PLATFORM FOR MEETINGS AND 3693 02:35:46,920 --> 02:35:48,600 REPORTS AND COMMITTEES. 3694 02:35:48,600 --> 02:35:51,360 IT PROVIDES A REPOSITORY FOR 3695 02:35:51,360 --> 02:35:53,240 SAFETY EVENT AND MANAGES THE 3696 02:35:53,240 --> 02:35:55,760 SAFETY EVENT FLOW AND SUPPORTS 3697 02:35:55,760 --> 02:35:57,360 NIDCR ADMINISTRATIVE FUNCTIONS 3698 02:35:57,360 --> 02:35:59,800 TO HELP US MANAGE OUR WORKFLOW. 3699 02:35:59,800 --> 02:36:05,120 SO WHEN WE TALK ABOUT A CONSTANT 3700 02:36:05,120 --> 02:36:07,960 EVOLVING -- IN THE CLINICAL 3701 02:36:07,960 --> 02:36:09,000 RESEARCH ENVIRONMENT AND PUTTING 3702 02:36:09,000 --> 02:36:11,680 THINGS IN PLACE TO MEET THE 3703 02:36:11,680 --> 02:36:13,360 NEEDS AND CHALLENGES AND LOOKING 3704 02:36:13,360 --> 02:36:16,240 AT WAYS TO IMPROVE 3705 02:36:16,240 --> 02:36:18,000 INFRASTRUCTURE WHAT ARE THESE 3706 02:36:18,000 --> 02:36:19,320 OPPORTUNITIES IN FRONT OF US? 3707 02:36:19,320 --> 02:36:22,280 WE HAVE THE ELECTRONIC SYSTEM 3708 02:36:22,280 --> 02:36:27,280 THROUGH THE NIDCR -- AND WANT TO 3709 02:36:27,280 --> 02:36:34,160 LEVERAGE THESE CAPABILITIES. 3710 02:36:34,160 --> 02:36:36,240 AND WORK WITH INVESTIGATIVE 3711 02:36:36,240 --> 02:36:39,680 TEAMS AND OVERSIGHT BODIES TO 3712 02:36:39,680 --> 02:36:42,360 MONITOR PROGRESS AND ADAPT 3713 02:36:42,360 --> 02:36:44,320 STRATEGIES TO HAVE THE SAME 3714 02:36:44,320 --> 02:36:46,080 SUCCESS IN CARRYING OUT THE 3715 02:36:46,080 --> 02:36:48,080 STUDIES AS WE'VE HAD IN 3716 02:36:48,080 --> 02:36:48,920 LAUNCHING THE STUDIES. 3717 02:36:48,920 --> 02:36:51,520 SO THROUGHOUT THE LIFE CYCLE. 3718 02:36:51,520 --> 02:36:52,880 CLINICAL STUDY. 3719 02:36:52,880 --> 02:36:54,960 WHAT CAN WE OFFER IN THE FORM OF 3720 02:36:54,960 --> 02:36:58,080 EDUCATION AND TRAINING TO BETTER 3721 02:36:58,080 --> 02:37:00,160 PREPARE TEAMS FOR CLINICAL TRIAL 3722 02:37:00,160 --> 02:37:01,520 MANAGEMENT? 3723 02:37:01,520 --> 02:37:04,080 ARE THERE UNIQUE ASPECT FROM THE 3724 02:37:04,080 --> 02:37:05,760 COMMUNITIES RELATED TO CLINICAL 3725 02:37:05,760 --> 02:37:07,200 RESEARCH THAT COULD BE 3726 02:37:07,200 --> 02:37:09,120 INCORPORATED INTO SUCH TRAINING. 3727 02:37:09,120 --> 02:37:10,480 WE'VE HEARD A LITTLE BIT ABOUT 3728 02:37:10,480 --> 02:37:11,880 THAT TODAY. 3729 02:37:11,880 --> 02:37:14,640 WE'RE HAVING THOSE CONVERSATIONS 3730 02:37:14,640 --> 02:37:16,400 AND THESE CONVERSATIONS ARE 3731 02:37:16,400 --> 02:37:17,360 PARTICULARLY IMPORTANT FOR THE 3732 02:37:17,360 --> 02:37:18,440 NEXT GENERATION OF 3733 02:37:18,440 --> 02:37:20,960 INVESTIGATORS. 3734 02:37:20,960 --> 02:37:24,160 ANOTHER IMPORTANT ASPECT OF OUR 3735 02:37:24,160 --> 02:37:27,640 FEATURE DIRECTION IS THE 3736 02:37:27,640 --> 02:37:28,600 OPPORTUNITIES THE PANDEMIC HAS 3737 02:37:28,600 --> 02:37:30,360 PRESENTED AND WE'VE ALSO HEARD 3738 02:37:30,360 --> 02:37:32,560 THAT THERE ARE MANY FROM A 3739 02:37:32,560 --> 02:37:36,360 QUALITY AND SCIENTIFIC INTEGRITY 3740 02:37:36,360 --> 02:37:38,760 PERSPECTIVE ADAPTING TO -- 3741 02:37:38,760 --> 02:37:41,200 REMOTE AND ENSURING MAINTAINING 3742 02:37:41,200 --> 02:37:44,560 PROPER OVERSIGHT AND 3743 02:37:44,560 --> 02:37:46,120 COMMUNICATION WHICH CAN BE VERY 3744 02:37:46,120 --> 02:37:47,760 CHALLENGING AND THESE LESSONS 3745 02:37:47,760 --> 02:37:50,440 CONTINUE TO SHAPE OUR OVERSIGHT 3746 02:37:50,440 --> 02:37:52,360 ACTIVITIES AND HOW CAN WE BE 3747 02:37:52,360 --> 02:37:54,040 PREPARED TO MORE SWIFTLY 3748 02:37:54,040 --> 02:37:55,520 ADAPTED TO LAUNCHING AND 3749 02:37:55,520 --> 02:37:59,160 CARRYING OUT OUR STUDIES UNDER 3750 02:37:59,160 --> 02:38:00,520 EXTENUATING CIRCUMSTANCES. 3751 02:38:00,520 --> 02:38:02,400 WE CONTINUE TO LEARN FROM THESE 3752 02:38:02,400 --> 02:38:06,080 EXPERIENCES. 3753 02:38:06,080 --> 02:38:08,560 SO AS WE LOOK TO THE FUTURE AND 3754 02:38:08,560 --> 02:38:11,200 IN THINKING ABOUT THE NIDCR'S 3755 02:38:11,200 --> 02:38:12,760 STRATEGIC PLAN AS DR. LEE 3756 02:38:12,760 --> 02:38:15,120 MENTIONED EARLIER I WANTED TO 3757 02:38:15,120 --> 02:38:16,760 HIGHLIGHT ITS GUIDING 3758 02:38:16,760 --> 02:38:18,360 PRINCIPLES. 3759 02:38:18,360 --> 02:38:20,600 SO HERE THOSE CORE VALUES THAT 3760 02:38:20,600 --> 02:38:22,160 GROUND OUR THINKING AND GUIDE 3761 02:38:22,160 --> 02:38:24,560 OUR DECISIONS ACROSS ALL ASPECTS 3762 02:38:24,560 --> 02:38:28,360 OF THE NIDCR RESEARCH ENDEAVOUR 3763 02:38:28,360 --> 02:38:30,200 -- SCIENTIFIC EXCELLENCE AND 3764 02:38:30,200 --> 02:38:32,120 INTEGRITY AND ENSURING ALL 3765 02:38:32,120 --> 02:38:33,800 RESEARCH IS CONDUCTED ETHICALLY 3766 02:38:33,800 --> 02:38:36,800 AND THE DATA IS WELL DESCRIBED 3767 02:38:36,800 --> 02:38:41,600 FOR REPLICATION FOR APPLICATION. 3768 02:38:41,600 --> 02:38:43,800 STRENGTHENING OUR EFFORTS TO 3769 02:38:43,800 --> 02:38:46,800 INCREASE DIVERSITY AND EQUITY 3770 02:38:46,800 --> 02:38:48,200 AND INCLUSION IS VERY IMPORTANT. 3771 02:38:48,200 --> 02:38:52,720 AND MAINTAINING OUR COMMITMENT 3772 02:38:52,720 --> 02:38:55,800 TO BE PROPER STEWARDS OF OUR 3773 02:38:55,800 --> 02:38:59,560 RESOURCES. 3774 02:38:59,560 --> 02:39:01,800 AND LASTLY OUR COMMITMENT TO 3775 02:39:01,800 --> 02:39:04,000 EMBRACE AND MANAGE CHANGE TO BE 3776 02:39:04,000 --> 02:39:06,360 PROACTIVE AND NIMBLE IN OUR 3777 02:39:06,360 --> 02:39:06,840 RESPONSES. 3778 02:39:06,840 --> 02:39:11,240 AND I THINK WE CAN OVERLAY AND 3779 02:39:11,240 --> 02:39:14,640 ALIGN MUCH OF WHAT WE'RE 3780 02:39:14,640 --> 02:39:16,560 DISCUSSING TODAY WITH OUR CORE 3781 02:39:16,560 --> 02:39:17,560 VALUES AND THE PARTNERSHIPS THAT 3782 02:39:17,560 --> 02:39:25,080 WE HAVE. 3783 02:39:25,080 --> 02:39:28,760 WE CONTINUE TO SHAPE -- THESE 3784 02:39:28,760 --> 02:39:30,760 CORE VALUES AND THESE 3785 02:39:30,760 --> 02:39:32,160 PARTNERSHIPS BEYOND OUR 3786 02:39:32,160 --> 02:39:36,400 INSTITUTE IMPORTANT TO THESE 3787 02:39:36,400 --> 02:39:39,720 ENDEAVORS. 3788 02:39:39,720 --> 02:39:41,160 >> THANKS, ANNA. 3789 02:39:41,160 --> 02:39:42,760 THE ONE THING THAT I WANT TO 3790 02:39:42,760 --> 02:39:47,240 POINT OUT IS THE FACT THAT THIS 3791 02:39:47,240 --> 02:39:48,760 INTENTIONAL SEPARATION BETWEEN 3792 02:39:48,760 --> 02:39:50,960 OCTOM AND OCD WAS BRILLIANT. 3793 02:39:50,960 --> 02:39:54,240 AND I SAY IS THAT BECAUSE IT 3794 02:39:54,240 --> 02:39:57,960 ALLOWS US TO NAVIGATE SUPPORT 3795 02:39:57,960 --> 02:40:00,360 BUT WE HAVE A GROUP THAT HELPS 3796 02:40:00,360 --> 02:40:03,360 OVERSEE AND MONITOR WITHOUT THE 3797 02:40:03,360 --> 02:40:04,400 PERCEIVED CONFLICT. 3798 02:40:04,400 --> 02:40:09,720 SO THIS IS REALLY IMPORTANT AND 3799 02:40:09,720 --> 02:40:13,560 ANNA GRAPPLED THROUGH THIS ISSUE 3800 02:40:13,560 --> 02:40:15,280 TO TO BE SURE IS THAT WE'RE 3801 02:40:15,280 --> 02:40:18,960 NEVER COMPROMISING. 3802 02:40:18,960 --> 02:40:21,280 JUST TO CONTINUE I WANT TO ALSO 3803 02:40:21,280 --> 02:40:22,880 POINT OUT THAT TO BE ABLE TO DO 3804 02:40:22,880 --> 02:40:24,760 THE EFFECTIVE RESEARCH THAT 3805 02:40:24,760 --> 02:40:26,440 WE'RE CURRENTLY EMBARKING ON WE 3806 02:40:26,440 --> 02:40:28,440 HAVE TO HAVE STRONG PARTNERSHIPS 3807 02:40:28,440 --> 02:40:30,760 AND I'M POINTING OUT THE 3808 02:40:30,760 --> 02:40:33,200 PARTNERSHIPS THAT INCLUDE THE 3809 02:40:33,200 --> 02:40:35,600 PHARMACEUTICAL AS WELL AS THE 3810 02:40:35,600 --> 02:40:37,120 INTERMURAL AND EXTRAMURAL 3811 02:40:37,120 --> 02:40:38,600 PARTNERSHIPS THAT WE HAVE. 3812 02:40:38,600 --> 02:40:44,320 WE HAVE A MOU BECAUSE THIS 3813 02:40:44,320 --> 02:40:46,160 ISth MOST COST EFFICIENT WAY 3814 02:40:46,160 --> 02:40:47,760 TO RUN OUR BUSINESS. 3815 02:40:47,760 --> 02:40:50,320 WE ALSO HAVE THE FIRST PROGRAM 3816 02:40:50,320 --> 02:40:52,760 LETTER OF AGREEMENT WITH HOWARD 3817 02:40:52,760 --> 02:40:55,160 UNIVERSITY SCHOOL OF DENTISTRY. 3818 02:40:55,160 --> 02:40:57,400 THIS IS THE FIRST WE'VE HAD THIS 3819 02:40:57,400 --> 02:41:01,040 AND TRULY EXCITING AND WHEN WE 3820 02:41:01,040 --> 02:41:03,800 TALK ABOUT WHEN WE MOVE AT THE 3821 02:41:03,800 --> 02:41:04,840 SPEED OF TRUST THIS IS ONE OF 3822 02:41:04,840 --> 02:41:07,320 THE FIRST STEPS IN MOVING 3823 02:41:07,320 --> 02:41:08,320 >>> OUR COMMUNITY AND 3824 02:41:08,320 --> 02:41:09,080 COMMUNITY-BASED TRIALS. 3825 02:41:09,080 --> 02:41:13,320 WE HAVE A MULTITUDE OF MTAs. 3826 02:41:13,320 --> 02:41:15,680 AND DATA SHARING AGREEMENTS. 3827 02:41:15,680 --> 02:41:17,480 BUT I WANT TO POINT OUT ONE 3828 02:41:17,480 --> 02:41:20,360 OTHER THING THAT WE DO AS A 3829 02:41:20,360 --> 02:41:20,960 SMALL INSTITUTE SOMETHING THAT 3830 02:41:20,960 --> 02:41:24,960 IS YOU SNEAK AND WE HAVE 12 -- 3831 02:41:24,960 --> 02:41:27,200 CLINICAL TRIAL AGREEMENTS. 3832 02:41:27,200 --> 02:41:30,480 WE ARE ACTUALLY DOING AN AMAZING 3833 02:41:30,480 --> 02:41:33,480 JOB PARTNERING WITH OUR PRIVATE 3834 02:41:33,480 --> 02:41:34,000 INDUSTRY FOLKS. 3835 02:41:34,000 --> 02:41:35,800 AND YOU CAN SEE A COUPLE OF 3836 02:41:35,800 --> 02:41:36,960 THOSE LISTED HERE. 3837 02:41:36,960 --> 02:41:38,760 THIS IS OBVIOUSLY THE EFFORTS OF 3838 02:41:38,760 --> 02:41:40,760 THE INVESTIGATORS BECAUSE THIS 3839 02:41:40,760 --> 02:41:42,880 IS ALL INVESTIGATOR INITIATED 3840 02:41:42,880 --> 02:41:43,600 RESEARCH. 3841 02:41:43,600 --> 02:41:46,520 I ALSO WANT TO POINT OUT BASED 3842 02:41:46,520 --> 02:41:48,320 ON THOSE STRONG DISCUSSIONS 3843 02:41:48,320 --> 02:41:50,360 WE'RE ANTICIPATING ANOTHER FOUR 3844 02:41:50,360 --> 02:41:52,200 CLINICAL TRIALS TO INITIATE OVER 3845 02:41:52,200 --> 02:41:54,040 THE NEXT ONE TO TWO YEARS. 3846 02:41:54,040 --> 02:41:56,360 AN EXAMPLE OF LAYING THE 3847 02:41:56,360 --> 02:41:58,160 FOUNDATION SO THAT WE CAN OPEN 3848 02:41:58,160 --> 02:42:02,560 AND CLOSE TRIALS EFFICIENT -- 3849 02:42:02,560 --> 02:42:02,960 EFFICIENTLY. 3850 02:42:02,960 --> 02:42:05,960 THE BENCH TO BEDSIDE AND BACK 3851 02:42:05,960 --> 02:42:09,160 INITIATIVES ARE WAYS FOR THE 3852 02:42:09,160 --> 02:42:10,640 EXTRAMURAL COMMUNITY TO WORK 3853 02:42:10,640 --> 02:42:12,240 WITH INTERMURAL INVESTIGATORS 3854 02:42:12,240 --> 02:42:15,480 AND I'M PLEASED TO DEMONSTRATE 3855 02:42:15,480 --> 02:42:16,880 THAT WE'VE STARTED THE FIRST ONE 3856 02:42:16,880 --> 02:42:20,680 FOR THE NIDCR. 3857 02:42:20,680 --> 02:42:22,280 DR. YOE WILL BE UTILIZING THE 3858 02:42:22,280 --> 02:42:25,880 RESOURCES TO STUDY TMJ 3859 02:42:25,880 --> 02:42:26,160 DEVELOPMENT. 3860 02:42:26,160 --> 02:42:30,480 WE ALSO HAVE A U54 WITH 3861 02:42:30,480 --> 02:42:33,960 DR. BRENDAN LEE. 3862 02:42:33,960 --> 02:42:38,280 STUDYING -- THE EFFECTIVENESS OF 3863 02:42:38,280 --> 02:42:40,040 ENVISION LINE. 3864 02:42:40,040 --> 02:42:40,640 *. 3865 02:42:40,640 --> 02:42:41,360 WE GOT US? 3866 02:42:41,360 --> 02:42:43,920 THAT DR. COLLINS WARN ERAS WELL 3867 02:42:43,920 --> 02:42:48,720 AS PARTNERS IN NICHD WILL BE 3868 02:42:48,720 --> 02:42:53,840 EMBARKING ON AN AWARD LOOKING AT 3869 02:42:53,840 --> 02:42:57,720 BONE PRESERVATION IN CHILDREN 3870 02:42:57,720 --> 02:43:03,080 WITH SJORGEN'S SYNDROME. 3871 02:43:03,080 --> 02:43:04,800 *. 3872 02:43:04,800 --> 02:43:06,160 HOWARD UNIVERSITY IS THE MOST 3873 02:43:06,160 --> 02:43:08,720 RECENT PARTNER AND WE CONTINUE 3874 02:43:08,720 --> 02:43:11,360 TO TAP INTO OUR COMMUNITY. 3875 02:43:11,360 --> 02:43:13,600 BUT WE CAN DO MORE. 3876 02:43:13,600 --> 02:43:15,640 THIS SLIDE REMINDS ME TO SHARE 3877 02:43:15,640 --> 02:43:17,760 THAT ALL OF THIS HAPPENS AT THE 3878 02:43:17,760 --> 02:43:19,120 CLINICAL CENTER. 3879 02:43:19,120 --> 02:43:21,040 AMERICA'S RESEARCH HOSPITAL. 3880 02:43:21,040 --> 02:43:24,560 A 200 BED HOSPITAL WITH 82 DAY 3881 02:43:24,560 --> 02:43:26,000 HOSPITAL UNITS WHICH INCLUDES 3882 02:43:26,000 --> 02:43:28,480 THE DENTAL CLINIC. 3883 02:43:28,480 --> 02:43:30,600 ALL PATIENTS ARE SUBJECTS OF A 3884 02:43:30,600 --> 02:43:31,040 PROTOCOL. 3885 02:43:31,040 --> 02:43:33,880 AND SERVICES ARE FOR FREE. 3886 02:43:33,880 --> 02:43:39,520 YOU CAN SEE THE BREAKDOWN -- 3887 02:43:39,520 --> 02:43:43,960 OVER 1500 -- THEY ARE SIMILAR. 3888 02:43:43,960 --> 02:43:46,480 WE ARE REFLECTING IS THAT OUR 3889 02:43:46,480 --> 02:43:48,360 CLINICAL TRIAL NUMBERS HAS GROWN 3890 02:43:48,360 --> 02:43:49,680 OVER THE COURSE OF THE LAST FEW 3891 02:43:49,680 --> 02:43:50,280 YEARS. 3892 02:43:50,280 --> 02:43:52,440 THE UNIQUENESS IS THAT WE FOCUS 3893 02:43:52,440 --> 02:43:54,960 ON RARE AND UNDIAGNOSED DISEASES 3894 02:43:54,960 --> 02:43:57,000 SO WE DON'T NECESSARILY COMPETE 3895 02:43:57,000 --> 02:43:59,720 WITH OUR EXTRAMURAL COLLEAGUES. 3896 02:43:59,720 --> 02:44:02,480 WE ALSO HAVE OUTSTANDING 3897 02:44:02,480 --> 02:44:03,800 CAPABILITIES FOR DEEP 3898 02:44:03,800 --> 02:44:05,520 PHENOTYPING THAT YOU CANNOT GET 3899 02:44:05,520 --> 02:44:07,960 ANYWHERE ELSE IN THE MOST COST 3900 02:44:07,960 --> 02:44:10,440 EFFECTIVE WAY. 3901 02:44:10,440 --> 02:44:12,960 NOW THE DENTAL CLINIC IS NESTED 3902 02:44:12,960 --> 02:44:14,840 IN THE CLINICAL CENTER AND IS IN 3903 02:44:14,840 --> 02:44:17,320 WHERE WE ASK OUR HOSPITAL 3904 02:44:17,320 --> 02:44:19,480 DENTISTS TO THINK ABOUT 3905 02:44:19,480 --> 02:44:20,880 THEMSELVES IN THE BIGGER BROADER 3906 02:44:20,880 --> 02:44:21,280 COMMUNITY. 3907 02:44:21,280 --> 02:44:22,800 THE MISSION IS TO PROVIDE 3908 02:44:22,800 --> 02:44:24,480 CLINICAL CARE AS WELL AS 3909 02:44:24,480 --> 02:44:27,800 CONSULTS FOR ALL OF THE NIDCR 3910 02:44:27,800 --> 02:44:29,280 SUBJECTS AND PATIENTS. 3911 02:44:29,280 --> 02:44:32,760 BUT THEY ALSO SUPPORT THE 3912 02:44:32,760 --> 02:44:34,520 CLINICAL RESEARCH AND OUR 3913 02:44:34,520 --> 02:44:37,280 DENTIST ARE DOING A PHENOMENAL 3914 02:44:37,280 --> 02:44:39,600 JOB REACHING OUT TO OTHER 3915 02:44:39,600 --> 02:44:41,120 COLLABORATORS. 3916 02:44:41,120 --> 02:44:43,360 THAT PHOTO INCLUDES ALL OF OUR 3917 02:44:43,360 --> 02:44:45,240 RESEARCH NURSES AND THEY ARE 3918 02:44:45,240 --> 02:44:49,360 TRULY THE BACKBONE OF WHY WE CAN 3919 02:44:49,360 --> 02:44:51,320 DO SUCH EFFECTIVE AND RIGOROUS 3920 02:44:51,320 --> 02:44:52,160 WORK. 3921 02:44:52,160 --> 02:44:53,720 THINK THEY THERE IS AN ARMY. 3922 02:44:53,720 --> 02:44:55,800 THIS IS OUR ARMY. 3923 02:44:55,800 --> 02:44:57,440 I JUST WANTED TO MAKE SURE THAT 3924 02:44:57,440 --> 02:45:00,680 THEY ARE RECOGNIZED IN THE 3925 02:45:00,680 --> 02:45:04,240 ENDEAVORS OF THE INTERMURAL 3926 02:45:04,240 --> 02:45:04,480 PROGRAM. 3927 02:45:04,480 --> 02:45:07,840 I ALSO WANT TO POINT OUT THAT 3928 02:45:07,840 --> 02:45:10,920 OUR HOSPITAL DENTIST ARE THE 3929 02:45:10,920 --> 02:45:13,560 CONNECTION BETWEEN A NUMBER OF 3930 02:45:13,560 --> 02:45:15,840 OUR MEDICALLY BASED PROTOCOLS TO 3931 02:45:15,840 --> 02:45:18,840 THE ORAL HEALTH AND MARIE HAS 3932 02:45:18,840 --> 02:45:21,120 BEEN WITH US SINCE 2018 AND SHE 3933 02:45:21,120 --> 02:45:23,760 IS OUR CHIEF OF DENTAL CLINICAL 3934 02:45:23,760 --> 02:45:24,680 OPERATIONS. 3935 02:45:24,680 --> 02:45:26,960 I'M PLEASED TO ANNOUNCE THAT 3936 02:45:26,960 --> 02:45:29,160 WE'VE HIRED TWO NEW STAFF 3937 02:45:29,160 --> 02:45:41,520 CLINICIANS. 3938 02:45:41,520 --> 02:45:43,960 WE HIRED HER KNOWING THAT WE'RE 3939 02:45:43,960 --> 02:45:45,960 EXPANDING THE AREA OF EARLY 3940 02:45:45,960 --> 02:45:47,880 CHILDHOOD DEVELOPMENT AS WELL AS 3941 02:45:47,880 --> 02:45:59,440 ORAL HEALTH AND DR. KHAVANDG AR. 3942 02:45:59,440 --> 02:46:01,560 SPENDING TIME IN THE DENTAL 3943 02:46:01,560 --> 02:46:04,960 INCLUDE ANYBODY AS HER NEW 3944 02:46:04,960 --> 02:46:06,360 DENTAL PATIENT SAFETY OFFICER 3945 02:46:06,360 --> 02:46:07,080 AND LIAISON. 3946 02:46:07,080 --> 02:46:09,200 THEY OVERSEE THE STAFF HERE ON 3947 02:46:09,200 --> 02:46:10,880 THE LEFT AND IT INCLUDES A 3948 02:46:10,880 --> 02:46:13,120 NUMBER OF PART-TIME 3949 02:46:13,120 --> 02:46:14,560 PRACTITIONERS WHO HAVE 3950 02:46:14,560 --> 02:46:16,160 MAINTAINED A QUALITY OF CARE FOR 3951 02:46:16,160 --> 02:46:18,560 US AS WELL AS OUR DENTAL SUPPORT 3952 02:46:18,560 --> 02:46:20,400 STAFF. 3953 02:46:20,400 --> 02:46:21,560 THESE ARE JUST SOME OF THE 3954 02:46:21,560 --> 02:46:23,440 THINGS THAT OUR DENTAL CLINIC 3955 02:46:23,440 --> 02:46:24,400 STAFF DO. 3956 02:46:24,400 --> 02:46:30,320 IT REFLECTS OUR RESEARCH AREAS. 3957 02:46:30,320 --> 02:46:33,800 AND IN THIS SETTING WE, ONE OF 3958 02:46:33,800 --> 02:46:35,560 OUR MISSIONS IS TO TRAIN THE 3959 02:46:35,560 --> 02:46:36,520 NEXT GENERATION. 3960 02:46:36,520 --> 02:46:39,040 BECAUSE OF SUCH A STRONG SUPPORT 3961 02:46:39,040 --> 02:46:41,160 NETWORK I THINK WE HAVE A VERY 3962 02:46:41,160 --> 02:46:42,600 STRONG CLINICAL RESEARCH 3963 02:46:42,600 --> 02:46:44,120 FELLOWSHIP PROGRAM THAT HAS 3964 02:46:44,120 --> 02:46:46,200 GROWN AND HAS IMPROVED AND THAT 3965 02:46:46,200 --> 02:46:48,360 IS BECAUSE THE ENVIRONMENT HAS 3966 02:46:48,360 --> 02:46:49,200 NOW BECOME AN ENVIRONMENT THAT 3967 02:46:49,200 --> 02:46:51,480 IS SUPPORTIVE FOR CLINICAL 3968 02:46:51,480 --> 02:46:51,760 RESEARCH. 3969 02:46:51,760 --> 02:46:55,000 THIS PROGRAM WAS ESTABLISHED IN 3970 02:46:55,000 --> 02:46:57,800 2010 BY JIM MELVIN AND IT'S 3971 02:46:57,800 --> 02:46:59,920 UNIQUE BECAUSE WE OFFER MENTORED 3972 02:46:59,920 --> 02:47:01,600 RESEARCH TRAINING TO IMPROVE 3973 02:47:01,600 --> 02:47:03,960 ORAL HEALTH AND THIS IS BY 3974 02:47:03,960 --> 02:47:05,520 ENSURING THAT WE HAVE WELL 3975 02:47:05,520 --> 02:47:06,960 PREPARED INVESTIGATORS AND 3976 02:47:06,960 --> 02:47:09,760 FACULTY AND WE DO THIS BY 3977 02:47:09,760 --> 02:47:11,320 CUSTOMIZING THEIR CAREER 3978 02:47:11,320 --> 02:47:12,040 DEVELOPMENT. 3979 02:47:12,040 --> 02:47:13,320 WE DON'T ACCEPT MORE THAN THREE 3980 02:47:13,320 --> 02:47:16,640 A YEAR. 3981 02:47:16,640 --> 02:47:19,320 WE'RE ABLE TO FOCUS ON THE 3982 02:47:19,320 --> 02:47:20,760 GROWTH AND DEVELOPMENT OF THE 3983 02:47:20,760 --> 02:47:22,600 YOUNG INDIVIDUALS. 3984 02:47:22,600 --> 02:47:24,640 75% OF THE TIME THEY ARE DOING 3985 02:47:24,640 --> 02:47:27,840 RESEARCH BUT THEY DEDICATE DOING 3986 02:47:27,840 --> 02:47:29,560 THEIR OWN RESEARCH OR WORKING 3987 02:47:29,560 --> 02:47:32,320 WITH THEIR INVESTIGATOR AND WE 3988 02:47:32,320 --> 02:47:34,600 ENCOURAGE GRANT WRITING. 3989 02:47:34,600 --> 02:47:36,880 WHEN JIM RETIRED HE HANDED THE 3990 02:47:36,880 --> 02:47:42,520 BATON TO ME BUT I'VE ANDED THE 3991 02:47:42,520 --> 02:47:48,360 BATON TO DR. JACKIE WHO IS A 3992 02:47:48,360 --> 02:47:53,920 FELLOW. 3993 02:47:53,920 --> 02:47:56,560 OUR FELLOWSHIP PROGRAM REQUIRES 3994 02:47:56,560 --> 02:47:59,160 THAT YOU HAVE A DENTAL DEGREE. 3995 02:47:59,160 --> 02:48:01,560 RESEARCH EXPERIENCE IS 3996 02:48:01,560 --> 02:48:01,840 PREFERRED. 3997 02:48:01,840 --> 02:48:03,680 U.S. CITIZENSHIP IS NOT REQUIRED 3998 02:48:03,680 --> 02:48:05,360 BUT YOU HAVE TO BE PREPARED TO 3999 02:48:05,360 --> 02:48:08,480 BE VERY DENSE,ED AT THE CLINICAL 4000 02:48:08,480 --> 02:48:09,360 * CENTER. 4001 02:48:09,360 --> 02:48:11,560 AT A TWO TO THREE-YEAR RESEARCH 4002 02:48:11,560 --> 02:48:12,760 TRAINING EXPERIENCE. 4003 02:48:12,760 --> 02:48:14,680 YOU'RE FULLY IMMERSED. 4004 02:48:14,680 --> 02:48:16,560 EVERY TRAINEE IS EXPECTED TO 4005 02:48:16,560 --> 02:48:19,000 HAVE A RESEARCH PROTOCOL WITH A 4006 02:48:19,000 --> 02:48:20,760 PI AND THEN WE HAVE THE PERKS 4007 02:48:20,760 --> 02:48:22,560 AND BENEFITS OF GREAT HEALTH 4008 02:48:22,560 --> 02:48:24,960 INSURANCE AND SALARY IS THAT IS 4009 02:48:24,960 --> 02:48:25,640 COMMENSURATE WITH THE 4010 02:48:25,640 --> 02:48:26,520 EXPERIENCE. 4011 02:48:26,520 --> 02:48:28,160 I'M PLEASED TO SHOW YOU THAT 4012 02:48:28,160 --> 02:48:33,280 THAT PHOTO IS DR. -- FROM BRINK 4013 02:48:33,280 --> 02:48:36,160 AMISTAR STAR AND THAT IS FROM 4014 02:48:36,160 --> 02:48:39,720 2014 AND WE WERE DOING 4015 02:48:39,720 --> 02:48:40,440 TELECONFERENCING. 4016 02:48:40,440 --> 02:48:42,120 WE WERE AHEAD OF THE CURVE AND 4017 02:48:42,120 --> 02:48:43,280 NICE TO SEE THAT BECAUSE ONE OF 4018 02:48:43,280 --> 02:48:49,560 THE PURPOSES OF OCD AND OCTOM IS 4019 02:48:49,560 --> 02:48:51,680 TO ALWAYS STAY AHEAD. 4020 02:48:51,680 --> 02:48:52,760 OUR CURRICULUM IS CENTERED 4021 02:48:52,760 --> 02:48:58,960 AROUND A WEEKLY CLINICAL CASE 4022 02:48:58,960 --> 02:49:00,160 CONFERENCE. 4023 02:49:00,160 --> 02:49:01,800 INVITES BOTH INTERMURAL AND 4024 02:49:01,800 --> 02:49:02,680 EXTRAMURAL SPEAKERS. 4025 02:49:02,680 --> 02:49:06,200 WE'VE HAD RECENT WOMEN IN 4026 02:49:06,200 --> 02:49:09,640 SCIENCE SERIES WHICH HAS INVITED 4027 02:49:09,640 --> 02:49:17,240 INTERNATIONAL SPEAKERS. 4028 02:49:17,240 --> 02:49:19,560 WE'RE USING THIS PLATFORM TO 4029 02:49:19,560 --> 02:49:21,360 MAKE SURE OUR FELLOWS CAN 4030 02:49:21,360 --> 02:49:23,240 NETWORK AND THEY TOO ARE GIVEN 4031 02:49:23,240 --> 02:49:25,200 OPPORTUNITIES TO SPEAK WITH 4032 02:49:25,200 --> 02:49:32,080 THESE WORLD-CLASS LEADERS. 4033 02:49:32,080 --> 02:49:35,640 IN PREPARING THE FUTURE WE HAVE 4034 02:49:35,640 --> 02:49:38,320 TO LOOK AT OUR METRICS. 4035 02:49:38,320 --> 02:49:41,160 WE HAVE SEND 24 FELLOWS 4036 02:49:41,160 --> 02:49:44,760 >>> THE PROGRAM SINCE 2010 AND 4037 02:49:44,760 --> 02:49:47,320 THE GENDER SPLIT IS EQUAL AT 4038 02:49:47,320 --> 02:49:49,160 THIS TIME I'M HAPPY TO SAY. 4039 02:49:49,160 --> 02:49:52,040 YOU CAN SEE THE RACE AND ETHNIC 4040 02:49:52,040 --> 02:49:52,880 BREAK DOWN. 4041 02:49:52,880 --> 02:49:54,760 WE'VE BEEN TRACKING WHERE THESE 4042 02:49:54,760 --> 02:49:56,640 FELLOWS END UP. 4043 02:49:56,640 --> 02:49:58,840 AND YOU CAN SEE THAT OF THE 16 4044 02:49:58,840 --> 02:50:00,760 WHO COMPLETED THIS PROGRAM OR 4045 02:50:00,760 --> 02:50:03,160 WERE TRANSFERRED OUT AND I SAY 4046 02:50:03,160 --> 02:50:05,360 TRANSFERRED BECAUSE I'M HAPPY TO 4047 02:50:05,360 --> 02:50:08,800 SAY WITH THE MIXED EMOTIONS THAT 4048 02:50:08,800 --> 02:50:10,800 OUR FELLOWS ARE GETTING CHERRY 4049 02:50:10,800 --> 02:50:16,600 PICKED AND SOME OF THEM LEAVE 4050 02:50:16,600 --> 02:50:17,520 BEFORE THE YEARS. 4051 02:50:17,520 --> 02:50:19,960 WE HAVE HAD TWO GO ON TO PRIVATE 4052 02:50:19,960 --> 02:50:20,560 PRACTICE. 4053 02:50:20,560 --> 02:50:22,400 WE HAVE 8 IN FACULTY POSITIONS 4054 02:50:22,400 --> 02:50:23,320 THROUGHOUT THE COUNTRY. 4055 02:50:23,320 --> 02:50:25,560 WE HAVE ONE AT THE FDA. 4056 02:50:25,560 --> 02:50:28,600 ONE AT CMS. 4057 02:50:28,600 --> 02:50:30,600 THE FIRST CHIEF DENTAL OFFICER 4058 02:50:30,600 --> 02:50:31,800 FOR CMS. 4059 02:50:31,800 --> 02:50:36,080 WE HAVE TWO STAFF SCIENTIST AT 4060 02:50:36,080 --> 02:50:43,880 THE NIDCR AND TWO ACI OR TENURED 4061 02:50:43,880 --> 02:50:47,440 TRACKED ALSO AT THE NIDCR. 4062 02:50:47,440 --> 02:50:49,560 IT'S A COMPETITIVE PROCESS AND 4063 02:50:49,560 --> 02:50:53,720 YOU CAN SEE SEAN ABRAMS IS OUR 4064 02:50:53,720 --> 02:50:54,160 NEWEST FELLOW. 4065 02:50:54,160 --> 02:50:57,680 HE JOINED US IN 2021 AND YOU CAN 4066 02:50:57,680 --> 02:50:59,240 SEE OUR FEARLESS LEADER ON THE 4067 02:50:59,240 --> 02:51:01,760 LEFT. 4068 02:51:01,760 --> 02:51:03,600 DOING WHAT SHE LOVES THE MOST 4069 02:51:03,600 --> 02:51:11,080 AND IN ACT GIVING A -- SEMINAR. 4070 02:51:11,080 --> 02:51:13,240 SO I JUST WANT TO CONCLUDE WITH 4071 02:51:13,240 --> 02:51:15,960 SOME OF THE AREAS THAT ANN AND I 4072 02:51:15,960 --> 02:51:17,760 ARE LOOKING TOWARDS *. 4073 02:51:17,760 --> 02:51:21,640 WE ARE THINKING ABOUT OR I HAVE 4074 02:51:21,640 --> 02:51:24,160 STARTED TO -- CHANGING THE MODEL 4075 02:51:24,160 --> 02:51:26,280 OF BUSINESS. 4076 02:51:26,280 --> 02:51:27,800 AS THINGS EVOLVE WE CERTAINLY 4077 02:51:27,800 --> 02:51:35,120 HAVE TO. 4078 02:51:35,120 --> 02:51:36,400 TO BE MORE INVOLVED IN THE 4079 02:51:36,400 --> 02:51:37,360 STRATEGIC PLANNING. 4080 02:51:37,360 --> 02:51:39,920 NOT JUST RECIPIENTS OF SUPPORT 4081 02:51:39,920 --> 02:51:42,360 AND IS NOT JUST TO PROVIDE -- 4082 02:51:42,360 --> 02:51:45,200 BUT BE PART OF THE PLANNING 4083 02:51:45,200 --> 02:51:47,960 BECAUSE WE NOW HAVE VETERAN 4084 02:51:47,960 --> 02:51:50,960 INVESTIGATORS WHO CAN TELL YOU 4085 02:51:50,960 --> 02:51:53,200 MORE ABOUT RESEARCH PROTOCOL 4086 02:51:53,200 --> 02:51:55,440 DEVELOPMENT AND CLINICAL TRIALS 4087 02:51:55,440 --> 02:51:56,600 DEVELOPMENT BETTER THAN MOST OF 4088 02:51:56,600 --> 02:51:58,800 US IN MY OFFICE AND SO I'M GOING 4089 02:51:58,800 --> 02:52:01,600 TO BE UTILIZING THAT EXPERTISE 4090 02:52:01,600 --> 02:52:03,360 EVEN MORE AGGRESSIVELY IN THE 4091 02:52:03,360 --> 02:52:05,320 NEXT FIVE YEARS. 4092 02:52:05,320 --> 02:52:08,400 WE HAVE TO BE NICKEL AND WE'VE 4093 02:52:08,400 --> 02:52:10,760 HEARD THE TERM PIVOT AND BEING 4094 02:52:10,760 --> 02:52:14,120 NIMBLE AND IT IS TRUE. 4095 02:52:14,120 --> 02:52:16,720 WE CAN TRACK AND DO OUR 4096 02:52:16,720 --> 02:52:20,960 ANALYTICS AND SEE WHERE OUR 4097 02:52:20,960 --> 02:52:26,520 POINTS OF WEEKNESS ARE AND THE 4098 02:52:26,520 --> 02:52:27,240 ROADBLOCKS ARE. 4099 02:52:27,240 --> 02:52:30,960 WE WANT TO TO MAKE SURE WE HAVE 4100 02:52:30,960 --> 02:52:32,160 A STRONG PARTNERSHIP. 4101 02:52:32,160 --> 02:52:35,280 WE HAVE 12 AGREEMENTS WITH 4102 02:52:35,280 --> 02:52:36,560 DIFFERENT GROUPS AND COMPANIES. 4103 02:52:36,560 --> 02:52:38,720 AND SO WE HAVE TO MAINTAIN THIS. 4104 02:52:38,720 --> 02:52:40,600 BECAUSE WE'RE EXPANDING WITHOUT 4105 02:52:40,600 --> 02:52:42,760 BREAKING OUR BUDGET. 4106 02:52:42,760 --> 02:52:46,840 WE ALSO ARE TAKING A PAGE FROM 4107 02:52:46,840 --> 02:52:52,520 THE PBRN AND THE NIMHD PLAYBOOK. 4108 02:52:52,520 --> 02:52:56,120 BECAUSE WE WANT TO DEVELOP THAT 4109 02:52:56,120 --> 02:52:58,080 LEVEL OF TRUST WHERE WE CAN NOW 4110 02:52:58,080 --> 02:52:59,760 HAVE STUDIES GOING OUT INTO THE 4111 02:52:59,760 --> 02:53:01,360 COMMUNITY. 4112 02:53:01,360 --> 02:53:04,240 WE'RE ALSO EXAMINING OUR METRICS 4113 02:53:04,240 --> 02:53:06,160 AND WE TALK ABOUT THIS 4114 02:53:06,160 --> 02:53:06,440 REGULARLY. 4115 02:53:06,440 --> 02:53:08,160 BUT ONE AREA THAT I HOPE TO 4116 02:53:08,160 --> 02:53:10,320 EXPAND IS THE CO-ORDER NATION 4117 02:53:10,320 --> 02:53:12,600 BEYOND MY OFFICE TO IMPROVE THE 4118 02:53:12,600 --> 02:53:15,600 EFFICIENCIES OF PROCESSES. 4119 02:53:15,600 --> 02:53:18,200 WE'RE GOING TO LOOK AT HIRING 4120 02:53:18,200 --> 02:53:20,560 PROCESSES TO BE SURE THAT WE CAN 4121 02:53:20,560 --> 02:53:21,680 RESPOND WHEN OUR CONTRACTS ARE 4122 02:53:21,680 --> 02:53:23,880 IN PLACE AND WE NEED PERSONNEL 4123 02:53:23,880 --> 02:53:25,800 BECAUSE THEY TOO ARE THE 4124 02:53:25,800 --> 02:53:27,720 BACKBONE OF US BEING ABLE TO DO 4125 02:53:27,720 --> 02:53:28,960 THIS QUICKLY. 4126 02:53:28,960 --> 02:53:30,560 WE'RE ASKING OUR INVESTIGATORS 4127 02:53:30,560 --> 02:53:32,640 TO START LOOKING AT THEIR 4128 02:53:32,640 --> 02:53:34,440 SUBJECT ENROLLMENT AND IMPROVE 4129 02:53:34,440 --> 02:53:37,880 THE DIVERSITY. 4130 02:53:37,880 --> 02:53:40,120 AND WE ARE TRAINING THE NEXT 4131 02:53:40,120 --> 02:53:42,200 GENERATION AND WE WOULD LIKE TO 4132 02:53:42,200 --> 02:53:44,640 INCORPORATE TRAINING MODELS THAT 4133 02:53:44,640 --> 02:53:46,960 INCLUDE CLINICAL RESEARCH 4134 02:53:46,960 --> 02:53:47,800 IMPLEMENTATION. 4135 02:53:47,800 --> 02:53:50,560 AS YOU JUST SAW BRIEFLY THAT 4136 02:53:50,560 --> 02:53:52,120 CLINICAL TRIAL MANAGEMENT IS A 4137 02:53:52,120 --> 02:53:54,120 SKILL SET THAT I THINK NOT EVERY 4138 02:53:54,120 --> 02:53:55,800 PROGRAM IN THE COUNTRY PROVIDES. 4139 02:53:55,800 --> 02:53:57,720 AND WE'RE FORTUNATE BECAUSE I 4140 02:53:57,720 --> 02:54:02,000 CAN SNAKE THREE SPECIFIC 4141 02:54:02,000 --> 02:54:06,320 FELLOWS. 4142 02:54:06,320 --> 02:54:08,520 THEY'VE BEEN INTIMATELY INVOLVED 4143 02:54:08,520 --> 02:54:10,320 AND I THINK THAT LESSON IS WHAT 4144 02:54:10,320 --> 02:54:14,720 THEY ARE GOING TO TAKE TO THEIR 4145 02:54:14,720 --> 02:54:17,120 UNIVERSITIES SO WE'RE LUCKY AND 4146 02:54:17,120 --> 02:54:19,040 PLEASED AND I LEAVE YOU WITH 4147 02:54:19,040 --> 02:54:20,560 THIS QUOTE. 4148 02:54:20,560 --> 02:54:23,160 WE NORMALLY TALK ABOUT SCIENCE 4149 02:54:23,160 --> 02:54:25,080 BUT TODAY WE THOUGHT WE WOULD 4150 02:54:25,080 --> 02:54:27,040 TELL YOU ABOUT IMPLEMENTATION 4151 02:54:27,040 --> 02:54:29,720 BECAUSE WE REALLY NEED ALL OF 4152 02:54:29,720 --> 02:54:32,760 THIS INFRASTRUCTURE IN PLACE TO 4153 02:54:32,760 --> 02:54:40,080 GET US TO GET DR. SOUZA'S VISION 4154 02:54:40,080 --> 02:54:41,880 IN PLACE. 4155 02:54:41,880 --> 02:54:44,960 WE CAN TEACH A MAN OR WOMAN TO 4156 02:54:44,960 --> 02:54:47,320 FISH BUT IT WILL ONLY FEED THEM 4157 02:54:47,320 --> 02:54:50,360 FOR A DAY. 4158 02:54:50,360 --> 02:54:52,960 BUT IF YOU GIVE -- SORRY. 4159 02:54:52,960 --> 02:54:57,440 IF YOU GIVE A MAN OR WOMEN A 4160 02:54:57,440 --> 02:54:59,800 FISH THEY WILL ONLY EAT FOR A 4161 02:54:59,800 --> 02:55:00,240 DAY. 4162 02:55:00,240 --> 02:55:02,840 BUT IF YOU TEACH A MAN OR WOMAN 4163 02:55:02,840 --> 02:55:10,200 TO FISH THEY WILL FEED THEIR 4164 02:55:10,200 --> 02:55:11,240 INSTITUTE. 4165 02:55:11,240 --> 02:55:12,960 >> THAT WAS TRULY WONDERFUL. 4166 02:55:12,960 --> 02:55:17,120 THANK YOU. 4167 02:55:17,120 --> 02:55:20,760 IT'S SO PARALLELS THE RFAs 4168 02:55:20,760 --> 02:55:23,280 THAT COUNCIL HAS APPROVED OF 4169 02:55:23,280 --> 02:55:25,200 CREATING A PHILOSOPHY OF 4170 02:55:25,200 --> 02:55:27,840 PRACTICE BASED RESEARCH 4171 02:55:27,840 --> 02:55:30,240 PHILOSOPHY WITHIN DENTAL SCHOOLS 4172 02:55:30,240 --> 02:55:32,760 THAT WILL HELP BREED THIS NEW 4173 02:55:32,760 --> 02:55:36,680 GENERATION OF CLINICAL SCHOLARS. 4174 02:55:36,680 --> 02:55:38,560 AND OFFER CONTINUE TO CONTRIBUTE 4175 02:55:38,560 --> 02:55:40,560 TO THE GROWTH OF THE PROFESSION 4176 02:55:40,560 --> 02:55:42,600 AND THE PROGRESS IS REMARKABLE. 4177 02:55:42,600 --> 02:55:43,880 I THANK YOU FOR ALL OF THE WORK 4178 02:55:43,880 --> 02:55:44,480 THAT YOU DO. 4179 02:55:44,480 --> 02:55:47,240 AND I KNOW THERE WILL BE LOTS OF 4180 02:55:47,240 --> 02:55:50,560 CONNECTIONS COMING FORTH I HOPE 4181 02:55:50,560 --> 02:55:54,360 FROM AFTER COUNCIL THAT WE CAN 4182 02:55:54,360 --> 02:55:54,680 STRENGTHEN. 4183 02:55:54,680 --> 02:55:55,960 THANK YOU FOR THE EFFORT AND 4184 02:55:55,960 --> 02:55:57,720 SINCE YOU TALKED ABOUT FISH IT 4185 02:55:57,720 --> 02:56:01,120 IS CLOSE TO LUNCHTIME AND WE DO 4186 02:56:01,120 --> 02:56:03,720 NEED TO TAKE A BREAK. 4187 02:56:03,720 --> 02:56:07,440 I'LL PASS THIS ON TO LYNN WHO 4188 02:56:07,440 --> 02:56:09,160 WILL TELL US ABOUT THE NEXT ITEM 4189 02:56:09,160 --> 02:56:11,480 OF BUSINESS 4190 02:56:11,480 --> 02:56:14,120 >> WE HAVE SAY MINUTE BREAK 4191 02:56:14,120 --> 02:56:17,720 SCHEDULED SO WE'LL RECONVENE AT 4192 02:56:17,720 --> 02:56:26,040 1:10. 4193 02:56:26,040 --> 02:56:27,680 >> WE GO INTO CLOSED SESSION. 4194 02:56:27,680 --> 02:56:31,640 >> IS NOT. 4195 02:56:31,640 --> 02:56:35,240 THE CONCEPTS. 4196 02:56:35,240 --> 02:56:36,360 >> THANK YOU. 4197 02:56:36,360 --> 02:56:37,760 WE'LL TAKE A BREAK AND BE BACK 4198 02:56:37,760 --> 02:56:39,520 IN 15 MINUTES. 4199 02:56:39,520 --> 02:56:42,800 >>I AM GOING TO JUMP IN WITH 4200 02:56:42,800 --> 02:56:44,520 THE NEXT AGENDA ITEM. 4201 02:56:44,520 --> 02:56:48,320 I HAVE TO MAYBE TAKE ONE SECOND 4202 02:56:48,320 --> 02:56:50,520 TO SPEAK TO THE FACT THAT THIS 4203 02:56:50,520 --> 02:57:00,400 IS REALLY AN ENERGIZING MORNING. 4204 02:57:00,400 --> 02:57:03,480 THANKS TO ALL OF THOSE SPEAKERS. 4205 02:57:03,480 --> 02:57:07,160 AND WITH THAT I WISH YOU A GOOD 4206 02:57:07,160 --> 02:57:08,960 AFTERNOON AND I'M TODAY GOING TO 4207 02:57:08,960 --> 02:57:12,280 ACTUALLY MAYBE I'LL INTRODUCE 4208 02:57:12,280 --> 02:57:15,320 MYSELF AND MENTION THAT I'M THE 4209 02:57:15,320 --> 02:57:20,720 DIRECTOR FOR NIDCR FOR CLINICAL 4210 02:57:20,720 --> 02:57:22,480 RESEARCH AND TODAY I'M 4211 02:57:22,480 --> 02:57:24,920 PRESENTING THE 2022 ADVISORY 4212 02:57:24,920 --> 02:57:26,680 COUNCIL REPORT ON COMPLIANCE 4213 02:57:26,680 --> 02:57:28,000 WITH THE NIH INCLUSION COMBINE 4214 02:57:28,000 --> 02:57:29,880 LINES. 4215 02:57:29,880 --> 02:57:32,880 SO THIS IS A SUMMARY OF THE 4216 02:57:32,880 --> 02:57:34,880 ACCOMPANYING TRIENNIAL INCLUSION 4217 02:57:34,880 --> 02:57:37,080 REPORT THAT YOU SHOULD HAVE WITH 4218 02:57:37,080 --> 02:57:38,320 YOUR COUNCIL MATERIALS AND 4219 02:57:38,320 --> 02:57:41,720 ULTIMATELY WE'RE SEEKING COUNCIL 4220 02:57:41,720 --> 02:57:43,640 CERTIFICATION OF NIDCR'S 4221 02:57:43,640 --> 02:57:48,200 INCLUSION DATA FOR THE FISCAL 4222 02:57:48,200 --> 02:57:49,720 YEARS 2019-2021. 4223 02:57:49,720 --> 02:57:54,800 SO NEXT SLIDE PLEASE. 4224 02:57:54,800 --> 02:57:57,720 I'D LIKE TO START BY OFFERING A 4225 02:57:57,720 --> 02:58:00,040 BACKGROUND ABOUT THE INCLUSION 4226 02:58:00,040 --> 02:58:01,440 REPORTING REQUIREMENTS THAT ARE 4227 02:58:01,440 --> 02:58:02,840 IN PLACE. 4228 02:58:02,840 --> 02:58:08,200 AND THIS ALL BEGAN IN 1993 WITH 4229 02:58:08,200 --> 02:58:12,360 THE NIH REVITALIZATION ACT WHICH 4230 02:58:12,360 --> 02:58:14,720 REQUIRES THAT NIH ESTABLISH 4231 02:58:14,720 --> 02:58:17,160 GUIDELINES FOR THE INCLUSION OF 4232 02:58:17,160 --> 02:58:20,720 WOMEN IN MINORITIES AND NIH 4233 02:58:20,720 --> 02:58:23,440 FUNDED CLINICAL RESEARCH. 4234 02:58:23,440 --> 02:58:28,920 THIS CONTINUED WITH THE 21st 4235 02:58:28,920 --> 02:58:32,360 CENTURY CURES ACT DECEMBER 2016 4236 02:58:32,360 --> 02:58:34,920 AND THE 21st CENTURY CURES 4237 02:58:34,920 --> 02:58:38,320 ACT THERE WERE A NUMBER OF 4238 02:58:38,320 --> 02:58:39,280 ELEMENTS TO IT. 4239 02:58:39,280 --> 02:58:41,920 FROM AN INCLUSION REPORTING 4240 02:58:41,920 --> 02:58:43,440 PERSPECTIVE IT REQUIRES THAT 4241 02:58:43,440 --> 02:58:46,400 PHASE III CLINICAL TRIALS 4242 02:58:46,400 --> 02:58:48,400 SUPPORTED BY NIH REPORT THE 4243 02:58:48,400 --> 02:58:51,480 RESULTS OF ANALYSIS BY SEX AND 4244 02:58:51,480 --> 02:58:54,560 GENDER AND/OR RACE AND ETHNICITY 4245 02:58:54,560 --> 02:59:03,880 TO CLINICAL TRIALS.--.GOV. 4246 02:59:03,880 --> 02:59:05,440 THEN ANOTHER ELEMENT OF THIS ACT 4247 02:59:05,440 --> 02:59:10,840 WAS CONSIDERATION OF INDIVIDUALS 4248 02:59:10,840 --> 02:59:13,600 OF ALL AGES IN NIH FUNDED 4249 02:59:13,600 --> 02:59:15,040 CLINICAL RESEARCH AND REQUIRES 4250 02:59:15,040 --> 02:59:18,680 THE REPORTING OF PARTICIPANT AGE 4251 02:59:18,680 --> 02:59:20,800 AND ENROLLMENT IN THE PROGRESS 4252 02:59:20,800 --> 02:59:21,320 REPORTS. 4253 02:59:21,320 --> 02:59:22,760 AND THIS ASPECT OF THE 4254 02:59:22,760 --> 02:59:26,200 REQUIREMENT CAME INTO PLACE FOR 4255 02:59:26,200 --> 02:59:29,160 APPLICATIONS SUBMITTED ON OR 4256 02:59:29,160 --> 02:59:31,920 AFTER JANUARY 25, 2019 SO THOSE 4257 02:59:31,920 --> 02:59:33,360 OF YOU WHO ARE CONDUCTING 4258 02:59:33,360 --> 02:59:35,560 CLINICAL RESEARCH FOR WHICH 4259 02:59:35,560 --> 02:59:37,240 INCLUSION REPORTING IS REQUIRED 4260 02:59:37,240 --> 02:59:40,120 MAY BE SEEING THIS COME ABOUT 4261 02:59:40,120 --> 02:59:42,720 WITH YOUR ANNUAL PROGRESS AND 4262 02:59:42,720 --> 02:59:49,640 REPORTS. 4263 02:59:49,640 --> 02:59:50,680 SO A LITTLE BIT OF INFORMATION 4264 02:59:50,680 --> 02:59:52,920 ABOUT REPORTING. 4265 02:59:52,920 --> 02:59:55,200 ANOTHER PIECE OF THE 21st 4266 02:59:55,200 --> 02:59:59,200 CENTURY CURES ACT IS THAT THE -- 4267 02:59:59,200 --> 03:00:00,680 IT AMENDED THE REPORTING 4268 03:00:00,680 --> 03:00:02,880 REQUIREMENT TO ADVISORY COUNCILS 4269 03:00:02,880 --> 03:00:13,320 FROM BIANNUAL TO TRY ANIAL. 4270 03:00:13,320 --> 03:00:31,200 -- TRI-ANIAL. 4271 03:00:31,200 --> 03:00:35,240 I'M GOING TO OFFER A SUMMARY. 4272 03:00:35,240 --> 03:00:36,800 I WILL MENTION WHERE THIS DATA 4273 03:00:36,800 --> 03:00:39,480 COMES FROM IS THESE ARE 4274 03:00:39,480 --> 03:00:42,560 INCLUSION DATA THAT ARE REPORTED 4275 03:00:42,560 --> 03:00:46,640 BY GRANTEES TO NIH IN ANNUAL 4276 03:00:46,640 --> 03:00:48,200 PROGRESS REPORTS AND FINAL 4277 03:00:48,200 --> 03:00:51,120 PROGRESS REPORTS. 4278 03:00:51,120 --> 03:00:58,600 AND SO I'M GOING TO START WITH 4279 03:00:58,600 --> 03:01:01,440 SPEAKING ABOUT ENROLLED STUDY 4280 03:01:01,440 --> 03:01:01,920 PARTICIPANTS. 4281 03:01:01,920 --> 03:01:06,600 THIS PERTAINS TO TABLES 2, 3 AND 4282 03:01:06,600 --> 03:01:09,560 4 IN THE ACCOMPANYING REPORT AND 4283 03:01:09,560 --> 03:01:14,040 THIS EXTRAMURAL AND INTERMURAL 4284 03:01:14,040 --> 03:01:15,920 NIH DEFINED CLINICAL RESEARCH. 4285 03:01:15,920 --> 03:01:16,840 FIRST I WOULD LIKE TO MENTION 4286 03:01:16,840 --> 03:01:18,640 THAT THE NUMBER OF STUDIES 4287 03:01:18,640 --> 03:01:21,600 CONTRIBUTING TO ENROLLMENT DATA 4288 03:01:21,600 --> 03:01:23,280 HAVE INCREASED OVER THE 4289 03:01:23,280 --> 03:01:27,920 REPORTING TIME FRAME FROM ABOUT 4290 03:01:27,920 --> 03:01:30,920 123 IN 2019 UP TO 141 IN 2021 4291 03:01:30,920 --> 03:01:33,520 AND WHILE THE NUMBER OF STUDIES 4292 03:01:33,520 --> 03:01:35,400 CONTRIBUTING DATA HAS INCREASED 4293 03:01:35,400 --> 03:01:38,200 WE CAN SEE IS THAT THE NUMBER OF 4294 03:01:38,200 --> 03:01:40,680 STUDY PARTICIPANTS HAS DECREASED 4295 03:01:40,680 --> 03:01:43,480 WITH OVER 27,000 IN 2019. 4296 03:01:43,480 --> 03:01:45,280 OF COURSE QUITE A SIGNIFICANT 4297 03:01:45,280 --> 03:01:48,120 DIP IN 2020 IN THE EARLY DAYS 4298 03:01:48,120 --> 03:01:52,520 AND MAYBE THE HEART OF THE 4299 03:01:52,520 --> 03:01:52,760 PANDEMIC. 4300 03:01:52,760 --> 03:01:56,040 AND SOME RECOVERY IN 2021 BUT IS 4301 03:01:56,040 --> 03:02:00,960 NOT UP TO PREPANDEMIC ENROLLMENT 4302 03:02:00,960 --> 03:02:02,280 NUMBERS. 4303 03:02:02,280 --> 03:02:04,760 SO I THINK BASED UPON THESE 4304 03:02:04,760 --> 03:02:06,120 NUMBERS WE CAN SPECULATE IS THAT 4305 03:02:06,120 --> 03:02:08,920 THE COVID PANDEMIC HAS AFFECTED 4306 03:02:08,920 --> 03:02:12,200 ENROLLMENT IN NIDCR FUNDED 4307 03:02:12,200 --> 03:02:17,720 CLINICAL RESEARCH STUDIES. 4308 03:02:17,720 --> 03:02:19,720 SO THIS TABLE REPRESENTS 4309 03:02:19,720 --> 03:02:22,040 ENROLLED STUDY PARTICIPANTS. 4310 03:02:22,040 --> 03:02:24,320 THE TOP PORTION IS BY SEX AND 4311 03:02:24,320 --> 03:02:25,760 GENDER. 4312 03:02:25,760 --> 03:02:28,440 OF COURSE, THIS IS EXTRAMURAL 4313 03:02:28,440 --> 03:02:33,960 AND INTERMURAL NIH DEFINED 4314 03:02:33,960 --> 03:02:35,360 CLINICAL RESEARCH. 4315 03:02:35,360 --> 03:02:39,120 FEMALE PARTICIPATION HAS 4316 03:02:39,120 --> 03:02:43,680 REMAINED STABLE. 4317 03:02:43,680 --> 03:02:49,280 AND THE BOTTOM HALF OF THE TABLE 4318 03:02:49,280 --> 03:02:52,960 IS ETHNICITY DATA AND WE CAN SEE 4319 03:02:52,960 --> 03:02:56,080 THAT THOSE SELF-REPORTING AS 4320 03:02:56,080 --> 03:02:58,720 BEING HISPANIC OR LATINO 4321 03:02:58,720 --> 03:03:01,280 ETHNICITY HAS DECREASED 4322 03:03:01,280 --> 03:03:01,520 SOMEWHAT. 4323 03:03:01,520 --> 03:03:03,000 AND I WOULD ALSO LIKE TO POINT 4324 03:03:03,000 --> 03:03:05,520 OUT THAT THOSE WITH UNKNOWN OR 4325 03:03:05,520 --> 03:03:07,800 NOT REPORTED ETHNICITY DOES 4326 03:03:07,800 --> 03:03:10,960 COMPRISE A PORTION OF ENROLLED 4327 03:03:10,960 --> 03:03:18,720 STUDY PARTICIPANTS. 4328 03:03:18,720 --> 03:03:24,720 THIS IS BY RACE FOR ALL NIH 4329 03:03:24,720 --> 03:03:27,920 DEFINED CLINICAL RESEARCH AND A 4330 03:03:27,920 --> 03:03:30,000 FEW TRENDS IS THAT PARTICIPATION 4331 03:03:30,000 --> 03:03:31,800 OF WHITE INDIVIDUALS HAS 4332 03:03:31,800 --> 03:03:33,680 REMAINED RELATIVELY STABLE OVER 4333 03:03:33,680 --> 03:03:35,760 THIS REPORTING PERIOD AT ABOUT 4334 03:03:35,760 --> 03:03:37,320 50%. 4335 03:03:37,320 --> 03:03:40,440 THOSE WHO REPORT AS BEING BLACK 4336 03:03:40,440 --> 03:03:42,920 OR AFRICAN-AMERICAN HAS 4337 03:03:42,920 --> 03:03:44,360 DECREASED SLIGHTLY OVER THAT 4338 03:03:44,360 --> 03:03:46,520 REPORTING TIME FRAME. 4339 03:03:46,520 --> 03:03:48,400 WE COULD PERHAPS SAY THAT 4340 03:03:48,400 --> 03:03:52,920 AMERICAN INDIAN AND ALASKAN 4341 03:03:52,920 --> 03:03:55,480 NATIVE PARTICIPANTS HAS SLIGHTLY 4342 03:03:55,480 --> 03:03:56,080 INCREASED. 4343 03:03:56,080 --> 03:03:58,840 AND ONE INTERESTING FEATURE IS 4344 03:03:58,840 --> 03:04:00,600 THOSE WHO SELF-REPORT AS BEING 4345 03:04:00,600 --> 03:04:04,760 OF MORE THAN ONE RACE TOOK A 4346 03:04:04,760 --> 03:04:06,960 SIGNIFICANT AND INTERESTING DIP 4347 03:04:06,960 --> 03:04:09,520 IN 2020 DURING THE HEIGHT OF THE 4348 03:04:09,520 --> 03:04:12,600 PANDEMIC BUT APPEARS TO HAVE 4349 03:04:12,600 --> 03:04:16,400 INCREASED IN 2021. 4350 03:04:16,400 --> 03:04:18,200 AND OF COURSE I WILL MENTION 4351 03:04:18,200 --> 03:04:21,160 THAT AS OCCURRED WITH THE 4352 03:04:21,160 --> 03:04:24,360 ETHNICITY DATA THOSE WITH AN 4353 03:04:24,360 --> 03:04:26,080 UNKNOWN OR NOT REPORTED RACE 4354 03:04:26,080 --> 03:04:28,920 DOES COMPRISE A PORTION OF THE 4355 03:04:28,920 --> 03:04:41,040 ENROLLED STUDY PARTICIPANTS. 4356 03:04:41,040 --> 03:04:44,480 THIS IS NIDCR SUPPORTED PHASE 4357 03:04:44,480 --> 03:04:45,720 III CLINICAL TRIALS. 4358 03:04:45,720 --> 03:04:51,120 AND THIS ALIGNS WITH TABLES 5, 6 4359 03:04:51,120 --> 03:04:57,280 AND 7 IN YOUR TRIENNIAL REPORT. 4360 03:04:57,280 --> 03:05:03,400 SO I THINK FIRST IT'S HELPFUL TO 4361 03:05:03,400 --> 03:05:05,440 MENTION THAT GRANTEES OR 4362 03:05:05,440 --> 03:05:09,520 AWARDEES SELF-REPORT WHETHER OR 4363 03:05:09,520 --> 03:05:11,680 NOT THEIR TRIAL MEETS THE PHASE 4364 03:05:11,680 --> 03:05:14,800 III DEFINITION AND TO POINT OUT 4365 03:05:14,800 --> 03:05:17,080 THAT NIH'S PHASE III DEFINITION 4366 03:05:17,080 --> 03:05:19,280 IS AN INTERVENTION THAT IS 4367 03:05:19,280 --> 03:05:21,880 ADMINISTERED TO LARGE GROUPS OF 4368 03:05:21,880 --> 03:05:23,480 PEOPLE BELIEVED TO BE AT LEAST A 4369 03:05:23,480 --> 03:05:25,400 THOUSAND TO A FEW THOUSAND AND 4370 03:05:25,400 --> 03:05:27,640 COMPARED WITH THOSE WHO DO NOT 4371 03:05:27,640 --> 03:05:36,640 RECEIVE THE INTERVENTION WITHOUT 4372 03:05:36,640 --> 03:05:37,680 EFFECTIVENESS AND SAFETY AND 4373 03:05:37,680 --> 03:05:38,920 SIDE EFFECTS. 4374 03:05:38,920 --> 03:05:40,920 SO OVER THE COURSE OF THIS 4375 03:05:40,920 --> 03:05:43,480 REPORTING PERIOD NIDCR HAS 4376 03:05:43,480 --> 03:05:45,240 SUPPORTED SEVEN TO 8 PHASE III 4377 03:05:45,240 --> 03:05:47,320 TRIALS. 4378 03:05:47,320 --> 03:05:49,520 AND WHILE THE NUMBER OF TRIALS 4379 03:05:49,520 --> 03:05:52,400 HAS REMAINED RELATIVELY 4380 03:05:52,400 --> 03:05:53,960 CONSISTENT THERE IS SOMEWHAT OF 4381 03:05:53,960 --> 03:05:56,320 A DECREASE IN PARTICIPANT 4382 03:05:56,320 --> 03:05:57,520 ENROLLMENT. 4383 03:05:57,520 --> 03:05:59,040 I REALIZE THE NUMBERS ARE 4384 03:05:59,040 --> 03:06:00,600 SMALLER BUT IF WE THROUGH ABOUT 4385 03:06:00,600 --> 03:06:02,520 THE NUMBER OF TRIALS BEING 4386 03:06:02,520 --> 03:06:05,760 SUPPORTED THERE IS A DECREASE IN 4387 03:06:05,760 --> 03:06:06,040 ENROLLMENT 4388 03:06:06,040 --> 03:06:10,320 >>> PHASE III TRIALS OVER THIS * 4389 03:06:10,320 --> 03:06:13,320 REPORTING TIME FRAME. 4390 03:06:13,320 --> 03:06:13,800 *. 4391 03:06:13,800 --> 03:06:17,120 7 OR 8 PHASE III TRIALS IS QUITE 4392 03:06:17,120 --> 03:06:19,040 SIGNIFICANT. 4393 03:06:19,040 --> 03:06:20,440 THESE ARE LARGE TRIALS AND I 4394 03:06:20,440 --> 03:06:21,720 JUST WANT TO MENTION THAT THEY 4395 03:06:21,720 --> 03:06:23,680 ARE ON A NUMBER OF VARIETY OF 4396 03:06:23,680 --> 03:06:27,680 TOPIC AREAS. 4397 03:06:27,680 --> 03:06:28,720 INCLUDING DENTAL CARRY 4398 03:06:28,720 --> 03:06:32,120 PREVENTION. 4399 03:06:32,120 --> 03:06:32,320 *. 4400 03:06:32,320 --> 03:06:34,640 TREATMENT AND ACUTE POST 4401 03:06:34,640 --> 03:06:38,120 SURGICAL PAIN MANAGEMENT. 4402 03:06:38,120 --> 03:06:40,920 TOBACCO SESSION SAYS AND 4403 03:06:40,920 --> 03:06:44,360 REDUCTION IN DENTAL ANXIETY. 4404 03:06:44,360 --> 03:06:47,720 A NUMBER OF TOPICS. 4405 03:06:47,720 --> 03:06:53,480 SO FOR PHASE III TRIAL 4406 03:06:53,480 --> 03:06:54,720 ENROLLMENT THE TOP PORTION OF 4407 03:06:54,720 --> 03:07:00,920 THE TABLE THIS IS SEX, GENDER 4408 03:07:00,920 --> 03:07:02,320 ENROLLMENT AND WE CAN SEE OUR 4409 03:07:02,320 --> 03:07:05,320 FEMALE ENROLLMENT HAS REMAINED 4410 03:07:05,320 --> 03:07:05,960 STABLE. 4411 03:07:05,960 --> 03:07:09,520 ACTUALLY HAS INCREASED 4412 03:07:09,520 --> 03:07:12,640 REPRESENTING 65-69% OF ENROLLED 4413 03:07:12,640 --> 03:07:13,280 PARTICIPANTS. 4414 03:07:13,280 --> 03:07:16,080 THIS HAS BEEN A TREND OVER MANY 4415 03:07:16,080 --> 03:07:21,320 YEARS THAT THERE HAS BEEN A 4416 03:07:21,320 --> 03:07:24,760 GREAT A GREATER RATE OF FEMALE 4417 03:07:24,760 --> 03:07:28,920 ENROLLMENT FOR PHASE III TRIALS. 4418 03:07:28,920 --> 03:07:31,520 AND MOST LIKELY DUE TO THE FACT 4419 03:07:31,520 --> 03:07:33,840 THAT A GOOD NUMBER OF OUR PHASE 4420 03:07:33,840 --> 03:07:37,200 III TRIALS ADDRESS ORAL HEALTH 4421 03:07:37,200 --> 03:07:39,320 DISPARITIES AND WHEN WE THINK OF 4422 03:07:39,320 --> 03:07:45,240 ORAL HEALTH DISPARITIES WE MIGHT 4423 03:07:45,240 --> 03:07:46,600 ENROLL YOUNG CHILDREN IN PHASE 4424 03:07:46,600 --> 03:07:49,280 III TRIALS AND MANY TIMES IT'S 4425 03:07:49,280 --> 03:07:52,480 CARE GIVER CHILD DIE ADDS * THAT 4426 03:07:52,480 --> 03:07:55,600 ARE ENROLLED AND MANY TIMES THE 4427 03:07:55,600 --> 03:07:57,320 CAREGIVERS ARE FEMALE. 4428 03:07:57,320 --> 03:07:59,320 SO IS THAT IS A TREND THAT WE'VE 4429 03:07:59,320 --> 03:08:01,720 SEEN OVER THE MANY YEARS. 4430 03:08:01,720 --> 03:08:06,120 LOOKING AT THE BOTTOM PORTION OF 4431 03:08:06,120 --> 03:08:08,560 THE TABLE WITH OUR ETHNICITY 4432 03:08:08,560 --> 03:08:12,000 DATA THERE IS AN INCREASING 4433 03:08:12,000 --> 03:08:13,120 TREND OF HISPANIC LATINO 4434 03:08:13,120 --> 03:08:15,840 ETHNICITY. 4435 03:08:15,840 --> 03:08:18,360 AND ALSO NOTABLE DECREASE IN 4436 03:08:18,360 --> 03:08:21,240 THOSE REPORTING UNKNOWN OR NOT 4437 03:08:21,240 --> 03:08:22,400 REPORTED ETHNICITY OVER THE 4438 03:08:22,400 --> 03:08:25,120 STUDY TIME FRAME. 4439 03:08:25,120 --> 03:08:28,960 AND I WILL SPECULATE THAT THAT 4440 03:08:28,960 --> 03:08:31,720 DECREASE WE'RE SEEING IS REALLY 4441 03:08:31,720 --> 03:08:35,160 SOME NIH WIDE EFFORTS TO TRY TO 4442 03:08:35,160 --> 03:08:38,520 OBTAIN ETHNICITY DATA IN 4443 03:08:38,520 --> 03:08:40,280 ADDITION TO HISTORICALLY RACE 4444 03:08:40,280 --> 03:08:43,440 DATA HAD BEEN RELATIVELY 4445 03:08:43,440 --> 03:08:45,160 COMPLETE WITH MUCH OF OUR 4446 03:08:45,160 --> 03:08:47,560 ETHNICITY DATA BEING UNKNOWN OR 4447 03:08:47,560 --> 03:08:49,280 NOT RECORDED AND THERE HAVE BEEN 4448 03:08:49,280 --> 03:08:51,840 EFFORTS TO TRY TO OVERCOME THAT 4449 03:08:51,840 --> 03:08:52,280 CHALLENGE. 4450 03:08:52,280 --> 03:08:53,720 PERHAPS THAT IS WHAT WE'RE 4451 03:08:53,720 --> 03:08:54,640 SEEING. 4452 03:08:54,640 --> 03:08:59,480 AND THE NEXT SLIDE. 4453 03:08:59,480 --> 03:09:02,000 SO FOR PHASE III TRIAL 4454 03:09:02,000 --> 03:09:03,920 ENROLLMENT BY RACE THERE IS SOME 4455 03:09:03,920 --> 03:09:05,240 INTERESTING TRENDS THAT HAVE 4456 03:09:05,240 --> 03:09:06,920 COME ABOUT OVER THIS REPORTING 4457 03:09:06,920 --> 03:09:08,400 TIME FRAME. 4458 03:09:08,400 --> 03:09:10,840 MOST NOTABLY THERE IS A 4459 03:09:10,840 --> 03:09:12,800 SUBSTANTIAL DECREASE IN THE 4460 03:09:12,800 --> 03:09:16,520 ENROLLMENT OF WHITE PARTICIPANTS 4461 03:09:16,520 --> 03:09:17,960 IN PHASE III TRIALS. 4462 03:09:17,960 --> 03:09:21,400 GOING FROM 48 TO 38 AND THEN TO 4463 03:09:21,400 --> 03:09:24,600 32% IN 2021 AND AT THAT SAME 4464 03:09:24,600 --> 03:09:27,120 TIME FRAME THERE WAS A NOTABLE 4465 03:09:27,120 --> 03:09:30,760 INCREASE IN BLACK OR 4466 03:09:30,760 --> 03:09:31,560 AFRICAN-AMERICAN ENROLLMENT IN 4467 03:09:31,560 --> 03:09:34,440 PHASE III TRIALS. 4468 03:09:34,440 --> 03:09:36,320 SUCH THAT SHOWS WHO 4469 03:09:36,320 --> 03:09:38,680 SELF-REPORTED AS BLACK OR 4470 03:09:38,680 --> 03:09:40,000 AFRICAN-AMERICAN EXCEEDED THAT 4471 03:09:40,000 --> 03:09:42,320 OF WHITE PARTICIPANTS IN PHASE 4472 03:09:42,320 --> 03:09:47,640 III TRIALS IN FY2020 AND 21. 4473 03:09:47,640 --> 03:09:50,640 SO REALLY REMARKABLE. 4474 03:09:50,640 --> 03:09:53,760 I WILL ALSO POINT OUT THAT THE 4475 03:09:53,760 --> 03:09:57,440 AMERICAN INDIAN ALASKA NATIVE 4476 03:09:57,440 --> 03:09:59,320 PARTICIPATION HAS BEEN LOW AND 4477 03:09:59,320 --> 03:10:02,800 THOSE WITH UNKNOWN OR NOT 4478 03:10:02,800 --> 03:10:04,040 REPORTED RACE WHILE THE RATES 4479 03:10:04,040 --> 03:10:06,440 ARE LESS THAN THAT FOR OVER-ALL 4480 03:10:06,440 --> 03:10:09,320 CLINICAL RESEARCH IT DOES 4481 03:10:09,320 --> 03:10:12,960 COMPRISE A PROPORTION OF THE 4482 03:10:12,960 --> 03:10:17,480 CLINICAL RESEARCH PARTICIPANTS. 4483 03:10:17,480 --> 03:10:21,440 JUST TO OFFER A SUMMARY OF WHAT 4484 03:10:21,440 --> 03:10:23,280 I AM PRESENTING HERE TODAY. 4485 03:10:23,280 --> 03:10:25,320 GENERAL TRENDS. 4486 03:10:25,320 --> 03:10:28,480 I WILL MENTION -- OVER-ALL 4487 03:10:28,480 --> 03:10:32,640 DECREASED STUDY PARTICIPANT 4488 03:10:32,640 --> 03:10:34,400 ENROLLMENT IN THIS CLINICAL 4489 03:10:34,400 --> 03:10:35,880 RESEARCH INCLUDING PHASE III 4490 03:10:35,880 --> 03:10:38,080 TRIALS AND POSSIBLY AFFECTING 4491 03:10:38,080 --> 03:10:40,440 CERTAIN RACIAL AND ETHNIC GROUPS 4492 03:10:40,440 --> 03:10:44,080 MORE THAN OTHERS SUCH AS 4493 03:10:44,080 --> 03:10:45,000 INDIVIDUAL SELF-REPORTING AS 4494 03:10:45,000 --> 03:10:47,440 HISPANIC LATINO ETHNICITY AND 4495 03:10:47,440 --> 03:10:52,120 BLACK OR AFRICAN-AMERICAN RACE. 4496 03:10:52,120 --> 03:10:53,880 BASED UPON LITERATURE THAT HAS 4497 03:10:53,880 --> 03:10:56,160 BEEN PUBLISHED AND WHAT WE KNOW 4498 03:10:56,160 --> 03:10:57,800 ABOUT THE PANDEMIC THIS IS 4499 03:10:57,800 --> 03:11:01,200 PERHAPS DUE TO THE COVID RELATED 4500 03:11:01,200 --> 03:11:03,920 IMPACTS UPON CLINICAL RESEARCH 4501 03:11:03,920 --> 03:11:05,960 ACTIVITIES IN THOSE AFFECTING 4502 03:11:05,960 --> 03:11:07,680 CERTAIN RACIAL AND ETHNIC GROUPS 4503 03:11:07,680 --> 03:11:09,680 MORE THAN OTHERS. 4504 03:11:09,680 --> 03:11:11,640 THERE HAVE BEEN A SUBSTANTIAL 4505 03:11:11,640 --> 03:11:14,960 AND CONSISTENT NUMBERS OF WOMEN 4506 03:11:14,960 --> 03:11:19,360 ENROLLED IN NIDCR STUDIES 4507 03:11:19,360 --> 03:11:21,360 INCLUDING PHASE III TRIALS. 4508 03:11:21,360 --> 03:11:23,520 OVER-ALL CLINICAL STUDY 4509 03:11:23,520 --> 03:11:25,400 PARTICIPATION REFLECTS THAT OF 4510 03:11:25,400 --> 03:11:28,160 THE U.S. POPULATION IN SOME BUT 4511 03:11:28,160 --> 03:11:31,120 NOT ALL RACIAL AND ETHNIC 4512 03:11:31,120 --> 03:11:31,880 CATEGORIES. 4513 03:11:31,880 --> 03:11:33,560 FOR EXAMPLE AMERICAN INDIAN AND 4514 03:11:33,560 --> 03:11:35,720 ALASKA NATIVE PARTICIPATION DOES 4515 03:11:35,720 --> 03:11:38,240 CONTINUE TO BE A CHALLENGE AS 4516 03:11:38,240 --> 03:11:42,560 WELL AS I BELIEVE THAT 4517 03:11:42,560 --> 03:11:44,920 ENROLLMENT INTO DIVERSE ETHNIC 4518 03:11:44,920 --> 03:11:46,800 GROUPS HAS BEEN A CHALLENGE FOR 4519 03:11:46,800 --> 03:11:48,680 NIDCR. 4520 03:11:48,680 --> 03:11:52,600 PHASE III CLINICAL TRIAL 4521 03:11:52,600 --> 03:11:54,520 PARTICIPATION IT'S BEEN SO 4522 03:11:54,520 --> 03:11:56,840 ENCOURAGING TO SEE THE 4523 03:11:56,840 --> 03:11:59,160 SIGNIFICANT IMPROVEMENT IN BLACK 4524 03:11:59,160 --> 03:12:01,320 AND AFRICAN ENROLLMENT IN TRIALS 4525 03:12:01,320 --> 03:12:02,920 TO THE EXTENT THIS THESE 4526 03:12:02,920 --> 03:12:05,040 INDIVIDUALS COMPRISE THE 4527 03:12:05,040 --> 03:12:07,440 MAJORITY OF THE PHASE III 4528 03:12:07,440 --> 03:12:08,840 CLINICAL TRIAL PARTICIPATION. 4529 03:12:08,840 --> 03:12:12,360 AND MAYBE TO TIE THAT INTO THE 4530 03:12:12,360 --> 03:12:14,240 ENGAGING PRESENTATIONS WE'VE 4531 03:12:14,240 --> 03:12:16,040 HEARD TODAY THIS IS AN 4532 03:12:16,040 --> 03:12:17,160 ILLUSTRATION PERHAPS OF ONE OF 4533 03:12:17,160 --> 03:12:24,720 THE THEMES THAT DR. -- 4534 03:12:24,720 --> 03:12:27,480 PEREZ-STABLE MENTIONED EARLIER 4535 03:12:27,480 --> 03:12:29,800 AND ALSO MICHELLE CULP MENTIONED 4536 03:12:29,800 --> 03:12:30,480 THAT AS WELL. 4537 03:12:30,480 --> 03:12:36,520 AND I WILL ALSO POINT OUT THERE 4538 03:12:36,520 --> 03:12:49,600 IS AN -- ANNEX EXPECTATION -- TO 4539 03:12:49,600 --> 03:12:56,240 REPORT. 4540 03:12:56,240 --> 03:12:58,960 TO MENTION THE PHASE III TRIALS 4541 03:12:58,960 --> 03:13:07,320 DO ADDRESS A VARIETY OF ORAL AND 4542 03:13:07,320 --> 03:13:10,600 CRANIOFACIAL ISSUES. 4543 03:13:10,600 --> 03:13:16,920 SO WITH THAT -- I WELCOME ANY 4544 03:13:16,920 --> 03:13:20,400 QUESTIONS OR PERHAPS ANY -- IF 4545 03:13:20,400 --> 03:13:24,040 THERE ARE NO QUESTIONS THEN WE 4546 03:13:24,040 --> 03:13:27,200 MIGHT NEED TO TRY TO OBTAIN 4547 03:13:27,200 --> 03:13:29,760 CERTIFICATION OF THE INCLUSION 4548 03:13:29,760 --> 03:13:32,240 DATA. 4549 03:13:32,240 --> 03:13:33,920 >> SO DO COUNCILMEMBERS HAVE ANY 4550 03:13:33,920 --> 03:13:38,920 QUESTIONS OR COMMENTS? 4551 03:13:38,920 --> 03:13:41,000 THE NEXT STEP WOULD BE FOR 4552 03:13:41,000 --> 03:13:42,240 COUNCIL TO VOTE ACCEPTANCE OF 4553 03:13:42,240 --> 03:13:44,840 THE CONCEPT OF THE REPORT. 4554 03:13:44,840 --> 03:13:46,320 AND WOULD ANY MEMBER OF COUNCIL 4555 03:13:46,320 --> 03:13:49,080 LIKE TO MAKE A MOTION TO ACCEPT 4556 03:13:49,080 --> 03:13:50,960 THE TRIENNIAL REPORT ON NIH 4557 03:13:50,960 --> 03:13:53,320 INCLUSION GUIDELINES 4558 03:13:53,320 --> 03:13:56,200 >> I MOVE -- 4559 03:13:56,200 --> 03:13:56,600 >> THANK YOU. 4560 03:13:56,600 --> 03:13:58,560 ANYONE LIKE TO SECOND THE MOTION 4561 03:13:58,560 --> 03:14:03,160 >> AGAIN SECONDED. 4562 03:14:03,160 --> 03:14:05,080 >> AND ALL IN FAVOR. 4563 03:14:05,080 --> 03:14:07,840 >> AYE. 4564 03:14:07,840 --> 03:14:09,800 >> ANY OPPOSED? 4565 03:14:09,800 --> 03:14:10,600 OKAY. 4566 03:14:10,600 --> 03:14:12,600 THE NEXT PHASE IS TO MOVE ON TO 4567 03:14:12,600 --> 03:14:14,840 THE CONCEPT CLEARANCES. 4568 03:14:14,840 --> 03:14:17,440 WE HAVE THREE CONCEPT CLEARANCES 4569 03:14:17,440 --> 03:14:22,440 THAT WILL BE PRESENTED TODAY. 4570 03:14:22,440 --> 03:14:28,640 AND WE ARE REQUIRED TO DOCUMENT 4571 03:14:28,640 --> 03:14:31,520 THE CLEARANCE OF CONCEPTS BY 4572 03:14:31,520 --> 03:14:32,840 PRESENTING THE PURPOSE, SCOPE 4573 03:14:32,840 --> 03:14:34,960 AND OBJECTIVES IN A PUBLIC FORUM 4574 03:14:34,960 --> 03:14:35,960 SUCH AS COUNCIL. 4575 03:14:35,960 --> 03:14:38,280 THE COUNCIL MEETING AND GIVING 4576 03:14:38,280 --> 03:14:46,640 COUNCIL AMERICAS AN -- MEMBERS AND 4577 03:14:46,640 --> 03:14:48,520 THE PUBLIC AN OPPORTUNITY TO 4578 03:14:48,520 --> 03:14:54,560 COMMENT. 4579 03:14:59,920 --> 03:15:07,600 DR. LOREN A BLACKBERRY 4580 03:15:26,480 --> 03:15:30,120 MY COLLEAGUE MELISSA RIDDLE ARE 4581 03:15:30,120 --> 03:15:32,360 EXCITED TO PRESENT YOU TO ON BE 4582 03:15:32,360 --> 03:15:35,760 HALF OF THE NIDCR A REQUEST FOR 4583 03:15:35,760 --> 03:15:42,840 THE REISSUANCE ENTITLED NIDCR 4584 03:15:42,840 --> 03:15:44,720 SMALL RESEARCH GRANTS FOR ORAL 4585 03:15:44,720 --> 03:15:48,840 HEALTH DATA ANALYSIS. 4586 03:15:48,840 --> 03:15:50,920 THIS FUNDING OPPORTUNITY 4587 03:15:50,920 --> 03:15:52,960 SUPPORTS TWO TYPES OF GRANT 4588 03:15:52,960 --> 03:15:53,920 APPLICATIONS. 4589 03:15:53,920 --> 03:15:59,000 INVESTIGATORS MAY PROPOSE TO 4590 03:15:59,000 --> 03:16:04,320 ANALYZE THE EXISTING DENTAL, 4591 03:16:04,320 --> 03:16:11,680 ORAL OR CRANIOFACIAL DATA. 4592 03:16:11,680 --> 03:16:14,000 IT IS DUE TO EXPIRE IN ABOUT 4593 03:16:14,000 --> 03:16:17,800 FOUR MONTHS AND WE WOULD LIKE TO 4594 03:16:17,800 --> 03:16:20,800 REQUEST A REISSUANCE. 4595 03:16:20,800 --> 03:16:23,240 TO PROVIDE SOME BACKGROUND THIS 4596 03:16:23,240 --> 03:16:26,120 OPPORTUNITY ENCOURAGES 4597 03:16:26,120 --> 03:16:29,440 APPLICATIONS. 4598 03:16:29,440 --> 03:16:30,800 PROVIDES LIMITED RESEARCH 4599 03:16:30,800 --> 03:16:33,120 SUPPORT INVESTIGATORS FOR UP TO 4600 03:16:33,120 --> 03:16:33,600 TWO YEARS. 4601 03:16:33,600 --> 03:16:36,240 THE RESPONSE TO THE CURRENT 4602 03:16:36,240 --> 03:16:36,920 FUNDING OPPORTUNITY WHICH WAS 4603 03:16:36,920 --> 03:16:40,920 FIRST PUBLISHED TWO YEARS AGO WE 4604 03:16:40,920 --> 03:16:43,920 HAVE RECEIVED 59 COMPETITIVE 4605 03:16:43,920 --> 03:16:47,000 GRANT APPLICATIONS AND SEVEN OF 4606 03:16:47,000 --> 03:16:49,000 THEM WERE AWARDED TO 4607 03:16:49,000 --> 03:16:49,600 NONINVESTIGATORS. 4608 03:16:49,600 --> 03:16:53,200 A INNING WHO THE NINE AWARDEES 4609 03:16:53,200 --> 03:16:58,520 78% WERE FEMALES AND 22% WERE 4610 03:16:58,520 --> 03:17:10,000 UNDER REPRESENTED MINORITIES. 4611 03:17:10,000 --> 03:17:15,400 APPROXIMATELY 43% OF THE AWARDS 4612 03:17:15,400 --> 03:17:21,200 PROPOSED -- OF THESE AWARDS -- 4613 03:17:21,200 --> 03:17:21,480 -- AND 4614 03:17:21,480 --> 03:17:27,760 [ INAUDIBLE ] OVER THE YEARS 4615 03:17:27,760 --> 03:17:30,600 INVESTIGATORS -- HAVE BEEN VERY 4616 03:17:30,600 --> 03:17:32,480 PROACTIVE WITH APPROXIMATELY 80% 4617 03:17:32,480 --> 03:17:35,920 OF THE AWARDS RESULTED IN ONE OR 4618 03:17:35,920 --> 03:17:41,720 MORE PUBLICATION. 4619 03:17:41,720 --> 03:17:46,760 AND THE CURRENT FUNDING 4620 03:17:46,760 --> 03:17:48,120 OPPORTUNITIES ARE PART OF A 4621 03:17:48,120 --> 03:17:51,520 SERIES IS THAT BEGAN IN 2004. 4622 03:17:51,520 --> 03:17:53,480 WE'VE CONTINUED TO RECEIVE OVER 4623 03:17:53,480 --> 03:17:56,440 THE YEARS A ROBUST RESPONSE FROM 4624 03:17:56,440 --> 03:17:57,480 BOTH JUNIOR AND SENIOR 4625 03:17:57,480 --> 03:17:59,200 INVESTIGATORS. 4626 03:17:59,200 --> 03:18:03,320 WHO HAVE BEEN PROPOSING EITHER 4627 03:18:03,320 --> 03:18:05,320 SECONDARY ANALYSIS OR NEW 4628 03:18:05,320 --> 03:18:06,800 STATISTICAL METHODOLOGY. 4629 03:18:06,800 --> 03:18:11,120 THIS IS A VERY EFFICIENT WAY TO 4630 03:18:11,120 --> 03:18:15,320 UTILIZE DATA THAT HAVE -- BEEN 4631 03:18:15,320 --> 03:18:19,800 PRODUCED AS IT IS OUT OF NIDCR 4632 03:18:19,800 --> 03:18:22,480 FUNDED RESEARCH AND SO NOW WE 4633 03:18:22,480 --> 03:18:24,800 CAN CAPITALIZE ON THE EXISTING 4634 03:18:24,800 --> 03:18:29,640 DATA THROUGH ADDITIONAL ANALYSIS 4635 03:18:29,640 --> 03:18:33,200 AND NEW HYPOTHESIS. 4636 03:18:33,200 --> 03:18:35,760 THE INVESTIGATORS ALSO HAVE AN 4637 03:18:35,760 --> 03:18:40,960 OPPORTUNITY TO INTEGRATE DATA. 4638 03:18:40,960 --> 03:18:43,440 TO ANSWER SOPHISTICATED RESEARCH 4639 03:18:43,440 --> 03:18:48,080 QUESTIONS ON THE CRANIOFACIAL 4640 03:18:48,080 --> 03:18:57,640 COMPLEX. 4641 03:19:20,520 --> 03:19:24,520 THIS ANALYSIS IN TURN MAY 4642 03:19:24,520 --> 03:19:25,280 ENCOURAGE ADDITIONAL 4643 03:19:25,280 --> 03:19:27,440 HARMONIZATION. 4644 03:19:27,440 --> 03:19:29,320 THIS INCLUDES ALSO GLOBAL DATA 4645 03:19:29,320 --> 03:19:32,480 RESOURCES FOR RARE DISEASES AND 4646 03:19:32,480 --> 03:19:35,520 FOR -- DATA. 4647 03:19:35,520 --> 03:19:41,000 THIS ANALYSIS MAY BE UTILIZED BY 4648 03:19:41,000 --> 03:19:44,120 JUNIOR INVESTIGATORS TO APPLY TO 4649 03:19:44,120 --> 03:19:47,600 THEN DEVELOP SOME NEW HYPOTHESIS 4650 03:19:47,600 --> 03:19:49,720 AND APPLY FOR LARGER GRANT 4651 03:19:49,720 --> 03:19:56,480 APPLICATIONS. 4652 03:19:56,480 --> 03:19:59,480 ONE OF THE INTERESTING 4653 03:19:59,480 --> 03:20:00,600 CHARACTERISTICS OF THIS 4654 03:20:00,600 --> 03:20:03,680 OPPORTUNITY IS THE FACT THAT IT 4655 03:20:03,680 --> 03:20:07,920 IS DISEASE DIAGNOSTIC. 4656 03:20:07,920 --> 03:20:09,520 BECAUSE IT IS NOT RESTRICT. 4657 03:20:09,520 --> 03:20:12,760 WE CAN SEE EXAMPLES OF THE BROAD 4658 03:20:12,760 --> 03:20:14,800 RANGE. 4659 03:20:14,800 --> 03:20:19,120 THAT ARE BEING PROPOSED. 4660 03:20:19,120 --> 03:20:23,560 THE MOST RECENT APPLICATIONS 4661 03:20:23,560 --> 03:20:26,360 HAVE INVOLVED TMJ. 4662 03:20:26,360 --> 03:20:31,120 ACCESS TO DENTAL CARE, 4663 03:20:31,120 --> 03:20:34,720 EPIGENETICS. 4664 03:20:34,720 --> 03:20:39,720 ---SO IT'S A WIDE RANGE OF 4665 03:20:39,720 --> 03:20:43,560 TOPICS AND ALSO EXAMPLES OF -- 4666 03:20:43,560 --> 03:20:46,360 [ INAUDIBLE ] HAVE INCLUDED 4667 03:20:46,360 --> 03:20:46,760 NETWORK ANALYSIS. 4668 03:20:46,760 --> 03:20:48,560 MACHINE LEARNING AND DEEP 4669 03:20:48,560 --> 03:20:51,200 LEARNING TECHNIQUES AND 4670 03:20:51,200 --> 03:20:52,760 MULTI-LEVEL LEARNING. 4671 03:20:52,760 --> 03:20:54,040 INVESTIGATORS ARE ABLE TO THINK 4672 03:20:54,040 --> 03:20:57,320 ABOUT THEIR OWN RESEARCH AND 4673 03:20:57,320 --> 03:21:04,920 THEN PROPOSE ANALYSIS OR NEW -- 4674 03:21:04,920 --> 03:21:06,320 METHODS. 4675 03:21:06,320 --> 03:21:08,680 AND -- 4676 03:21:08,680 --> 03:21:16,720 [ INAUDIBLE ] AND ON BEHALF OF 4677 03:21:16,720 --> 03:21:19,120 NIDCR I WOULD LIKE TO THANK YOU 4678 03:21:19,120 --> 03:21:21,000 FOR YOUR ATTENTION AND CONSIDERS 4679 03:21:21,000 --> 03:21:23,320 OF THE ISSUANCE OF THIS FUNDING 4680 03:21:23,320 --> 03:21:24,760 OPPORTUNITY AND I WOULD ALSO 4681 03:21:24,760 --> 03:21:29,040 LIKE TO ESPECIALLY THANK 4682 03:21:29,040 --> 03:21:31,320 DR. COOPER -- FOR THEIR REVIEW 4683 03:21:31,320 --> 03:21:36,320 AND I WOULD LIKE TO NOW INVITE 4684 03:21:36,320 --> 03:21:38,280 THEM NOW TO COMMENT ON THE 4685 03:21:38,280 --> 03:21:38,520 CONCEPTS. 4686 03:21:38,520 --> 03:21:39,240 >> THANK YOU. 4687 03:21:39,240 --> 03:21:43,160 THIS IS DAVID COOPER. 4688 03:21:43,160 --> 03:21:47,720 I'LL START OFF. 4689 03:21:47,720 --> 03:21:49,960 I FEEL THAT BOTH ASPECTS THIS 4690 03:21:49,960 --> 03:21:52,440 INITIATIVE ARE IMPORTANT. 4691 03:21:52,440 --> 03:21:54,960 BOTH IN DEVELOPING NEW 4692 03:21:54,960 --> 03:21:57,040 METHODOLOGY AND ANALYZING 4693 03:21:57,040 --> 03:21:58,800 EXISTING DATA. 4694 03:21:58,800 --> 03:22:00,640 ONE MIGHT THINK THAT STATISTICAL 4695 03:22:00,640 --> 03:22:03,520 METHODS ARE FAIRLY GENERAL BUT 4696 03:22:03,520 --> 03:22:07,840 IF WE TAKE INTO SOME CONCEPTS 4697 03:22:07,840 --> 03:22:10,440 SUCH AS THE FACIAL ARRANGEMENT 4698 03:22:10,440 --> 03:22:12,520 OF THE TEETH IN THE MOUTH THERE 4699 03:22:12,520 --> 03:22:15,840 MAY BE METHODS THAT CAN BE 4700 03:22:15,840 --> 03:22:16,640 DEVELOPED SPECIFICALLY FOR THAT 4701 03:22:16,640 --> 03:22:19,720 THAT WOULD NOT BE RELEVANT TO 4702 03:22:19,720 --> 03:22:22,880 ANY OTHER DISEASE AREA. 4703 03:22:22,880 --> 03:22:24,480 IT'S IMPORTANT TO DEVELOP NEW 4704 03:22:24,480 --> 03:22:27,880 METHODS THAT MAY BE SPECIFIC TO 4705 03:22:27,880 --> 03:22:28,400 DENTAL RESEARCH. 4706 03:22:28,400 --> 03:22:31,600 IN TERMS OF ANALYZING EXISTING 4707 03:22:31,600 --> 03:22:34,800 DATA -- DR. BACCAGLINI MENTIONED 4708 03:22:34,800 --> 03:22:37,880 SEVERAL USES BUT WE SHOULD NOT 4709 03:22:37,880 --> 03:22:39,960 FORGET EXISTING DATA. 4710 03:22:39,960 --> 03:22:42,600 SO NIDCR SPENDS A LOT OF MONEY 4711 03:22:42,600 --> 03:22:44,800 ON FUNDING CLINICAL TRIALS AND 4712 03:22:44,800 --> 03:22:45,960 OBSERVATIONAL RESEARCH. 4713 03:22:45,960 --> 03:22:49,040 AND WHEN THE FUNDING ENDS THE 4714 03:22:49,040 --> 03:22:52,120 INVESTIGATORS EITHER THEMSELVES 4715 03:22:52,120 --> 03:22:54,400 OR WHAT OTHER INSTITUTES DON'T 4716 03:22:54,400 --> 03:22:56,040 HAVE THE RESOURCES TO MAKE MORE 4717 03:22:56,040 --> 03:23:00,440 USE OF THE DATA GENERATED AT 4718 03:23:00,440 --> 03:23:01,920 LARGE EXPENSE. 4719 03:23:01,920 --> 03:23:05,520 ONE OF THE TRIALS FUNDED BY 4720 03:23:05,520 --> 03:23:08,520 NIDCR WAS AT THE MOTOR CLINICAL 4721 03:23:08,520 --> 03:23:08,720 TRIALS. 4722 03:23:08,720 --> 03:23:10,920 AND THEN LAST YEAR SOMEONE FROM 4723 03:23:10,920 --> 03:23:12,360 A DIFFERENT INSTITUTE CONTACTED 4724 03:23:12,360 --> 03:23:14,400 US AND ASKED US FOR THE DATA 4725 03:23:14,400 --> 03:23:18,360 BECAUSE THEY HAD SOME NEW 4726 03:23:18,360 --> 03:23:20,920 HYPOTHESIS THAT THEY WANTED TO 4727 03:23:20,920 --> 03:23:21,320 ANALYZE. 4728 03:23:21,320 --> 03:23:22,960 SO HAVING FUNDING AVAILABLE FOR 4729 03:23:22,960 --> 03:23:24,760 PEOPLE TO USE THE DATA THAT HAS 4730 03:23:24,760 --> 03:23:27,520 BEEN GENERATED AT GREAT EXPENSE 4731 03:23:27,520 --> 03:23:29,040 IS VERY VALUABLE. 4732 03:23:29,040 --> 03:23:31,880 SO I STRONGLY SUPPORT THIS 4733 03:23:31,880 --> 03:23:35,120 CONCEPT. 4734 03:23:35,120 --> 03:23:40,240 >> THANK YOU. 4735 03:23:40,240 --> 03:23:43,120 >> THANK YOU. 4736 03:23:43,120 --> 03:23:45,360 SO TO ADD A LITTLE BIT TO WHAT 4737 03:23:45,360 --> 03:23:47,400 DAVID ALREADY MENTIONED. 4738 03:23:47,400 --> 03:23:50,440 I'M ALSO EXCITED ABOUT THIS. 4739 03:23:50,440 --> 03:23:52,760 CONCEPT SO IN MY OPINION THIS 4740 03:23:52,760 --> 03:23:54,440 RESONATES PRETTY WELL WITH 4741 03:23:54,440 --> 03:23:56,120 RECENT MAJOR ADVANCES IN THE 4742 03:23:56,120 --> 03:23:57,960 AREA OF DATA SCIENCE. 4743 03:23:57,960 --> 03:24:00,720 SO I THINK IT'S BECOMING 4744 03:24:00,720 --> 03:24:02,160 INCREASINGLY CLEAR THAT THE NEW 4745 03:24:02,160 --> 03:24:03,520 DATA GENERATION METHODS THAT 4746 03:24:03,520 --> 03:24:05,840 THEY ARE USING IN MANY AREAS OF 4747 03:24:05,840 --> 03:24:08,280 SCIENCE SOME OF WHICH CREATE 4748 03:24:08,280 --> 03:24:10,600 THIS MASSIVE AMOUNTS OF DATA 4749 03:24:10,600 --> 03:24:13,120 NEED TO BE ACCOMPANIED BY DATA 4750 03:24:13,120 --> 03:24:15,480 ANALYSIS STRATEGIES. 4751 03:24:15,480 --> 03:24:18,680 MY BACKGROUND IS IN THE FIELD OF 4752 03:24:18,680 --> 03:24:22,680 GENOMICS WHERE THIS PARADIGM OF 4753 03:24:22,680 --> 03:24:24,520 ANALYZING DATA HAS A LONG 4754 03:24:24,520 --> 03:24:25,040 TRADITION. 4755 03:24:25,040 --> 03:24:29,040 THIS IS INCREASINGLY APPLICABLE. 4756 03:24:29,040 --> 03:24:31,680 THOSE WITHIN THE NIDCR FUNDING 4757 03:24:31,680 --> 03:24:33,520 PORTFOLIO. 4758 03:24:33,520 --> 03:24:37,800 BECAUSE MANY OF THESE NEW TOOLS 4759 03:24:37,800 --> 03:24:39,320 CREATE COMPLEX DATASETS. 4760 03:24:39,320 --> 03:24:41,000 AND IT'S IMPORTANT TO KEEP IN 4761 03:24:41,000 --> 03:24:43,240 MIND THAT OFTEN TIMES THOSE WHO 4762 03:24:43,240 --> 03:24:45,120 GENERATE THE DATE SAY ARE 4763 03:24:45,120 --> 03:24:46,560 INTERESTED IN ONE PARTICULAR 4764 03:24:46,560 --> 03:24:49,480 QUESTION BUT WITH THESE 4765 03:24:49,480 --> 03:24:52,400 MULTI-DIMENSIONAL TYPES OF DATA 4766 03:24:52,400 --> 03:24:54,680 COLLECTION THERE ARE ENORMOUS 4767 03:24:54,680 --> 03:24:55,960 OPPORTUNITIES FOR DOWNSTREAM 4768 03:24:55,960 --> 03:25:00,440 SECONDARY ANALYSIS TO GENERATE 4769 03:25:00,440 --> 03:25:02,320 POWERFUL INSIGHTS. 4770 03:25:02,320 --> 03:25:04,440 AND ANOTHER ASPECT IS THAT 4771 03:25:04,440 --> 03:25:06,320 THROUGH THE CLOSE INTERACTION OF 4772 03:25:06,320 --> 03:25:08,880 THOSE WHO GENERATE THE DATA AND 4773 03:25:08,880 --> 03:25:10,520 THEN THOSE WHO DEVELOP THE TOOLS 4774 03:25:10,520 --> 03:25:12,760 TO ANALYZE SUCH DATA. FOR 4775 03:25:12,760 --> 03:25:15,400 EXAMPLE UNDER THIS OPPORTUNITY 4776 03:25:15,400 --> 03:25:18,360 IT'S POSSIBLE TO OPTIMIZE STUDY 4777 03:25:18,360 --> 03:25:21,320 DESIGNS AND DATA COLLECTION 4778 03:25:21,320 --> 03:25:23,080 STRATEGIES UP FRONT TO INCREASE 4779 03:25:23,080 --> 03:25:28,840 THE POWER OF THE SUBSEQUENT 4780 03:25:28,840 --> 03:25:31,360 STATISTICAL ANALYSIS. 4781 03:25:31,360 --> 03:25:35,680 RECOGNIZING THIS -- THIS CONCEPT 4782 03:25:35,680 --> 03:25:35,800 -- 4783 03:25:35,800 --> 03:25:38,160 [ INAUDIBLE ] TO TAKE ADVANTAGE 4784 03:25:38,160 --> 03:25:40,400 OF THIS APPROACH FOR NIDCR 4785 03:25:40,400 --> 03:25:41,840 MISSION CRITICAL NEEDS AND I 4786 03:25:41,840 --> 03:25:43,600 BELIEVE THE OUTCOMES FROM 4787 03:25:43,600 --> 03:25:48,680 PREVIOUS VERSIONS OF THIS -- 4788 03:25:48,680 --> 03:25:50,280 DEMONSTRATE THAT IT'S EFFECTIVE 4789 03:25:50,280 --> 03:25:53,160 BOTH FOR SECONDARY DATA ANALYSIS 4790 03:25:53,160 --> 03:25:55,160 AS WELL AS DEVELOP NEW METHODS 4791 03:25:55,160 --> 03:25:57,280 FOR NEW TYPES OF DATA. 4792 03:25:57,280 --> 03:25:59,720 ONE FINAL ASPECT IS IS THAT WITH 4793 03:25:59,720 --> 03:26:03,120 THE SMALLEST -- 4794 03:26:03,120 --> 03:26:04,760 [ INAUDIBLE ] IT'S A GREAT 4795 03:26:04,760 --> 03:26:07,880 OPPORTUNITY FOR NEW AND EARLY 4796 03:26:07,880 --> 03:26:09,680 STAGE INVESTIGATORS AND THIS IS 4797 03:26:09,680 --> 03:26:11,680 OBVIOUS FROM THE PAST FUNDING 4798 03:26:11,680 --> 03:26:17,360 STATISTICS WHERE NEARLY HALF OF 4799 03:26:17,360 --> 03:26:19,840 ALL WERE NEW. 4800 03:26:19,840 --> 03:26:22,280 IN SUMMARY I'M ALSO EXCITED AND 4801 03:26:22,280 --> 03:26:24,520 FULLY SUPPORTIVE OF THE 4802 03:26:24,520 --> 03:26:26,080 REISSUANCE OF THIS FUNDING 4803 03:26:26,080 --> 03:26:27,800 OPPORTUNITY. 4804 03:26:27,800 --> 03:26:28,400 >> THANK YOU. 4805 03:26:28,400 --> 03:26:29,520 ANY OTHER OF COMMENTS FROM 4806 03:26:29,520 --> 03:26:33,120 COUNCIL? 4807 03:26:33,120 --> 03:26:34,680 WOULD A MEMBER OF COUNCIL LIKE 4808 03:26:34,680 --> 03:26:40,960 TO MAKE A MOTION TO RECOMMEND -- 4809 03:26:40,960 --> 03:26:46,760 [ INAUDIBLE ] 4810 03:26:46,760 --> 03:26:47,240 >> SECOND. 4811 03:26:47,240 --> 03:26:51,680 [ INAUDIBLE ]. 4812 03:26:51,680 --> 03:26:53,120 >> LYNN I REALLY APPRECIATE THE 4813 03:26:53,120 --> 03:26:56,160 FEEDBACK AND DAVID'S COMMENT ON 4814 03:26:56,160 --> 03:26:58,880 WHAT HAPPENS WHEN A STUDY 4815 03:26:58,880 --> 03:27:00,520 ACTUALLY ENDS OR IS NO LONGER 4816 03:27:00,520 --> 03:27:02,680 FUNDED AND WE HAVE A DATASET 4817 03:27:02,680 --> 03:27:04,680 THAT IS ACTUALLY VERY 4818 03:27:04,680 --> 03:27:06,360 INFORMATIVE. 4819 03:27:06,360 --> 03:27:09,080 HOW DO WE MAINTAIN A CONTINUUM 4820 03:27:09,080 --> 03:27:12,000 OF INQUIRY INTO THESE IMPORTANT 4821 03:27:12,000 --> 03:27:13,160 AREAS. 4822 03:27:13,160 --> 03:27:14,320 THAT WILL NEED FOLLOW-UP. 4823 03:27:14,320 --> 03:27:16,320 WE CAN DO OUR OWN ANALYSIS AND 4824 03:27:16,320 --> 03:27:20,520 COME UP WITH WAYS IN WHICH WE 4825 03:27:20,520 --> 03:27:22,440 CAN LEVERAGE FROM WORK THAT IS 4826 03:27:22,440 --> 03:27:24,520 NO LONGER ACTIVE FOR ONE REASON 4827 03:27:24,520 --> 03:27:25,760 OR THE OTHER. 4828 03:27:25,760 --> 03:27:27,640 >> THANK YOU. 4829 03:27:27,640 --> 03:27:30,680 >> LET ME FINISH THE VOTE. 4830 03:27:30,680 --> 03:27:32,040 >> OH, YEAH. 4831 03:27:32,040 --> 03:27:33,040 SORRY. 4832 03:27:33,040 --> 03:27:33,520 >> THAT'S OKAY. 4833 03:27:33,520 --> 03:27:35,480 ALL IN FAVOR. 4834 03:27:35,480 --> 03:27:37,400 >> AYE. 4835 03:27:37,400 --> 03:27:40,200 >> AND ANY OPPOSED? 4836 03:27:40,200 --> 03:27:41,000 >> OKAY. 4837 03:27:41,000 --> 03:27:41,200 GREAT. 4838 03:27:41,200 --> 03:27:47,920 THANKS. 4839 03:27:47,920 --> 03:27:53,440 DR. MELISSA GHIM. 4840 03:27:53,440 --> 03:28:07,800 WILL PRESENT THE NEXT CONCEPT. 4841 03:28:07,800 --> 03:28:13,520 >> THIS CONCEPT -- FOR IMPROVING 4842 03:28:13,520 --> 03:28:15,040 PATIENT CENTERED TRANSLATIONAL 4843 03:28:15,040 --> 03:28:17,880 RESEARCH OR TMD IMPACT. 4844 03:28:17,880 --> 03:28:21,080 THE PRIMARY GOAL OF THIS CONCEPT 4845 03:28:21,080 --> 03:28:24,800 IS TO ADVANCE BASIC CLINICAL 4846 03:28:24,800 --> 03:28:26,760 RESEARCH AND TRANSLATION TO 4847 03:28:26,760 --> 03:28:28,680 EVIDENCE BASED TREATMENTS AND 4848 03:28:28,680 --> 03:28:30,600 IMPROVED CLINICAL CARE. 4849 03:28:30,600 --> 03:28:33,640 VIA THE ESTABLISHMENT OF A 4850 03:28:33,640 --> 03:28:52,400 NATIONAL INTERDISCIPLINARY. 4851 03:28:52,400 --> 03:29:03,320 -- I ALSO WANT TO HIGHLIGHT THE 4852 03:29:03,320 --> 03:29:06,360 INTERDISCIPLINARY NATURE TO BE 4853 03:29:06,360 --> 03:29:07,880 IMPLEMENTED IN THE COMPOSITION 4854 03:29:07,880 --> 03:29:10,480 OF THE TEAM AS WELL AS 4855 03:29:10,480 --> 03:29:11,800 APPROACHES INCLUDING THE 4856 03:29:11,800 --> 03:29:13,720 CONSIDERATION OF CO-MORBIDITIES 4857 03:29:13,720 --> 03:29:17,000 AND CO-OCCURRING PAIN 4858 03:29:17,000 --> 03:29:19,400 CONDITIONS. 4859 03:29:19,400 --> 03:29:22,920 AND FINALLY IT'S IMPORTANT TO 4860 03:29:22,920 --> 03:29:27,520 REITERATE THAT IT WILL BE 4861 03:29:27,520 --> 03:29:36,800 PATIENT CENTERED. 4862 03:29:36,800 --> 03:29:38,800 TMD RESEARCH FROM PATIENT CARE 4863 03:29:38,800 --> 03:29:43,440 LAGS BEHIND ADVANCES IN OTHER 4864 03:29:43,440 --> 03:29:46,320 MUST COULD YOU LOW SKELETAL, 4865 03:29:46,320 --> 03:29:49,920 JOINT AND PAIN DISORDERS DUE TO 4866 03:29:49,920 --> 03:29:58,200 FACTORS SUCH AS COORDINATED 4867 03:29:58,200 --> 03:29:59,000 INTERDISCIPLINARY 4868 03:30:12,800 --> 03:30:13,320 -- 4869 03:32:14,040 --> 03:32:15,680 >> SO SPECIFIC AREAS OF INTEREST 4870 03:32:15,680 --> 03:32:20,440 FOR THIS CONCEPT -- INCLUDE 4871 03:32:20,440 --> 03:32:24,320 MECHANISTIC UNDER PINNINGS OF 4872 03:32:24,320 --> 03:32:26,440 SUBGROUPS AND PHENOTYPES AND THE 4873 03:32:26,440 --> 03:32:28,480 EYE QUAKE AND VALIDATION OF 4874 03:32:28,480 --> 03:32:30,440 TARGETS FOR DIGITALS, PREVENTION 4875 03:32:30,440 --> 03:32:32,760 AND TREATMENT OR THEIR CLINICAL 4876 03:32:32,760 --> 03:32:33,200 END POINT. 4877 03:32:33,200 --> 03:32:34,880 THE ESTABLISHMENT OF BEST 4878 03:32:34,880 --> 03:32:36,480 PRACTICES FOR INTEGRATED 4879 03:32:36,480 --> 03:32:40,440 CLINICAL MANAGEMENT IN THE 4880 03:32:40,440 --> 03:32:45,320 CONTEXT OF -- PAIN MANAGEMENT OR 4881 03:32:45,320 --> 03:32:52,400 CO-MORBIDITIES. 4882 03:32:52,400 --> 03:32:57,120 TO FACILITATE ACCESS TO THE TMJ 4883 03:32:57,120 --> 03:33:00,000 JOINT AND TO ADVANCE CURRENT 4884 03:33:00,000 --> 03:33:01,600 STANDARDS OF DETECTION AND 4885 03:33:01,600 --> 03:33:02,680 MEASUREMENT. 4886 03:33:02,680 --> 03:33:05,040 ALSO THE USE OF ARTIFICIAL 4887 03:33:05,040 --> 03:33:05,960 INTELLIGENCE, MACHINE LEARNING 4888 03:33:05,960 --> 03:33:08,400 AND DEEP LEARNING INCLUDING 4889 03:33:08,400 --> 03:33:10,520 COMPUTATIONAL METHODS FOR LARGE 4890 03:33:10,520 --> 03:33:13,160 DATASETS FOR PURPOSES SUCH AS 4891 03:33:13,160 --> 03:33:22,520 INTEREST -- INTEGRATION OF DATA. 4892 03:33:22,520 --> 03:33:24,720 ANOTHER AREA OF INTEREST IS 4893 03:33:24,720 --> 03:33:26,920 STRENGTHENING THE EVIDENCE BASED 4894 03:33:26,920 --> 03:33:29,840 FOR EXISTING TREATMENTS 4895 03:33:29,840 --> 03:33:32,840 INCLUDING PRAGMATIC TRIALS AS 4896 03:33:32,840 --> 03:33:34,640 WELL AS DEVELOPMENT AND 4897 03:33:34,640 --> 03:33:36,280 DISSEMINATION OF NEW EVIDENCE 4898 03:33:36,280 --> 03:33:41,080 BASED TREATMENTS. 4899 03:33:41,080 --> 03:33:43,360 INTERVENTIONS THAT ALLOW EARLIER 4900 03:33:43,360 --> 03:33:47,040 DIAGNOSIS OF PREVENTION STEMMING 4901 03:33:47,040 --> 03:33:54,600 FROM DEGENERATIVE CAUSES. 4902 03:33:54,600 --> 03:33:56,880 THIS IS NOT ALL-INCLUSIVE. 4903 03:33:56,880 --> 03:33:59,280 SO WHAT WOULD THIS LOOK LIKE? 4904 03:33:59,280 --> 03:34:02,240 HOW WOULD THE COLLABORATIVE 4905 03:34:02,240 --> 03:34:03,080 MANIFEST. 4906 03:34:03,080 --> 03:34:05,520 SHOWN HERE ARE TWO POTENTIAL 4907 03:34:05,520 --> 03:34:06,040 MODELS. 4908 03:34:06,040 --> 03:34:09,560 7 THE FIRST EXAMPLES A CLASSIC 4909 03:34:09,560 --> 03:34:13,760 MODEL THAT IS FREQUENTLY USED BY 4910 03:34:13,760 --> 03:34:14,600 HEAL. 4911 03:34:14,600 --> 03:34:17,720 OR THE NEW HEAL PRECISION 4912 03:34:17,720 --> 03:34:19,920 NETWORK AND THIS CONSIST OF A 4913 03:34:19,920 --> 03:34:22,040 COORDINATING AND DATACENTER 4914 03:34:22,040 --> 03:34:24,800 SERVING AS A CENTER OF 4915 03:34:24,800 --> 03:34:26,560 ADMINISTRATIVE HUB AND RESOURCE 4916 03:34:26,560 --> 03:34:28,360 SUPPORTING SPECIALIZED RESOURCE 4917 03:34:28,360 --> 03:34:28,800 CENTERS. 4918 03:34:28,800 --> 03:34:37,200 THIS IS ALSO USED BY HEAL -- 4919 03:34:37,200 --> 03:34:39,040 EPIC SENATE. 4920 03:34:39,040 --> 03:34:41,120 ANOTHER POSSIBLE MODEL DEPENDING 4921 03:34:41,120 --> 03:34:44,240 ON THE INPUT OF PARTNERS IS TO 4922 03:34:44,240 --> 03:34:46,320 STRUCTURE THE COLLABORATIVE AS A 4923 03:34:46,320 --> 03:34:48,080 CLUSTER OF SPECIALIZED CENTERS. 4924 03:34:48,080 --> 03:34:51,160 THE DENTAL, ORAL AND 4925 03:34:51,160 --> 03:34:54,360 CRANIOFACIAL TISSUE REGENERATION 4926 03:34:54,360 --> 03:34:57,280 CONSORTIUM UTILIZES THIS 4927 03:34:57,280 --> 03:35:05,280 STRUCTURE. 4928 03:35:05,280 --> 03:35:07,680 SO I'LL CONCLUDE WITH THE 4929 03:35:07,680 --> 03:35:10,280 DEPICTION OF AN EARLY EXAMPLE OF 4930 03:35:10,280 --> 03:35:13,400 AN -- USING INTEGRATED AND 4931 03:35:13,400 --> 03:35:14,360 SYSTEMS BIOLOGY. 4932 03:35:14,360 --> 03:35:19,920 FROM THE LAB OF -- THIS IS AN 4933 03:35:19,920 --> 03:35:21,080 ILLUSTRATION OF THE THOUSAND OF 4934 03:35:21,080 --> 03:35:24,040 KNOWN REACTIONS OCCURRING INSIDE 4935 03:35:24,040 --> 03:35:25,320 OUR BODIES AND THIS IS BEING 4936 03:35:25,320 --> 03:35:27,800 USED TO ILLUSTRATE THE POINT 4937 03:35:27,800 --> 03:35:30,080 THAT THIS COLLABORATIVE 4938 03:35:30,080 --> 03:35:32,680 CAPITALIZES ON THE IDEA OF THE 4939 03:35:32,680 --> 03:35:35,600 WHOLE BEING GREATER THAN THE SUM 4940 03:35:35,600 --> 03:35:37,440 OF ITS PARTS. 4941 03:35:37,440 --> 03:35:39,080 BY BRINGING TOGETHER RESOURCES 4942 03:35:39,080 --> 03:35:40,960 AS WELL AS DIVERSE THINKING AND 4943 03:35:40,960 --> 03:35:44,040 APPROACHES TO FOCUS ON TARGETED 4944 03:35:44,040 --> 03:35:44,840 PRIORITIZED RESEARCH QUESTIONS 4945 03:35:44,840 --> 03:35:47,600 AND CHALLENGES WE CAN OBTAIN THE 4946 03:35:47,600 --> 03:35:49,120 GREATER THAN BENEFIT. 4947 03:35:49,120 --> 03:35:52,320 THE ADVANTAGE THAT A MULTI-LEVEL 4948 03:35:52,320 --> 03:35:53,440 COORDINATED PARTNERSHIP CAN 4949 03:35:53,440 --> 03:35:55,840 DELIVER THAT IS OVER AND BEYOND 4950 03:35:55,840 --> 03:35:57,120 WHAT SINGLE INVESTIGATORS CAN 4951 03:35:57,120 --> 03:35:59,960 DELIVER. 4952 03:35:59,960 --> 03:36:04,560 SO WITH THIS I'LL TURN THIS OVER 4953 03:36:04,560 --> 03:36:08,600 TO OUR COUNCILMEMBERS TO 4954 03:36:08,600 --> 03:36:19,800 DISCUSS. 4955 03:36:19,800 --> 03:36:21,680 >> HELLO, EVERYONE. 4956 03:36:21,680 --> 03:36:22,880 I'M CLARKE STANFORD. 4957 03:36:22,880 --> 03:36:25,600 THANK YOU FOR THE PRESENTATION. 4958 03:36:25,600 --> 03:36:28,680 WE HAD THE OPPORTUNITY ON THE 4959 03:36:28,680 --> 03:36:32,520 7th OF JANUARY TO REVIEW THIS 4960 03:36:32,520 --> 03:36:33,320 WITH YOU. 4961 03:36:33,320 --> 03:36:34,560 AND I THANK YOU FOR YOUR TIME. 4962 03:36:34,560 --> 03:36:38,520 THIS IS AN OUTGROWTH OF THE 4963 03:36:38,520 --> 03:36:39,920 ACTIONS AND OPPORTUNITIES THAT 4964 03:36:39,920 --> 03:36:42,840 CAME OUT OF THE INSTITUTE OF 4965 03:36:42,840 --> 03:36:51,280 MEDICINE REPORT THAT THEN LED TO 4966 03:36:51,280 --> 03:36:55,080 AN INTER COUNCIL GROUP. 4967 03:36:55,080 --> 03:36:56,920 WE WORKED OVER TIME TO COME UP 4968 03:36:56,920 --> 03:36:59,920 WITH THE CONSTRUCT TO HELP NIDCR 4969 03:36:59,920 --> 03:37:01,560 IN TERMS OF HOW TO RESPOND TO 4970 03:37:01,560 --> 03:37:03,720 THAT INSTITUTE OF MEDICINE 4971 03:37:03,720 --> 03:37:03,960 REPORT. 4972 03:37:03,960 --> 03:37:05,920 ONE OF THE THINGS THAT CAME OUT 4973 03:37:05,920 --> 03:37:09,440 OF THIS WAS THE IDEA THAT TMJD 4974 03:37:09,440 --> 03:37:12,440 IS NOT AN ENTITY THAT LIES 4975 03:37:12,440 --> 03:37:14,760 WITHIN ANY ONE DISCIPLINE OR 4976 03:37:14,760 --> 03:37:16,840 LIES WITHIN ANY ONE INSTITUTE. 4977 03:37:16,840 --> 03:37:20,200 HISTORICALLY MANY TIMES BECAUSE 4978 03:37:20,200 --> 03:37:23,720 TMJD TENDS TO HAVE A MANAGEMENT 4979 03:37:23,720 --> 03:37:25,880 BY A DENTAL COMMUNITY AS ONE 4980 03:37:25,880 --> 03:37:31,200 POTENTIAL -- IT HAS FALLEN TO 4981 03:37:31,200 --> 03:37:32,840 NIDCR AND THIS LED TO THE GREAT 4982 03:37:32,840 --> 03:37:37,560 WORK DONE BY BILL -- WITH THE 4983 03:37:37,560 --> 03:37:39,800 STUDY BUT THE QUESTION NOW RISES 4984 03:37:39,800 --> 03:37:42,000 IS IT TIME FOR A NEW DAY AND TO 4985 03:37:42,000 --> 03:37:43,920 BRING IN MANY OF THE OTHER 4986 03:37:43,920 --> 03:37:45,680 COLLABORATIVE GROUPS THAT HAVE 4987 03:37:45,680 --> 03:37:47,240 EXPERTISE THAT DON'T NECESSARILY 4988 03:37:47,240 --> 03:37:52,080 GET APPLIED TO THE ASPECTS AND 4989 03:37:52,080 --> 03:37:53,280 ISSUES OF TMJD. 4990 03:37:53,280 --> 03:37:55,920 AS YOU HEARD EARLIER NIDCR IS 4991 03:37:55,920 --> 03:37:58,240 STARTING TO ADDRESS THIS TO DEAL 4992 03:37:58,240 --> 03:38:01,120 WITH AT THE CELLULAR LEVEL WHAT 4993 03:38:01,120 --> 03:38:03,800 MAY BE UNDERLYING POTENTIAL 4994 03:38:03,800 --> 03:38:05,280 MECHANISMS TO TARGET. 4995 03:38:05,280 --> 03:38:07,680 WHEN YOU LOOK AT THE REPORT THE 4996 03:38:07,680 --> 03:38:10,760 ASPECT THAT THERE IS AT LEAST 30 4997 03:38:10,760 --> 03:38:17,680 DIFFERENT PET GENIUS HEALTH 4998 03:38:17,680 --> 03:38:22,000 DISORDERS -- * EMPHASIZES A 4999 03:38:22,000 --> 03:38:23,960 SIGNIFICANT AMOUNT OF WORK IS 5000 03:38:23,960 --> 03:38:26,520 NEEDED SO THAT BASIC MECHANISMS 5001 03:38:26,520 --> 03:38:29,600 CAN BE TARGETED SO THERE IS THE 5002 03:38:29,600 --> 03:38:30,720 POTENTIAL FOR GREATER 5003 03:38:30,720 --> 03:38:33,400 UNDERSTANDING OF PREVENTION 5004 03:38:33,400 --> 03:38:42,640 FOLLOWED BY DIGITA DIAGNOSIS AND BY 5005 03:38:42,640 --> 03:38:44,280 THERAPEUTIC INTERVENTIONS THAT 5006 03:38:44,280 --> 03:38:46,960 HAVE EVIDENCE TO SHOW 5007 03:38:46,960 --> 03:38:49,400 SIGNIFICANT PATIENT RELATED 5008 03:38:49,400 --> 03:38:51,400 OUTCOMES. 5009 03:38:51,400 --> 03:38:54,400 WHAT WAS PROPOSED HERE IS THE 5010 03:38:54,400 --> 03:38:56,960 FIRST STEP IN OUR CONVERSATIONS 5011 03:38:56,960 --> 03:39:01,400 AND THIS IS A NATIONAL 5012 03:39:01,400 --> 03:39:02,360 INTERDISCIPLINARY AND THIS IS 5013 03:39:02,360 --> 03:39:03,920 NOT GOING TO BE SOMETHING THAT 5014 03:39:03,920 --> 03:39:06,680 LIES WITHIN NIDCR BUT IN NIDCR 5015 03:39:06,680 --> 03:39:09,720 WILL BE ABLE TO TAKE THE LEAD IN 5016 03:39:09,720 --> 03:39:11,840 TERMS OF BRINGING TOGETHER A 5017 03:39:11,840 --> 03:39:13,960 VARIETY OF DIFFERENT 5018 03:39:13,960 --> 03:39:16,080 INVESTIGATORS AND I WOULD 5019 03:39:16,080 --> 03:39:17,640 INCLUDE PATIENT ORIENTED GROUPS 5020 03:39:17,640 --> 03:39:19,360 BECAUSE THEIR VOICE IS NEEDED IN 5021 03:39:19,360 --> 03:39:23,680 TERMS OF THE OUTCOME MEASURES 5022 03:39:23,680 --> 03:39:25,320 AND THEY ARE IMPORTANT IN TERMS 5023 03:39:25,320 --> 03:39:26,600 OF THE SOCIAL MEDIA OF BEING 5024 03:39:26,600 --> 03:39:29,040 ABLE TO GET THE CORRECT 5025 03:39:29,040 --> 03:39:30,960 SCIENTIFIC MESSAGING OUT. 5026 03:39:30,960 --> 03:39:33,280 SO FROM DAY ONE THAT WOULD BE TO 5027 03:39:33,280 --> 03:39:34,920 ME SOMETHING TO HIGHLY RECOMMEND 5028 03:39:34,920 --> 03:39:38,640 AS A PART OF SUCH CONSORTIUM. 5029 03:39:38,640 --> 03:39:41,760 IS BRINGING IN THE PATIENT 5030 03:39:41,760 --> 03:39:42,920 RELATED COMMUNITIES OF INTEREST 5031 03:39:42,920 --> 03:39:43,680 INTO THIS. 5032 03:39:43,680 --> 03:39:46,280 A KEY PART OF THIS IS ALSO THE 5033 03:39:46,280 --> 03:39:48,120 TRAINING THE NEXT GENERATION. 5034 03:39:48,120 --> 03:39:49,960 AS YOU HEARD EARLIER TRAINING 5035 03:39:49,960 --> 03:39:54,120 FOR NIDCR IS EXTREMELY 5036 03:39:54,120 --> 03:39:54,400 IMPORTANT. 5037 03:39:54,400 --> 03:39:56,000 WE'RE TALKING ABOUT THE TEAM 5038 03:39:56,000 --> 03:39:57,280 SILENCED INDICATION AND TRAINING 5039 03:39:57,280 --> 03:39:59,040 THAT IS NEEDED AROUND COMPLEX 5040 03:39:59,040 --> 03:40:05,080 ISSUES OF CHRONIC PAIN AND IN 5041 03:40:05,080 --> 03:40:06,440 DISABILITIES THAT CAN BE A 5042 03:40:06,440 --> 03:40:07,080 ASSOCIATED WITH THIS. 5043 03:40:07,080 --> 03:40:10,280 THAT IS WHY THIS CONCEPT OF A 5044 03:40:10,280 --> 03:40:11,720 COLLABORATION IS CRITICALLY 5045 03:40:11,720 --> 03:40:13,680 IMPORTANT IN MY OPINION TO MOVE 5046 03:40:13,680 --> 03:40:17,080 FORWARD AND I WOULD STRONGLY 5047 03:40:17,080 --> 03:40:18,720 ENCOURAGE COUNCIL TO ENDORSE 5048 03:40:18,720 --> 03:40:20,280 THIS. 5049 03:40:20,280 --> 03:40:21,680 THANK YOU. 5050 03:40:21,680 --> 03:40:22,520 DR. ALBERS. 5051 03:40:22,520 --> 03:40:22,920 >> YES. 5052 03:40:22,920 --> 03:40:26,120 I TOTALLY SUPPORT AND AGREE WITH 5053 03:40:26,120 --> 03:40:27,160 EVERYTHING THAT WAS SAID. 5054 03:40:27,160 --> 03:40:29,280 THIS IS SUCH A NEEDED AREA FOR 5055 03:40:29,280 --> 03:40:30,520 RESEARCH IN TERMS OF THE 5056 03:40:30,520 --> 03:40:32,720 CLINICAL OUTCOMES AS WELL AS AT 5057 03:40:32,720 --> 03:40:35,080 THE BASIC SCIENCE LEVEL. 5058 03:40:35,080 --> 03:40:36,560 WE JUST DON'T KNOW ENOUGH ABOUT 5059 03:40:36,560 --> 03:40:39,520 THIS REALLY COMPLEX JOINT. 5060 03:40:39,520 --> 03:40:45,600 ABOUT HOW PAIN RELATED TO TMJ 5061 03:40:45,600 --> 03:40:47,560 DISORDER OR CONDITIONS MANY 5062 03:40:47,560 --> 03:40:50,120 TIMES THEY INTERSECT WITH OTHER 5063 03:40:50,120 --> 03:40:52,240 INFLAMMATORY CONDITIONS OF THE 5064 03:40:52,240 --> 03:40:52,640 BODY. 5065 03:40:52,640 --> 03:40:54,320 THIS WOULD BE AN OPPORTUNITY TO 5066 03:40:54,320 --> 03:40:58,520 REALLY GET A HOLD ON WHAT TYPES 5067 03:40:58,520 --> 03:40:59,960 OF PATIENT GROUPS ARE OUT THERE 5068 03:40:59,960 --> 03:41:03,600 IN TERMS OF THE TYPES OF TMDs 5069 03:41:03,600 --> 03:41:08,200 AND TO RELATE IT BACK TO BASIC 5070 03:41:08,200 --> 03:41:10,520 SCIENCE STUDIES IN ORDER TO 5071 03:41:10,520 --> 03:41:11,200 DEVELOP APPROACHES IS THAT WILL 5072 03:41:11,200 --> 03:41:13,360 BE EFFECTIVE IN TREATING THESE 5073 03:41:13,360 --> 03:41:14,200 DISORDERS. 5074 03:41:14,200 --> 03:41:18,200 I KNOW SEVERAL PEOPLE THAT HAVE 5075 03:41:18,200 --> 03:41:20,080 TMD AND IT'S REMARKABLE THAT AS 5076 03:41:20,080 --> 03:41:23,040 A PERSON IN THE PAIN RESEARCH 5077 03:41:23,040 --> 03:41:24,960 FIELD YOU SPEAK TO THEM AND SAY 5078 03:41:24,960 --> 03:41:27,320 WERE YOU TREATED AND DID IT 5079 03:41:27,320 --> 03:41:27,520 WORK? 5080 03:41:27,520 --> 03:41:29,080 ALMOST EVERY TIME NO. 5081 03:41:29,080 --> 03:41:30,480 NO. 5082 03:41:30,480 --> 03:41:32,480 SOME RESOLUTION BUT IT WAS NEVER 5083 03:41:32,480 --> 03:41:33,720 TREATED SUFFICIENTLY. 5084 03:41:33,720 --> 03:41:35,600 SO THERE IS SUCH A NEED HERE TO 5085 03:41:35,600 --> 03:41:37,000 REALLY UNDERSTAND WHAT IS GOING 5086 03:41:37,000 --> 03:41:41,080 ON WITH THESE DISORDERS AND THIS 5087 03:41:41,080 --> 03:41:45,160 IS CERTAINLY AN AMBITIOUS 5088 03:41:45,160 --> 03:41:46,520 INITIATIVE BUT IT'S SO NECESSARY 5089 03:41:46,520 --> 03:41:48,320 TO ADVANCE UNDERSTANDING IN THIS 5090 03:41:48,320 --> 03:41:48,880 AREA. 5091 03:41:48,880 --> 03:41:51,840 SO I REALLY SUPPORT APPROVAL OF 5092 03:41:51,840 --> 03:41:56,880 THIS CONCEPT BY THE COUNCIL. 5093 03:41:56,880 --> 03:41:58,240 >> ANY OTHER QUESTIONS OR 5094 03:41:58,240 --> 03:42:02,000 COMMENTS? 5095 03:42:02,000 --> 03:42:03,720 >> LYNN, IT'S JOEL STROM 5096 03:42:03,720 --> 03:42:04,560 CALLING. 5097 03:42:04,560 --> 03:42:05,480 HOW ARE YOU DOING? 5098 03:42:05,480 --> 03:42:07,600 >> GOOD. 5099 03:42:07,600 --> 03:42:08,920 >> I SUPPORT EVERYTHING THAT HAS 5100 03:42:08,920 --> 03:42:10,680 BEEN SAID. 5101 03:42:10,680 --> 03:42:12,160 BUT THERE IS ONE AREA THAT I 5102 03:42:12,160 --> 03:42:15,120 LEARNED ABOUT RECENTLY THAT HAS 5103 03:42:15,120 --> 03:42:16,920 BEEN EFFECTIVE AT LEAST IN OUR 5104 03:42:16,920 --> 03:42:18,800 AREA OF TOWN HERE IN LOS ANGELES 5105 03:42:18,800 --> 03:42:21,800 AND THAT HAS TO DO WITH TMS 5106 03:42:21,800 --> 03:42:23,640 TREATMENT AND APNEA. 5107 03:42:23,640 --> 03:42:26,320 AND LEARNING MORE ABOUT HOW THAT 5108 03:42:26,320 --> 03:42:28,720 IS INTERTWINED -- CAN BE 5109 03:42:28,720 --> 03:42:31,360 INTERTWINED WITH TMD ISSUES. 5110 03:42:31,360 --> 03:42:34,800 SO I WOULD LIKE TO PUT A WORD IN 5111 03:42:34,800 --> 03:42:37,840 AND A FOCUS ON SLEEP RELATED 5112 03:42:37,840 --> 03:42:39,800 CAUSES AND THEN THEREFORE 5113 03:42:39,800 --> 03:42:45,320 TREATMENTS THAT MIGHT BE 5114 03:42:45,320 --> 03:42:46,560 INVESTIGATED. 5115 03:42:46,560 --> 03:42:51,360 THERE IS A LOT OF FROM MY 5116 03:42:51,360 --> 03:42:52,160 PERSPECTIVE INTERRELATED ISSUES 5117 03:42:52,160 --> 03:42:54,600 THAT COME UP WITH SLEEP. 5118 03:42:54,600 --> 03:42:57,080 THE CONCEPT OF PROPER SLEEP AND 5119 03:42:57,080 --> 03:43:00,080 TMD PAIN AND IN MY PATIENTS I 5120 03:43:00,080 --> 03:43:03,520 FOUND IT TO BE EFFECTIVE. 5121 03:43:03,520 --> 03:43:05,160 PSYCHOSOCIAL FACTORS, MAYBE THAT 5122 03:43:05,160 --> 03:43:07,920 IS WHERE IT MIGHT FIT BUT IF YOU 5123 03:43:07,920 --> 03:43:09,400 DO A CLUSTER APPROACH PERHAPS 5124 03:43:09,400 --> 03:43:11,360 THERE WOULD BE ONE RELATED TO 5125 03:43:11,360 --> 03:43:16,320 SLEEP ISSUES. 5126 03:43:16,320 --> 03:43:17,920 >> ANY OTHER COMMENTS? 5127 03:43:17,920 --> 03:43:23,240 OR QUESTIONS? 5128 03:43:23,240 --> 03:43:25,120 IF NOT WOULD A MEMBER OF COUNCIL 5129 03:43:25,120 --> 03:43:27,520 LIKE TO MAKE A MOTION, 5130 03:43:27,520 --> 03:43:28,840 RECOMMENDATION TO APPROVE THIS 5131 03:43:28,840 --> 03:43:30,560 CONCEPT? 5132 03:43:30,560 --> 03:43:31,560 >> THIS IS AMY. 5133 03:43:31,560 --> 03:43:33,320 I'LL MAKE A MOTION 5134 03:43:33,320 --> 03:43:38,320 >> I'LL SECOND IT. 5135 03:43:38,320 --> 03:43:39,920 >> ALL IN FAVOR. 5136 03:43:39,920 --> 03:43:40,840 AYE. 5137 03:43:40,840 --> 03:43:44,120 >> ANY OPPOSED? 5138 03:43:44,120 --> 03:43:57,320 OKAY. 5139 03:43:57,320 --> 03:43:58,680 DR. ZHONG CHEN. 5140 03:43:58,680 --> 03:43:59,800 COUNCILMEMBERS WHO ARE INVITED 5141 03:43:59,800 --> 03:44:07,040 TO COMMENT ARE DR. GARCIA AND 5142 03:44:07,040 --> 03:44:08,040 SHI. 5143 03:44:08,040 --> 03:44:09,800 >> HI, EVERYONE. 5144 03:44:09,800 --> 03:44:15,360 MY NAME IS ZHONG CHEN. 5145 03:44:15,360 --> 03:44:18,120 TODAY I'M GOING TO PRESENT A 5146 03:44:18,120 --> 03:44:19,240 CONCEPT AHEAD. 5147 03:44:19,240 --> 03:44:24,240 WHICH STANDS FOR THE ADVANCEMENT 5148 03:44:24,240 --> 03:44:27,680 OF HEAD AND NECK CANCER EARLY 5149 03:44:27,680 --> 03:44:40,280 DETECTION RESEARCH. 5150 03:44:40,280 --> 03:45:16,680 [ INAUDIBLE ] HOWEVER WHEN WE 5151 03:45:16,680 --> 03:45:22,400 LOOK -- HUMID HPV IS SPONGE FOR 5152 03:45:22,400 --> 03:45:25,360 UP TO 70% OF THE CANCER IN THE 5153 03:45:25,360 --> 03:45:29,520 UNITED STATES. 5154 03:45:29,520 --> 03:45:49,040 *. 5155 03:45:49,040 --> 03:45:49,160 -- 5156 03:45:49,160 --> 03:45:53,120 [ INAUDIBLE ] ALSO HIGH NECK 5157 03:45:53,120 --> 03:45:58,520 CANCERS -- ARE QUITE LIKELY TO 5158 03:45:58,520 --> 03:46:05,040 AFFECT MEN RATHER THAN WOMEN. 5159 03:46:05,040 --> 03:46:09,280 AFRICAN-AMERICAN MEN -- -- 5160 03:46:09,280 --> 03:46:36,000 [ INAUDIBLE ] 5161 03:46:36,000 --> 03:47:18,480 [ INAUDIBLE ] CERTAIN CERTAIN 5162 03:47:46,000 --> 03:48:23,680 [ INDISCERNIBLE ] 5163 03:48:23,680 --> 03:48:28,320 SO CURRENTLY THE RESEARCH GAP -- 5164 03:48:28,320 --> 03:48:32,880 LIMITED BIOMARKERS -- THAT CAN 5165 03:48:32,880 --> 03:48:34,520 PREDICT EARLY ORAL LESION 5166 03:48:34,520 --> 03:48:38,840 PROGRESSION TO CANCER AND ALSO 5167 03:48:38,840 --> 03:48:41,120 LACK OF SYSTEMATIC DISCOVERY AND 5168 03:48:41,120 --> 03:48:43,680 VALIDATION OF POTENTIAL 5169 03:48:43,680 --> 03:48:45,920 BIOMARKERS FOR CLINICAL USAGE. 5170 03:48:45,920 --> 03:48:48,840 SO THE RESEARCH OPPORTUNITY TO 5171 03:48:48,840 --> 03:48:52,120 UNDERSTAND THE MOLECULAR 5172 03:48:52,120 --> 03:48:54,680 CHARACTERISTICS OF DYSPLASTIC 5173 03:48:54,680 --> 03:48:57,320 LESIONS AS WELL AS EARLY 5174 03:48:57,320 --> 03:48:59,560 RECURRENCE AND METASTASIS TO 5175 03:48:59,560 --> 03:49:01,360 IMPROVE ORAL LESION 5176 03:49:01,360 --> 03:49:04,920 CLASSIFICATION AND A PREDICTOR 5177 03:49:04,920 --> 03:49:10,280 OF CANCER PROGRESSION. 5178 03:49:10,280 --> 03:49:12,040 AND WE ESTABLISHED PARTNERSHIP 5179 03:49:12,040 --> 03:49:17,080 WITH NCI TO INTERACT WITH THE 5180 03:49:17,080 --> 03:49:18,440 EARLY DETECTION NETWORK AND WE 5181 03:49:18,440 --> 03:49:23,080 HAVE A LONG HISTORY WITH NCI AND 5182 03:49:23,080 --> 03:49:25,760 MANY OTHER PROGRAMS SUCH AS THE 5183 03:49:25,760 --> 03:49:27,440 MOONSHOT PROGRAM AND THE SPORE 5184 03:49:27,440 --> 03:49:34,520 PROGRAM. 5185 03:49:34,520 --> 03:49:35,880 THE SPECIFIC AREA OF INTEREST 5186 03:49:35,880 --> 03:49:40,200 FOR THE RESEARCH TOPICS INCLUDE 5187 03:49:40,200 --> 03:49:44,280 DISCOVER MOLECULAR GENOMIC, 5188 03:49:44,280 --> 03:49:47,040 IMMUNOLOGICAL, CELLULAR, 5189 03:49:47,040 --> 03:49:48,600 MICROBIOME AND IMAGING 5190 03:49:48,600 --> 03:49:51,000 SIGNATURES. 5191 03:49:51,000 --> 03:49:54,320 EVALUATE BIOMARKERS AND 5192 03:49:54,320 --> 03:49:56,520 TECHNOLOGIES WHICH CAN 5193 03:49:56,520 --> 03:50:01,880 COMPLIMENT CURRENT CLINICAL 5194 03:50:01,880 --> 03:50:04,120 METHODS. 5195 03:50:04,120 --> 03:50:06,360 ALSO TO DEVELOP THE TOOLS AND 5196 03:50:06,360 --> 03:50:09,320 METHODS FOR DETECTING BIOMARKERS 5197 03:50:09,320 --> 03:50:17,360 IN BODILY FLUIDS. 5198 03:50:17,360 --> 03:50:19,280 AND ALSO WOULD LIKE TO INTEGRATE 5199 03:50:19,280 --> 03:50:22,760 THE HIGH THROUGH PUT 5200 03:50:22,760 --> 03:50:28,160 TECHNOLOGIES WITH DATA SCIENCE 5201 03:50:28,160 --> 03:50:30,000 -- ARTIFICIAL INTELLIGENCE AND 5202 03:50:30,000 --> 03:50:34,760 MACHINE LEARNING AND DEEP 5203 03:50:34,760 --> 03:50:38,000 LEARNING FOR THE VALIDATION 5204 03:50:38,000 --> 03:50:45,360 PROCESS. 5205 03:50:45,360 --> 03:50:48,560 AND TO IDENTIFY FACTORS OF 5206 03:50:48,560 --> 03:50:52,760 NUTRITION OR EARLY DETECTION OF 5207 03:50:52,760 --> 03:50:55,400 CANCER INCLUDING NUTRITION, 5208 03:50:55,400 --> 03:50:57,880 MICRO BIOME, ORAL HEALTH AND 5209 03:50:57,880 --> 03:50:59,680 HEALTH DISPARITY. 5210 03:50:59,680 --> 03:51:01,280 I WILL STOP HERE. 5211 03:51:01,280 --> 03:51:12,800 THANK YOU FOR YOUR ATTENTION. 5212 03:51:12,800 --> 03:51:13,160 >> THANK YOU. 5213 03:51:13,160 --> 03:51:16,280 WE HAD THE OPPORTUNITY TO MEET 5214 03:51:16,280 --> 03:51:18,280 WITH DR. CHEN AND DISCUSS THE 5215 03:51:18,280 --> 03:51:20,760 CONCEPT. 5216 03:51:20,760 --> 03:51:24,480 THE CONCEPT -- ADDRESSES THIS. 5217 03:51:24,480 --> 03:51:26,480 IMPORTANTLY THE OVER-ALL PROGRAM 5218 03:51:26,480 --> 03:51:28,680 THE AHEAD PROGRAM PROPOSED BY 5219 03:51:28,680 --> 03:51:31,040 THIS CONCEPT CLEARANCE HAS VERY 5220 03:51:31,040 --> 03:51:33,000 HIGH CLINICAL AND PUBLIC HEALTH 5221 03:51:33,000 --> 03:51:35,640 RELEVANCE. 5222 03:51:35,640 --> 03:51:39,960 TO ACCELERATE RESEARCH AND AIMS 5223 03:51:39,960 --> 03:51:41,520 TO MEET KEY GAPS AND KNOWLEDGE 5224 03:51:41,520 --> 03:51:43,360 BY BUILDING ON TIMELY 5225 03:51:43,360 --> 03:51:45,800 OPPORTUNITIES INCLUDING MANY 5226 03:51:45,800 --> 03:51:47,280 ADVANCEMENTS MADE IN HIGH 5227 03:51:47,280 --> 03:51:50,440 THROUGH PUT TECHNOLOGIES AS WELL 5228 03:51:50,440 --> 03:51:52,120 AS COMPUTATIONAL TECHNOLOGY. 5229 03:51:52,120 --> 03:51:55,640 THE PARTNERSHIP WITH NCI WILL 5230 03:51:55,640 --> 03:51:57,000 FACILITATE WITH THE EARLY 5231 03:51:57,000 --> 03:51:58,880 DETECTION NETWORK AS WELL AS 5232 03:51:58,880 --> 03:52:00,760 YIELD ACCESS TO OTHER IMPORTANT 5233 03:52:00,760 --> 03:52:03,880 RESOURCE THAT'S WILL CLEARLY 5234 03:52:03,880 --> 03:52:05,600 ENHANCE THE INVESTIGATORS TO 5235 03:52:05,600 --> 03:52:06,680 ACHIEVE THEIR GOALS. 5236 03:52:06,680 --> 03:52:08,560 WE DISCUSSED SOME OF THE 5237 03:52:08,560 --> 03:52:13,280 CHALLENGES REGARDING 5238 03:52:13,280 --> 03:52:14,760 OPERATIONALIZING THIS CONCEPT. 5239 03:52:14,760 --> 03:52:17,000 SOME OF THE CHALLENGES INCLUDED 5240 03:52:17,000 --> 03:52:21,120 THE BASIC AND VERY AMBITIOUS 5241 03:52:21,120 --> 03:52:22,760 GOAL AND THE SCOPE OF THE 5242 03:52:22,760 --> 03:52:31,880 CONCEPT. 5243 03:52:31,880 --> 03:52:33,320 WE SUGGESTED TO CONSIDER THE 5244 03:52:33,320 --> 03:52:35,280 BENEFITS OF TAKING A MORE 5245 03:52:35,280 --> 03:52:38,280 FOCUSED APPROACH. 5246 03:52:38,280 --> 03:52:41,600 LIMITING THE SCOPE IS TO ORAL 5247 03:52:41,600 --> 03:52:45,320 CAVITY. 5248 03:52:45,320 --> 03:52:47,000 AND SALIVARY GLAND TUMORS. 5249 03:52:47,000 --> 03:52:49,560 THE OTHER WAS THE OVER-ALL 5250 03:52:49,560 --> 03:52:50,400 READINESS FOR TRANSLATION. 5251 03:52:50,400 --> 03:52:53,080 IN ORDER TO ACCELERATE 5252 03:52:53,080 --> 03:52:55,840 TRANSLATION ONE NEEDS A CERTAIN 5253 03:52:55,840 --> 03:52:58,240 FOUNDATION OF SCIENTIFIC 5254 03:52:58,240 --> 03:53:00,240 FINDINGS TO TRANSLATE. 5255 03:53:00,240 --> 03:53:05,480 THE INSTITUTES PORTFOLIO HAS 5256 03:53:05,480 --> 03:53:08,680 ONLY HAD A HANDFUL OF STUDIES. 5257 03:53:08,680 --> 03:53:11,520 CLEARLY THERE IS A NEED TO 5258 03:53:11,520 --> 03:53:13,080 ACCELERATE IN THIS AREA BUT THE 5259 03:53:13,080 --> 03:53:14,520 QUESTION IS EVEN THOUGH THE NEED 5260 03:53:14,520 --> 03:53:18,280 FOR MORE WORK IS APPARENT IS 5261 03:53:18,280 --> 03:53:19,600 THERE SUFFICIENT PROGRESS MADE 5262 03:53:19,600 --> 03:53:21,080 ALREADY TO MOVE SUCCESSFULLY 5263 03:53:21,080 --> 03:53:23,760 INTO THE TRANSLATION PHASE. 5264 03:53:23,760 --> 03:53:25,320 AND LAST BUT NOT LEAST FOR 5265 03:53:25,320 --> 03:53:27,880 MOVING AHEAD IS TO LEARN FROM 5266 03:53:27,880 --> 03:53:29,080 THE PAST. 5267 03:53:29,080 --> 03:53:30,920 TO WHAT EXTENT CAN WE LEARN 5268 03:53:30,920 --> 03:53:32,520 ABOUT SIMILAR PAST EFFORTS AT 5269 03:53:32,520 --> 03:53:34,600 THE INSTITUTE THAT CAN BETTER 5270 03:53:34,600 --> 03:53:37,440 INFORM PLANNING FOR THIS ONE. 5271 03:53:37,440 --> 03:53:40,800 A DECADE AND A HALF AGO -- IN 5272 03:53:40,800 --> 03:53:44,240 THE AREA OF SALIVARY 5273 03:53:44,240 --> 03:53:45,320 DIAGNOSTICS. 5274 03:53:45,320 --> 03:53:48,920 WHAT HAVE WE LEARNED AND CAN 5275 03:53:48,920 --> 03:53:50,520 APPLY MOVING FORWARD. 5276 03:53:50,520 --> 03:53:52,520 ENTHUSIASTIC ABOUT MOVING 5277 03:53:52,520 --> 03:53:54,520 FORWARD WITH THIS AND NOW I'LL 5278 03:53:54,520 --> 03:53:58,320 TURN IT OVER TO DR. SHI 5279 03:53:58,320 --> 03:54:00,800 >> A COMPLETELY AGREE WITH 5280 03:54:00,800 --> 03:54:01,960 DR. GARCIA'S ASSESSMENT. 5281 03:54:01,960 --> 03:54:06,040 AND WE HAD A GREAT CONVERSATION 5282 03:54:06,040 --> 03:54:10,360 WITH DR. CHEN AND DR. MALIO. 5283 03:54:10,360 --> 03:54:15,000 AND WE ALL AGREED THIS IS A VERY 5284 03:54:15,000 --> 03:54:17,600 WELL RETURN PROPOSAL ADDRESSING 5285 03:54:17,600 --> 03:54:18,560 SOME IMPORTANT AREAS. 5286 03:54:18,560 --> 03:54:21,320 TO ME ONE OF THE MOST EXCITING 5287 03:54:21,320 --> 03:54:26,160 THINGS IS MOST OF THE DENTAL 5288 03:54:26,160 --> 03:54:29,480 RESEARCH -- FOCUSED ON THE OSCC 5289 03:54:29,480 --> 03:54:31,920 AND BY ELEVATING TO THE HEAD AND 5290 03:54:31,920 --> 03:54:35,080 NECK CANCER AND HOPING WE WILL 5291 03:54:35,080 --> 03:54:37,440 BE PROMOTING MORE PEOPLE IN THE 5292 03:54:37,440 --> 03:54:40,360 ENT AREA TO BE INVOLVED IN THIS 5293 03:54:40,360 --> 03:54:41,600 OVER-ALL HEAD NECK CANCER 5294 03:54:41,600 --> 03:54:42,000 ACTIVITY. 5295 03:54:42,000 --> 03:54:46,600 7 SO HAVING THIS AS A JOINT 5296 03:54:46,600 --> 03:54:51,040 EFFORT WITH NCI IS GREAT. 5297 03:54:51,040 --> 03:54:53,080 WE'RE EVEN THINKING COULD EXTEND 5298 03:54:53,080 --> 03:54:54,720 TO MORE INSTITUTES THAT ARE 5299 03:54:54,720 --> 03:54:59,240 INVOLVED IN THE HEAD AND NECK, 5300 03:54:59,240 --> 03:55:00,920 NASAL AND EYE AREA SINCE THEY 5301 03:55:00,920 --> 03:55:03,000 ARE ALL PART OF THE SAME SYSTEM. 5302 03:55:03,000 --> 03:55:13,360 7 THE ONLY CONCERN FROM MY END 5303 03:55:13,360 --> 03:55:15,920 IS WE CAN ONLY CONTINUE DOING 5304 03:55:15,920 --> 03:55:17,680 THE EARLY DISCOVERY AND THERE IS 5305 03:55:17,680 --> 03:55:19,920 A LOT OF WORK ALREADY BEEN DOING 5306 03:55:19,920 --> 03:55:23,080 AND TRY TO FIND A BIOMARKER 5307 03:55:23,080 --> 03:55:29,000 RELATED TO THE ORAL CANCER IN 5308 03:55:29,000 --> 03:55:29,240 SALIVA. 5309 03:55:29,240 --> 03:55:30,560 SO I THINK IT'S VERY IMPORTANT 5310 03:55:30,560 --> 03:55:33,200 TO TRY TO AVOID TO REPEAT THE 5311 03:55:33,200 --> 03:55:35,280 OLD WORK. 5312 03:55:35,280 --> 03:55:39,720 7 AND WE WILL BRAINSTORM HOW WE 5313 03:55:39,720 --> 03:55:43,960 CAN GUIDE THIS PARTICULAR 5314 03:55:43,960 --> 03:55:46,720 PROPOSAL AND TO ASK FOR 5315 03:55:46,720 --> 03:55:48,240 INTRODUCING SOME OF THE NEW 5316 03:55:48,240 --> 03:55:49,920 TECHNOLOGIES LIKE AI AND THE 5317 03:55:49,920 --> 03:55:53,120 MORE LOOKING AT MORE BROADER 5318 03:55:53,120 --> 03:55:55,520 APPROACH INSTEAD OF JUST THOSE 5319 03:55:55,520 --> 03:55:58,120 OLD EARLY DISCOVERY PROCESSES SO 5320 03:55:58,120 --> 03:56:02,200 WE'RE NOT REPEATING THE EFFORT. 5321 03:56:02,200 --> 03:56:05,920 THAT IS REALLY -- WAS THE MAIN 5322 03:56:05,920 --> 03:56:08,880 CHALLENGE OF THIS PROPOSAL. 5323 03:56:08,880 --> 03:56:10,440 BUT THIS IS A VERY IMPORTANT 5324 03:56:10,440 --> 03:56:12,520 AREA AND WE NEED TO SPEND MORE 5325 03:56:12,520 --> 03:56:14,920 MONEY ON IT SO WE'RE VERY GLAD 5326 03:56:14,920 --> 03:56:16,840 TO SEE THERE IS SUCH A PROPOSAL 5327 03:56:16,840 --> 03:56:17,840 ON THE TABLE. 5328 03:56:17,840 --> 03:56:37,280 >> THANK YOU. 5329 03:56:37,280 --> 03:56:41,640 >> SO THIS IS -- THANK YOU. 5330 03:56:41,640 --> 03:56:46,760 THAT IS JACYUE -- NOR. 5331 03:56:46,760 --> 03:56:50,640 I WANT TO THANK DR. CHEN FOR 5332 03:56:50,640 --> 03:56:51,600 PUTTING THIS TOGETHER. 5333 03:56:51,600 --> 03:56:54,480 IT'S TIMELY AND IMPORTANT. 5334 03:56:54,480 --> 03:56:57,480 * S. I WANT TO COMMENT THAT THIS 5335 03:56:57,480 --> 03:56:59,280 ALIGNS VERY WELL WITH THIS 5336 03:56:59,280 --> 03:57:02,000 CONCEPT -- OF SOME OF THE MAIN 5337 03:57:02,000 --> 03:57:03,680 TOPIC THAT'S WERE BROUGHT UP 5338 03:57:03,680 --> 03:57:06,440 LAST WEEK IN THE THINK TANK 5339 03:57:06,440 --> 03:57:10,880 DISCUSSION THAT WE HAD THAT WAS 5340 03:57:10,880 --> 03:57:13,920 JUST AS SPECTACULAR. 5341 03:57:13,920 --> 03:57:16,200 THEY WERE ABLE TO PUT TOGETHER A 5342 03:57:16,200 --> 03:57:17,800 GREAT GROUP OF PEOPLE TO HAVE 5343 03:57:17,800 --> 03:57:18,680 THAT CONVERSATION. 5344 03:57:18,680 --> 03:57:23,080 SO THIS BIOMARKER IS VERY, VERY 5345 03:57:23,080 --> 03:57:24,680 IMPORTANT. 5346 03:57:24,680 --> 03:57:26,560 OF COURSE, WHILE I'M THINKING 5347 03:57:26,560 --> 03:57:34,280 THAT SOME OF THE ASPECTS THAT 5348 03:57:34,280 --> 03:57:37,320 DR. GARCIA AND DR. SHI BROUGHT 5349 03:57:37,320 --> 03:57:42,200 UP -- FOCUSING MORE ON THE SCOPE 5350 03:57:42,200 --> 03:57:47,080 AND PERHAPS GUIDING THE -- 5351 03:57:47,080 --> 03:57:49,720 TOWARDS INNOVATIVE TECHNOLOGIES. 5352 03:57:49,720 --> 03:57:52,200 THIS IS VERY IMPORTANT CONCEPTS. 5353 03:57:52,200 --> 03:57:55,200 I WANT TO BRING UP ONE MORE 5354 03:57:55,200 --> 03:57:56,120 SUGGESTION HERE PERHAPS. 5355 03:57:56,120 --> 03:57:59,680 7 THE CONCEPT OF RESPONSE TO 5356 03:57:59,680 --> 03:58:01,320 TREATMENT. 5357 03:58:01,320 --> 03:58:09,680 IN USING BIOMARKERS TO HELP 5358 03:58:09,680 --> 03:58:13,320 GUIDE TREATMENT INTENSITY AND 5359 03:58:13,320 --> 03:58:16,600 THE PRINCIPLE OF TUMOR RELAPSE 5360 03:58:16,600 --> 03:58:18,520 MIMICS IN MANY WAYS BUT IT'S 5361 03:58:18,520 --> 03:58:22,600 ALSO DIFFERENT IN OTHER WAYS TO 5362 03:58:22,600 --> 03:58:24,600 THROUGH EARLY LESIONS AND 5363 03:58:24,600 --> 03:58:27,240 PRIMARY LESIONS SO PERHAPS THAT 5364 03:58:27,240 --> 03:58:31,400 IS ONE AREA THAT COULD ALSO BE 5365 03:58:31,400 --> 03:58:33,640 FOSTERED IS THROUGH THIS RFA IS 5366 03:58:33,640 --> 03:58:37,320 THE DISCOVERY OF BIOMARKERS FOR 5367 03:58:37,320 --> 03:58:41,120 TUMOR RELAPSE AND USE OF THIS 5368 03:58:41,120 --> 03:58:44,280 BIOMARKERS TO MODULATE TREATMENT 5369 03:58:44,280 --> 03:58:45,280 INTENSITY. 5370 03:58:45,280 --> 03:58:48,160 THIS HAS BECOME QUITE IMPORTANT 5371 03:58:48,160 --> 03:58:51,040 NOW ESPECIALLY WITH HPV POSITIVE 5372 03:58:51,040 --> 03:58:53,400 TUMORS THAT PERHAPS ONE CAN 5373 03:58:53,400 --> 03:58:55,640 DEESCALATE THE INTENSITY OF 5374 03:58:55,640 --> 03:58:57,720 TREATMENT IF ONE HAS GOOD-BYE OH 5375 03:58:57,720 --> 03:58:59,480 MARKERS TO DETECT RESPONSE. 5376 03:58:59,480 --> 03:59:01,800 THANK YOU FOR THE OPPORTUNITY TO 5377 03:59:01,800 --> 03:59:08,520 SAY A COUPLE OF WORDS HERE. 5378 03:59:08,520 --> 03:59:08,720 *. 5379 03:59:08,720 --> 03:59:14,000 ANY OTHER COMMENTS? 5380 03:59:14,000 --> 03:59:19,520 IF NOT -- WOULD A COUNCILMEMBER 5381 03:59:19,520 --> 03:59:23,560 LIKE TO MAKE A MOTION. 5382 03:59:23,560 --> 03:59:24,880 >> SO MOVED. 5383 03:59:24,880 --> 03:59:29,120 >> A SECOND? 5384 03:59:29,120 --> 03:59:30,680 >> SECOND. 5385 03:59:30,680 --> 03:59:32,480 ALL APPROVE? 5386 03:59:32,480 --> 03:59:34,360 >> AYE. 5387 03:59:34,360 --> 03:59:39,960 >> AND ANY OPPOSED? 5388 03:59:39,960 --> 03:59:40,680 OKAY. 5389 03:59:40,680 --> 03:59:42,080 AT THIS POINT WE HAVE REACHED 5390 03:59:42,080 --> 03:59:44,480 THE END OF THE OPEN SESSION. 5391 03:59:44,480 --> 03:59:47,040 I WANT TO REMIND EVERYONE THAT 5392 03:59:47,040 --> 03:59:48,600 YOU MAY SUBMIT COMMENTS OR 5393 03:59:48,600 --> 03:59:50,200 QUESTIONS ABOUT THE OPEN SESSION 5394 03:59:50,200 --> 03:59:56,040 TO THIS MAILBOX POSTED HERE AND 5395 03:59:56,040 --> 03:59:59,000 YOU MAY SUBMIT QUESTIONS OR 5396 03:59:59,000 --> 04:00:01,920 COMMENTS BY FEBRUARY 11, 2022. 5397 04:00:01,920 --> 04:00:05,320 AND I WILL NOW TURN THE MEETING 5398 04:00:05,320 --> 04:00:24,800 BACK TO DR. RENA DE REMEMBER -- DR. DEE SO UZA. 5399 04:00:24,800 --> 04:00:25,280 *. 5400 04:00:27,040 --> 04:00:30,480 THEY TIED IN THE THEME OF US 5401 04:00:30,480 --> 04:00:31,920 LEVERAGING SCIENCE AND 5402 04:00:31,920 --> 04:00:34,560 TECHNOLOGIES SO MUCH MORE FULLY 5403 04:00:34,560 --> 04:00:39,640 SUCH THAT WE CAN ACTUALLY CREATE 5404 04:00:39,640 --> 04:00:43,920 REDUCTIONS IN DISPARITIES THAT 5405 04:00:43,920 --> 04:00:45,520 EXIST THROUGHOUT OUR SYSTEM AT 5406 04:00:45,520 --> 04:00:46,480 MANY LEVELS. 5407 04:00:46,480 --> 04:00:47,080 RIGHT. 5408 04:00:47,080 --> 04:00:48,720 SO THERE IS THAT AND THE REASON 5409 04:00:48,720 --> 04:00:54,600 IT BECOMES CENTRAL TO ME IS THAT 5410 04:00:54,600 --> 04:00:57,080 NIDCR IS FUNDED BY TAXPAYERS. 5411 04:00:57,080 --> 04:00:59,520 WE WERE FOUNDED ON THE BASES OF 5412 04:00:59,520 --> 04:01:03,120 PUBLIC HEALTH WHEN FLUORIDE 5413 04:01:03,120 --> 04:01:06,680 BECAME A WONDERFUL INTERVENTION 5414 04:01:06,680 --> 04:01:08,040 AND COMMUNITY FLUORIDATION IT 5415 04:01:08,040 --> 04:01:11,000 WAS AT THE TIME WHEN THE COUNTRY 5416 04:01:11,000 --> 04:01:14,400 HAD EXPERIENCED MEN OVER 45 5417 04:01:14,400 --> 04:01:16,480 LOSING PRACTICALLY ALL OF THEIR 5418 04:01:16,480 --> 04:01:18,560 TEETH AND VETERANS AND THOSE 5419 04:01:18,560 --> 04:01:23,120 SIGNING IN TO BE ENLIST EDUCATED 5420 04:01:23,120 --> 04:01:27,120 SUCH BAD 10 TALL -- THAT HEADED 5421 04:01:27,120 --> 04:01:36,320 PRESIDENT HARRY TRUMAN T -- -- 5422 04:01:36,320 --> 04:01:37,920 MAKING ORAL HEALTH POSSIBLE FOR 5423 04:01:37,920 --> 04:01:39,720 ALL AND WE HAVE MULTIPLE LAYERS. 5424 04:01:39,720 --> 04:01:42,000 ITSELF THINK OF COMPLEXITY BUT 5425 04:01:42,000 --> 04:01:44,440 WE'LL ALSO HAVE A TIGHT-KNIT 5426 04:01:44,440 --> 04:01:46,240 COMMUNITY THAT WE WILL RELY ON. 5427 04:01:46,240 --> 04:01:48,800 OUR STAKE HOLDERS WHO ARE WELL 5428 04:01:48,800 --> 04:01:52,520 KNIT IN WITHIN NIDCR AND STAND 5429 04:01:52,520 --> 04:01:54,960 BY TO SUPPORT US SO WE CAN FORGE 5430 04:01:54,960 --> 04:01:55,760 AHEAD. 5431 04:01:55,760 --> 04:01:58,200 BUT YOU ALSO HEARD THREE 5432 04:01:58,200 --> 04:02:00,240 CONCEPTS THAT SO ALIGN WITH OUR 5433 04:02:00,240 --> 04:02:01,400 STRATEGIC PLAN. 5434 04:02:01,400 --> 04:02:03,160 AND I WILL BE CONSTANTLY I THINK 5435 04:02:03,160 --> 04:02:05,360 ALL OF US ARE GOING TO BE 5436 04:02:05,360 --> 04:02:06,800 CROSS-CHECKING WHAT WE DO WITH 5437 04:02:06,800 --> 04:02:08,920 WHAT WE HAD PROPOSED TO DO OVER 5438 04:02:08,920 --> 04:02:10,760 THE NEXT FIVE YEARS. 5439 04:02:10,760 --> 04:02:13,440 WE MAY NOT ACCOMPLISH EVERYTHING 5440 04:02:13,440 --> 04:02:14,720 BUT IT IS WORTH THE EFFORT RIGHT 5441 04:02:14,720 --> 04:02:16,320 NOW BECAUSE THE TIME IS RIGHT 5442 04:02:16,320 --> 04:02:18,960 AND THE STARS ARE IN FACT 5443 04:02:18,960 --> 04:02:19,680 ALIGNED. 5444 04:02:19,680 --> 04:02:22,000 AND YOU WILL NOTICE THAT IT'S A 5445 04:02:22,000 --> 04:02:23,920 DISEASE AGNOSTIC AND IT'S NOT 5446 04:02:23,920 --> 04:02:25,520 JUST BECAUSE I AM. 5447 04:02:25,520 --> 04:02:30,080 BUT IT'S BECAUSE OF THE CAUSE -- 5448 04:02:30,080 --> 04:02:33,640 CALLS FOR ACTION. 5449 04:02:33,640 --> 04:02:37,400 SO WE HAVE THE STATISTICS OF 5450 04:02:37,400 --> 04:02:40,280 HAVING CARRIES AS THE MOST 5451 04:02:40,280 --> 04:02:44,880 COMMON CHILDHOOD DISEASE. 5452 04:02:44,880 --> 04:02:47,120 PERIODONTAL DECEASE. 5453 04:02:47,120 --> 04:02:51,520 AND HPV RISING TO THE TOP. 5454 04:02:51,520 --> 04:02:52,920 * ALL OF THAT COMES ATTENTION TO 5455 04:02:52,920 --> 04:02:58,520 TO INDICATE THAT THE 5456 04:02:58,520 --> 04:03:00,320 RESPONSIBILITY IS ON US. 5457 04:03:00,320 --> 04:03:03,040 AND FOR THAT REASON I APPEAL TO 5458 04:03:03,040 --> 04:03:04,560 COUNCIL AND TO ALL WHO ARE 5459 04:03:04,560 --> 04:03:09,520 LISTENING TO ENGAGE WITH NIDCR 5460 04:03:09,520 --> 04:03:13,320 FURTHER AND WE HAVE AS 5461 04:03:13,320 --> 04:03:15,600 >> Jacqueline: MENTIONED THAT * 5462 04:03:15,600 --> 04:03:17,000 THINK TANK SECTION WAS USEFUL 5463 04:03:17,000 --> 04:03:19,440 AND THERE ARE SO MANY TOPICS 5464 04:03:19,440 --> 04:03:23,520 THAT WE CAN EXPLORE AND SO, THAT 5465 04:03:23,520 --> 04:03:25,640 IS GOING TO HAPPEN ALONG WITH 5466 04:03:25,640 --> 04:03:26,680 WORKING GROUPS OF COUNCIL. 5467 04:03:26,680 --> 04:03:28,920 SO I WANT TO THANK YOU ALL FOR 5468 04:03:28,920 --> 04:03:32,720 LISTENING IN PATIENTLY AND FOR 5469 04:03:32,720 --> 04:03:34,000 YOU MORE THAN EVER STAYING 5470 04:03:34,000 --> 04:03:36,040 CONNECTED WITH US IN THESE TIMES 5471 04:03:36,040 --> 04:03:39,320 IN THESE VIRTUAL TIMES WHEN 5472 04:03:39,320 --> 04:03:40,680 HUMAN CONNECTIONS AND SCIENCE 5473 04:03:40,680 --> 04:03:42,800 HAVE NEVER BEEN MORE IMPORTANT 5474 04:03:42,800 --> 04:03:43,240 THANK YOU VERY MUCH. 5475 04:03:43,240 --> 04:03:44,920 AND WITH THAT I THINK WE CAN 5476 04:03:44,920 --> 04:03:47,240 TAKE A BREAK BEFORE WE GET INTO 5477 04:03:47,240 --> 04:03:49,120 CLOSED SESSION. 5478 04:03:49,120 --> 04:03:51,120 >> I HAVE ONE FINAL ANNOUNCEMENT 5479 04:03:51,120 --> 04:03:52,440 FOR EVERYONE. 5480 04:03:52,440 --> 04:03:53,880 THAT OUR NEXT COUNCIL MEETING 5481 04:03:53,880 --> 04:03:56,120 WILL BE MAY 18th AND I HOPE 5482 04:03:56,120 --> 04:03:57,280 YOU WILL JOIN US. 5483 04:03:57,280 --> 04:03:58,840 IT WILL BE ANOTHER VIRTUAL 5484 04:03:58,840 --> 04:03:59,360 SESSION. 5485 04:03:59,360 --> 04:04:04,040 AND YES WE WILL TAKE A BREAK. 5486 04:04:04,040 --> 04:04:08,280 AND WE CAN -- IF WE CAN RETURN 5487 04:04:08,280 --> 04:04:12,720 AT 2:30. 5488 04:04:12,720 --> 04:04:14,640 FOR THE CLOSED SESSION OF 5489 04:04:14,640 --> 00:00:00,000 COUNCIL.